0001144204-13-008209.txt : 20130213 0001144204-13-008209.hdr.sgml : 20130213 20130213161127 ACCESSION NUMBER: 0001144204-13-008209 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20121231 FILED AS OF DATE: 20130213 DATE AS OF CHANGE: 20130213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DYNASIL CORP OF AMERICA CENTRAL INDEX KEY: 0000030831 STANDARD INDUSTRIAL CLASSIFICATION: GLASS, GLASSWARE, PRESSED OR BLOWN [3220] IRS NUMBER: 221734088 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-35011 FILM NUMBER: 13603254 BUSINESS ADDRESS: STREET 1: 385 COOPER RD CITY: WEST BERLIN STATE: NJ ZIP: 08091 BUSINESS PHONE: 8567674600 MAIL ADDRESS: STREET 1: 385 COOPER RD CITY: WEST BERLIN STATE: NJ ZIP: 08091 10-Q 1 v332547_10q.htm FORM 10-Q

 

U. S. SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 10-Q

(Mark One)

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE

— ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2012

 

¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE

— ACT OF 1934 FOR THE TRANSITION PERIOD FROM _______ TO ______.

 

Commission file number: 000-27503

 

DYNASIL CORPORATION OF AMERICA

(Exact name of registrant as specified in its charter)

 

  Delaware 22-1734088  
  (State or other jurisdiction of (I.R.S. Employer  
  incorporation or organization) Identification No.)  

 

  44 Hunt Street, Watertown, MA 02472  
  (Address of principal executive offices) (Zip Code)  

 

Registrant’s telephone number, including area code: (617) 668-6855

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days Yes S No¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

Large accelerated filer ¨ Accelerated filer ¨
Non-accelerated filer ¨ Smaller reporting company x

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ¨ No x

 

As of February 7, 2013 there were 14,960,200 shares of common stock, par value $.0005 per share, outstanding.

 

 
 

 

DYNASIL CORPORATION OF AMERICA AND SUBSIDIARIES

 

INDEX

 

    Page
PART 1. FINANCIAL INFORMATION    
Item 1. Financial Statements    
     
DYNASIL CORPORATION OF AMERICA AND SUBSIDIARIES    
     
CONSOLIDATED BALANCE SHEETS AS OF DECEMBER 31, 2012 AND SEPTEMBER 30, 2012   3
     
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) FOR THE THREE MONTHS ENDED DECEMBER 31, 2012 AND 2011   5
     
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY FOR THE THREE MONTHS ENDED DECEMBER 31, 2012   6
     
CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE THREE MONTHS ENDED DECEMBER 31, 2012 AND 2011   7
     
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS   8
     
Item 1A. Risk Factors   16
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   16
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk   22
     
Item 4. Controls and Procedures   23
     
PART II. OTHER INFORMATION   23
     
Item 6. Exhibits   23
     
Signatures   24

 

2
 

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS.

 

DYNASIL CORPORATION OF AMERICA AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

 

   December 31,   September 30, 
   2012   2012 
   (unaudited)     
         
ASSETS 
Current assets          
Cash and cash equivalents  $2,471,900   $3,414,880 
Accounts receivable, net of allowance for doubtful accounts of $149,280 and $146,210 and sales returns allowance of $44,004 and $51,860 for December 31, 2012 and September 30, 2012, respectively.   4,849,552    5,475,142 
Costs in excess of billings and unbilled receivables   1,941,547    1,735,798 
Inventories, net of reserves   3,550,710    3,271,700 
Deferred tax asset   126,187    126,187 
Prepaid expenses and other current assets   1,401,925    1,334,649 
Total current assets   14,341,821    15,358,356 
           
Property, Plant and Equipment, net   5,093,097    4,984,150 
           
Other Assets          
Intangibles, net   6,527,608    6,703,305 
Goodwill   10,264,499    10,254,160 
Deferred financing costs, net   152,650    165,457 
Total other assets   16,944,757    17,122,922 
           
Total Assets  $36,379,675   $37,465,428 
           
LIABILITIES AND STOCKHOLDERS' EQUITY 
Current Liabilities          
Current portion of long-term debt  $11,511,905   $11,984,492 
Accounts payable   2,807,421    2,416,397 
Deferred revenue   826,880    694,672 
Accrued expenses and other liabilities   1,951,680    2,809,580 
Total current liabilities   17,097,886    17,905,141 
           
Long-term Liabilities          
Pension liability   342,848    345,443 
Deferred tax liability   365,328    371,256 
Total long-term liabilities   708,176    716,699 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

3
 

 

DYNASIL CORPORATION OF AMERICA AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(UNAUDITED) (Continued)

 

   December 31,   September 30, 
   2012   2012 
   (unaudited)     
         
LIABILITIES AND STOCKHOLDERS' EQUITY (Continued) 
           
Stockholders' Equity          
Common Stock, $0.0005 par value, 40,000,000 shares authorized, 15,620,314 and 15,610,517 shares issued, 14,810,154 and and 14,800,357 shares outstanding at December 31, 2012 and September 30, 2012, respectively.   7,810    7,805 
Additional paid in capital   17,117,241    17,037,618 
Accumulated other comprehensive income   91,645    61,906 
Retained earnings   2,343,259    2,722,601 
    19,559,955    19,829,930 
Less 810,160 shares of treasury stock - at cost   (986,342)   (986,342)
Total stockholders' equity   18,573,613    18,843,588 
           
Total Liabilities and Stockholders' Equity  $36,379,675   $37,465,428 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

4
 

 

DYNASIL CORPORATION OF AMERICA AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(UNAUDITED)

 

   Three Months Ended 
   December 31, 
   2012   2011 
Net revenue  $10,553,275   $12,132,295 
Cost of revenue   5,926,409    7,005,347 
Gross profit   4,626,866    5,126,948 
Operating expenses:          
Sales and marketing expenses:   479,878    392,801 
Research and development expenses   637,129    519,395 
General and administrative expenses   3,701,146    4,028,424 
Total operating expenses   4,818,153    4,940,620 
Income (loss) from operations   (191,287)   186,328 
Interest expense, net   186,757    124,157 
Income (loss) before income tax (benefit) provision   (378,044)   62,171 
Income tax (benefit) provision   1,298    (308,167)
Net income (loss)  $(379,342)  $370,338 
           
Net income (loss)  $(379,342)  $370,338 
Other comprehensive income (loss):          
Foreign currency translation   29,739    (60,360)
Total comprehensive income (loss)  $(349,603)  $309,978 
           
Basic net income per common share  $(0.03)  $0.02 
Diluted net income per common share  $(0.03)  $0.02 
           
Weighted average shares outstanding          
Basic   14,673,356    15,583,103 
Diluted   14,673,356    15,683,834 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

5
 

 

DYNASIL CORPORATION OF AMERICA AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(UNAUDITED)

 

           Additional   Other               Total 
   Common   Common   Paid-in   Comprehensive   Retained   Treasury Stock   Stockholders' 
   Shares   Amount   Capital   Income   Earnings   Shares   Amount   Equity 
Balance, September 30, 2012   15,610,517   $7,805   $17,037,618   $61,906   $2,722,601    810,160   ($986,342)  $18,843,588 
Issuance of shares of common stock under employee stock purchase plan   5,797    3    6,107    -0-    -0-    -0-    -0-    6,110 
                                         
Stock-based compensation costs   4,000    2    73,516    -0-    -0-    -0-    -0-    73,518 
                                         
Foreign currency translation adjustment   -0-    -0-    -0-    29,739    -0-    -0-    -0-    29,739 
                                         
Net loss   -0-    -0-    -0-    -0-    (379,342)   -0-    -0-    (379,342)
Balance, December 31, 2012   15,620,314    7,810    17,117,241    91,645    2,343,259    810,160    (986,342)   18,573,613 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

6
 

 

DYNASIL CORPORATION OF AMERICA AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

   Three Months Ended 
   December 31, 
   2012   2011 
Cash flows from operating activities:          
Net income (loss)  $(379,342)  $370,338 
Adjustments to reconcile net income (loss) to net cash provided by operating activities:          
Stock compensation expense   73,516    199,212 
Foreign exchange loss   26,398    (48,277)
Gain on sale of property, plant and equipment   (87,803)   -0- 
Depreciation and amortization   426,458    380,120 
Noncash interest expense   12,807    9,978 
Provision for doubtful accounts and sales returns   3,160    60,970 
Inventory reserves   11,208    -0- 
Deferred income taxes   1,532    (122,727)
Other changes in assets and libilities:          
Accounts receivable, net   607,217    (1,647,098)
Inventories   (322,298)   272,350 
Costs in excess of billings / unbilled receivables   (205,749)   184,105 
Prepaid expenses and other assets   (76,842)   (124,256)
Accounts payable   399,184    (484,930)
Accrued expenses and other liabilities   (852,463)   (92,853)
Deferred Revenue   140,355    262,942 
Net cash used in operating activities   (222,662)   (780,126)
           
Cash flows from investing activities:          
Proceeds from sale of property, plant, and equipment   80,252    -0- 
Purchases of property, plant and equipment   (315,568)   (405,341)
Net cash used in investing activities   (235,316)   (405,341)
           
Cash flows from financing activities          
Proceeds from issuance of common stock   6,110    15,133 
Repayment of long-term debt   (472,587)   (475,159)
Net cash used in financing activities   (466,477)   (460,026)
           
Effect of exchange rates on cash and cash equivalents   (18,525)   (96,923)
           
Net decrease in cash and cash equivalents   (942,980)   (1,742,416)
           
Cash and cash equivalents, beginning   3,414,880    4,479,840 
Cash and cash equivalents, ending  $2,471,900   $2,737,424 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

7
 

 

DYNASIL CORPORATION OF AMERICA

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

Note 1 - Basis of Presentation and Ability to Continue as a Going Concern

 

The accompanying consolidated balance sheet as of December 31, 2012, the consolidated statements of operations and comprehensive income (loss) for the three months ended December 31, 2012 and 2011, changes in stockholders’ equity for the three months ended December 31, 2012 and cash flows for the three months ended December 31, 2012 and 2011 of Dynasil Corporation of America and subsidiaries (the “Company”), and the related information contained in these notes have been prepared by management and are unaudited. In the opinion of management, all adjustments (which include normal recurring and nonrecurring items) necessary to present fairly the financial position, results of operations and cash flows in conformity with generally accepted accounting principles for the periods presented have been made. Interim operating results are not necessarily indicative of operating results for a full year.

 

The preparation of our unaudited consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Certain information and note disclosures normally included in the Company's annual financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted. These consolidated financial statements should be read in conjunction with the financial statements and notes thereto included in the Company's September 30, 2012 Annual Report on Form 10-K previously filed by the Company with the Securities and Exchange Commission.

 

The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplates continuation of the Company as a going concern. However, the Company has failed to comply with the financial covenants set forth in the terms of its outstanding loan agreements and sustained a substantial loss from operations for the year ended September 30, 2012. The Company has continued to sustain losses from operations for the three months ended December 31, 2012. These factors raise substantial doubt over the Company’s ability to continue as a going concern.

 

The Company continues to be in default of the financial covenants set forth in the terms of its loan agreements for its fiscal first quarter ended December 31, 2012. These covenants require the Company to maintain specified ratios of earnings before interest, taxes, depreciation and amortization (EBITDA) to fixed charges and to total/senior debt. A default gives the lenders the right to accelerate the maturity of the outstanding indebtedness. Furthermore, Sovereign Bank, N.A, the Company’s senior lender, may, at its option, impose a default interest rate with respect to the senior debt outstanding, which is 5% higher than the rate otherwise in effect. To date, the lenders have not taken any such actions. However, the Company cannot predict when or whether a resolution of this situation will be achieved.

 

The Company is current with all principal and interest payments due on all its outstanding indebtedness through February 13, 2013, the date of this filing, and management is engaged in discussions with its senior lender to address the financial covenant situation. Because of the uncertainty of any resolution of the covenant violations and possibility of an acceleration of the indebtedness by the lenders, the Company reclassified all of its outstanding indebtedness as a current liability in the accompanying consolidated balance sheets.

 

The Company’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and positive cash flows and/or to obtain the necessary financing from shareholders or other sources to meet its outstanding obligations and repay its liabilities arising from normal business operations when they become due.

 

In view of the matters described in the preceding paragraphs, recoverability of a major portion of the recorded asset amounts shown in the accompanying consolidated balance sheet is dependent upon the continued operations of the Company. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence.

 

8
 

 

The Company has recently taken and will continue to take actions to improve its liquidity, including the implementation of a number of initiatives designed to conserve cash, optimize profitability and right-size the cost structure of its various businesses. The Company has retained Argus Management Corporation and Mirus Capital as financial advisors to assist it in evaluating strategic and restructuring alternatives, including the potential sale of product lines and/or a Company division. While the Company is actively considering such strategic alternatives, there can be no assurances that any such transaction will occur, or, if a transaction is completed, it will be on terms favorable to the Company. The Company does not currently have cash available to satisfy its obligations under its indebtedness if it were to be accelerated or payment demanded. If the Company is not able to resolve its current defaults under its outstanding indebtedness and improve its liquidity through the actions described above, it may not have sufficient liquidity to meet its anticipated cash needs for the next twelve months.

 

We consider events or transactions that have occurred after the unaudited consolidated balance sheet date of December 31, 2012, but prior to the filing of the unaudited consolidated financial statements with the SEC on this Form 10-Q, to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure, as applicable. Subsequent events have been evaluated through the date of the filing of this Quarterly Report on Form 10-Q with the SEC.

 

Note 2 –Debt Classification

 

The Company was in default of certain financial covenants set forth in the terms of its outstanding indebtedness as of December 31, 2012 and September 30, 2012. Based on the covenant violations and the resulting possibility of an acceleration of the indebtedness by the lenders, all of the outstanding indebtedness of the Company has been classified as current liabilities in the accompanying balance sheets.

 

Note 3 - Inventories

 

Inventories are stated at the lower of average cost or market. Cost is determined using the first-in, first-out (FIFO) method. Inventories consist of raw materials, work-in-process and finished goods. The Company evaluates inventory levels and expected usage on a periodic basis and records, as a charge to cost of revenue, any amounts required to reduce the carrying value to net realizable value.

 

Inventories, net of reserves, consists of the following:

 

   December 31,   September 30, 
   2012   2012 
Raw Materials  $2,334,613   $2,096,681 
Work-in-Process   689,134    885,328 
Finished Goods   526,963    289,691 
   $3,550,710   $3,271,700 

 

Note 4 – Costs in Excess of Billings and Unbilled Receivables

 

Costs in excess of billings and unbilled receivables relate to research and development contracts and consist of actual revenues earned under the contracts which have not yet been billed to customers.

 

9
 

 

Note 5 – Intangible Assets

 

Intangible assets at December 31, 2012 and September 30, 2012 consist of the following:

 

     Useful   Gross   Accumulated     
December 31, 2012    Life (years)   Amount   Amortization   Net 
Acquired Customer Base   5-15   $7,858,775   $2,387,612   $5,471,163 
Know How   15    512,000    172,115    339,885 
Trade Names   15 - Indefinite    558,435    66,872    491,563 
Biomedical Technologies   5    300,000    75,003    224,997 
        $9,229,210   $2,701,602   $6,527,608 

 

     Useful   Gross   Accumulated     
September 30, 2012    Life (years)   Amount   Amortization   Net 
Acquired Customer Base   5-15   $7,858,775   $2,257,533   $5,601,242 
Know How   15    512,000    145,147    366,853 
Trade Names   15 - Indefinite    558,435    63,222    495,213 
Biomedical Technologies   5    300,000    60,003    239,997 
        $9,229,210   $2,525,905   $6,703,305 

 

Amortization expense for the three months ended December 31, 2012 and 2011 was $181,268 and $162,803 respectively. Estimated amortization expense for each of the next five fiscal years is as follows:

 

   2013 (9 Months)   2014   2015   2016   2017   Thereafter   Total 
Acquired Customer Base  $406,961   $542,615   $542,615   $542,615   $542,615   $2,893,742   $5,471,163 
Know How   25,600    34,133    34,133    34,133    34,133    177,753    339,885 
Trade Names   10,950    14,600    14,600    14,600    14,600    81,992    151,342 
Biomedical Technologies   45,000    60,000    60,000    59,997    -0-    -0-    224,997 
   $488,511   $651,348   $651,348   $651,345   $591,348   $3,153,487   $6,187,387 

 

Note 6 – Goodwill

 

Goodwill is subject to an annual impairment test. We consider many factors which may indicate the requirement to perform additional, interim impairment tests. These include:

 

·A significant adverse long term outlook for any of our industries;
·An adverse finding or rejection from a regulatory body involved in new product regulatory approvals;
·Failure of an anticipated commercialization of a product or product line;
·Unanticipated competition or the introduction of a disruptive technology;
·The testing for recoverability under the Impairment or Disposal of Long-Lived Assets Subsections of Subtopic 360-10 of a significant asset group within a reporting unit;
·A loss of key personnel; and
·An expectation that a reporting unit carrying goodwill, or a significant portion of a reporting unit, will be sold or otherwise disposed of.

 

There were no changes, aside from foreign exchange rate fluctuations, in the carrying value of goodwill during the three months ended December 31, 2012.

 

10
 

 

Note 7 – Earnings (Loss) Per Common Share

 

Basic earnings (loss) per common share is computed by dividing the net income applicable or loss attributable to common shares by the weighted average number of common shares. Diluted earnings per common share adjusts basic earnings per share for the effects of common stock options, common stock warrants, convertible preferred stock and other potential dilutive common shares outstanding during the periods.

 

For purposes of computing diluted earnings per share, 100,731 common share equivalents related to stock options were assumed to be outstanding for the three months ended December 31, 2011. For the three months ended December 31, 2012, no common share equivalents related to stock options were included in the calculation of dilutive shares since there was a loss from continuing operations and the inclusion of common share equivalents would be anti-dilutive. Also, if the Company had not been in a loss position as of December 31, 2012, 116,834 shares of restricted stock would have been considered in the denominator used to calculate diluted earnings per common share. In addition, as of December 31, 2012 and 2011, common stock options for 774,483 and 815,624 shares, respectively, with exercise prices above current quarterly average market price per share have been excluded from the calculation of dilutive earnings per share since their effect is also anti-dilutive.

 

The computation of the weighted shares outstanding for the three months ended December 31 is as follows:

 

   December 31, 2012   December 31, 2011 
Weighted average shares outstanding          
Basic   14,673,356    15,583,103 
Effect of dilutive securities          
Stock Options   0    100,731 
Dilutive Average Shares Outstanding   14,673,356    15,683,834 

 

Note 8 - Stock Based Compensation

 

The fair value of the stock options granted is estimated at the date of grant using the Black-Scholes option pricing model.

 

A summary of stock option activity for the three months ended December 31, 2012 is presented below:

 

   Options
Outstanding
   Weighted Average
Exercise Price per
Share ($)
   Weighted Average
Remain Contractual
Term (in Years)
 
Balance at September 30, 2012   794,483    3.34    1.75 
Outstanding and exercisable at September 30, 2012   794,483    3.34    1.75 
Granted   0    0      
Exercised   0    0      
Cancelled   (20,000)   4.06      
Balance at December 31, 2012    774,483    3.32    1.54 
Outstanding and exercisable at December 31, 2012    774,483    3.32    1.54 

 

A summary of restricted stock activity for the three months ended December 31, 2012 and 2011 is presented below:

 

Restricted Stock Activity for the Three
Months ended December 31, 2012
  Shares   Weighted-Average
Grant-Date Fair Value
 
Nonvested at September 30, 2012   127,834   $1.92 
           
Granted    4,000   $1.45 
Vested    (15,000)  $1.53 
Cancelled    -0-    -0- 
Nonvested at December 31, 2012   116,834   $1.95 

 

11
 

 

Restricted Stock Activity for the Three

Months ended December 31, 2011

  Shares   Weighted-Average
Grant-Date Fair Value
 
Nonvested at September 30, 2011   403,000   $4.02 
           
Granted   -0-    -0- 
Vested   (37,500)  $4.00 
Cancelled   -0-    -0- 
Nonvested at December 31, 2011   365,500   $4.02 

 

Stock Compensation Expense for the three months ended December 31, 2012 and 2011 is as follows:

 

   Three Months Ended   Three Months Ended 
  December 31, 2012   December 31, 2011 
Stock Compensation Expense        
Stock Grants   52,461    60,281 
Restricted Stock Grants   12,618    109,302 
Option Grants   7,359    22,055 
Employee Stock Purchase Plan   1,078    2,692 
Total  $73,516   $194,330 

 

At December 31, 2012, there was approximately $144,000 in unrecognized stock compensation cost, which is expected to be recognized over a weighted average period of eight months.

 

Note 9 – Segment, Customer and Geographical Reporting

 

Segment Financial Information

 

Dynasil’s business is comprised of four segments: contract research (“Contract Research”), optics (“Optics”), instruments (“Instruments”) and biomedical (“Biomedical”). Within these segments, there is a segregation of reportable units based upon the organizational structure used to evaluate performance and make decisions on resource allocation, as well as availability and materiality of separate financial results consistent with that structure. The Contract Research segment is one of the largest small business participants in U.S. government-funded research. The Optics segment manufactures optical materials, components and coatings. The Instruments segment manufactures specialized instruments used in various applications in the medical, industrial, and homeland security/defense sectors. The Biomedical segment is developing technologies for a wide spectrum of applications, including hematology, hypothermic core cooling and tissue sealants and will primarily pursue product commercialization of technologies and technology licensing opportunities though no assurance can be given that any of these technologies will become successfully commercialized.

 

The Company’s segment information for the three months ended December 31, 2012 and 2011 is summarized below:

 

12
 

 

 

Results of Operations for the Three Months Ended December 31, 
2012 
   Contract
Research
   Optics   Instruments   Biomedical   Total 
Revenue   4,910,840    4,251,940    1,284,038    106,457    10,553,275 
Gross Profit   2,214,053    1,700,555    605,801    106,457    4,626,866 
Operating Income (Loss)   (606)   385,676    (455,694)   (120,663)   (191,287)
                          
Depreciation and Amortization   62,782    185,628    163,048    15,000    426,458 
Capital expenditures   186,330    122,146    7,092    -    315,568 
                          
Intangibles, Net   339,886    946,525    5,016,201    224,996    6,527,608 
Goodwill   4,938,625    1,310,802    4,015,072    -    10,264,499 
Total Assets   13,290,669    10,607,828    12,092,507    388,671    36,379,675 

 

Results of Operations for the Three Months Ended December 31, 
2011 
   Contract
Research
   Optics   Instruments   Biomedical   Total 
Revenue   6,225,283    3,912,551    1,983,536    10,925    12,132,295 
Gross Profit   2,440,288    1,462,418    1,251,423    (27,181)   5,126,948 
Operating Income (Loss)   145,217    164,123    79,544    (202,556)   186,328 
                          
Depreciation and Amortization   37,160    193,503    134,457    15,000    380,120 
Capital expenditures   262,020    140,876    2,445    -    405,341 
                          
Intangibles, Net   429,400    1,075,619    5,493,933    285,000    7,283,952 
Goodwill   4,938,625    1,283,775    6,299,571    -    12,521,971 
Total Assets   11,284,826    13,692,936    15,351,880    384,688    40,714,330 

 

Customer Financial Information

 

For the three months ended December 31, 2012 and 2011, the top three customers for the Contract Research segment were various agencies of the U.S. Government. For the three months ended December 31, 2012 and 2011, these customers made up 68% and 78%, respectively, of Contract Research revenue.

 

For the three months ended December 31, 2012 and 2011, there was no customer in the Optics segment whose revenue represented more than 10% of the total segment revenue for the three months ended December 31, 2012 and 2011.

 

For the three months ended December 31, 2012 and 2011, the top three customers for the Instruments segment made up 40% and 36%, respectively, of Instruments revenue.

 

For the three months ended December 31, 2012, the Biomedical segment had two customers whose revenue represented 100% of the total segment revenue. There was no revenue for the three months ended December 31, 2011.

 

Geographic Financial Information

 

Revenue by geographic location in total and as a percentage of total revenue, for the three months ended December 31, 2012 and 2011 are as follows:

 

13
 

 

   Three Months Ended   Three Months Ended 
   December 31, 2012   December 31, 2011 
Geographic Location  Revenue   % of Total   Revenue   % of Total 
United States   8,494,488    80.5%  $10,028,479    82.7%
Europe   888,341    8.4%   1,126,352    9.3%
Other   1,170,446    11.1%   977,464    8.1%
   $10,553,275    100.0%  $12,132,295    100.0%

 

Note 10 - Income Taxes

 

Dynasil Corporation of America and its wholly-owned U.S. subsidiaries file a consolidated federal income tax return and various state returns. The Company’s U.K. subsidiary files tax returns in the U.K.

 

The Company uses the asset and liability approach to account for income taxes. Under this approach, deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and net operating loss and tax credit carryforwards. The amount of deferred taxes on these temporary differences is determined using the tax rates that are expected to apply to the period when the asset is realized or the liability is settled, as applicable, based on tax rates, and tax laws, in the respective tax jurisdiction then in effect.

 

In assessing the ability to realize the net deferred tax assets, management considers various factors including taxable income in carryback years, future reversals of existing taxable temporary differences, tax planning strategies and projections of future taxable income, to determine whether it is more likely than not that some portion or all of the net deferred tax assets will not be realized. Based upon the Company’s recent losses and uncertainty of future profits, the Company has determined that the uncertainty regarding the realization of these assets is sufficient to warrant the need for a full valuation allowance against its U.S. net deferred tax assets. As a result, the Company has recorded a valuation allowance of approximately $1.7 million.

 

The Company applies the authoritative provisions related to accounting for uncertainty in income taxes. As required by these provisions, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more-likely-than-not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being reached upon ultimate settlement with the relevant tax authority. As of December 31, 2012 and September 30, 2012, the Company has no unrecorded liabilities for uncertain tax positions. Interest and penalty charges, if any, related to uncertain tax positions would be classified as income tax expense in the accompanying consolidated statement of operations. As of December 31, 2012 and September 30, 2012, the Company had no accrued interest or penalties related to uncertain tax positions. The Company currently has no federal or state tax examinations in progress.

 

The effective rate of (0.34%) for the three months ended December 31, 2012 differs from the U.S. federal statutory income tax rate of 34% primarily due to a full valuation allowance against the Company’s U.S. deferred tax asset. The effective rate of (96.85%) for the three months ended December 31, 2011 is primarily due to the recognition of research credits.

 

The Company files its tax returns as prescribed by the tax laws of the jurisdictions in which it operates. The Company’s tax filings for federal and state jurisdictions for the tax years beginning with 2009 are still subject to examination.

 

Note 11 – Fair Value Measurements

 

The Company uses a fair value hierarchy that prioritizes the inputs to valuation methods used to measure fair value. Assets and liabilities measured at fair value are to be categorized into one of the three hierarchy levels based on the inputs used in the valuation. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of fair value hierarchy are as follows:

 

14
 

 

Level 1: Observable inputs based on quoted prices (unadjusted) in active markets for identical assets or liabilities.

 

Level 2: Observable inputs based on quoted prices for similar assets and liabilities in active markets, or quoted prices for identical assets and liabilities in inactive markets.

 

Level 3: Unobservable inputs that reflect an entity’s own assumptions about what inputs a market participant would use in pricing the asset or liability based on the best information available in the circumstances.

 

A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

 

The carrying amounts reported in the consolidated balance sheets for cash and cash equivalents, accounts receivable and accounts payable approximate fair value because of the immediate or short-term maturity of these financial instruments. The carrying amounts for fixed rate long-term debt and variable rate long term debt approximate fair value because the underlying instruments are primarily at current market rates available to the Company for similar borrowings.

 

Note 11 – Subsequent Events

 

The Company has evaluated subsequent events through the date that the financial statements were released.

 

15
 

 

ITEM 1A.   RISK FACTORS

 

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended September 30, 2012, which could materially affect our business, financial condition or future results. The risks described in this report and in our Annual Report on Form 10-K are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or future results.

 

ITEM 2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following management's discussion and analysis should be read in conjunction with our financial statements and the notes thereto in the Dynasil Corporation of America ("Dynasil", the "Company" or "we") Form 10-K for the fiscal year ended September 30, 2012.

 

General Business Overview

 

On December 31, 2012, the Company announced it is in default of certain financial covenants set forth in the terms of its outstanding indebtedness with respect to its fiscal year ended September 30, 2012. Under the default condition, our lenders have the ability to require immediate payment of all indebtedness under our loan agreements. While the lenders have not exercised this right, their ability to require immediate payment has caused all of our outstanding indebtedness to be accelerated to current classification on our consolidated financial statements.

 

The Company continues to be current with all principal and interest payments due on all its outstanding indebtedness and management expects to continue discussions with its lenders to address the financial covenant situation. However, the Company cannot predict when or whether a resolution of this situation will be achieved.

 

Given the uncertainty created by the defaults under the Company’s outstanding indebtedness, the Company's independent registered public accounting firm has included a “going concern” qualification in its audit opinion for the year ended September 30, 2012.

 

Revenue for the first quarter of fiscal year 2013, which ended December 31, 2012, was $10.6 million, a decrease of 13.0% compared with revenue of $12.1 million for the quarter ended December 31, 2011. The decrease in revenue was primarily in the Contract Research and Instruments segments. Contract Research revenues declined $1.3 million or 21.1% primarily as a result of lower billable material and subcontractor costs. Contract revenue backlog continues to be strong at approximately $33.3 million. The Instruments segment revenues declined $699,000 or 35.3% primarily due to delays by customers of purchases of the existing products in anticipation of the availability of newly refreshed products which have not yet been approved by the necessary regulatory agencies.

 

Cost of Revenue for the first quarter of 2013 was $5.9 million, a decrease of 15.4% compared with $7.0 million for the quarter ended December 31, 2011. Total operating expenses decreased $122,000 or 2.5% to $4.8 million from the three month period ended December 31, 2011.

 

Loss from Operations for the quarter ended December 31, 2012 was ($191,000) compared with Income from Operations of $186,000 for the quarter ended December 31, 2011. Loss before Taxes for the quarter was ($378,000) compared with Income before Taxes of $62,000 for the quarter ended December 31, 2011.  Net Loss was ($379,000) or ($0.03) per share for the quarter ended December 31, 2012, compared with Net Income of $370,000, or $0.02 per share, for the quarter ended December 31, 2011.

 

We continue to invest in efforts to support growth initiatives for organic product development of specific product lines within Instruments, our dual mode detector commercialization effort within Contract Research and development of Biomedical technologies. These investments include technology development activities, capital equipment depreciation, development of intellectual property, and staff additions. The dual mode detector technology is producing revenue while still under development. We are currently delivering limited quantities of commercial grade crystals now and are working to further improve the size and quality of this product. Also, at the current time, the Company is actively exploring commercialization opportunities in thin film digital x-rays, sensors for nondestructive testing and radiation dosimeters based on technologies developed in the Contracts Research segment. Additionally, Dynasil has prepared a separate business and financing plan for one of the biomedical technologies. Our intention is to spin out the tissue sealant technology into an independent entity in which Dynasil will retain a substantial interest. This will accomplish both the elimination of some of the G&A support for these technologies as well as enable us to recruit additional expertise to help us advance the technology. While we expect to complete this financing plan in the next three months, we do not have definitive agreements, lender approval or commitments from investors and there can be no assurance that we can consummate this transaction in that timeframe or at any future time.

 

16
 

 

Commercialization of technology from our extensive research and development portfolio and strategic acquisitions are expected to be the key drivers of our future growth and we plan to continue to invest in these growth opportunities, depending upon the availability of capital to fund these endeavors.  

 

Results of Operations

 

Results of Operations for the Three Months Ended December 31, 
2012 
   Contract
Research
   Optics   Instruments   Biomedical   Total 
Revenue   4,910,840    4,251,940    1,284,038    106,457    10,553,275 
Gross Profit   2,214,053    1,700,555    605,801    106,457    4,626,866 
Operating Income (Loss)   (606)   385,676    (455,694)   (120,663)   (191,287)
                          
Depreciation and Amortization   62,782    185,628    163,048    15,000    426,458 
Capital expenditures   186,330    122,146    7,092    -    315,568 
                          
Intangibles, Net   339,886    946,525    5,016,201    224,996    6,527,608 
Goodwill   4,938,625    1,310,802    4,015,072    -    10,264,499 
Total Assets   13,290,669    10,607,828    12,092,507    388,671    36,379,675 

 

Results of Operations for the Three Months Ended December 31, 
2011 
   Contract
Research
   Optics   Instruments   Biomedical   Total 
Revenue   6,225,283    3,912,551    1,983,536    10,925    12,132,295 
Gross Profit   2,440,288    1,462,418    1,251,423    (27,181)   5,126,948 
Operating Income (Loss)   145,217    164,123    79,544    (202,556)   186,328 
                          
Depreciation and Amortization   37,160    193,503    134,457    15,000    380,120 
Capital expenditures   262,020    140,876    2,445    -    405,341 
                          
Intangibles, Net   429,400    1,075,619    5,493,933    285,000    7,283,952 
Goodwill   4,938,625    1,283,775    6,299,571    -    12,521,971 
Total Assets   11,284,826    13,692,936    15,351,880    384,688    40,714,330 

 

Revenue for the three months ended December 31, 2012 was $10,553,275, a 13.0% decrease from $12,132,295 for the three months ended December 31, 2011. Revenue from our Contract Research segment decreased $1,314,443 or 21.1% while revenue from our Instruments segment decreased $699,498 or 35.3%. The Contract Research segment revenue decline primarily reflects lower billable material and subcontractor costs during the three months ended December 31, 2012 compared to the three months ended December 31, 2011. The research backlog for the Contracts research segment has remained consistent at nearly 18 months. The Company expects the Contract Research revenue to continue to be below the prior year in the quarter ending March 31, 2012. We believe the Instruments segment revenue decline is a result of customers delaying purchases of our existing products in anticipation of the availability of newly refreshed products which have not yet been approved by the necessary regulatory agencies. We have taken steps to reduce costs while awaiting regulatory approvals which are expected imminently but the timing is as yet unknown. Further, there can be no assurance when or if regulatory approvals will be obtained. We believe that without and until we obtain regulatory approvals, product revenues in the Instruments segment will continue to deteriorate. The Optics segment revenue increased $339,389 or 8.7% for the three months ended December 31, 2012, primarily as a result of the timing and mix of product sales. The Biomedical segment revenues primarily relate to a technology development contract with the Mayo Clinic.

 

17
 

 

Gross Profit for the three months ended December 31, 2012 was $4,626,866, or 43.8% of sales, compared to $5,126,948 or 42.3% of sales for the three months ended December 31, 2011. Gross profit as a percent of sales increased for the Contract Research segment to 45.1% at December 31, 2012 from 39.2% at December 31, 2011 primarily as a result of timing of certain non-billable costs and the level of profitability of the contracts in process during the respective periods. Gross profit for the Instruments segment decreased to 47.2% of sales at December 31, 2012 from 63.1% of sales for the quarter ended December 31, 2011 as a result of lower product volumes and unfavorable manufacturing efficiencies. Gross profit for the Optics segment increased to 40.0% of sales at December 31, 2012 from 37.4% of sales for the quarter ended December 31, 2011 primarily as a result of better margins on the mix of products sold. The Biomedical segment gross profit equals its revenue because the cost of the funded research is included in research and development expense beginning in fiscal 2013.

 

Total operating expenses for the three months ended December 31, 2012 decreased slightly to $4,818,153, or 45.7% of sales compared to $4,940,620 or 40.7% of sales for the three months ended December 31, 2011. The decrease in total operating expenses includes an approximate $600,000 decrease in general and administrative expenses associated with the product refresh within the Instruments segment, partially offset by increased personnel costs in the other segments.

 

Loss from Operations for the three months ended December 31, 2012 was ($191,287) compared to Income from Operations of $186,328, a decrease of $377,615 from the prior year comparable period. The decrease was primarily associated with the lower sales in the Contracts Research and Instruments segments discussed above as well as higher costs measured as a percentage of sales in the Instruments segment. The increase in operating income in the Optics and Biomedical segments primarily reflect the increase in revenue and improved gross profit discussed above.

 

Net interest expense for the three months ended December 31, 2012 was $186,757, compared with $124,157 for the three months ended December 31, 2011. The increase in interest expense was primarily associated with the issuance of a $3 million subordinated note payable in July, 2012 at an interest rate of 10%. Interest-bearing debt outstanding at December 31, 2012 was $11,511,905, compared to $11,984,492 at September 30, 2012.

 

Income tax expense for the three months ended December 31, 2012 consisted primarily of state tax expense offset by the estimated NOL carryback to 2011 and certain U.K. tax research credits. The Company recorded a tax benefit of $308,000 for the three months ended December 31, 2011 primarily from the recognition of Research and Experimentation credits and certain state tax losses.

 

Net Loss for the three months ended December 31, 2012 was ($379,342), or ($0.03) in basic earnings per share, compared with Net Income of $370,338, or $0.02 in basic earnings per share, for the quarter ended December 31, 2011.

 

Liquidity and Capital Resources

 

Liquidity Overview

 

On December 31, 2012, the Company announced it is in default of the financial covenants set forth in the terms of its outstanding indebtedness at September 30, 2012. These covenants require the Company to maintain specified ratios of earnings before interest, taxes, depreciation and amortization (EBITDA) to fixed charges and to total/senior debt. The Company continues to be current with all principal and interest payments due on all its outstanding indebtedness and management expects to continue discussions with its lenders to address the financial covenant situation.

 

These financial covenant defaults give the lenders the right to accelerate the maturity of the indebtedness outstanding and foreclose on any security interest. Furthermore, Sovereign Bank, N.A, the Company's senior lender, may, at its option, impose a default interest rate with respect to the senior debt outstanding, which is 5% higher than the rate otherwise in effect. To date, the lenders have not taken any such actions.

 

18
 

 

As of December 31, 2012, the Company had total indebtedness outstanding of approximately $12 million, consisting of approximately $9.0 million of senior debt owed to Sovereign Bank and approximately $3.0 million of subordinated debt owed to Massachusetts Capital Resources Company. The Company's indebtedness is secured by substantially all the accounts and assets of the Company and is guaranteed by its subsidiaries.

 

The causes for the covenant violations are lower revenue and higher than expected expenses in the Company's Instruments and Contract Research segments during the fiscal quarter ended September 30, 2012 and continuing into the first quarter of fiscal 2013, combined with the continued investment in its Biomedical technologies and its Dual Mode nuclear detection initiative. In addition, the Company incurred a significant, non-recurring charge in the fourth quarter of 2012 of approximately $466,000 to its selling, general and administrative expenses related to costs incurred as a result of a review, under the direction of the Audit Committee of the Board, of certain cash application processes and billing practices of the RMD division. This investigation has been completed and has resulted in modifications in the division's practices and internal controls. The Company does not anticipate additional expenses for this matter.

 

Management expects to continue discussions with its lenders to address the financial covenant defaults as of September 30, 2012 as described above. These financial covenant defaults continued through the first quarter of fiscal 2013. The Company cannot predict when or whether a resolution of this situation will be achieved.

 

The Company has recently taken and will continue to take actions to improve its liquidity, including the implementation of a number of initiatives designed to conserve cash, optimize profitability and right-size the cost structure of its various businesses. The Company has retained Argus Management Corporation and Mirus Capital as financial advisors to assist it in evaluating strategic and restructuring alternatives, including the potential sale of product lines and/or a Company division. While the Company is actively considering such strategic alternatives, there can be no assurances that any such transaction will occur, or, if a transaction is completed, it will be on terms favorable to the Company.

 

Liquidity Outlook

 

Net cash as of December 31, 2012 was $2,472,900 or approximately $943,000 less than the net cash of $3,414,880 at September 30, 2012. The Company does not currently have cash available to satisfy its obligations under its indebtedness if it were to be accelerated or payment demanded. If the Company is not able to resolve its current defaults under its outstanding indebtedness and improve its liquidity through the actions described above, it may not have sufficient liquidity to meet its anticipated cash needs for the next twelve months.

 

Cash Provided by (Used in) Operating Activities

 

In total, including the changes accounts receivable and accounts payable and accrued expenses, operating activities used cash of $223,000 for the three months ended December 31, 2012.

 

Cash Used in Investing and Financing Activities

 

Cash used for the purchase of property, plant and equipment for the three months ended December 31, 2012 was approximately $316,000. Payments of long term debt for the three months ended December 31, 2012 were $473,000 primarily as part of regularly scheduled payments to Sovereign Bank, N.A., the Company’s senior lender, under the five year Term Debt and Acquisition Line of Credit. Net cash used in financing activities was approximately $466,000 for the three months ended December 31, 2012.

 

Critical Accounting Policies and Estimates

 

There have been no material changes in our critical accounting policies or critical accounting estimates since September 30, 2012. We have not adopted any accounting policies since September 30, 2012 that have or will have a material impact on our consolidated financial statements. For further discussion of our accounting policies see the “Summary of Significant Accounting Policies” in the Notes to Consolidated Financial Statements in our Annual Report on Form 10-K for the fiscal year ended September 30, 2012 as well as the notes in this Form 10-Q.

 

The accounting policies that reflect our more significant estimates, judgments and assumptions and which we believe are the most critical to aid in fully understanding and evaluating our reported financial results include the following:

 

19
 

 

Revenue Recognition

 

Revenue from sales of products is recognized at the time title and the risks and rewards of ownership pass. Revenue from research and development activities is derived generally from the following types of contracts: reimbursement of costs plus fees, fixed price or time and material type contracts. Revenue is recognized when the products are shipped per customers’ instructions, the contract has been executed, the contract or sales price is fixed or determinable, delivery of services or products has occurred and the Company’s ability to collect the contract price is considered reasonably assured.

 

Government funded services revenues from cost plus contracts are recognized as costs are incurred on the basis of direct costs plus allowable indirect costs and an allocable portion of the contracts’ fixed fees. Revenue from fixed-type contracts is recognized under the percentage of completion method with estimated costs and profits included in contract revenue as work is performed. Revenues from time and materials contracts are recognized as costs are incurred at amounts generally commensurate with billing amounts. Recognition of losses on projects is taken as soon as the loss is reasonably determinable.

 

The majority of the Company’s contract research revenue is derived from the United States government and government related contracts. Such contracts have certain risks which include dependence on future appropriations and administrative allotment of funds and changes in government policies. Costs incurred under United States government contracts are subject to audit. The Company believes that the results of such audits will not have a material adverse effect on its financial position or its results of operations.

 

Goodwill

 

Goodwill is subject to an annual impairment test. We consider many factors which may indicate the requirement to perform additional, interim impairment tests. These include:

 

·A significant adverse long term outlook for any of our industries;
·An adverse finding or rejection from a regulatory body involved in new product regulatory approvals;
·Failure of an anticipated commercialization product line;
·Unanticipated competition or a disruptive technology introduction;
·The testing for recoverability under the Impairment or Disposal of Long-Lived Assets Subsections of Subtopic 360-10 of a significant asset group within a reporting unit;
·A loss of key personnel; and
·An expectation that a reporting unit carrying goodwill, or a significant portion of a reporting unit, will be sold or otherwise disposed of.

 

Goodwill is tested by reviewing the carrying value compared to the fair value at the reporting unit level. Fair value for the reporting unit is derived using the income approach. Under the income approach, fair value is calculated based on the present value of estimated future cash flows. Assumptions by management are necessary to evaluate the impact of operating and economic changes and to estimate future cash flows. Management’s evaluation includes assumptions on future growth rates and cost of capital that are consistent with internal projections and operating plans.

 

The Company generally performs its annual impairment testing of goodwill during the fourth quarter of its fiscal year, or more frequently if events or changes in circumstances indicate that the assets might be impaired. The Company tests impairment at the reporting unit level using the two-step process. The Company’s primary reporting units tested for impairment are Radiation Monitoring Devices, which comprises our Contract Research segment, Dynasil Products (previously known as RMD Instruments), which is a component of our Instruments segment, and Hilger Crystals, also a component of our Optics segment.

 

The carrying value of goodwill in our Instruments segment exceeded the new residual fair value of goodwill in the fourth quarter of 2012, and, as a result, the Company recorded a pre-tax impairment loss of $2,284,499 in the quarter ended September 30, 2012.

 

20
 

 

Intangible Assets

 

The Company’s intangible assets consist of an acquired customer base of Optometrics, LLC, acquired customer relationships and trade names of RMD Instruments, LLC, and acquired backlog and know-how of Radiation Monitoring Devices, Inc. and purchased biomedical technologies within the Biomedical Segment. The Company amortizes its intangible assets with definitive lives over their useful lives, which range from 4 to 15 years, based on the time period the Company expects to receive the economic benefit from these assets. No impairment charge was recorded during the periods ended December 31, 2012 and 2011.

 

Impairment of Long-Lived Assets

 

The Company’s long-lived assets include property, plant and equipment and intangible assets subject to amortization. The Company evaluates long-lived assets for recoverability whenever events or changes in circumstances indicate that an asset may have been impaired. In evaluating an asset for recoverability, the Company estimates the future cash flow expected to result from the use of the asset and eventual disposition. If the expected future undiscounted cash flow is less than the carrying amount of the asset, an impairment loss, equal to the excess of the carrying amount over the fair value of the asset, is recognized.

 

Allowance for Doubtful Accounts Receivable

 

The Company performs ongoing credit evaluations of our customers and adjust credit limits based upon payment history and the customer's current credit worthiness, as determined by our review of their current credit information. We continuously monitor collections and payments from our customers and maintain a provision for estimated credit losses based upon our historical experience and any specific customer collection issues that we have identified. While such credit losses have historically been minimal, within our expectations and the provisions established, we cannot guarantee that we will continue to experience the same credit loss rates that we have in the past. A significant change in the liquidity or financial position of any of our significant customers could have a material adverse effect on the collectability of our accounts receivable and our future operating results.

 

Stock-Based Compensation

 

The Company accounts for stock-based compensation using fair value. Compensation costs are recognized for stock options granted to employees and directors. Options and warrants granted to employees and non-employees are recorded as an expense over the requisite service period based on the grant date estimated fair value of the grant, determined using the Black-Scholes option pricing model.

 

Income Taxes

 

As part of the process of preparing our consolidated financial statements, we are required to estimate our income tax provision (benefit) in each of the jurisdictions in which we operate. This process involves estimating our current income tax provision (benefit) together with assessing temporary differences resulting from differing treatment of items for tax and accounting purposes. These differences result in deferred tax assets and liabilities, which are included within our consolidated balance sheets. We regularly evaluate our ability to recover the reported amount of our deferred income taxes considering several factors, including our estimate of the likelihood of the Company generating sufficient taxable income in future years during the period over which temporary differences reverse.

 

RECENTLY ISSUED ACCOUNTING STANDARDS

 

In June 2011, the FASB issued Accounting Standards Update 2011-05 (“ASU 2011-05”), Comprehensive Income (Topic 220), Presentation of Comprehensive Income. ASU 2011-05 eliminates the current option to report other comprehensive income and its components in the statement of changes in stockholder’s equity. In addition, the new guidance requires consecutive presentation of the statement of net income and other comprehensive income with the presentation of reclassification adjustments from other comprehensive income to net income on the face of the financial statements. In December 2011, the FASB issued Accounting Standards Update 2011-12 (“ASU 2011-12”), Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of Items Out of Accumulated Other Comprehensive Income in Accounting Standards Update No. 2011-05, which is an update to ASU 2011-05. This amendment indefinitely defers the guidance relating to the presentation of reclassification adjustments. ASUs 2011-05 and 2011-12 are effective for fiscal years, and interim periods within those years, beginning after December 15, 2011, with early adoption permitted. The Company adopted ASU 2011-05 and ASU 2011-12 effective March 31, 2012 with the effect being a change in financial statement presentation.

 

21
 

 

In September 2011, the FASB issued Accounting Standards Update 2011-08 (“ASU 211-08”), Intangibles—Goodwill and Other (Topic 350), Testing Goodwill for Impairment, to simplify how entities test goodwill for impairment. ASU 2011-08 allows entities to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If a greater than 50 percent likelihood exists that the fair value is less than the carrying amount, then a two-step goodwill impairment test as described in Topic 350 must be performed. The qualitative assessment is optional, allowing companies to go directly to the quantitative assessment. The guidance provided by this update becomes effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. This new standard is effective for the Company beginning in fiscal 2013. The Company does not expect it to have a material impact on its consolidated financial statements.

 

In May 2011, the FASB issued ASU No. 2011-04, Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRS. The amendments result in a consistent definition of fair value and common requirements for measurement of and disclosure regarding fair value between U.S. GAAP and International Financial Reporting Standards. Specifically, the amendments clarify the application of existing fair value measurement and disclosure requirements, including: a) application of the highest and best use and valuation premise concepts, b) measurement of the fair value of an instrument classified in a reporting entity's shareholders equity, and c) quantitative disclosure about the unobservable inputs used in a fair value measurement that is categorized within Level 3 of the fair value hierarchy. The amendments also change a particular principle or requirement for fair value measurement and disclosure, including: a) measurement of the fair value of financial instruments that are managed within a portfolio, b) application of premiums and discounts in a fair value measurement, and c) additional disclosure about fair value measurements. This new standard has been adopted as of October 1, 2012 and did not have a material impact on its consolidated financial statements.

 

Forward-Looking Statements

 

The statements contained in this Quarterly Report on Form 10-Q which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements regarding future events and our future results are based on current expectations, estimates, forecasts, and projections and the beliefs and assumptions of our management, including, without limitation, our expectations regarding results of operations, our default under the financial covenants under our loan agreements with Sovereign Bank and Massachusetts Capital Resource Company, the commercialization of our products including our dual mode detectors, our development of new technologies including at Dynasil Biomedical, the adequacy of our current financing sources to fund our current operations, our growth initiatives, our capital expenditures and the strength of our intellectual property portfolio. These forward-looking statements may be identified by the use of words such as “may,” “could,” “expect,” “estimate,” “anticipate,” “continue” or similar terms, though not all forward-looking statements contain such words. The actual results of the future events described in such forward-looking statements could differ materially from those stated in such forward-looking statements due to a number of important factors. These factors that could cause actual results to differ from those anticipated or predicted include, without limitation, our ability to resolve our current default under our outstanding indebtedness, our ability to develop and commercialize our products, including obtaining regulatory approvals, the size and growth of the potential markets for our products and our ability to serve those markets, the rate and degree of market acceptance of any of our products, our ability to address our material weaknesses in our internal controls, general economic conditions, costs and availability of raw materials and management information systems, our ability to obtain and maintain intellectual property protection for our products, competition, the loss of key management and technical personnel, our ability to obtain timely payment of our invoices to governmental customers, litigation, the effect of governmental regulatory developments, the availability of financing sources, our ability to identify and execute on acquisition opportunities and integrate such acquisitions into our business, and seasonality, as well as the uncertainties set forth in the Company’s Annual Report on Form 10-K, including the risk factors contained in Item 1a, and from time to time in the Company's other filings with the Securities and Exchange Commission. The Company disclaims any intention or obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

 

ITEM 3   Quantitative and Qualitative Disclosures About Market Risk.

 

Dynasil, as a smaller reporting company, is not required to complete this item.

 

22
 

 

ITEM 4   Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures.

 

Our Interim Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2012. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

 

Based on the evaluation of our disclosure controls and procedures as of December 31, 2012, our Interim Chief Executive Officer and our Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were not effective.

 

As disclosed in our Annual Report on Form 10-K for the year ended September 30, 2012, which was filed with the SEC on January 15, 2013 (the “Form 10-K”), we identified material weaknesses in our internal control over financial reporting as of September 30, 2012. Internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) are an integral part of disclosure controls and procedures. These material weaknesses, which are described in detail in the Form 10-K, can be summarized as relating to: (i) inadequate and ineffective monitoring controls,(ii) inadequate and ineffective control over the periodic financial close process and (iii) inadequate and ineffective controls over cash accounts and accounts receivable function at our RMD division.

 

The measures that we have identified to address the material weaknesses are discussed in detail in our Form 10-K. We expect to continue to develop our remediation plans and implement additional measures to make necessary improvements to our internal control over financial reporting. We expect that our remediation efforts, including design, implementation and testing will continue throughout fiscal year 2013, although the material weakness will not be considered remediated until our controls are operational for a period of time, tested, and management concludes that these controls are operating effectively.

 

Changes in Internal Control Over Financial Reporting

 

There have been changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during our last fiscal quarter that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. We have begun to implement measures to address the material weaknesses identified in our annual report on internal control over financial reporting. Specifically, during the first fiscal quarter, within our RMD division, we have begun to implement new timekeeping practices and procedures that are more automated, including an electronic time-keeping system integrated with our payroll and human resource systems. Further, legacy bank accounts relating to the acquisition of RMD in 2008 have been closed and improvements in the controllership function of this division have been implemented, including new personnel, increased training and improved controls. We have also begun to implement an improved purchase order and receiving system to record vendor purchase orders to provide visibility into receipts in order to properly accrue for goods received.

 

PART II – OTHER INFORMATION

 

ITEM 6    Exhibits

 

(a) Exhibits and index of Exhibits

 

10.01 Omnibus Amendment to Leases, dated December 6, 2012, filed as Exhibit 10.1 to Form 8-K filed on December 12, 2012, and incorporated herein by reference.

 

23
 

 

10.02 Employment Letter of Thomas C. Leonard, dated January 4, 2013, filed as Exhibit 10.1 to Form 8-K filed on January 10, 2013, and incorporated herein by reference.

 

31.1(a) Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

31.1(b) Rule 13a-14(a)/15d-14(a) Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

32.1 Section 1350 Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002(furnished but not filed for purposes of the Securities Exchange Act of 1934)

 

99.1 Press release, dated February 13, 2013 issued by Dynasil Corporation of America announcing its financial results for the quarter ended December 31, 2012.

 

101** The following materials from Dynasil Corporation of America’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2012, formatted in XBRL (eXtensible Business Reporting Language); (i) Consolidated Balance Sheets as of December 31, 2012 and September 30, 2012, (ii) Consolidated Statements of Operations for the three months ended December 31, 2012 and 2011, (iii) Consolidated Statements of Changes in Stockholders’ Equity for the three months ended December 31, 2012; (iv) Consolidated Statements of Cash Flows for the three months ended December 31, 2012 and 2011, and (v) Notes to Consolidated Financial Statements.

 

** Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

DYNASIL CORPORATION OF AMERICA

 

BY: /s/ Peter Sulick   DATED: February 13, 2013
  Peter Sulick,    
  Interim Chief Executive Officer and Interim President

 

/s/ Thomas C. Leonard   DATED: February 13, 2013
 Thomas C. Leonard,  
 Chief Financial Officer  

 

24

 

EX-31.1 2 v332547_ex31-1a.htm EXHIBIT 31.1A

 

EXHIBIT 31.1 (a)

 

CERTIFICATION PURSUANT TO RULE 13a–14(a)/15d-14(a) and SECTION 302 OF THE SARBANES-OXLEY ACT

 

I, Peter Sulick, certify that:

 

1. I have reviewed this Form 10-Q of Dynasil Corporation of America;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15 d-15(f))for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: February 13, 2013 /s/ Peter Sulick  
  Peter Sulick
  Interim Chief Executive Officer and Interim President

 

 

EX-31.1 3 v332547_ex31-1b.htm EXHIBIT 31.1B

 

EXHIBIT 31.1 (b)

 

CERTIFICATION PURSUANT TO RULE 13a–14(a)/15d-14(a) and SECTION 302 OF THE SARBANES-OXLEY ACT

 

I, Thomas Leonard, certify that:

 

1. I have reviewed this Form 10-Q of Dynasil Corporation of America;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15 d-15(f))for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: February 13, 2013 /s/ Thomas C. Leonard  
  Thomas C. Leonard
  Chief Financial Officer

 

 

 

EX-32.1 4 v332547_ex32-1.htm EXHIBIT 32.1

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C.SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of DYNASIL CORPORATION OF AMERICA (the "Company") on Form 10Q for the period ended December 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Peter Sulick, Interim Chief Executive Officer and President of the Company and Thomas C. Leonard, Chief Financial Officer of the Company, each certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

  /s/ Peter Sulick  
  Peter Sulick
  Interim Chief Executive Officer and Interim President
   
  /s/ Thomas C. Leonard  
  Thomas C. Leonard
  Chief Financial Officer

February 13, 2013

 

 

EX-99.1 5 v332547_ex99-1.htm EXHIBIT 99.1

 

 

Contacts:

Patty Kehe
Corporate Secretary
Dynasil Corporation of America
Phone: (617) 668-6855
pkehe@dynasil.com

 

David Calusdian
Executive Vice President and Partner
Sharon Merrill
617.542.5300
DYSL@InvestorRelations.com

 
Dynasil Corporation of America Reports
First Quarter Fiscal 2013 Financial Results
Company to Host Earnings Conference Call at 5:00 p.m. (ET) Today 

 

 

Watertown, MA, February 13, 2013 – Dynasil Corporation of America (NASDAQ: DYSL), a leading developer of sensing, detection and analysis technology for homeland security, medical and industrial applications, today announced financial results for the fiscal 2013 first quarter ended December 31, 2012.

“Our first-quarter results underscore our focus on right-sizing the cost structure of our various businesses as we work to conserve cash, work through our debt issues and achieve profitability,” said Dynasil Chairman and Interim CEO Peter Sulick. “In the first quarter of fiscal 2013 we were able to reduce operating expenses to their lowest level in five quarters,” said Dynasil Chairman and Interim CEO Peter Sulick. “Total operating expenses decreased from the first quarter of 2012 and were down 5.5% on a sequential basis. General and administrative expenses, which represent a significant component of our total operating expenses, have declined by over $300,000 as compared to the first quarter of fiscal year 2012.

 

Net revenue for the first quarter of fiscal 2013 was $10.6 million, compared with $12.1 million for the first quarter of fiscal 2012. Contract Research revenues declined to $4.9 million from $6.2 million in the first quarter of fiscal 2012, primarily due to lower billable material and subcontractor costs in the 2013 period. The Company’s Contract Research backlog has remained consistent at nearly 18 months. Instruments segment revenues were $1.3 million in the first quarter of fiscal 2013 compared with $2.0 million for the 2012 comparable period. The Company attributes this result to customers delaying the purchase of two existing products, a lead paint analyzer and gamma medical probe, in anticipation of the availability of new versions of these products. Dynasil has completed development work on both refreshed products, which are awaiting required regulatory approvals. Offsetting these revenue decreases were increases in the Company’s Optics business of approximately $300,000.

 

 
 

 

Gross profit for the first quarter of 2013 totaled $4.6 million, or 43.8% of net revenue, compared with $5.1 million, or 42.3% of revenue for the first quarter of fiscal 2012.

 

Total operating expenses for the first quarter of fiscal 2013 declined to $4.8 million from $4.9 million for the same period of 2012.

 

Dynasil reported a net loss for the fiscal 2013 first quarter of $0.4 million, or $0.03 per share, compared with net income of $0.4 million, or $0.02 per diluted share, for the same period of 2012.

 

On December 31, 2012, the Company announced it is in default of certain financial covenants set forth in the terms of its outstanding indebtedness with respect to its fiscal year ended September 30, 2012. The Company continues to be current with all principal and interest payments due on all its outstanding indebtedness and management expects to continue discussions with its lenders to address the financial covenant situation. However, the Company cannot predict when or whether a resolution of this situation will be achieved.

 

Recent Highlights: Delivery of Pilot Production Order to Thermo Fisher Scientific

 

In January 2013, Dynasil announced that Thermo Fisher Scientific Inc. (NYSE: TMO) is integrating the Company’s proprietary gamma and neutron scintillator detection technology, known as CLYC, into the Thermo Fisher Scientific RadEye® GN+ Personal Radiation Detector. The device is being deployed to homeland security, defense and law enforcement agencies worldwide.

 

“We are excited about the prospects of our CLYC dual mode scintillator crystals for homeland security applications as well as other large market opportunities,” Sulick said. “In addition to being able to identify illicit nuclear materials and other threats, our CLYC crystals have broad applicability in industries such as well-logging, where they are used to determine the presence of rocks, minerals, oil, gas and other substances of value. Our Hilger Crystals business unit, which is commercializing this program with support from our RMD business, continues to significantly enhance the CLYC production processes. We have received expressions of interest in CLYC from several prospective customers, and are engaged in design activity on a number of fronts.”

 

 
 

 

Conference Call Information

 

Dynasil will host a conference call for investors and analysts at 5:00 p.m. ET today. The call will be hosted by Chairman and Interim CEO and President Peter Sulick and Chief Financial Officer Thomas Leonard. Those who wish to listen to the conference call should visit the Investor Information section of the Company’s website at www.dynasil.com. The call also may be accessed by dialing (877) 407-5790 or (201) 689-8328. For interested individuals unable to join the live conference call, a webcast replay will be available on the Company’s website for one year.

 

About Dynasil

 

Dynasil Corporation of America (NASDAQ: DYSL) develops and manufactures detection and analysis technology, precision instruments and optical components for the homeland security, medical and industrial markets.  Combining world-class technology with expertise in research and materials science, Dynasil is commercializing products including dual-mode radiation detection solutions for Homeland Security and commercial applications, probes for medical imaging and sensors for non-destructive testing.  The Company is building a relationship with the Mayo Clinic to develop early-stage opportunities such as advanced biomedical technologies. Dynasil has an impressive and growing portfolio of issued and pending U.S. patents. The Company is based in Watertown, Massachusetts, with additional operations in Mass., Minn., NY, NJ and the United Kingdom. More information about the Company is available at www.dynasil.com.

 

 
 

 

Forward-looking Statements

 

This news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements regarding future events and our future results are based on current expectations, estimates, forecasts, and projections and the beliefs and assumptions of our management, including, without limitation, our expectations regarding results of operations, the commercialization of our products including our dual mode detectors, the adequacy of our current financing sources to fund our current operations, our growth initiatives, our capital expenditures and the strength of our intellectual property portfolio. These forward-looking statements may be identified by the use of words such as “may,” “could,” “expect,” “estimate,” “anticipate,” “continue” or similar terms, though not all forward-looking statements contain such words. The actual results of the future events described in such forward-looking statements could differ materially from those stated in such forward-looking statements due to a number of important factors. These factors that could cause actual results to differ from those anticipated or predicted include, without limitation, our ability to resolve our current default under our outstanding indebtedness, our ability to develop and commercialize our products, including obtaining regulatory approvals, the size and growth of the potential markets for our products and our ability to serve those markets, the rate and degree of market acceptance of any of our products, our ability to address our material weaknesses in our internal controls, general economic conditions, costs and availability of raw materials and management information systems, our ability to obtain and maintain intellectual property protection for our products, competition, the loss of key management and technical personnel, our ability to obtain timely payment of our invoices to governmental customers, litigation, the effect of governmental regulatory developments, the availability of financing sources, our ability to identify and execute on acquisition opportunities and integrate such acquisitions into our business, and seasonality, as well as the uncertainties set forth in the Company’s Annual Report on Form 10-K, including the risk factors contained in Item 1a, and from time to time in the Company's other filings with the Securities and Exchange Commission. The Company disclaims any intention or obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

 

# # #

 

 
 

 

Dynasil Corporation of America and Subsidiaries

Consolidated Balance Sheets

 

 

   31-Dec   30-Sep 
   2012   2012 
   (Unaudited)     
ASSETS          
Current Assets          
Cash and cash equivalents  $2,471,900   $3,414,880 
Accounts receivable, net   4,849,552    5,475,142 
Cost in excess of billings and unbilled receivables   1,941,547    1,735,798 
Inventories, net of reserves   3,550,710    3,271,700 
Deferred tax asset   126,187    126,187 
Prepaid expenses and other current assets   1,401,925    1,334,649 
Total current assets   14,341,821    15,358,356 
           
Property, Plant and Equipment, net   5,093,097    4,984,150 
Other Assets          
Intangibles, net   6,527,608    6,703,305 
Goodwill   10,264,499    10,254,160 
Deferred financing costs, net   152,650    165,457 
Total other assets   16,944,757    17,122,922 
           
Total Assets  $36,379,675   $37,465,428 
           
LIABILITIES AND STOCKHOLDERS' EQUITY          
Current Liabilities          
Current portion of long-term debt  $11,511,905   $11,984,492 
Accounts payable   2,807,421    2,416,397 
Deferred revenue   826,880    694,672 
Accrued expenses and other liabilities   1,951,680    2,809,580 
Total current liabilities   17,097,886    17,905,141 
           
Long-term Liabilities          
Pension liability   342,848    345,443 
Deferred tax liability   365,328    371,256 
Total long-term liabilities   708,176    716,699 
           
Stockholders' Equity   18,573,613    18,843,588 
           
Total Liabilities and Stockholders' Equity  $36,379,675   $37,465,428 

 

 
 

 

Dynasil Corporation of America

Consolidated Statement of Operations

(Unaudited)

 

   Three Months Ended 
   December 31, 
   2012   2011 
Net revenue  $10,553,275   $12,132,295 
Cost of revenue   5,926,409    7,005,347 
Gross profit   4,626,866    5,126,948 
Operating expenses:          
Sales and marketing expenses   479,878    392,801 
Research and development expenses   637,129    519,395 
General and administrative expenses   3,701,146    4,028,424 
Total operating expenses   4,818,153    4,940,620 
Income (loss) from operations   (191,287)   186,328 
Interest expense, net   186,767    124,157 
Income (loss) before income tax (benefit) provision   (378,044)   62,171 
Income tax (benefit) provision   1,298    (308,167)
Net income (loss)  $(379,342)  $370,338 
           
Net Income (loss)  $(379,342)  $370,338 
Other comprehensive income (loss):          
Foreign currency translation   29,739    (60,360)
Total comprehensive income (loss)  $(349,603)  $309,978 
           
Basic net income per common share  $(0.03)  $0.02 
Diluted net income per common share  $(0.03)  $0.02 
           
Weighted average shares outstanding          
Basic   14,673,356    15,583,103 
Diluted   14,673,356    15,683,834 

 

 

 

GRAPHIC 6 tlogo.jpg GRAPHIC begin 644 tlogo.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`/0$*`P$1``(1`0,1`?_$`,\```(#``(#`0$````` M```````*!P@)`04#!`8+`@$``00"`P$```````````````8'"`D$!0$#"@(0 M```&`0,"`P0'!`<&!P````$"`P0%!@<`$0@2"2$Q$T$4%19182(R(Q<*<208 M>+'!0E(S.#F!D;0EMQE#-%2U)K9W$0`!`@0$!`(%!@<+"0D````!`@,`$00% M(1(&!S%!$PA1(F%Q,A0)@9&A0B,5\+%2LC,6%\'18G*"LW0EQ78WHL)#4T0F M-A@X\9+2@R0T5&0G_]H`#`,!``(1`Q$`/P!WK->/\\79:#5PQR%9X/)'MWZ< MRW>X>K.4T9]=PHV,R!*DC_)(,5>F,'=S)HD8]6YWX#E%_,K>X<)SM2''?P*=]6N0; M8Q0$/:#<=A\=A\M:QZBN+@FW6J0L&8FRVL?YOSSG"EH+QI1E1^\K&FH21+[. MM?8(],RA^?JD!S]$0W9&/?!J"1EZ_(=O?,J20FZ4#M\NXQFW)"AOU$9O&EAA M4U3[>!1D2%W'Q,`>.M&[0ZY:)71U]O<''*Y3.()_E(>4/\D#\4.5;+WVUUF5 MO4.F]5TCA2`7:2[T;^4\U!NHMC1EQ(3U3X%1XQ7&X]PSNU8/``S/VPG-JBVY M15(Y#8/O`&M/67;="WR<%MM]6T!C MT'W`X?2$K2!\DSZ(=*P;==E&K&Q3LZ_U1INYN$!(NUG:=9!/)3]"\I`3/Z[A M:',I'"/@*;^H^PN>6-7\F<>,D4J?9']&3B8^?BY";8&(/2L9W5K''5">8^GL M/V5DRC].DZK=ZHMSI8OUEK*99.,L?GS)2"?4KU3AZ+?\-ROUO;UW+9K<+2.J MFD\$L.>>1X9^@NJ4VH_DJ3Q]HB+RXU[VO;_R(LDU=Y+F\=.U1`OHY"JS^,23 M..WV5'T,>>8I^(^`F4*'M$0UOZ'=O1=8L(=>>IE'_7-*2`?`D9A\LY0R>M>P MWN;T2'''[#]X4[9,U4;J79"8&*%AMP$S]G(3XQH?CO/F%,N-4G>,1TRCI=6^\6FZ@&W5+#TQ]1:5'Y@9Q%V_Z0 MU7I1\TVI;;74+Z3(I?8<;,_Y20#X@@R(QB7-;*$[!H@@T00:((-$$&B"#1!! MH@@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@@ MT00:((-$$&B".-@\!V#W=;)4U%'J)V[2_$=WYT!T[;KIQG5NFDD)RU9 M+=6?!C(*%8RS6+GB"RKK**56R10 MHUR*W+ZIG=!OL5O!3YB)%`ZC0#-I5J387+1#<`TREZT??M+OA=8@IIE'!YHF M4^044R*#_&]46<:!WNV`[I;>NFLG2_6-#8ZULKT(9JDS$E%"25-U#2#Y>JTH MDX$I$\)TP5WU.>?&A5A&R^0'64Z>Q]),86_MPM216B1B@"15Y!PC/(D*4/`& ML@VV]@>S6WM6M-46I">C4JJ6A_HW@")>`4/-],1_W3[)]L+VIY^STJ[?<)J/ MV"^GYSQG@I"O44@>DPQ]PS_4:\4L^HQT'FE@ZPO:%/10?S[0[BPT)NY4'H,X METBHA;*@R$PANJNV>L$"[F5>E*&^G8L&XM!E&,U!S#! M8<4S4(4V\DR4E0(4DCB%).((Y@QWNN8ZX-$'#&*3NA9,(-JXIQYI\\^W M^YLXJ,DIF0ZH;'$EM,OQQ MH+;\-IV]5/N&G-T-O[A=%#RLLU:5+4>0"4.*<,S@,J%&?$1,&&.^_P`#\K2, M?#6.;O6%I&04(@DZR=644JN5RHH":::ULJDG9XE@B(B&Z[TS1`G]HP>.MC:M MT])W1:6E+>IG5&4GFR@3\,TR(06X?PVNZ705$[`Z<-MQIU`=:4E;2A-*DF84/$$1!.MH:ZV5CMN MN;+M/<&%E#C3B%MN-K3@I*T+2E:%`X24D'T1WFON,:#1!!H@@T00:((-$$&B M"#1!!H@@T00:((-$$&B"*)/<(BU<%*0[I($_4`IRJ:V*;PS664WJTI-4STRM*0<(6MVGO&F-VAM!N4[^K]Z;N**.H=<:6^W3J=(#;JDMR4XRL*2H+1,Y%9I M'A%'>`/=HA^>^;I_%M7PM,8WBZSC*2R!(3=CMD?./WSE"QUR!9Q;"/BHMJ@V M0%.;456556,?J(4I2``B.DKI+<.EU=<5V^FIG&4ML9R5J23,+"2F0\)\8DGW M/=CM_P"UW0M!K#4%^HKJ]<;O[DVU3,.MA`%.\\IU:G9&:NFD)2D'`DD\HV-T MX409@T00:((-$$&B"#1!!H@B+,RX4Q5R#QU8<3YEHE>R'C^T-1:S%;L;(KEH M<>DQ47[%<@I/H>:CS&]1H^:*H/&BP%415(>->19)PTQ[=),"NIVG3P(+/SXRO[Q(B23F628HJ+Q4IZ:199HBH"A2 MND%?4C[K;2/ZMNFOMR3]T/K$Q,J*%_YJ3\T7=]IO<_\`M\M#NB-DR2-D0<.2R-MP18Y`[+'.9HU`2#+KUD?Q4<89 ME!FF8S258$*SD50*21;.2``IN!IW5%38W!G47;2OVDSF4>E/[W`RBN/>[9"A MN+BWFT*1<`#TWI`9#C)+O-:%'#,9J0/9\(_1+XD5RMU9::YVW7!!;JVE%*@?1S'B#Q!YB+)Z[HP8XZ2@. MX``#Y;[!OM^W1'$A.?,0@;P62`.Z_AY,!$`)RFO8AL.VX$D+T.P^'B`[;;:B M7I$J.XU,F9F*U_Y@'$R]4Q./3UW4(3_R*WY,AE_4^U&4OX=`?QD_/#]YTDUD MC(JID525()%$E"%.FH0Q>DQ#D,`E.4P#L("&PAJ64@I,E8B4>8="E((6V2%# M$$8$'Q!C%3N']GK#/):L63(6%*[7L3S:4D>&E;A6X]50 MP0\_69%(1DFZ`D0DFB9P.!E2H*D:/16L;AI&Z?=EP*C:BYD=:6?T*@U71G$U8\HEXI@,4#!Y#XAK,.!E"/20H9A(@^&,?,6 MZ\4V@183EYM=;ID(+A)H,U:YV+KL25VOO[NU-)2[IFS*X<"`@F03@8XAL`#K MK==;81U'E)0T.*E$`#D)DX8F-K9['>]0UHMNGJ*KK[DH$AJF:6^Z0!,D-MI4 ML@#$R&`Q.$1\VY(\>7C=^[:9VPVY:13=)W*NF^4*0LWBVB[E)D@ZD5DIPR;% MNN]7(B0Z@E(94Y2`(F,`#A&[6L9C[S394":CU422#+$XX"9`QA2O[8;F4CS% M-5Z$>Q4>0F#+_9I"FT/+N- M[O9XF!/:)2&I]SK]E=QE>3>-X\\Q)!#/WJ<>R]]=$3`RQB=1A\-P`1#[IKG; MJQ:FZ2H9=<2G,H(6E4DSE,D$CC&)?MO]>:6MR+MJ:R7:W6YVI]W0Y54CU,EQ M[)U.FWUD(SJR>8A,Y#C$$3G<@X)UNT.:9-[CKW;:>\VK0^IGK55,I=9=%`_D=;6D*0X@E`S(6DA2%#!0((BR^.?L_H`=9*4S]$)\F0SXC83D5(7*O(C$ M]*G43"5Q7Y*XQ+B?:F`1#9W"1B[Z5:".W_BHDUI:_4-AM3@:N-;2LK/);B4_ MC(AU-&;';S;AT7WEHC2M^N=NPDZQ1/K:5.H+794%(745%$^ MAE!69)"W"G*G,9)$R)D@<8S[[I/"[C'R^LM#D<@\I:3QTRQCR%?1J*UGGZ6H M65I$R^^(D2E*I8+-6I$J+>20549OD5BE`5%2'*H&W0E=>:4L.J`R;A7MT=6R ME0!SH$TD@J!"R)$2P/R1)GLS[E=XNW^W7>ETCHVX:LT+=:E*W`RS6CI533>0 MK;J*:F?2M)04I>:4!.23F3+S6^XA8BPOA+A%!47`5W)DS&[&G7U['9'3>-GJ M=YFG[N?5LUD069%"/*W=SY'!$4V_4@DBD0I#J`'J&4%FMMMM.F6Z&T.=6@0R MHI7,$+FDS5-/E,SX80Q.\.NM>[E=P59JS?N1_G4Q;U\6A( M3L=I9*1(?K1_9]3#ENI*Q0/!H@@T00:((-$$&B"#1!!H@BIO.;C]6.3W$W.> M&[0T262L="FGT`\,1+UH2Z5QJ>P4R?:*J$.9!>)L<:W4$2](G1]1,1Z3FUJ; M[0-7*SU-"Z/*XRH?+*:3ZP0,88E#J`!W'?8P;!]6HEL/HD`)/R$B<>FO4NGV^JX60KIYB4SXR42L?,%2]$I15&7AY"I6>&L$.=5H_B9 M=B_9JHB)5"K-G2:A>DQ1W#KVZ1#V@.MTR^$MDH'C^'R1&73;)0.>7(G`"*ZZ6.^0?&VI\GOE\#&,QA,JT6PUR@6*89H;^ MFR'*QAVW.3\DE`^$\)#T-4NF6?$`*4@GQ(`(,^`EQAR'3I1&"#1!""7!?\`U8\0_P`TM^_X^]ZB M7I#_`!(8_IU3^<['I[[J/^A:_?W.M7YU!#]@>0?L#4LQPCS!CA`(`/F`#^T- M],[.0K1%DTS-CNJY+D6Z!>E(UB,XEZ=.N^D"@`*29ZND MX5V^\LHU[C%P4YV4 M)I\N/M=8@@91_&&5,(J MKF$J&D!PIPRU#?E2L$`90M"3PQ4O$C&<*/8;<:@O>ZF MY_:9K-8KK59[H_4T+%0KJ=6T5X0^[1365%2:-ZH1TQ(@,OE.`:"0Y3P'Y/1W M+CBOBC,2:Z)[+)0*4#D1FCX!%9'K1$XRX,CDV#TR+R*7O:`>UJZ2-OXZDUIJ M\LW^QT]T:,RM("AS2L#S`^F>/RB*`^XK:*NV,WEOFVU6E?N='5J72+4)%VB? M)=RM4,:<`,TQ5E:Q\A)Y59QF+:?%/T$'`/+%8Y!! MR9\BBKU&!2N0L:[DBJ@4?25:D$!`=ATG]SJ]B@T75A[*IQ]'30")C,KGZ,H! M4#Q!`/IAX_A_Z,O6K^ZC3E5:2MNFLJW+C5/)!DW3T[9`2J7M)??6VP4?6#BI MB7'/KM$\-:[6.WGR'S#D*GQ,A(6[-E,1K-P!\1U.`FF=;3])9$XII6" MPB]DP$=A,0K-4/$A!!+;=:::H]&5E95-CK5Z'%`*`)Z000B?KEFD)C@9Q)?O MKW^O&J.[;36CM-UKC5%HJY4C6=M:IFXO5+2ZQ1*3E*FDANF.4D$)=1,I)GC? MVEN/%OY19HN."HB]V+&^*;ABY*0Y!RM(5;QMLL6/(*Q0KAC1XJ7416&+3M=I M=-2/%0(H4S-)0IR*%'H,VFW5IK-07>HMB'ELVYRG"JA2?;4VA4D-I/(JGD MME)P2[E,P`"&&1[^-4<`7UTVP-51((^FH0=M/#6[0Z0>I%LT:'6:I23)>8K\Q&!4E1DK'C@ M(JVT?\43N:L^I6;CK!^UWO3/5!?HUTC=,%M3\P9=INDXVXE/Z,J4XB8&=*AA M&.G9VS3E[C#SU1XH6"4>MJ?>[5>L7Y`H2CQ9:#B,C4YC.KQUH@FJAC(Q\D$I M73M%54B$][9N?Q0,8B0D;+;"Z7"PZJ5IJI4I;#C[K*T_5#C.;*X@3D,P3(RE M,2B=WQ!MNM`;P=M:.X.Q,M_K%0L45=35@2$NU%OK%M(-+4D)FO*E]MQ*E*46 MUH4$F3BIN`YRH]XR5C.S43'^0EL5SMK9'@EK\PC`EIRM0TB4S6;?UAJJZ:-$ MK.,:JHFP9;Q*B>:IC*`3Q.!GSB:]?\3CNE=N@N%/66 M&AMH7A2MVUDTP$@$H)<*GEA*0$I^U20!(EW9K%@6(D;'359X!*X*B0R+YHFJ4B1A43!IJ!;V@ M-QDV>VU"WJ!QYM*TS\N1T@$$`R+B"<`>$SB)RBRO61I.\SL0=W'W!LS5NU@F MSUE;2KR*"::HMBE$5%$XI/4%)6I9.:G4XL)#RIK4$-DL5=Z_/>1\`\(Y>0Q= M+259L>1+W5\7N[;#K*M96N5Z?:34E.N(J01,1:-DI-G!BP3<$$JJ171C)B50 M"F!X]S+Q<+-IA;UN*DONO(:S@R*`N?!3EWB64MV M7;A/W;-R%BGD[-BUA?U:>YJ<0W?&1A)E2+BSMK19"V%B`.SR:CA1KZBID`*5 M1(XF;O;S1.DM16;[QN*W*JZ+62XGJ&:,3(X',0>9\>43E[XN[;N=V%W&1H[0 M=!36/;MNAIU4=8JB14)JRXV%/)#[J54S?07]F&&T)6@)F3)0$:_XE[,/&G`/ M(G%/(K"EBR'6)3&\K,22]-GYQ*XUN<1F*U-5XR"+J5:DL$.X;A,>L54';@AA M3Z13^UN"_MFV&G[->F;U;'*EIUE2CTR4K0H*24RQ`4./B?W8@MK_`+_M[-V= MI;OM-N,Q9J^WW5NG`JV6#25#*J>I9J4G*RKH.A72R*S-I/F*@KE%'/U(%6@% M,9\8K:I#1AK(WR1\J$^>7ISRS\)XRX3B3WPB+I=F-;ZSLS%0ZBSJM%)4%D* M4$%Y%5TTNRG(+"7%)S`3*3(F0$:,]L4`#M6X%````##%VV`/(/\`G]T\OHTN M=%DG;^AG_P##/XE1#GNP)/>?JTG$_K4C\YJ,'_TZW^<#+'\NLK_U#HNFCV8_ MXAJ/Z$?YU,6@_%J_P/TM_>C^SZF'+-25B@:#1!!H@@T00:((-$$&B"#1!%`. MYARD@.*7$?*=R>/FY+C;(&1QUC&(.X!-W,WBW1SJ-9*-D2F]8[:NLE5I-T8` MZ2H-1`1`3%W2VLK\QI_3[]8Z0'U)+;0YJ6L2$O5.9/*7JB2G:1LQ=M\-]K+I M>D;<^Y*2I;KK@\`2ABCIG$*65\AUEY*=`GYG'4@B4S'YUDI#%.W!,`ZA3*`= M6P_:V#I`=OKZ=_/41&'LA2F9D#Q^6/+K+UZ9-E4@:U2ON$IZXS:Y0(QC8A@<'2Y%W!A],JK@J?20HCN.XCK M8&O4V>FE0RGCC$4-WZVCT_9EI"@J[U'V;30$UDJFGS)`F!PD<8;(["''.=M. M:^1'/J2AUXC'4W48[C1QX5=H@@>S52N3[6U;8(7FU& MRM5;HEZ0_P`2&/Z=4_G.QZ>^ZC_H6OW]SK5^=00_8'D'[`U+,<(\P8X1 MP8Y2;;^WR\OV^T0USS`YF`D#C^'C\T(J][[-L'E[G=;X^N/2RD1ABG5[$JKI MN?UDE;)%N9:QVIHW$HCZBD9,6(S%0"^3ALTK@N7(/:3Q_Q"O#1K'VU[@J&?LG+U`OK5+*[P5<@0KLXJ$`[= M6"MLB#=R)=C"AZQ-^DP[O@QI9-?M^UIBK"4U!HP!_`=RY@H'D0KF,1C%0%Q[ MDE:1[U[CW!:;4I=G&IGU+0%%0J;:5FG>;,B,Z7*8%;8.$PA4@H"6._86Y%36 M%N1.3N&V2B+0I,ANYI]"1,@H9)2`S-C@CB-M-=(DJXQ8E6'<1$BBRY1$!';79N*^O5.M+ M?HVF4E3+2@IT`G`JQ5FXB0;G\\HTW8W:Z'MM[3-6=U>HT)3=[BRX:!+@RE;5 M(LL4C2`9$FJN2N(,E(;3/`3AE>S4ZOX\XUV>@U1@2+K%*PK/U6OQZ92%*SAX M"D/(N.0V3(F03D:-B`80#[1MQ\QT]M13M4EJ72L"3+5.4)'@$HD/H$5$Z9O% M?J#<^WWVZN*=NE;?F'WE*Q)==JT.+F9F9S*/,^N%7?TX0!_$SF\=O'^'N+_^ M_P!=#3";*$_>U<.7NR?YTQ=3\7'_``FTAZ-1OGYZ!(/T"'%C?=-^P?Z-2,'& M*&CPA*#'Y")]_P`>%(4"E_C+R,?I*&P`8\3:5#B`![3G,(C](CJ+U#Y=Y"$X M`W-_\QR/0?K-Q3GPJ:=;A)(T3:!CX"II0!\@2!Z@(U"[GG>'O7&_+SWC-QGJ M<)-9.BFL(C<;O9VCR?9P,]9VR#Z$J=1J+!RU).6,S&1:J*K.5CH$4<$1*W5/ MU"5Q->;D55CN(T[8&0[=JD]+.5F[(!1;H^^NC`F03JJ`4-SJ',(F%L+G MI^GTUKUBV4[JWLCM,2M0D2I;B5$R&&(E,\3SBP?;K>&Z[]]E=^W)O=!0VVIJ MK-J)E-+2YPRRS24SS++:0HR,DI22H!.97(2$/$\AL`XVY.XFM.&,LP?QVE6Q MLFF\117]RDXU^T5(ZB9Z"DBIJJ1D["OTB+MER@(%.7I.4Y#&(:5%TM5OO5"Y M;KDC/3.#Y01P(/(CD8\YVV6YNL]G];46X.@JGW74="I105`+:=0M)0ZP^V<' M&'FU*0ZC`E)\I2J1"JN?NP9R?Q'+JW'BWD>-RK'QZYW,(Q7E_P`K\O1*9`!5 M--M*)NF]8E7:0E`H+(OHTRA@`01`1V"/UVV?O]K=-5I:IZK:)J2F9:='\50P M5AABH>,74[=?$^V6W`MOW!O]9%VE^HDAY89^]+4X20"KI+2JI82HB90MNID? M]+(1$&&NZ3W">".2D<:!!,N M_O?*UE+BAPTR537XRE3OUY=7"N2!B>DHZAK#C):4CU5DAW%%?W9 MR4%"#XD.`E'Q#2DWGJ6JRPV^K8Q8=?*T^I34Q$;OA66&ZZ6WDU]IJ^-="\V^ MT(IWV\?(ZS<4MK3CC(*293C2SMC?Z5N!O_QB[?\`O]TTN]%?X?T/]#/XEQ"[ MNO\`^L[5G]ZD?G-1@_\`IUO\X&6/Y=97_J'1=-)LQ_Q#4?T(_P`ZF+0?BU?X M'Z6_O1_9]3#EFI*Q0-!H@@T00:((-$$&B".!$`#;NZ@/*GD9"AU7%2GE2F<_63@!,F'FV6V$W'WYU`+)H6B4N@0M*:B MN="D45*E7-U\8%;^51O>0!-&P<.5Q%XXQQ%.%W M<-28-RLF:VL`9I$? MHF@K-TQX$X`J/UE<^0`$>D#ME[?-"=MFBCI[3:C4WBI#:[C<'^FV[5.H!DI& M,F:9O,H-T^8B1SK)<),0Q4N/1?O'(CTIAT>)C!L`Z27ORU*%.RE;CBL!E$R2>`$N<.%J;<^WYGK1I)/WK M=&@5.*;.6GITIQ*WJDR92D<5`JP`,Y1NOQ![35XY`1D'^9E2GN.G$]LY:23N MD/P5BT[%(]H-,DR?XOK]$FLD82HHI%,#@KU:&VIN-R=3:3T+R;E(BW;MT2```4/$=Q$1$1$9+L,,4K"*:E0&Z="0$I&`2!R$5'W6 M[W6_7)^\WRH=JKM5.J=>==.9QQQ9FM2E<22?'@)`8"/JM=L:^.LDIJ(A6RCV M9DX^)9)?XKV3>-F#-+<0`/4]VI4J M=J#P2D%2C+C(`3,N?DI:,CH)OR;O;Y>:?/VK2)09*OKP M*3Q:1<*ILTVRH*EZ5!.!3=0;#XAJ)&E'&F]QVE+4D-)K'R53\OF+A&/#ZPCT M_P#<[2UE=V.WNEHV'G:QS2%I2EI"%+=*B:`E(;2"LJ3(YP`*B(PCY MY]^&CLJ]-XLX4+/[;;YUNM#JYN?QKN-KM:!XF9`ZV/825:HS-IL^RFS5RJW0 M8H*;*$!R(`735ZIW;M[;:[;I@]6Y+&4/2/322,,@$RM1'#@!Q,Y2BR?ME^&7 MJFY7.GUKW'!NUZ4I5=55I#J/>Z@((.6N=2HLV^GD)N!:NJM,T_9JQBJ?:R[2 MN3 M1/<$RPC\2L5BLEAJU.E'28BFO:[>\^8LF3$49103D2B(]5C#MQ`#`1!9=+?[ M(ZW>TUN?N-97:SKP2Z^\I",)"9.9:D^@`Y!CP$H:+XE.NK3H'1NC^U+1"^G8 M[10LU-6T""4H;;Z-"AR6!+A#U0K@<\E$8@PPSR.MU9HN`\S6BVS,?7Z_$8PO M+F1E91V@R9MB#6I%-,IUG"B9/6:8ME0_4*2A ME+*R5*,@!E/$G`>'KBKO:RTW*^[EZ?L]F8=J;F_>:-#;32%.+434-_50"9`3 M4H\D@DX"%+?TZUVJ4%RQR57)B>C8^=NN"B1E3C73MNBXG)"&ML#+2D?'$.H` MN7S6-*9R9(OV_124,`"!#;1[V5JF!>JILJ2%N4PR^9.)2X20,9DR/(1>#\6F MP7JJV;TY0$(R4++6-0[XPY+&YP`8_?\R;F9I;S2K$L"LC+&GZY'/RR9EBL_ACN M9F8AP,!MAWU%6CKZ+]K@K>LT*95R,>C?6FB-6, M_#%3I9=OK/UD9T-;'%TP8>+R4M.TKZP4!!5F2R%**0)X'TQ(?>+P)E3CGSD7 MY8QL"ZD\<9"MM`R75;BHU6>UR/OU-;P)7M-LSMN!THQ99[64G+8%3$!VS<"" M0B=-0I=AN5:Z[3NL5:J;0M5N=#:PO$H"TR!0H\B2,,)$'CA"7[!MRM![S]KJ M]@[K5BGUA;+=<;;4,)<`J%4-6I:D5C#9.9\-]4A;384M+B3G0E*@3L'BKO[\ M0+?7(0EMJN9:QDZ9,Q8'QY7Z&O>5).S/UDVJ$149B$?>A-?$)!<$VOO!&2IQ M,4#IE'3ET.[>F[@RC,BI3<5)2.B$AQ15+$(R*(./B4DQ7_K7X9O<%I.X52Z2 MIL%7HI@.O?>3E MYVZBIB:HZ2BJ'K-U.D\)95(7($*;5CU$3F"9"4N4Y1`73GP[+E M4;G778[5>IK?0[F?=7WK:%LYGZ>LHVW%,NMUE*M+=72OJDEQD-YU$)>.524I M49'J7Z@#@A-0Z+VRES+3Y0$NI:%D\PILDS]!$Y_1&DO7PP>Z6U5ON]`Q8[E3%1D[35Z4!*)RSK; MJDLO@3Y!"B!RC'?G#GJ;[R6?\08WX@8-M;IMC]M8(=2_V2,;,WIV=KD8DSJ9 MNCN.7D(^F4.KIQ_KD3>.SNEUEU/32!0Q4SMUJ:[JW0O%)3:7IG5TC,TJ=4F6 M!(S9B?92.0F9J,3R[<]N[?\`#OVOU'JON"U!;4W&\]!QJV4KQJ*@.%MQU+:&V0@+*U90!8KOAUND8'XF<#>,4;:&4A.8R,LP1:.'39*8?P M%2Q\TJSNTN([UQ<,V$G-N=DA,'2)S&(41$AMMMNW34EMTY:;*PZA2V3(`J&8 MI0V$S()'.7SPV7PR+QJ'O8M[IX MRF5#K@5DX,T=(*I$/L95-=(Q0$%"[K[1592C;NF=+B.FQ2+"S,>4I"I@DX9GHZ.E+O@BPPM29N7:"2LW+L;;3YYS%LP.NX! M(-SF(B<0`>D=--LQ54PU-4,]1'5-&4@9AYCG"CEQQDD$F46:?%BL-YJMAK)6 MTU+4KI+;J=)J5AIS*R%4;[25+.6027%)1/AF('$B'4O5+]?T>SS^CSU)[*8\ M]V9O\I/S_A\W&/+KYCF#1!'`B`;;^T=OZ_ZM<*4$B9X01UTC,Q4.V,]EI)C% MLR`8RCN1=MV+5,I?O"=PZ422(`?6(:ZW'FF6^J\I*&AS40D?.2([:=A^K=#% M(VXZ^3@E"2LGU!(,5+R;SLXZXV2<(A;%[S-(F43)!8^8*V5PHLF'V4CR:!DH M!J!S^&ZCLNWT:05^W/T=8B6W*KWBI'U*<=96'B1Y!Z9JAZM&]NF[.M?+0W`P+".?62^:+=*P\G= M7")R]`&8%D03A(93I#?\)N]5(([E5`0WTR>H]\[_`'-M=/IJF%$Q++U5CJNX MX`A*)A!GR(5$X-J>R_;.TN-W/<2MJ]258,Q34:'&*-)&,EO)"G'0.="@%8^8A2Y``FS*\.WD+7 M*XVP''F$#*FAR!F+*XEW+U$))OTXNAUUR)=]CH&DRD-_9';Q=:Q;#5[[B7=1 M58:8,LS:!G5ZLV`$SZY1%C?]8OSK/RG`>B0$5_[K=SF\F\% M-]T:DN0I-)SPMMO;%)0RY!32%9WO2:A;RE8$J,7D`H%WV#;<=Q^L=@#0;0#2.O]TJL6W) M)JH+.UG,179N/BW[T3MR@5PNB=8A-R%,!1$-:*_::M.HPT+HEQ0:S90EUQL> M:4YA"@%>R)3!EC+B8>[9SN)W8V#]\5M?74U`]7%)=<514=0[)`5)*':EAUQM M/F.8-*0%8%0)`E4LW8T[9EV-NV\P737)A& M9<"0P&%-UE3))TC@'D50B=E1ZB_5OH1M7H=*LQHYJY3<<_\`%'R_\1[O#?06 MQJAM`,YY;=;>?'`TDOHBW&&.!'#K`$@WF,4\=<95B>:"11I9E8(E@M319,P& M*LULUE4F)QHJ`AN!DER#I36W2^G;-C;*1AIFMQ,QF0A2E#F(6=[UO+1'D?K==!=RF829^4$B8$CYCX8>F+??AV;,(VAT]?\`NPWE M8=M-BHK8ZU0"J2IA7NYRJJZM*7`%)ZR,M/2S`4ZI3A2"E226#N'W'6#XI\;\ M48*A3MW2E&K*#>?EVZ0)!/V^255EK;/F#8#F^*V!ZX4)U[F*B)">10`'@L-H M8L5GI[2Q^C91+UJ,RH_*HDQ5OO3N===YMT[WN9>04U5UKENH;Y,L"2*=D8G! MIA+:/"8)XDQ.UEJ55ND6K!W&M0%LA%ED'"T-98>/G8I5PU."K9=6.E&[IFHL MW4*!DS"03$,&X"`ZV;S350V67TI6T>*5`$'GB#@?EAOK9=;I9:U-RLU344EQ M1/*ZPXMIQ,Q(R6V4J$QA@>&$?%1.",'P,FPFX/#>*H:9BG)'L7+Q./:E'2D: M\3`03=Q\@SB$7;)RF!AZ5$SE,&_@.L9JVVYAP.LT["'1P4EM((]1`G"@N&X. MOKM1.VVZWR\55N>`#C3U;4NMN`&8"T+=4E0!$P%`R./&)->,VDBT=1\@U;/F M#YLNS>LGB"3EH\:.4C(N6KILL4Z+ALX1.8AR'*)3E$0$!`=9A`4"E0FDC&$F MVXXRXEYE2D.H4"E0)!!!F"",00<01B#$/_PW<=^CT_R%PQZ>W2"?Y7TCH`NV MW2!/@?3T@'L\M:X6:T),TTE,"#/!I''Q]GCZ86_[4-S,?]X[]CQ_K"KQPE(_ M;<)82X2B2)BI5:PP#JJ6"N04[5WS0L>]K:?P>X>8^NC#(E'XSX4JEXB7HR419X+'MHKZEUIQ$PL M98YRA!+UC)-$J%_KC@_JK05SKL39HDZP%$H+>X3+1ZV*N4HB`'`H'#V#K95= M+2UZ.G6M-O-^"TA0^8@PW>FM3:DT9=$7O2-PK;7>6YY7Z1]VG>2#B0'6E)7+ MT9I1TE5P=AND8]3Q-4\74.!Q@E[[TX^CZO#I4XWQ)XK(/_5KHM#1:_OCY8RJ MG6D;J..XZZV+?0TM**&G9;11BM25& MM/!:3DS3#WB3@!60.KZQU2XRJZ"1U=]^ MLS1O'I,S#O\`2GMK4JTEIE3G650TQ<\2@0Y=-W/]Q=)0BVT^N-4)H@)!/WE5 M&0E*047"H"7@1%E:1CG'^,X8E M1MQ*-IA;#C"#EJPQQ/C5E6I]PU>3M> M:46KMX.:=L1*9BZEHE&+(PDG#(Q`%$ZR9S)"`=(AKZ%#1!@TP9:]V(Q1D3E/ MK3*1^:.']::QJKHS?*J[W-V]4XDU4+JGU/MC'!MU3A<0,3@E0&)CTHW`F#(6 M08R\/AC%$3+1;E)[&2D;CNHL9*.>H#U(/&+YK#I.FCM`WB11,Y3E'R$-=;-K MME.X':>G8;=3P4EM"2.6!`!&&&$95?N#KZZ42[9<[Y>:FW."2VG:VI<;6#CY MD+=*58XX@XQ*WID_NAY[_P"WZ=;#,KQA&]-'@/P_#CQB-K^SRR[-&_EG9*57 MP3*Z^*A<:5,V\KHQ@0]S]Q&'O]'/'^CLIU]8.04Z@VZ.G[6!<$URD(^[UA"Y MG--"5S'+VG$2Q])]4*.POZ28+IU12W"I!ETQ352*;*>965T=7G!$I`!$C,S5 M.0B&1A>7PD'W?).(R#[!BL(S"BH#MXCM-\@DD!^K<0\=:)QK5/U'TC_R&C^. MH$+.EN&S:7$]>T7I29XYKNA(^4ILBS\PB#KM"\MR)*#+9*RFX:_:]5/%^$<3 MLU!)TCN""SOD$^>@&WD(D$=_9I,W%O4P*O>7KL4__69I0F7HD^5PX5DKMG5+ M3[C:[0AW,9?>%TN"Q+D%9;0VCY1Q\!%'[FACY*2.&8Y3FZ_=@?\`>32$#QQB M.L?'J%L1_8YN93((;;`0QC;;>.F\KAH@5'^\RM0J5E,^JD)1/TR4I/R?3$B- M,NZX72__`)RQMPVW(2Z;]T<4,,)Y*=I)7+U?)'>5#_MJ_N_ST&?NKQ]3\SAR M_P#"A#I'Q<_EJ'RH"&WT[IZS+7^Q+/YL\IB77ZV6?*63R<>'+C'1??\`G,"? MZI^XRF?^P_=86NJ.V.=$$&B"#1!!H@@T00:((-$$&B M"/ALF>\?E]<_=/G7WKY:F/0_+?X:.0/4]Q7Z?DOXR(1?S-_Z/U_P_7Z=]=%3 M/HJEFS93+++/P/LSPS2X3PC;V#I_?E'UO<^E[TU/WO/[K[8_]QTYKZ,_TF7' M+.$&\IQ';\7RE:UIS(?&](&Z++[U_2]F/4"V:=2^/!9ZZ5R_)*TR\!'IOT'7] MU+>@*-NAM.S;VF_J8V95.0E**UBA3_\\2-<+20( M;^\&%#?3M;6_J`%.#3)<-WEYB^$AZ7/*$DHEXY#ZXK#^(">]%5NI5;UIM:-I MNNWTTV%2EVD5$CTO>EK2V^7,OZ/WE`9]G(,TH8[)T](=/W?9Y_U^.GB5.>/& M*M!+*)<)"7JY1_6N(Y@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@@T01 "_]D_ ` end EX-101.INS 7 dysl-20121231.xml XBRL INSTANCE DOCUMENT 0000030831 2011-09-30 0000030831 2011-10-01 2011-12-31 0000030831 dysl:BiomedicalMember 2011-10-01 2011-12-31 0000030831 dysl:OpticsMember 2011-10-01 2011-12-31 0000030831 dysl:ContractResearchMember 2011-10-01 2011-12-31 0000030831 dysl:InstrumentsMember 2011-10-01 2011-12-31 0000030831 dysl:ProductsAndTechnologySegmentMember us-gaap:MaximumMember 2011-10-01 2011-12-31 0000030831 us-gaap:CustomerConcentrationRiskMember 2011-10-01 2011-12-31 0000030831 us-gaap:RestrictedStockMember 2011-10-01 2011-12-31 0000030831 us-gaap:CommonStockMember 2011-10-01 2011-12-31 0000030831 us-gaap:StockOptionMember 2011-10-01 2011-12-31 0000030831 us-gaap:EmployeeStockOptionMember 2011-10-01 2011-12-31 0000030831 dysl:UnitedStateMember us-gaap:SalesRevenueSegmentMember 2011-10-01 2011-12-31 0000030831 dysl:EuropeMember us-gaap:SalesRevenueSegmentMember 2011-10-01 2011-12-31 0000030831 us-gaap:OtherCreditDerivativesMember us-gaap:SalesRevenueSegmentMember 2011-10-01 2011-12-31 0000030831 2011-12-31 0000030831 dysl:BiomedicalMember 2011-12-31 0000030831 dysl:OpticsMember 2011-12-31 0000030831 dysl:ContractResearchMember 2011-12-31 0000030831 dysl:InstrumentsMember 2011-12-31 0000030831 2012-07-01 2012-09-30 0000030831 us-gaap:TradeNamesMember us-gaap:MinimumMember 2011-10-01 2012-09-30 0000030831 dysl:BiomedicalTechnologiesMember 2011-10-01 2012-09-30 0000030831 dysl:AcquiredCustomerBaseMember us-gaap:MinimumMember 2011-10-01 2012-09-30 0000030831 dysl:KnowHowMember 2011-10-01 2012-09-30 0000030831 dysl:AcquiredCustomerBaseMember us-gaap:MaximumMember 2011-10-01 2012-09-30 0000030831 us-gaap:TradeNamesMember us-gaap:MaximumMember 2011-10-01 2012-09-30 0000030831 2012-09-30 0000030831 dysl:BiomedicalTechnologiesMember 2012-09-30 0000030831 dysl:KnowHowMember 2012-09-30 0000030831 us-gaap:TradeNamesMember 2012-09-30 0000030831 dysl:AcquiredCustomerBaseMember 2012-09-30 0000030831 us-gaap:TreasuryStockMember 2012-09-30 0000030831 us-gaap:RetainedEarningsMember 2012-09-30 0000030831 us-gaap:AdditionalPaidInCapitalMember 2012-09-30 0000030831 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-09-30 0000030831 us-gaap:CommonStockMember 2012-09-30 0000030831 2012-10-01 2012-12-31 0000030831 dysl:BiomedicalMember 2012-10-01 2012-12-31 0000030831 dysl:OpticsMember 2012-10-01 2012-12-31 0000030831 dysl:ContractResearchMember 2012-10-01 2012-12-31 0000030831 dysl:InstrumentsMember 2012-10-01 2012-12-31 0000030831 dysl:ProductsAndTechnologySegmentMember us-gaap:MaximumMember 2012-10-01 2012-12-31 0000030831 us-gaap:CustomerConcentrationRiskMember 2012-10-01 2012-12-31 0000030831 us-gaap:TradeNamesMember us-gaap:MinimumMember 2012-10-01 2012-12-31 0000030831 dysl:BiomedicalTechnologiesMember 2012-10-01 2012-12-31 0000030831 dysl:AcquiredCustomerBaseMember us-gaap:MinimumMember 2012-10-01 2012-12-31 0000030831 dysl:KnowHowMember 2012-10-01 2012-12-31 0000030831 dysl:AcquiredCustomerBaseMember us-gaap:MaximumMember 2012-10-01 2012-12-31 0000030831 us-gaap:TradeNamesMember us-gaap:MaximumMember 2012-10-01 2012-12-31 0000030831 us-gaap:TreasuryStockMember 2012-10-01 2012-12-31 0000030831 us-gaap:RetainedEarningsMember 2012-10-01 2012-12-31 0000030831 us-gaap:AdditionalPaidInCapitalMember 2012-10-01 2012-12-31 0000030831 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-10-01 2012-12-31 0000030831 us-gaap:CommonStockMember 2012-10-01 2012-12-31 0000030831 us-gaap:RestrictedStockMember 2012-10-01 2012-12-31 0000030831 us-gaap:SalesRevenueSegmentMember 2012-10-01 2012-12-31 0000030831 us-gaap:CommonStockMember 2012-10-01 2012-12-31 0000030831 us-gaap:StockOptionMember 2012-10-01 2012-12-31 0000030831 us-gaap:EmployeeStockOptionMember 2012-10-01 2012-12-31 0000030831 dysl:UnitedStateMember us-gaap:SalesRevenueSegmentMember 2012-10-01 2012-12-31 0000030831 dysl:EuropeMember us-gaap:SalesRevenueSegmentMember 2012-10-01 2012-12-31 0000030831 us-gaap:OtherCreditDerivativesMember us-gaap:SalesRevenueSegmentMember 2012-10-01 2012-12-31 0000030831 2012-12-31 0000030831 dysl:BiomedicalMember 2012-12-31 0000030831 dysl:OpticsMember 2012-12-31 0000030831 dysl:ContractResearchMember 2012-12-31 0000030831 dysl:InstrumentsMember 2012-12-31 0000030831 dysl:BiomedicalTechnologiesMember 2012-12-31 0000030831 dysl:KnowHowMember 2012-12-31 0000030831 us-gaap:TradeNamesMember 2012-12-31 0000030831 dysl:AcquiredCustomerBaseMember 2012-12-31 0000030831 us-gaap:TreasuryStockMember 2012-12-31 0000030831 us-gaap:RetainedEarningsMember 2012-12-31 0000030831 us-gaap:AdditionalPaidInCapitalMember 2012-12-31 0000030831 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-12-31 0000030831 us-gaap:CommonStockMember 2012-12-31 0000030831 2013-02-07 iso4217:USD iso4217:USDxbrli:shares xbrli:shares xbrli:pure 4479840 2737424 3414880 2471900 5475142 4849552 1735798 1941547 3271700 3550710 126187 126187 1334649 1401925 15358356 14341821 4984150 5093097 7283952 285000 1075619 429400 5493933 6703305 239997 366853 495213 5601242 6527608 224996 946525 339886 5016201 224997 339885 491563 5471163 12521971 0 1283775 4938625 6299571 10254160 10264499 0 1310802 4938625 4015072 165457 152650 17122922 16944757 40714330 384688 13692936 11284826 15351880 37465428 36379675 388671 10607828 13290669 12092507 11984492 11511905 2416397 2807421 694672 826880 2809580 1951680 17905141 17097886 345443 342848 371256 365328 716699 708176 7805 7810 17037618 17117241 61906 91645 2722601 2343259 19829930 19559955 986342 986342 18843588 -986342 2722601 17037618 61906 7805 18573613 -986342 2343259 17117241 91645 7810 37465428 36379675 146210 149280 51860 44004 0.0005 0.0005 40000000 40000000 15610517 15620314 14800357 14810154 810160 810160 12132295 10925 3912551 6225283 1983536 10028479 1126352 977464 10553275 106457 4251940 4910840 1284038 8494488 888341 1170446 7005347 5926409 5126948 -27181 1462418 2440288 1251423 4626866 106457 1700555 2214053 605801 392801 479878 519395 637129 4028424 3701146 4940620 4818153 186328 -202556 164123 145217 79544 -191287 -120663 385676 -606 -455694 124157 186757 62171 -378044 -308167 1298 370338 -379342 0 -379342 0 0 0 -60360 29739 309978 -349603 0.02 -0.03 0.02 -0.03 15583103 14673356 15683834 14673356 810160 15610517 810160 15620314 6110 0 0 6107 0 3 0 5797 73518 0 0 73516 0 2 0 4000 29739 0 0 0 29739 0 199212 73516 48277 -26398 0 87803 380120 15000 193503 37160 134457 426458 15000 185628 62782 163048 9978 12807 60970 3160 0 -11208 -122727 1532 1647098 -607217 -272350 322298 184105 -205749 124256 76842 -484930 399184 -92853 -852463 262942 140355 -780126 -222662 -0 80252 405341 0 140876 262020 2445 315568 0 122146 186330 7092 -405341 -235316 15133 6110 475159 472587 -460026 -466477 -96923 -18525 -1742416 -942980 <p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>Note 1 - Basis of Presentation and Ability to Continue as a Going Concern</b></p><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The accompanying consolidated balance sheet as of December 31, 2012, the consolidated statements of operations and comprehensive income (loss) for the three months ended December 31, 2012 and 2011, changes in stockholders&#8217; equity for the three months ended December 31, 2012 and cash flows for the three months ended December 31, 2012 and 2011 of Dynasil Corporation of America and subsidiaries (the &#8220;Company&#8221;), and the related information contained in these notes have been prepared by management and are unaudited. In the opinion of management, all adjustments (which include normal recurring and nonrecurring items) necessary to present fairly the financial position, results of operations and cash flows in conformity with generally accepted accounting principles for the periods presented have been made. Interim operating results are not necessarily indicative of operating results for a full year.</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The preparation of our unaudited consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Certain information and note disclosures normally included in the Company's annual financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted. These consolidated financial statements should be read in conjunction with the financial statements and notes thereto included in the Company's September 30, 2012 Annual Report on Form 10-K previously filed by the Company with the Securities and Exchange Commission.</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplates continuation of the Company as a going concern. However, the Company has failed to comply with the financial covenants set forth in the terms of its outstanding loan agreements and sustained a substantial loss from operations for the year ended September 30, 2012. The Company has continued to sustain losses from operations for the three months ended December 31, 2012. These factors raise substantial doubt over the Company&#8217;s ability to continue as a going concern.</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The Company continues to be in default of the financial covenants set forth in the terms of its loan agreements for its fiscal first quarter ended December 31, 2012. These covenants require the Company to maintain specified ratios of earnings before interest, taxes, depreciation and amortization (EBITDA) to fixed charges and to total/senior debt. A default gives the lenders the right to accelerate the maturity of the outstanding indebtedness. Furthermore, Sovereign Bank, N.A, the Company&#8217;s senior lender, may, at its option, impose a default interest rate with respect to the senior debt outstanding, which is 5% higher than the rate otherwise in effect. To date, the lenders have not taken any such actions. However, the Company cannot predict when or whether a resolution of this situation will be achieved.</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The Company is current with all principal and interest payments due on all its outstanding indebtedness through February 13, 2013, the date of this filing, and management is engaged in discussions with its senior lender to address the financial covenant situation. Because of the uncertainty of any resolution of the covenant violations and possibility of an acceleration of the indebtedness by the lenders, the Company reclassified all of its outstanding indebtedness as a current liability in the accompanying consolidated balance sheets.</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The Company&#8217;s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and positive cash flows and/or to obtain the necessary financing from shareholders or other sources to meet its outstanding obligations and repay its liabilities arising from normal business operations when they become due.</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">In view of the matters described in the preceding paragraphs, recoverability of a major portion of the recorded asset amounts shown in the accompanying consolidated balance sheet is dependent upon the continued operations of the Company. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence.</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The Company has recently taken and will continue to take actions to improve its liquidity, including the implementation of a number of initiatives designed to conserve cash, optimize profitability and right-size the cost structure of its various businesses. The Company has retained Argus Management Corporation and Mirus Capital as financial advisors to assist it in evaluating strategic and restructuring alternatives, including the potential sale of product lines and/or a Company division. While the Company is actively considering such strategic alternatives, there can be no assurances that any such transaction will occur, or, if a transaction is completed, it will be on terms favorable to the Company. The Company does not currently have cash available to satisfy its obligations under its indebtedness if it were to be accelerated or payment demanded. If the Company is not able to resolve its current defaults under its outstanding indebtedness and improve its liquidity through the actions described above, it may not have sufficient liquidity to meet its anticipated cash needs for the next twelve months.</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">We consider events or transactions that have occurred after the unaudited consolidated balance sheet date of December 31, 2012, but prior to the filing of the unaudited consolidated financial statements with the SEC on this Form&#160;10-Q, to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure, as applicable. Subsequent events have been evaluated through the date of the filing of this Quarterly Report on Form&#160;10-Q with the SEC.</p> <p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>Note 2 &#8211;Debt Classification</b></p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The Company was in default of certain financial covenants set forth in the terms of its outstanding indebtedness as of December 31, 2012 and September 30, 2012. Based on the covenant violations and the resulting possibility of an acceleration of the indebtedness by the lenders, all of the outstanding indebtedness of the Company has been classified as current liabilities in the accompanying balance sheets.</p> <p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>Note 3 - Inventories</b></p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">Inventories are stated at the lower of average cost or market. Cost is determined using the first-in, first-out (FIFO) method. Inventories consist of raw materials, work-in-process and finished goods. The Company evaluates inventory levels and expected usage on a periodic basis and records, as a charge to cost of revenue, any amounts required to reduce the carrying value to net realizable value.</p><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">Inventories, net of reserves, consists of the following:</p><p style="text-align: center; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><table style="width: 65%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-align: center; vertical-align: top;" nowrap="nowrap"><b>&#160;</b></td><td style="text-align: center; vertical-align: top;" nowrap="nowrap"><b>&#160;</b></td><td style="text-align: center; vertical-align: top;" colspan="2" nowrap="nowrap"><b>December 31,</b></td><td style="text-align: center; vertical-align: top;" nowrap="nowrap"><b>&#160;</b></td><td style="text-align: center; vertical-align: top;" nowrap="nowrap"><b>&#160;</b></td><td style="text-align: center; vertical-align: top;" colspan="2" nowrap="nowrap"><b>September 30,</b></td><td style="text-align: center; vertical-align: top;" nowrap="nowrap"><b>&#160;</b></td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2">2012</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2">2012</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left; width: 58%;">Raw Materials</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">$</td><td style="text-align: right; width: 18%;">2,334,613</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">$</td><td style="text-align: right; width: 18%;">2,096,681</td><td style="text-align: left; width: 1%;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td>Work-in-Process</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">689,134</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">885,328</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 1pt;">Finished Goods</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">526,963</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">289,691</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">3,550,710</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">3,271,700</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td></tr></table> <p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>Note 4 &#8211; Costs in Excess of Billings and Unbilled Receivables</b></p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">Costs in excess of billings and unbilled receivables relate to research and development contracts and consist of actual revenues earned under the contracts which have not yet been billed to customers.</p> <p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>Note 5 &#8211; Intangible Assets</b></p><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">Intangible assets at December 31, 2012 and September 30, 2012 consist of the following:</p><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><table style="width: 90%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Useful</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Gross</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Accumulated</td><td style="font-weight: bold;">&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom;"><td style="border-bottom: black 1pt solid; font-weight: bold;">December 31, 2012</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2">Life (years)</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2">Amount</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2">Amortization</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2">Net</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left; width: 31%;">Acquired Customer Base</td><td style="width: 1%;">&#160;</td><td style="text-align: center; width: 1%;">&#160;</td><td style="text-align: center; width: 15%;"><font style="font: 10pt times new roman, times, serif;">5-15</font></td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">$</td><td style="text-align: right; width: 14%;">7,858,775</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">$</td><td style="text-align: right; width: 14%;">2,387,612</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">$</td><td style="text-align: right; width: 14%;">5,471,163</td><td style="text-align: left; width: 1%;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Know How</td><td>&#160;</td><td style="text-align: center;">&#160;</td><td style="text-align: center;">15</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">512,000</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">172,115</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">339,885</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left;">Trade Names</td><td>&#160;</td><td style="text-align: center;">&#160;</td><td style="text-align: center;"><font style="font: 10pt times new roman, times, serif;">15 - Indefinite</font></td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">558,435</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">66,872</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">491,563</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 1pt;">Biomedical Technologies</td><td style="padding-bottom: 1pt;">&#160;</td><td style="text-align: center; padding-bottom: 1pt;">&#160;</td><td style="text-align: center; padding-bottom: 1pt;">5</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">300,000</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">75,003</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">224,997</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="text-align: center; padding-bottom: 2.5pt;">&#160;</td><td style="text-align: center; padding-bottom: 2.5pt;">&#160;</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">9,229,210</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">2,701,602</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">6,527,608</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td></tr></table><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><table style="width: 90%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Useful</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Gross</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Accumulated</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">&#160;</td><td style="font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="border-bottom: black 1pt solid; font-weight: bold;">September 30, 2012</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2">Life (years)</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2">Amount</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2">Amortization</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2">Net</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left; width: 31%;">Acquired Customer Base</td><td style="width: 1%;">&#160;</td><td style="text-align: center; width: 1%;">&#160;</td><td style="text-align: center; width: 15%;"><font style="font: 10pt times new roman, times, serif;">5-15</font></td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">$</td><td style="text-align: right; width: 14%;">7,858,775</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">$</td><td style="text-align: right; width: 14%;">2,257,533</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">$</td><td style="text-align: right; width: 14%;">5,601,242</td><td style="text-align: left; width: 1%;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Know How</td><td>&#160;</td><td style="text-align: center;">&#160;</td><td style="text-align: center;">15</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">512,000</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">145,147</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">366,853</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left;">Trade Names</td><td>&#160;</td><td style="text-align: center;">&#160;</td><td style="text-align: center;"><font style="font: 10pt times new roman, times, serif;">15 - Indefinite</font></td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">558,435</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">63,222</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">495,213</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 1pt;">Biomedical Technologies</td><td style="padding-bottom: 1pt;">&#160;</td><td style="text-align: center; padding-bottom: 1pt;">&#160;</td><td style="text-align: center; padding-bottom: 1pt;">5</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">300,000</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">60,003</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">239,997</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="text-align: center; padding-bottom: 2.5pt;">&#160;</td><td style="text-align: center; padding-bottom: 2.5pt;">&#160;</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">9,229,210</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">2,525,905</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">6,703,305</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td></tr></table><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">Amortization expense for the three months ended December 31, 2012 and 2011 was $181,268 and $162,803<font style="color: red;"></font>respectively. Estimated amortization expense for each of the next five fiscal years is as follows:</p><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>&#160;</b></p><table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td nowrap="nowrap"><font style="font-size: 7pt;">&#160;</font></td><td style="padding-bottom: 1pt;" nowrap="nowrap"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 1pt solid; text-align: center;" colspan="2" nowrap="nowrap"><font style="font-size: 7pt;">2013 (9 Months)</font></td><td style="padding-bottom: 1pt;" nowrap="nowrap"><font style="font-size: 7pt;">&#160;</font></td><td style="padding-bottom: 1pt;" nowrap="nowrap"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 1pt solid; text-align: center;" colspan="2" nowrap="nowrap"><font style="font-size: 7pt;">2014</font></td><td style="padding-bottom: 1pt;" nowrap="nowrap"><font style="font-size: 7pt;">&#160;</font></td><td style="padding-bottom: 1pt;" nowrap="nowrap"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 1pt solid; text-align: center;" colspan="2" nowrap="nowrap"><font style="font-size: 7pt;">2015</font></td><td style="padding-bottom: 1pt;" nowrap="nowrap"><font style="font-size: 7pt;">&#160;</font></td><td style="padding-bottom: 1pt;" nowrap="nowrap"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 1pt solid; text-align: center;" colspan="2" nowrap="nowrap"><font style="font-size: 7pt;">2016</font></td><td style="padding-bottom: 1pt;" nowrap="nowrap"><font style="font-size: 7pt;">&#160;</font></td><td style="padding-bottom: 1pt;" nowrap="nowrap"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 1pt solid; text-align: center;" colspan="2" nowrap="nowrap"><font style="font-size: 7pt;">2017</font></td><td style="padding-bottom: 1pt;" nowrap="nowrap"><font style="font-size: 7pt;">&#160;</font></td><td style="padding-bottom: 1pt;" nowrap="nowrap"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 1pt solid; text-align: center;" colspan="2" nowrap="nowrap"><font style="font-size: 7pt;">Thereafter</font></td><td style="padding-bottom: 1pt;" nowrap="nowrap"><font style="font-size: 7pt;">&#160;</font></td><td style="padding-bottom: 1pt;" nowrap="nowrap"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 1pt solid; text-align: center;" colspan="2" nowrap="nowrap"><font style="font-size: 7pt;">Total</font></td><td style="padding-bottom: 1pt;" nowrap="nowrap"><font style="font-size: 7pt;">&#160;</font></td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left; width: 16%;"><font style="font-size: 7pt;">Acquired Customer Base</font></td><td style="width: 1%;"><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: left; width: 1%;"><font style="font-size: 7pt;">$</font></td><td style="text-align: right; width: 9%;"><font style="font-size: 7pt;">406,961</font></td><td style="text-align: left; width: 1%;"><font style="font-size: 7pt;">&#160;</font></td><td style="width: 1%;"><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: left; width: 1%;"><font style="font-size: 7pt;">$</font></td><td style="text-align: right; width: 9%;"><font style="font-size: 7pt;">542,615</font></td><td style="text-align: left; width: 1%;"><font style="font-size: 7pt;">&#160;</font></td><td style="width: 1%;"><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: left; width: 1%;"><font style="font-size: 7pt;">$</font></td><td style="text-align: right; width: 9%;"><font style="font-size: 7pt;">542,615</font></td><td style="text-align: left; width: 1%;"><font style="font-size: 7pt;">&#160;</font></td><td style="width: 1%;"><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: left; width: 1%;"><font style="font-size: 7pt;">$</font></td><td style="text-align: right; width: 9%;"><font style="font-size: 7pt;">542,615</font></td><td style="text-align: left; width: 1%;"><font style="font-size: 7pt;">&#160;</font></td><td style="width: 1%;"><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: left; width: 1%;"><font style="font-size: 7pt;">$</font></td><td style="text-align: right; width: 9%;"><font style="font-size: 7pt;">542,615</font></td><td style="text-align: left; width: 1%;"><font style="font-size: 7pt;">&#160;</font></td><td style="width: 1%;"><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: left; width: 1%;"><font style="font-size: 7pt;">$</font></td><td style="text-align: right; width: 9%;"><font style="font-size: 7pt;">2,893,742</font></td><td style="text-align: left; width: 1%;"><font style="font-size: 7pt;">&#160;</font></td><td style="width: 1%;"><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: left; width: 1%;"><font style="font-size: 7pt;">$</font></td><td style="text-align: right; width: 9%;"><font style="font-size: 7pt;">5,471,163</font></td><td style="text-align: left; width: 1%;"><font style="font-size: 7pt;">&#160;</font></td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;"><font style="font-size: 7pt;">Know How</font></td><td><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 7pt;">25,600</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 7pt;">34,133</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 7pt;">34,133</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 7pt;">34,133</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 7pt;">34,133</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 7pt;">177,753</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 7pt;">339,885</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left;"><font style="font-size: 7pt;">Trade Names</font></td><td><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 7pt;">10,950</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 7pt;">14,600</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 7pt;">14,600</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 7pt;">14,600</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 7pt;">14,600</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 7pt;">81,992</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 7pt;">151,342</font></td><td style="text-align: left;"><font style="font-size: 7pt;">&#160;</font></td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 1pt;"><font style="font-size: 7pt;">Biomedical Technologies</font></td><td style="padding-bottom: 1pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 1pt solid; text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 1pt solid; text-align: right;"><font style="font-size: 7pt;">45,000</font></td><td style="text-align: left; padding-bottom: 1pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="padding-bottom: 1pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 1pt solid; text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 1pt solid; text-align: right;"><font style="font-size: 7pt;">60,000</font></td><td style="text-align: left; padding-bottom: 1pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="padding-bottom: 1pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 1pt solid; text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 1pt solid; text-align: right;"><font style="font-size: 7pt;">60,000</font></td><td style="text-align: left; padding-bottom: 1pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="padding-bottom: 1pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 1pt solid; text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 1pt solid; text-align: right;"><font style="font-size: 7pt;">59,997</font></td><td style="text-align: left; padding-bottom: 1pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="padding-bottom: 1pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 1pt solid; text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 1pt solid; text-align: right;">-<font style="font-size: 7pt;">0-</font></td><td style="text-align: left; padding-bottom: 1pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="padding-bottom: 1pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 1pt solid; text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 1pt solid; text-align: right;">-<font style="font-size: 7pt;">0-</font></td><td style="text-align: left; padding-bottom: 1pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="padding-bottom: 1pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 1pt solid; text-align: left;"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 1pt solid; text-align: right;"><font style="font-size: 7pt;">224,997</font></td><td style="text-align: left; padding-bottom: 1pt;"><font style="font-size: 7pt;">&#160;</font></td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="padding-bottom: 2.5pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="padding-bottom: 2.5pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 2.5pt double; text-align: left;"><font style="font-size: 7pt;">$</font></td><td style="border-bottom: black 2.5pt double; text-align: right;"><font style="font-size: 7pt;">488,511</font></td><td style="text-align: left; padding-bottom: 2.5pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="padding-bottom: 2.5pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 2.5pt double; text-align: left;"><font style="font-size: 7pt;">$</font></td><td style="border-bottom: black 2.5pt double; text-align: right;"><font style="font-size: 7pt;">651,348</font></td><td style="text-align: left; padding-bottom: 2.5pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="padding-bottom: 2.5pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 2.5pt double; text-align: left;"><font style="font-size: 7pt;">$</font></td><td style="border-bottom: black 2.5pt double; text-align: right;"><font style="font-size: 7pt;">651,348</font></td><td style="text-align: left; padding-bottom: 2.5pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="padding-bottom: 2.5pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 2.5pt double; text-align: left;"><font style="font-size: 7pt;">$</font></td><td style="border-bottom: black 2.5pt double; text-align: right;"><font style="font-size: 7pt;">651,345</font></td><td style="text-align: left; padding-bottom: 2.5pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="padding-bottom: 2.5pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 2.5pt double; text-align: left;"><font style="font-size: 7pt;">$</font></td><td style="border-bottom: black 2.5pt double; text-align: right;"><font style="font-size: 7pt;">591,348</font></td><td style="text-align: left; padding-bottom: 2.5pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="padding-bottom: 2.5pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 2.5pt double; text-align: left;"><font style="font-size: 7pt;">$</font></td><td style="border-bottom: black 2.5pt double; text-align: right;"><font style="font-size: 7pt;">3,153,487</font></td><td style="text-align: left; padding-bottom: 2.5pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="padding-bottom: 2.5pt;"><font style="font-size: 7pt;">&#160;</font></td><td style="border-bottom: black 2.5pt double; text-align: left;"><font style="font-size: 7pt;">$</font></td><td style="border-bottom: black 2.5pt double; text-align: right;"><font style="font-size: 7pt;">6,187,387</font></td></tr></table> <p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>Note 6 &#8211; Goodwill </b></p><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>&#160;</b></p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">Goodwill is subject to an annual impairment test. We consider many factors which may indicate the requirement to perform additional, interim impairment tests. These include:</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 24pt;"></td><td style="width: 18pt;"><font style="font-family: symbol;">&#183;</font></td><td style="text-align: justify;"><font style="font-family: times new roman, times, serif;">A significant adverse long term outlook for any of our industries;</font></td></tr></table><table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 24pt;"></td><td style="width: 18pt;"><font style="font-family: symbol;">&#183;</font></td><td style="text-align: justify;"><font style="font-family: times new roman, times, serif;">An adverse finding or rejection from a regulatory body involved in new product regulatory approvals;</font></td></tr></table><table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 24pt;"></td><td style="width: 18pt;"><font style="font-family: symbol;">&#183;</font></td><td style="text-align: justify;"><font style="font-family: times new roman, times, serif;">Failure of an anticipated commercialization of a product or product line;</font></td></tr></table><table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 24pt;"></td><td style="width: 18pt;"><font style="font-family: symbol;">&#183;</font></td><td style="text-align: justify;"><font style="font-family: times new roman, times, serif;">Unanticipated competition or the introduction of a disruptive technology; </font></td></tr></table><table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 24pt;"></td><td style="width: 18pt;"><font style="font-family: symbol;">&#183;</font></td><td><font style="font-family: times new roman, times, serif;">The testing for recoverability under the Impairment or Disposal of Long-Lived Assets Subsections of Subtopic 360-10 of a significant asset group within a reporting unit;</font></td></tr></table><table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 24pt;"></td><td style="width: 18pt;"><font style="font-family: symbol;">&#183;</font></td><td><font style="font-family: times new roman, times, serif;">A loss of key personnel; and</font></td></tr></table><table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 24pt;"></td><td style="width: 18pt;"><font style="font-family: symbol;">&#183;</font></td><td><font style="font-family: times new roman, times, serif;">An expectation that a reporting unit carrying goodwill, or a significant portion of a reporting unit, will be sold or otherwise disposed of. </font></td></tr></table><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">There were no changes, aside from foreign exchange rate fluctuations, in the carrying value of goodwill during the three months ended December 31, 2012.</p> <p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>Note 7 &#8211; Earnings (Loss) Per Common Share </b></p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">Basic earnings (loss) per common share is computed by dividing the net income applicable or loss attributable to common shares by the weighted average number of common shares. Diluted earnings per common share adjusts basic earnings per share for the effects of common stock options, common stock warrants, convertible preferred stock and other potential dilutive common shares outstanding during the periods.</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">For purposes of computing diluted earnings per share, 100,731 common share equivalents related to stock options were assumed to be outstanding for the three months ended December 31, 2011. For the three months ended December 31, 2012, no common share equivalents related to stock options were included in the calculation of dilutive shares since there was a loss from continuing operations and the inclusion of common share equivalents would be anti-dilutive. Also, if the Company had not been in a loss position as of December 31, 2012, 116,834 shares of restricted stock would have been considered in the denominator used to calculate diluted earnings per common share. In addition, as of December 31, 2012 and 2011, common stock options for 774,483 and 815,624 shares, respectively, with exercise prices above current quarterly average market price per share have been excluded from the calculation of dilutive earnings per share since their effect is also anti-dilutive.</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">The computation of the weighted shares outstanding for the three months ended December 31 is as follows:</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><table style="width: 80%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31, 2012</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31, 2011</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td>Weighted average shares outstanding</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="padding-left: 0.25in; width: 66%;">Basic</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 14%;">14,673,356</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 14%;">15,583,103</td><td style="text-align: left; width: 1%;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left; padding-left: 0.25in;">Effect of dilutive securities</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 1pt; padding-left: 27pt;">Stock Options</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">0</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">100,731</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="padding-bottom: 2.5pt; padding-left: 0.25in;">Dilutive Average Shares Outstanding</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right;">14,673,356</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right;">15,683,834</td></tr></table> <p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>Note 8 - Stock Based Compensation</b></p><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The fair value of the stock options granted is estimated at the date of grant using the Black-Scholes option pricing model.</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">A summary of stock option activity for the three months ended December 31, 2012 is presented below:</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif; color: red;">&#160;</p><table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td style="padding-bottom: 1pt; color: black; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; color: black; font-weight: bold;" colspan="2" nowrap="nowrap">Options<br />Outstanding</td><td style="padding-bottom: 1pt; color: black; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="padding-bottom: 1pt; color: black; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; color: black; font-weight: bold;" colspan="2" nowrap="nowrap">Weighted&#160;Average<br />Exercise&#160;Price&#160;per<br />Share&#160;($)</td><td style="padding-bottom: 1pt; color: black; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="padding-bottom: 1pt; color: black; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; color: black; font-weight: bold;" colspan="2" nowrap="nowrap">Weighted&#160;Average<br />Remain&#160;Contractual<br />Term&#160;(in&#160;Years)</td><td style="padding-bottom: 1pt; color: black; font-weight: bold;" nowrap="nowrap">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="padding-bottom: 2.5pt; width: 61%; color: black;">Balance at September 30, 2012</td><td style="padding-bottom: 2.5pt; width: 1%; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; width: 1%; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; width: 10%; color: black;">794,483</td><td style="text-align: left; padding-bottom: 2.5pt; width: 1%; color: black;">&#160;</td><td style="padding-bottom: 2.5pt; width: 1%; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; width: 1%; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; width: 10%; color: black;">3.34</td><td style="text-align: left; padding-bottom: 2.5pt; width: 1%; color: black;">&#160;</td><td style="padding-bottom: 2.5pt; width: 1%; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; width: 1%; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; width: 10%; color: black;">1.75</td><td style="text-align: left; padding-bottom: 2.5pt; width: 1%; color: black;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2.5pt; color: black;">Outstanding and exercisable at September 30, 2012</td><td style="padding-bottom: 2.5pt; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">794,483</td><td style="text-align: left; padding-bottom: 2.5pt; color: black;">&#160;</td><td style="padding-bottom: 2.5pt; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">3.34</td><td style="text-align: left; padding-bottom: 2.5pt; color: black;">&#160;</td><td style="padding-bottom: 2.5pt; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">1.75</td><td style="text-align: left; padding-bottom: 2.5pt; color: black;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="color: black;">Granted</td><td style="color: black;">&#160;</td><td style="text-align: left; color: black;">&#160;</td><td style="text-align: right; color: black;">0</td><td style="text-align: left; color: black;">&#160;</td><td style="color: black;">&#160;</td><td style="text-align: left; color: black;">&#160;</td><td style="text-align: right; color: black;">0</td><td style="text-align: left; color: black;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="color: black;">Exercised</td><td style="color: black;">&#160;</td><td style="text-align: left; color: black;">&#160;</td><td style="text-align: right; color: black;">0</td><td style="text-align: left; color: black;">&#160;</td><td style="color: black;">&#160;</td><td style="text-align: left; color: black;">&#160;</td><td style="text-align: right; color: black;">0</td><td style="text-align: left; color: black;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="padding-bottom: 1pt; color: black;">Cancelled</td><td style="padding-bottom: 1pt; color: black;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left; color: black;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right; color: black;">(20,000</td><td style="text-align: left; padding-bottom: 1pt; color: black;">)</td><td style="padding-bottom: 1pt; color: black;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left; color: black;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right; color: black;">4.06</td><td style="text-align: left; padding-bottom: 1pt; color: black;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="text-align: right; padding-bottom: 1pt;">&#160;</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="padding-bottom: 2.5pt; color: black;">Balance at December 31, 2012</td><td style="padding-bottom: 2.5pt; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">&#160;&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">774,483</td><td style="text-align: left; padding-bottom: 2.5pt; color: black;">&#160;</td><td style="padding-bottom: 2.5pt; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">3.32</td><td style="text-align: left; padding-bottom: 2.5pt; color: black;">&#160;</td><td style="padding-bottom: 2.5pt; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">1.54</td><td style="text-align: left; padding-bottom: 2.5pt; color: black;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2.5pt; color: black;">Outstanding and exercisable at December 31, 2012</td><td style="padding-bottom: 2.5pt; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">&#160;&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">774,483</td><td style="text-align: left; padding-bottom: 2.5pt; color: black;">&#160;</td><td style="padding-bottom: 2.5pt; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">3.32</td><td style="text-align: left; padding-bottom: 2.5pt; color: black;">&#160;</td><td style="padding-bottom: 2.5pt; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">1.54</td><td style="text-align: left; padding-bottom: 2.5pt; color: black;">&#160;</td></tr></table><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">A summary of restricted stock activity for the three months ended December 31, 2012 and 2011 is presented below:</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><table style="width: 80%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" nowrap="nowrap">Restricted&#160;Stock&#160;Activity&#160;for&#160;the&#160;Three<br />Months&#160;ended&#160;December&#160;31,&#160;2012</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Shares</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Weighted-Average<br />Grant-Date&#160;Fair&#160;Value</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left; width: 52%; color: black;"><font style="font: 10pt times new roman, times, serif; color: black;">Nonvested at September 30, 2012</font></td><td style="text-align: left; width: 1%; color: black;">&#160;</td><td style="text-align: left; width: 1%; color: black;">&#160;</td><td style="text-align: right; width: 10%; color: black;">127,834</td><td style="text-align: left; width: 1%; color: black;">&#160;</td><td style="width: 1%; color: black;">&#160;</td><td style="text-align: left; width: 1%; color: black;">$</td><td style="text-align: right; width: 12%; color: black;">1.92</td><td style="text-align: left; width: 1%; color: black;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left; color: black;"><font style="font: 10pt times new roman, times, serif; color: black;">Granted </font></td><td style="text-align: left; color: black;">&#160;</td><td style="text-align: left; color: black;">&#160;</td><td style="text-align: right; color: black;">4,000</td><td style="text-align: left; color: black;">&#160;</td><td style="color: black;">&#160;</td><td style="text-align: left; color: black;">$</td><td style="text-align: right; color: black;">1.45</td><td style="text-align: left; color: black;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; color: black;"><font style="font: 10pt times new roman, times, serif; color: black;">Vested </font></td><td style="text-align: left; color: black;">&#160;</td><td style="text-align: left; color: black;">&#160;</td><td style="text-align: right; color: black;">(15,000</td><td style="text-align: left; color: black;">)</td><td style="color: black;">&#160;</td><td style="text-align: left; color: black;">$</td><td style="text-align: right; color: black;">1.53</td><td style="text-align: left; color: black;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 1pt; color: black;"><font style="font: 10pt times new roman, times, serif; color: black;">Cancelled </font></td><td style="text-align: left; padding-bottom: 1pt; color: black;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left; color: black;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right; color: black;">-0-</td><td style="text-align: left; padding-bottom: 1pt; color: black;">&#160;</td><td style="padding-bottom: 1pt; color: black;">&#160;</td><td style="text-align: left; padding-bottom: 1pt; color: black;">&#160;</td><td style="text-align: right; padding-bottom: 1pt; color: black;">-0-</td><td style="text-align: left; padding-bottom: 1pt; color: black;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2.5pt; color: black;"><font style="font: 10pt times new roman, times, serif; color: black;">Nonvested at December 31, 2012</font></td><td style="text-align: left; padding-bottom: 2.5pt; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">116,834</td><td style="text-align: left; padding-bottom: 2.5pt; color: black;">&#160;</td><td style="padding-bottom: 2.5pt; color: black;">&#160;</td><td style="text-align: left; padding-bottom: 2.5pt; color: black;">$</td><td style="text-align: right; padding-bottom: 2.5pt; color: black;">1.95</td><td style="text-align: left; padding-bottom: 2.5pt; color: black;">&#160;</td></tr></table><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><table style="width: 80%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" nowrap="nowrap"><p style="margin-top: 0px; margin-bottom: 0px;">Restricted&#160;Stock&#160;Activity&#160;for&#160;the&#160;Three</p><p style="margin-top: 0px; margin-bottom: 0px;">Months&#160;ended&#160;December&#160;31,&#160;2011</p></td><td style="padding-bottom: 1pt; color: black; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; color: black; font-weight: bold;" colspan="2" nowrap="nowrap">Shares</td><td style="padding-bottom: 1pt; color: black; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Weighted-Average<br />Grant-Date&#160;Fair&#160;Value</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="width: 52%; color: black;">Nonvested at September 30, 2011</td><td style="width: 1%; color: black;">&#160;</td><td style="text-align: left; width: 1%; color: black;">&#160;</td><td style="text-align: right; width: 10%; color: black;">403,000</td><td style="text-align: left; width: 1%; color: black;">&#160;</td><td style="width: 1%; color: black;">&#160;</td><td style="text-align: left; width: 1%; color: black;">$</td><td style="text-align: right; width: 12%; color: black;">4.02</td><td style="text-align: left; width: 1%; color: black;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="color: black;">Granted</td><td style="color: black;">&#160;</td><td style="text-align: left; color: black;">&#160;</td><td style="text-align: right; color: black;">-0-</td><td style="text-align: left; color: black;">&#160;</td><td style="color: black;">&#160;</td><td style="text-align: left; color: black;">&#160;</td><td style="text-align: right; color: black;">-0-</td><td style="text-align: left; color: black;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="color: black;">Vested</td><td style="color: black;">&#160;</td><td style="text-align: left; color: black;">&#160;</td><td style="text-align: right; color: black;">(37,500</td><td style="text-align: left; color: black;">)</td><td style="color: black;">&#160;</td><td style="text-align: left; color: black;">$</td><td style="text-align: right; color: black;">4.00</td><td style="text-align: left; color: black;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="padding-bottom: 1pt; color: black;">Cancelled</td><td style="padding-bottom: 1pt; color: black;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left; color: black;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right; color: black;">-0-</td><td style="text-align: left; padding-bottom: 1pt; color: black;">&#160;</td><td style="padding-bottom: 1pt; color: black;">&#160;</td><td style="text-align: left; padding-bottom: 1pt; color: black;">&#160;</td><td style="text-align: right; padding-bottom: 1pt; color: black;">-0-</td><td style="text-align: left; padding-bottom: 1pt; color: black;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="padding-bottom: 1pt; color: black;">Nonvested at December 31, 2011</td><td style="padding-bottom: 1pt; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">365,500</td><td style="text-align: left; padding-bottom: 1pt; color: black;">&#160;</td><td style="padding-bottom: 1pt; color: black;">&#160;</td><td style="text-align: left; padding-bottom: 1pt; color: black;">$</td><td style="text-align: right; padding-bottom: 1pt; color: black;">4.02</td><td style="text-align: left; padding-bottom: 1pt; color: black;">&#160;</td></tr></table><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">Stock Compensation Expense for the three months ended December 31, 2012 and 2011 is as follows:</p><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><table style="width: 82%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td nowrap="nowrap">&#160;</td><td style="text-align: center;" colspan="2" nowrap="nowrap">Three Months Ended</td><td nowrap="nowrap">&#160;</td><td nowrap="nowrap">&#160;</td><td style="text-align: center;" colspan="2" nowrap="nowrap">Three Months Ended</td><td nowrap="nowrap">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="padding-bottom: 1pt;" nowrap="nowrap"></td><td style="padding-bottom: 1pt;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center;" colspan="2" nowrap="nowrap">December 31, 2012</td><td style="padding-bottom: 1pt;" nowrap="nowrap">&#160;</td><td style="padding-bottom: 1pt;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center;" colspan="2" nowrap="nowrap">December 31, 2011</td><td style="padding-bottom: 1pt;" nowrap="nowrap">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td nowrap="nowrap"><u>Stock Compensation Expense</u></td><td nowrap="nowrap">&#160;</td><td style="text-align: center;" colspan="2" nowrap="nowrap">&#160;</td><td nowrap="nowrap">&#160;</td><td nowrap="nowrap">&#160;</td><td style="text-align: center;" colspan="2" nowrap="nowrap">&#160;</td><td nowrap="nowrap">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; width: 56%;">Stock Grants</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">52,461</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">60,281</td><td style="text-align: left; width: 1%;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left;">Restricted Stock Grants</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">12,618</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">109,302</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Option Grants</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">7,359</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">22,055</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 1pt;">Employee Stock Purchase Plan</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">1,078</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">2,692</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="padding-bottom: 2.5pt;">Total</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">73,516</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">194,330</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td></tr></table><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">At December 31, 2012, there was approximately $144,000 in unrecognized stock compensation cost, which is expected to be recognized over a weighted average period of eight months.</p> <p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>Note 9 &#8211; Segment, Customer and Geographical Reporting</b></p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">Segment Financial Information</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">Dynasil&#8217;s business is comprised of four segments: contract research (&#8220;Contract Research&#8221;), optics (&#8220;Optics&#8221;), instruments (&#8220;Instruments&#8221;) and biomedical (&#8220;Biomedical&#8221;). Within these segments, there is a segregation of reportable units based upon the organizational structure used to evaluate performance and make decisions on resource allocation, as well as availability and materiality of separate financial results consistent with that structure. The Contract Research segment is one of the largest small business participants in U.S. government-funded research. The Optics segment manufactures optical materials, components and coatings. The Instruments segment manufactures specialized instruments used in various applications in the medical, industrial, and homeland security/defense sectors. The Biomedical segment is developing technologies for a wide spectrum of applications, including hematology, hypothermic core cooling and tissue sealants and will primarily pursue product commercialization of technologies and technology licensing opportunities though no assurance can be given that any of these technologies will become successfully commercialized.</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The Company&#8217;s segment information for the three months ended December 31, 2012 and 2011 is summarized below:</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-align: center;" colspan="20"><b>Results&#160;of&#160;Operations&#160;for&#160;the&#160;Three&#160;Months&#160;Ended&#160;December&#160;31,</b></td><td style="font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="border-bottom: black 1pt solid; text-align: center;" colspan="20"><b>2012</b></td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Contract<br />Research</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Optics</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Instruments</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Biomedical</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Total</td><td style="font-weight: bold;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="width: 35%;">Revenue</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">4,910,840</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">4,251,940</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">1,284,038</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">106,457</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">10,553,275</td><td style="text-align: left; width: 1%;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Gross Profit</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">2,214,053</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">1,700,555</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">605,801</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">106,457</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">4,626,866</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left;">Operating Income (Loss)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(606</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">385,676</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(455,694</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(120,663</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(191,287</td><td style="text-align: left;">)</td></tr><tr style="background-color: white; vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left;">Depreciation and Amortization</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">62,782</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">185,628</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">163,048</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">15,000</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">426,458</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Capital expenditures</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">186,330</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">122,146</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">7,092</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">315,568</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Intangibles, Net</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">339,886</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">946,525</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">5,016,201</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">224,996</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">6,527,608</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td>Goodwill</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">4,938,625</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">1,310,802</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">4,015,072</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">10,264,499</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Total Assets</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">13,290,669</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">10,607,828</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">12,092,507</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">388,671</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">36,379,675</td><td style="text-align: left;">&#160;</td></tr></table><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-align: center;" colspan="20"><b>Results&#160;of&#160;Operations&#160;for&#160;the&#160;Three&#160;Months&#160;Ended&#160;December&#160;31,</b></td><td style="font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="border-bottom: black 1pt solid; text-align: center;" colspan="20"><b>2011</b></td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Contract<br />Research</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Optics</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Instruments</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Biomedical</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Total</td><td style="font-weight: bold;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="width: 35%;">Revenue</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">6,225,283</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">3,912,551</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">1,983,536</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">10,925</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">12,132,295</td><td style="text-align: left; width: 1%;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Gross Profit</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">2,440,288</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">1,462,418</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">1,251,423</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(27,181</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">5,126,948</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left;">Operating Income (Loss)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">145,217</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">164,123</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">79,544</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(202,556</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">186,328</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left;">Depreciation and Amortization</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">37,160</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">193,503</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">134,457</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">15,000</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">380,120</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Capital expenditures</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">262,020</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">140,876</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">2,445</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">405,341</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Intangibles, Net</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">429,400</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">1,075,619</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">5,493,933</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">285,000</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">7,283,952</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td>Goodwill</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">4,938,625</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">1,283,775</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">6,299,571</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">12,521,971</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Total Assets</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">11,284,826</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">13,692,936</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">15,351,880</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">384,688</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">40,714,330</td><td style="text-align: left;">&#160;</td></tr></table><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">Customer Financial Information</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;"><font style="color: black;">For the three months ended December 31, 2012 and 2011, the top three customers for the Contract Research segment were various agencies of the U.S. Government. For the three months ended December 31, 2012 and 2011, these customers </font>made up 68% and 78%, respe<font style="color: black;">ctively, of Contract Research revenue. </font></p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">For the three months ended December 31, 2012 and 2011, there was no customer in the Optics segment whose revenue represented more than 10% of the total segment revenue for the three months ended December 31, 2012 and 2011. <font style="color: red;"></font></p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif; color: red;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">For the three months ended December 31, 2012 and 2011, the top three customers for the Instruments segment made up 40% and 36%, respe<font style="color: black;">ctively, of Instruments revenue. </font></p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif; color: red;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">For the three months ended December 31, 2012, the Biomedical segment had two customers whose revenue represented 100% of the total segment revenue. There was no revenue for the three months ended December 31, 2011. <font style="color: red;"></font></p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif; color: red;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">Geographic Financial Information</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>&#160;</b></p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">Revenue by geographic location in total and as a percentage of total revenue, for the three months ended December 31, 2012 and 2011 are as follows:</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><table style="width: 82%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">Three Months Ended</td><td style="font-weight: bold;" nowrap="nowrap">&#160;</td><td style="font-weight: bold;" nowrap="nowrap">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">Three Months Ended</td><td style="font-weight: bold;" nowrap="nowrap">&#160;</td></tr><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td style="font-weight: bold;" nowrap="nowrap">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">December 31, 2012</td><td style="font-weight: bold;" nowrap="nowrap">&#160;</td><td style="font-weight: bold;" nowrap="nowrap">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">December 31, 2011</td><td style="font-weight: bold;" nowrap="nowrap">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="border-bottom: black 1pt solid; font-weight: bold;" nowrap="nowrap">Geographic Location</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Revenue</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">% of Total</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Revenue</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">% of Total</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left; width: 48%;">United States</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">8,494,488</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">80.5</td><td style="text-align: left; width: 1%;">%</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">$</td><td style="text-align: right; width: 10%;">10,028,479</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">82.7</td><td style="text-align: left; width: 1%;">%</td></tr><tr style="background-color: white; vertical-align: bottom;"><td>Europe</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">888,341</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">8.4</td><td style="text-align: left;">%</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">1,126,352</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">9.3</td><td style="text-align: left;">%</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="padding-bottom: 1pt;">Other</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">1,170,446</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">11.1</td><td style="text-align: left; padding-bottom: 1pt;">%</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">977,464</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">8.1</td><td style="text-align: left; padding-bottom: 1pt;">%</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">10,553,275</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right;">100.0</td><td style="text-align: left; padding-bottom: 2.5pt;">%</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">12,132,295</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right;">100.0</td><td style="text-align: left; padding-bottom: 2.5pt;">%</td></tr></table><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif; color: red;">&#160;</p> <p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>Note 10 - Income Taxes</b></p><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">Dynasil Corporation of America and its wholly-owned U.S. subsidiaries file a consolidated federal income tax return and various state returns. The Company&#8217;s U.K. subsidiary files tax returns in the U.K.</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The Company uses the asset and liability approach to account for income taxes. Under this approach, deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and net operating loss and tax credit carryforwards. The amount of deferred taxes on these temporary differences is determined using the tax rates that are expected to apply to the period when the asset is realized or the liability is settled, as applicable, based on tax rates, and tax laws, in the respective tax jurisdiction then in effect.</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">In assessing the ability to realize the net deferred tax assets, management considers various factors including taxable income in carryback years, future reversals of existing taxable temporary differences, tax planning strategies and projections of future taxable income, to determine whether it is more likely than not that some portion or all of the net deferred tax assets will not be realized. Based upon the Company&#8217;s recent losses and uncertainty of future profits, the Company has determined that the uncertainty regarding the realization of these assets is sufficient to warrant the need for a full valuation allowance against its U.S. net deferred tax assets. As a result, the Company recorded a valuation allowance of approximately $1.7 million.</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The Company applies the authoritative provisions related to accounting for uncertainty in income taxes. As required by these provisions, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more-likely-than-not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being reached upon ultimate settlement with the relevant tax authority. As of December 31, 2012 and September 30, 2012, the Company has no unrecorded liabilities for uncertain tax positions. Interest and penalty charges, if any, related to uncertain tax positions would be classified as income tax expense in the accompanying consolidated statement of operations. As of December 31, 2012 and September 30, 2012, the Company had no accrued interest or penalties related to uncertain tax positions. The Company currently has no federal or state tax examinations in progress.</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The effective rate of (0.34%) for the three months ended December 31, 2012 differs from the U.S. federal statutory income tax rate of 34% primarily due to a full valuation allowance against the Company&#8217;s U.S. deferred tax asset. The effective rate of (96.85%) for the three months ended December 31, 2011 is primarily due to the recognition of research credits.</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The Company files its tax returns as prescribed by the tax laws of the jurisdictions in which it operates. The Company&#8217;s tax filings for federal and state jurisdictions for the tax years beginning with 2009 are still subject to examination.</p> <p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>Note 11 &#8211; Fair Value Measurements</b></p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">The Company uses a fair value hierarchy that prioritizes the inputs to valuation methods used to measure fair value. <font style="color: black;">Assets and liabilities measured at fair value are to be categorized into one of the three hierarchy levels based on the inputs used in the valuation. </font>The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of fair value hierarchy are as follows:</p><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px 0pt 0.5in; font: 10pt times new roman, times, serif;">&#8226; <b>Level 1: </b>Observable inputs based on quoted prices (unadjusted) in active markets for identical assets or liabilities.</p><p style="text-align: justify; margin: 0pt 0px 0pt 0.5in; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px 0pt 0.5in; font: 10pt times new roman, times, serif;">&#8226; <b>Level 2: </b>Observable inputs based on quoted prices for similar assets and liabilities in active markets, or quoted prices for identical assets and liabilities in inactive markets.</p><p style="text-align: justify; margin: 0pt 0px 0pt 0.5in; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px 0pt 0.5in; font: 10pt times new roman, times, serif;">&#8226; <b>Level 3: </b>Unobservable inputs that reflect an entity&#8217;s own assumptions about what inputs a market participant would use in pricing the asset or liability based on the best information available in the circumstances.</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">A financial instrument&#8217;s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The carrying amounts reported in the consolidated balance sheets for cash and cash equivalents, accounts receivable and accounts payable approximate fair value because of the immediate or short-term maturity of these financial instruments. The carrying amounts for fixed rate long-term debt and variable rate long term debt approximate fair value because the underlying instruments are primarily at current market rates available to the Company for similar borrowings.</p> <p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>Note 11 &#8211; Subsequent Events</b></p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The Company has evaluated subsequent events through the date that the financial statements were released.</p> <p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">Inventories, net of reserves, consists of the following:</p><p style="text-align: center; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><table style="width: 65%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-align: center; vertical-align: top;" nowrap="nowrap"><b>&#160;</b></td><td style="text-align: center; vertical-align: top;" nowrap="nowrap"><b>&#160;</b></td><td style="text-align: center; vertical-align: top;" colspan="2" nowrap="nowrap"><b>December 31,</b></td><td style="text-align: center; vertical-align: top;" nowrap="nowrap"><b>&#160;</b></td><td style="text-align: center; vertical-align: top;" nowrap="nowrap"><b>&#160;</b></td><td style="text-align: center; vertical-align: top;" colspan="2" nowrap="nowrap"><b>September 30,</b></td><td style="text-align: center; vertical-align: top;" nowrap="nowrap"><b>&#160;</b></td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2">2012</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2">2012</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left; width: 58%;">Raw Materials</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">$</td><td style="text-align: right; width: 18%;">2,334,613</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">$</td><td style="text-align: right; width: 18%;">2,096,681</td><td style="text-align: left; width: 1%;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td>Work-in-Process</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">689,134</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">885,328</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 1pt;">Finished Goods</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">526,963</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">289,691</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">3,550,710</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">3,271,700</td></tr></table> <p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">Intangible assets at December 31, 2012 and September 30, 2012 consist of the following:</p><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><table style="width: 80%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;">Useful</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Gross</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Accumulated</td><td style="font-weight: bold;">&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom;"><td style="border-bottom: black 1pt solid; font-weight: bold;">December&#160;31,&#160;2012</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;">Life&#160;(years)</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2">Amount</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2">Amortization</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2">Net</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left; width: 28%;">Acquired Customer Base</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: center; width: 10%;"><font style="font: 10pt times new roman, times, serif;">5-15</font></td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">$</td><td style="text-align: right; width: 10%;">7,858,775</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">$</td><td style="text-align: right; width: 10%;">2,387,612</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">$</td><td style="text-align: right; width: 10%;">5,471,163</td><td style="text-align: left; width: 1%;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Know How</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: center;">15</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">512,000</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">172,115</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">339,885</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left;">Trade Names</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: center;" nowrap="nowrap"><font style="font: 10pt times new roman, times, serif;">15 - Indefinite</font></td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">558,435</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">66,872</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">491,563</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 1pt;">Biomedical Technologies</td><td style="padding-bottom: 1pt;">&#160;</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="text-align: center; padding-bottom: 1pt;">5</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">300,000</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">75,003</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">224,997</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="text-align: center; padding-bottom: 2.5pt;">&#160;</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">9,229,210</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">2,701,602</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">6,527,608</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td></tr></table><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><table style="width: 80%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;">Useful</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Gross</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Accumulated</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">&#160;</td><td style="font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="border-bottom: black 1pt solid; font-weight: bold;">September&#160;30,&#160;2012</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;">Life&#160;(years)</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2">Amount</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2">Amortization</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2">Net</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left; width: 28%;">Acquired Customer Base</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: center; width: 10%;"><font style="font: 10pt times new roman, times, serif;">5-15</font></td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">$</td><td style="text-align: right; width: 10%;">7,858,775</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">$</td><td style="text-align: right; width: 10%;">2,257,533</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">$</td><td style="text-align: right; width: 10%;">5,601,242</td><td style="text-align: left; width: 1%;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Know How</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: center;">15</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">512,000</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">145,147</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">366,853</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left;">Trade Names</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: center;" nowrap="nowrap"><font style="font: 10pt times new roman, times, serif;">15 - Indefinite</font></td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">558,435</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">63,222</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">495,213</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 1pt;">Biomedical Technologies</td><td style="padding-bottom: 1pt;">&#160;</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="text-align: center; padding-bottom: 1pt;">5</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">300,000</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">60,003</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">239,997</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="text-align: center; padding-bottom: 2.5pt;">&#160;</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">9,229,210</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">2,525,905</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">6,703,305</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td></tr></table><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">Amortization expense for the three months ended December 31, 2012 and 2011 was $181,268 and $162,803<font style="color: red;"></font>respectively. Estimated amortization expense for each of the next five fiscal years is as follows:</p><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>&#160;</b></p><table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center;" colspan="2">2013&#160;(9&#160;Months)</td><td style="padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center;" colspan="2">2014</td><td style="padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center;" colspan="2">2015</td><td style="padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center;" colspan="2">2016</td><td style="padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center;" colspan="2">2017</td><td style="padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center;" colspan="2">Thereafter</td><td style="padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center;" colspan="2">Total</td><td style="padding-bottom: 1pt;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left; width: 30%;">Acquired Customer Base</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">$</td><td style="text-align: right; width: 7%;">406,961</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">$</td><td style="text-align: right; width: 7%;">542,615</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">$</td><td style="text-align: right; width: 7%;">542,615</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">$</td><td style="text-align: right; width: 7%;">542,615</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">$</td><td style="text-align: right; width: 7%;">542,615</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">$</td><td style="text-align: right; width: 7%;">2,893,742</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">$</td><td style="text-align: right; width: 7%;">5,471,163</td><td style="text-align: left; width: 1%;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Know How</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">25,600</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">34,133</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">34,133</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">34,133</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">34,133</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">177,753</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">339,885</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left;">Trade Names</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">10,950</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">14,600</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">14,600</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">14,600</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">14,600</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">81,992</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">151,342</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 1pt;">Biomedical Technologies</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">45,000</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">60,000</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">60,000</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">59,997</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">-0-</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">-0-</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">224,997</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">488,511</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">651,348</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">651,348</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">651,345</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">591,348</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">3,153,487</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">6,187,387</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td></tr></table><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b></b>&#160;</p> <p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">The computation of the weighted shares outstanding for the three months ended December 31 is as follows:</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><table style="width: 80%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31, 2012</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31, 2011</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td>Weighted average shares outstanding</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="padding-left: 0.25in; width: 66%;">Basic</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 14%;">14,673,356</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 14%;">15,583,103</td><td style="text-align: left; width: 1%;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left; padding-left: 0.25in;">Effect of dilutive securities</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 1pt; padding-left: 27pt;">Stock Options</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">0</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">100,731</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="padding-bottom: 2.5pt; padding-left: 0.25in;">Dilutive Average Shares Outstanding</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right;">14,673,356</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right;">15,683,834</td></tr></table> <p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">A summary of stock option activity for the three months ended December 31, 2012 is presented below:</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif; color: red;">&#160;</p><table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td style="padding-bottom: 1pt; color: black; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; color: black; font-weight: bold;" colspan="2" nowrap="nowrap">Options<br />Outstanding</td><td style="padding-bottom: 1pt; color: black; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="padding-bottom: 1pt; color: black; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; color: black; font-weight: bold;" colspan="2" nowrap="nowrap">Weighted&#160;Average<br />Exercise&#160;Price&#160;per<br />Share&#160;($)</td><td style="padding-bottom: 1pt; color: black; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="padding-bottom: 1pt; color: black; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; color: black; font-weight: bold;" colspan="2" nowrap="nowrap">Weighted&#160;Average<br />Remain&#160;Contractual<br />Term&#160;(in&#160;Years)</td><td style="padding-bottom: 1pt; color: black; font-weight: bold;" nowrap="nowrap">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="padding-bottom: 2.5pt; width: 61%; color: black;">Balance at September 30, 2012</td><td style="padding-bottom: 2.5pt; width: 1%; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; width: 1%; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; width: 10%; color: black;">794,483</td><td style="text-align: left; padding-bottom: 2.5pt; width: 1%; color: black;">&#160;</td><td style="padding-bottom: 2.5pt; width: 1%; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; width: 1%; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; width: 10%; color: black;">3.34</td><td style="text-align: left; padding-bottom: 2.5pt; width: 1%; color: black;">&#160;</td><td style="padding-bottom: 2.5pt; width: 1%; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; width: 1%; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; width: 10%; color: black;">1.75</td><td style="text-align: left; padding-bottom: 2.5pt; width: 1%; color: black;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2.5pt; color: black;">Outstanding and exercisable at September 30, 2012</td><td style="padding-bottom: 2.5pt; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">794,483</td><td style="text-align: left; padding-bottom: 2.5pt; color: black;">&#160;</td><td style="padding-bottom: 2.5pt; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">3.34</td><td style="text-align: left; padding-bottom: 2.5pt; color: black;">&#160;</td><td style="padding-bottom: 2.5pt; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">1.75</td><td style="text-align: left; padding-bottom: 2.5pt; color: black;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="color: black;">Granted</td><td style="color: black;">&#160;</td><td style="text-align: left; color: black;">&#160;</td><td style="text-align: right; color: black;">0</td><td style="text-align: left; color: black;">&#160;</td><td style="color: black;">&#160;</td><td style="text-align: left; color: black;">&#160;</td><td style="text-align: right; color: black;">0</td><td style="text-align: left; color: black;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="color: black;">Exercised</td><td style="color: black;">&#160;</td><td style="text-align: left; color: black;">&#160;</td><td style="text-align: right; color: black;">0</td><td style="text-align: left; color: black;">&#160;</td><td style="color: black;">&#160;</td><td style="text-align: left; color: black;">&#160;</td><td style="text-align: right; color: black;">0</td><td style="text-align: left; color: black;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="padding-bottom: 1pt; color: black;">Cancelled</td><td style="padding-bottom: 1pt; color: black;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left; color: black;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right; color: black;">(20,000</td><td style="text-align: left; padding-bottom: 1pt; color: black;">)</td><td style="padding-bottom: 1pt; color: black;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left; color: black;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right; color: black;">4.06</td><td style="text-align: left; padding-bottom: 1pt; color: black;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="text-align: right; padding-bottom: 1pt;">&#160;</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="padding-bottom: 2.5pt; color: black;">Balance at December 31, 2012</td><td style="padding-bottom: 2.5pt; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">&#160;&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">774,483</td><td style="text-align: left; padding-bottom: 2.5pt; color: black;">&#160;</td><td style="padding-bottom: 2.5pt; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">3.32</td><td style="text-align: left; padding-bottom: 2.5pt; color: black;">&#160;</td><td style="padding-bottom: 2.5pt; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">1.54</td><td style="text-align: left; padding-bottom: 2.5pt; color: black;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2.5pt; color: black;">Outstanding and exercisable at December 31, 2012</td><td style="padding-bottom: 2.5pt; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">&#160;&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">774,483</td><td style="text-align: left; padding-bottom: 2.5pt; color: black;">&#160;</td><td style="padding-bottom: 2.5pt; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">3.32</td><td style="text-align: left; padding-bottom: 2.5pt; color: black;">&#160;</td><td style="padding-bottom: 2.5pt; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">1.54</td><td style="text-align: left; padding-bottom: 2.5pt; color: black;">&#160;</td></tr></table><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif; color: red;">&#160;</p> <p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">A summary of restricted stock activity for the three months ended December 31, 2012 and 2011 is presented below:</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><table style="width: 80%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" nowrap="nowrap">Restricted&#160;Stock&#160;Activity&#160;for&#160;the&#160;Three<br />Months&#160;ended&#160;December&#160;31,&#160;2012</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Shares</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Weighted-Average<br />Grant-Date&#160;Fair&#160;Value</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left; width: 52%; color: black;"><font style="font: 10pt times new roman, times, serif; color: black;">Nonvested at September 30, 2012</font></td><td style="text-align: left; width: 1%; color: black;">&#160;</td><td style="text-align: left; width: 1%; color: black;">&#160;</td><td style="text-align: right; width: 10%; color: black;">127,834</td><td style="text-align: left; width: 1%; color: black;">&#160;</td><td style="width: 1%; color: black;">&#160;</td><td style="text-align: left; width: 1%; color: black;">$</td><td style="text-align: right; width: 12%; color: black;">1.92</td><td style="text-align: left; width: 1%; color: black;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left; color: black;"><font style="font: 10pt times new roman, times, serif; color: black;">Granted </font></td><td style="text-align: left; color: black;">&#160;</td><td style="text-align: left; color: black;">&#160;</td><td style="text-align: right; color: black;">4,000</td><td style="text-align: left; color: black;">&#160;</td><td style="color: black;">&#160;</td><td style="text-align: left; color: black;">$</td><td style="text-align: right; color: black;">1.45</td><td style="text-align: left; color: black;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; color: black;"><font style="font: 10pt times new roman, times, serif; color: black;">Vested </font></td><td style="text-align: left; color: black;">&#160;</td><td style="text-align: left; color: black;">&#160;</td><td style="text-align: right; color: black;">(15,000</td><td style="text-align: left; color: black;">)</td><td style="color: black;">&#160;</td><td style="text-align: left; color: black;">$</td><td style="text-align: right; color: black;">1.53</td><td style="text-align: left; color: black;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 1pt; color: black;"><font style="font: 10pt times new roman, times, serif; color: black;">Cancelled </font></td><td style="text-align: left; padding-bottom: 1pt; color: black;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left; color: black;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right; color: black;">-0-</td><td style="text-align: left; padding-bottom: 1pt; color: black;">&#160;</td><td style="padding-bottom: 1pt; color: black;">&#160;</td><td style="text-align: left; padding-bottom: 1pt; color: black;">&#160;</td><td style="text-align: right; padding-bottom: 1pt; color: black;">-0-</td><td style="text-align: left; padding-bottom: 1pt; color: black;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2.5pt; color: black;"><font style="font: 10pt times new roman, times, serif; color: black;">Nonvested at December 31, 2012</font></td><td style="text-align: left; padding-bottom: 2.5pt; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">116,834</td><td style="text-align: left; padding-bottom: 2.5pt; color: black;">&#160;</td><td style="padding-bottom: 2.5pt; color: black;">&#160;</td><td style="text-align: left; padding-bottom: 2.5pt; color: black;">$</td><td style="text-align: right; padding-bottom: 2.5pt; color: black;">1.95</td><td style="text-align: left; padding-bottom: 2.5pt; color: black;">&#160;</td></tr></table><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><table style="width: 80%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" nowrap="nowrap"><p style="margin-top: 0px; margin-bottom: 0px;">Restricted&#160;Stock&#160;Activity&#160;for&#160;the&#160;Three</p><p style="margin-top: 0px; margin-bottom: 0px;">Months&#160;ended&#160;December&#160;31,&#160;2011</p></td><td style="padding-bottom: 1pt; color: black; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; color: black; font-weight: bold;" colspan="2" nowrap="nowrap">Shares</td><td style="padding-bottom: 1pt; color: black; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Weighted-Average<br />Grant-Date&#160;Fair&#160;Value</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="width: 52%; color: black;">Nonvested at September 30, 2011</td><td style="width: 1%; color: black;">&#160;</td><td style="text-align: left; width: 1%; color: black;">&#160;</td><td style="text-align: right; width: 10%; color: black;">403,000</td><td style="text-align: left; width: 1%; color: black;">&#160;</td><td style="width: 1%; color: black;">&#160;</td><td style="text-align: left; width: 1%; color: black;">$</td><td style="text-align: right; width: 12%; color: black;">4.02</td><td style="text-align: left; width: 1%; color: black;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="color: black;">Granted</td><td style="color: black;">&#160;</td><td style="text-align: left; color: black;">&#160;</td><td style="text-align: right; color: black;">-0-</td><td style="text-align: left; color: black;">&#160;</td><td style="color: black;">&#160;</td><td style="text-align: left; color: black;">&#160;</td><td style="text-align: right; color: black;">-0-</td><td style="text-align: left; color: black;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="color: black;">Vested</td><td style="color: black;">&#160;</td><td style="text-align: left; color: black;">&#160;</td><td style="text-align: right; color: black;">(37,500</td><td style="text-align: left; color: black;">)</td><td style="color: black;">&#160;</td><td style="text-align: left; color: black;">$</td><td style="text-align: right; color: black;">4.00</td><td style="text-align: left; color: black;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="padding-bottom: 1pt; color: black;">Cancelled</td><td style="padding-bottom: 1pt; color: black;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left; color: black;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right; color: black;">-0-</td><td style="text-align: left; padding-bottom: 1pt; color: black;">&#160;</td><td style="padding-bottom: 1pt; color: black;">&#160;</td><td style="text-align: left; padding-bottom: 1pt; color: black;">&#160;</td><td style="text-align: right; padding-bottom: 1pt; color: black;">-0-</td><td style="text-align: left; padding-bottom: 1pt; color: black;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="padding-bottom: 1pt; color: black;">Nonvested at December 31, 2011</td><td style="padding-bottom: 1pt; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right; color: black;">365,500</td><td style="text-align: left; padding-bottom: 1pt; color: black;">&#160;</td><td style="padding-bottom: 1pt; color: black;">&#160;</td><td style="text-align: left; padding-bottom: 1pt; color: black;">$</td><td style="text-align: right; padding-bottom: 1pt; color: black;">4.02</td><td style="text-align: left; padding-bottom: 1pt; color: black;">&#160;</td></tr></table> <div style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;<p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">Stock Compensation Expense for the three months ended December 31, 2012 and 2011 is as follows:</p><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><table style="width: 82%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td nowrap="nowrap">&#160;</td><td style="text-align: center;" colspan="2" nowrap="nowrap">Three Months Ended</td><td nowrap="nowrap">&#160;</td><td nowrap="nowrap">&#160;</td><td style="text-align: center;" colspan="2" nowrap="nowrap">Three Months Ended</td><td nowrap="nowrap">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="padding-bottom: 1pt;" nowrap="nowrap"></td><td style="padding-bottom: 1pt;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center;" colspan="2" nowrap="nowrap">December 31, 2012</td><td style="padding-bottom: 1pt;" nowrap="nowrap">&#160;</td><td style="padding-bottom: 1pt;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center;" colspan="2" nowrap="nowrap">December 31, 2011</td><td style="padding-bottom: 1pt;" nowrap="nowrap">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td nowrap="nowrap"><u>Stock Compensation Expense</u></td><td nowrap="nowrap">&#160;</td><td style="text-align: center;" colspan="2" nowrap="nowrap">&#160;</td><td nowrap="nowrap">&#160;</td><td nowrap="nowrap">&#160;</td><td style="text-align: center;" colspan="2" nowrap="nowrap">&#160;</td><td nowrap="nowrap">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; width: 56%;">Stock Grants</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">52,461</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">60,281</td><td style="text-align: left; width: 1%;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left;">Restricted Stock Grants</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">12,618</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">109,302</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Option Grants</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">7,359</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">22,055</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 1pt;">Employee Stock Purchase Plan</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">1,078</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">2,692</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="padding-bottom: 2.5pt;">Total</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">73,516</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">194,330</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td></tr></table></div> <p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The Company&#8217;s segment information for the three months ended December 31, 2012 and 2011 is summarized below:</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;&#160;</p><table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-align: center;" colspan="20"><b>Results&#160;of&#160;Operations&#160;for&#160;the&#160;Three&#160;Months&#160;Ended&#160;December&#160;31,</b></td><td style="font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="border-bottom: black 1pt solid; text-align: center;" colspan="20"><b>2012</b></td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Contract<br />Research</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Optics</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Instruments</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Biomedical</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Total</td><td style="font-weight: bold;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="width: 35%;">Revenue</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">4,910,840</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">4,251,940</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">1,284,038</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">106,457</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">10,553,275</td><td style="text-align: left; width: 1%;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Gross Profit</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">2,214,053</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">1,700,555</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">605,801</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">106,457</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">4,626,866</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left;">Operating Income (Loss)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(606</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">385,676</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(455,694</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(120,663</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(191,287</td><td style="text-align: left;">)</td></tr><tr style="background-color: white; vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left;">Depreciation and Amortization</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">62,782</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">185,628</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">163,048</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">15,000</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">426,458</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Capital expenditures</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">186,330</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">122,146</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">7,092</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">315,568</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Intangibles, Net</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">339,886</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">946,525</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">5,016,201</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">224,996</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">6,527,608</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td>Goodwill</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">4,938,625</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">1,310,802</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">4,015,072</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">10,264,499</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Total Assets</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">13,290,669</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">10,607,828</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">12,092,507</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">388,671</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">36,379,675</td><td style="text-align: left;">&#160;</td></tr></table><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-align: center;" colspan="20"><b>Results&#160;of&#160;Operations&#160;for&#160;the&#160;Three&#160;Months&#160;Ended&#160;December&#160;31,</b></td><td style="font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="border-bottom: black 1pt solid; text-align: center;" colspan="20"><b>2011</b></td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Contract<br />Research</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Optics</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Instruments</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Biomedical</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Total</td><td style="font-weight: bold;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="width: 35%;">Revenue</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">6,225,283</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">3,912,551</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">1,983,536</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">10,925</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">12,132,295</td><td style="text-align: left; width: 1%;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Gross Profit</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">2,440,288</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">1,462,418</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">1,251,423</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(27,181</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">5,126,948</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left;">Operating Income (Loss)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">145,217</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">164,123</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">79,544</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(202,556</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">186,328</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left;">Depreciation and Amortization</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">37,160</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">193,503</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">134,457</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">15,000</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">380,120</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Capital expenditures</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">262,020</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">140,876</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">2,445</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">405,341</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Intangibles, Net</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">429,400</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">1,075,619</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">5,493,933</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">285,000</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">7,283,952</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td>Goodwill</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">4,938,625</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">1,283,775</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">6,299,571</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">12,521,971</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Total Assets</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">11,284,826</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">13,692,936</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">15,351,880</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">384,688</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">40,714,330</td><td style="text-align: left;"></td></tr></table><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">Revenue by geographic location in total and as a percentage of total revenue, for the three months ended December 31, 2012 and 2011 are as follows:</p><p style="text-align: justify; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p><table style="width: 82%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">Three Months Ended</td><td style="font-weight: bold;" nowrap="nowrap">&#160;</td><td style="font-weight: bold;" nowrap="nowrap">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">Three Months Ended</td><td style="font-weight: bold;" nowrap="nowrap">&#160;</td></tr><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td style="font-weight: bold;" nowrap="nowrap">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">December 31, 2012</td><td style="font-weight: bold;" nowrap="nowrap">&#160;</td><td style="font-weight: bold;" nowrap="nowrap">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">December 31, 2011</td><td style="font-weight: bold;" nowrap="nowrap">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="border-bottom: black 1pt solid; font-weight: bold;" nowrap="nowrap">Geographic Location</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Revenue</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">% of Total</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Revenue</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">% of Total</td><td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="text-align: left; width: 48%;">United States</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">8,494,488</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">80.5</td><td style="text-align: left; width: 1%;">%</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">$</td><td style="text-align: right; width: 10%;">10,028,479</td><td style="text-align: left; width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="text-align: left; width: 1%;">&#160;</td><td style="text-align: right; width: 10%;">82.7</td><td style="text-align: left; width: 1%;">%</td></tr><tr style="background-color: white; vertical-align: bottom;"><td>Europe</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">888,341</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">8.4</td><td style="text-align: left;">%</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">1,126,352</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">9.3</td><td style="text-align: left;">%</td></tr><tr style="background-color: #ccffcc; vertical-align: bottom;"><td style="padding-bottom: 1pt;">Other</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">1,170,446</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">11.1</td><td style="text-align: left; padding-bottom: 1pt;">%</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">977,464</td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td><td style="border-bottom: black 1pt solid; text-align: right;">8.1</td><td style="text-align: left; padding-bottom: 1pt;">%</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">10,553,275</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right;">100.0</td><td style="text-align: left; padding-bottom: 2.5pt;">%</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">$</td><td style="border-bottom: black 2.5pt double; text-align: right;">12,132,295</td><td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td><td style="padding-bottom: 2.5pt;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: left;">&#160;</td><td style="border-bottom: black 2.5pt double; text-align: right;">100.0</td><td style="text-align: left; padding-bottom: 2.5pt;">%</td></tr></table><p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> 5.00 2096681 2334613 885328 689134 289691 526963 P15Y P5Y P5Y P15Y P15Y P0Y P15Y P5Y P5Y P15Y P15Y P0Y 9229210 300000 512000 558435 7858775 9229210 300000 512000 558435 7858775 2525905 60003 145147 63222 2257533 2701602 75003 172115 66872 2387612 488511 45000 25600 10950 406961 651348 60000 34133 14600 542615 651348 60000 34133 14600 542615 651345 59997 34133 14600 542615 591348 0 34133 14600 542615 3153487 0 177753 81992 2893742 6187387 224997 339885 151342 5471163 162803 181268 100731 0 100731 815624 774483 116834 794483 774483 794483 774483 0 0 -20000 3.34 3.32 3.34 3.32 0 0 4.06 P1Y9M P1Y6M14D P1Y9M P1Y6M14D 403000 365500 127834 116834 0 4000 -37500 -15000 0 0 4.02 4.02 1.92 1.95 0 1.45 4.00 1.53 0 0 194330 109302 60281 22055 2692 73516 12618 52461 7359 1078 144000 1.00 0.36 0.827 0.093 0.081 1.00 0.40 1.00 0.805 0.084 0.111 0.78 0.10 0.68 0.10 1700000 -0.0034 0.34 -0.9685 DYNASIL CORP OF AMERICA 0000030831 --09-30 Smaller Reporting Company dysl 14960200 10-Q false 2012-12-31 Q1 2013 Indefinite EX-101.SCH 8 dysl-20121231.xsd XBRL TAXONOMY EXTENSION SCHEMA 001 - Document - DOCUMENT AND ENTITY INFORMATION link:presentationLink link:definitionLink link:calculationLink 002 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 003 - Statement - CONSOLIDATED BALANCE SHEETS [Parenthetical] link:presentationLink link:definitionLink link:calculationLink 004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY link:presentationLink link:definitionLink link:calculationLink 006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Basis of Presentation and Ability to Continue as a Going Concern link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Debt Classification link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Inventories link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Costs in Excess of Billings and Unbilled Receivables link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Intangible Assets link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Goodwill link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Earnings (Loss) Per Common Share link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Stock Based Compensation link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Segment, Customer and Geographical Reporting link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Inventories (Tables) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Intangible Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Earnings (Loss) Per Common Share (Tables) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Stock Based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Segment, Customer and Geographical Reporting (Tables) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Basis of Presentation and Ability to Continue as a Going Concern (Details Textual) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Inventories (Details) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Intangible Assets (Details) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Intangible Assets (Details 1) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Intangible Assets (Details Textual) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Earnings (Loss) Per Common Share (Details) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Earnings (Loss) Per Common Share (Details Textual) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Stock Based Compensation (Details) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Stock Based Compensation (Details 1) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Stock Based Compensation (Details 2) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Stock Based Compensation (Details Textual) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Segment, Customer and Geographical Reporting (Details) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Segment, Customer and Geographical Reporting (Details 1) link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Segment, Customer and Geographical Reporting (Details Textual) link:presentationLink link:definitionLink link:calculationLink 038 - Disclosure - Income Taxes (Details Textual) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 9 dysl-20121231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 10 dysl-20121231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 11 dysl-20121231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 12 dysl-20121231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 13 R33.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Based Compensation (Details 2) (USD $)
3 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Total $ 73,516 $ 194,330
Stock Grants [Member]
   
Total 52,461 60,281
Restricted Stock [Member]
   
Total 12,618 109,302
Stock Option [Member]
   
Total 7,359 22,055
Employee Stock Option [Member]
   
Total $ 1,078 $ 2,692
XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
Inventories (Details) (USD $)
Dec. 31, 2012
Sep. 30, 2012
Raw Materials $ 2,334,613 $ 2,096,681
Work-in-Process 689,134 885,328
Finished Goods 526,963 289,691
Inventory, Net, Total $ 3,550,710 $ 3,271,700
XML 16 R37.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment, Customer and Geographical Reporting (Details Textual)
3 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Entity-Wide Revenue, Major Customer, Percentage 68.00% 78.00%
Concentration Risk, Percentage 100.00% 100.00%
Optics [Member] | Maximum [Member]
   
Entity-Wide Revenue, Major Customer, Percentage 10.00% 10.00%
Customer Concentration Risk [Member]
   
Concentration Risk, Percentage 40.00% 36.00%
Sales Revenue, Segment [Member]
   
Concentration Risk, Percentage 100.00%  
XML 17 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Inventories
3 Months Ended
Dec. 31, 2012
Inventory Disclosure [Abstract]  
Inventory Disclosure [Text Block]

Note 3 - Inventories

 

Inventories are stated at the lower of average cost or market. Cost is determined using the first-in, first-out (FIFO) method. Inventories consist of raw materials, work-in-process and finished goods. The Company evaluates inventory levels and expected usage on a periodic basis and records, as a charge to cost of revenue, any amounts required to reduce the carrying value to net realizable value.

 

Inventories, net of reserves, consists of the following:

 

  December 31,  September 30, 
  2012  2012 
Raw Materials $2,334,613  $2,096,681 
Work-in-Process  689,134   885,328 
Finished Goods  526,963   289,691 
  $3,550,710  $3,271,700 
EXCEL 18 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\V-V8R-S,U95\Q,31F7S0T8C9?831B8E]F,V4Y M860P,C=D,S0B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DEN=F5N=&]R:65S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T M4V]U#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/D5A#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/E-T;V-K7T)A#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/E-E9VUE;G1?0W5S=&]M97)?86YD7T=E;V=R87!H:3PO>#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/DEN8V]M95]487AE#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D9A:7)?5F%L=65?365A M#I%>&-E M;%=O#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E M;%=O#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/D)A#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/DEN=&%N M9VEB;&5?07-S971S7T1E=&%I;'-?,3PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DEN=&%N9VEB;&5?07-S971S7T1E=&%I;'-?5&5X M=#PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O M#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/E-T;V-K7T)A#I7;W)K#I%>&-E;%=O#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O&5S7T1E=&%I;'-?5&5X='5A;#PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I!8W1I=F53:&5E=#X- M"B`@/'@Z4')O=&5C=%-T#I0#I0#I0&UL/CPA6V5N9&EF72TM M/@T*/"]H96%D/@T*("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S:&]U;&0@ M8F4@;W!E;F5D('=I=&@@36EC'1087)T7S8W M9C(W,S5E7S$Q-&9?-#1B-E]A-&)B7V8S93EA9#`R-V0S-`T*0V]N=&5N="U, M;V-A=&EO;CH@9FEL93HO+R]#.B\V-V8R-S,U95\Q,31F7S0T8C9?831B8E]F M,V4Y860P,C=D,S0O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^1%E.05-)3"!#3U)0($]&($%-15))0T$\2!#96YT3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^,#`P,#`S,#@S,3QS<&%N/CPO'0^+2TP.2TS,#QS M<&%N/CPO'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^9'ES;#QS<&%N M/CPO'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^9F%L M'0^1&5C(#,Q+`T*"0DR,#$R/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M&-E'!E;G-E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA2!S=&]C:R`M(&%T(&-O3PO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V-V8R M-S,U95\Q,31F7S0T8C9?831B8E]F,V4Y860P,C=D,S0-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO-C=F,C'0O:'1M;#L@8VAA'!E;G-E'!E;G-E"`H8F5N969I="D@<')O=FES:6]N/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S-S@L,#0T*3QS<&%N/CPO"`H8F5N969I="D@<')O=FES:6]N/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M<#XQ+#(Y.#QS<&%N/CPO'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E;G-E/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW,RPU,38\2P@<&QA;G0@86YD(&5Q=6EP;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S MF%T M:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,C8L-#4X/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!R M97-E&5S/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XQ+#4S,CQS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&-E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$&-H86YG92!R871E'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'`@6QE/3-$)W1E>'0M86QI9VXZ M(&IU#L@9F]N=#H@,3!P="!T:6UE28C.#(R M,3LI+"!A;F0@=&AE(')E;&%T960@:6YF;W)M871I;VX@8V]N=&%I;F5D(&EN M('1H97-E(&YO=&5S(&AA=F4@8F5E;B!P2!M86YA9V5M96YT M(&%N9"!A2!I M;F1I8V%T:79E(&]F(&]P97)A=&EN9R!R97-U;'1S(&9O65A M3L@;6%R9VEN M.B`P<'0@,'!X.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L M('-E6QE/3-$)W1E>'0M86QI9VXZ(&IU M#L@9F]N=#H@,3!P="!T:6UE'!E;G-E3L@;6%R9VEN.B`P<'0@,'!X.R!F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;BP@=&EM97,L('-E6QE/3-$ M)W1E>'0M86QI9VXZ(&IU#L@9F]N=#H@ M,3!P="!T:6UE2!A8V-E<'1E9"!I;B!T:&4@56YI=&5D M(%-T871E65A3L@;6%R9VEN.B`P<'0@,'!X.R!F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;BP@=&EM97,L('-E6QE/3-$ M)W1E>'0M86QI9VXZ(&IU#L@9F]N=#H@ M,3!P="!T:6UEF%T:6]N("A%0DE41$$I('1O(&9I>&5D(&-H87)G97,@ M86YD('1O('1O=&%L+W-E;FEO28C.#(Q-SMS('-E M;FEO2P@870@:71S(&]P=&EO;BP@:6UP;W-E(&$@9&5F M875L="!I;G1E2!S=6-H(&%C=&EO;G,N($AO=V5V97(L M('1H92!#;VUP86YY(&-A;FYO="!P3L@;6%R9VEN M.B`P<'0@,'!X.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L M('-E6QE/3-$)W1E>'0M86QI9VXZ(&IU M#L@9F]N=#H@,3!P="!T:6UE2`Q,RP@,C`Q,RP@=&AE(&1A=&4@;V8@=&AI2!O M9B!A;GD@3L@;6%R9VEN.B`P<'0@,'!X.R!F M;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L('-E2!T;R!G M96YE2!F:6YA;F-I;F<@9G)O;2!S:&%R96AO;&1E3L@;6%R9VEN.B`P<'0@,'!X.R!F M;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L('-E6QE/3-$)W1E>'0M86QI9VXZ(&IU#L@9F]N=#H@,3!P="!T:6UE2!A9&IU&ES=&5N8V4N/"]P/CQP('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&IU#L@9F]N=#H@,3!P="!T:6UE M2!H87,@2P@:6YC M;'5D:6YG('1H92!I;7!L96UE;G1A=&EO;B!O9B!A(&YU;6)E2!H879E(&-A2!I2!T:')O=6=H('1H M92!A8W1I;VYS(&1E6QE/3-$)W1E>'0M86QI9VXZ(&IU#L@ M9F]N=#H@,3!P="!T:6UE2!297!O'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)W1E>'0M86QI9VXZ(&IU#L@9F]N=#H@,3!P="!T:6UE3L@;6%R9VEN.B`P<'0@,'!X.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R M;VUA;BP@=&EM97,L('-E6QE/3-$)W1E M>'0M86QI9VXZ(&IU#L@9F]N=#H@,3!P M="!T:6UE'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!$:7-C;&]S=7)E(%M497AT M($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'`@3L@;6%R9VEN.B`P<'0@,'!X.R!F M;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L('-E6QE/3-$)W1E>'0M M86QI9VXZ(&IU#L@9F]N=#H@,3!P="!T M:6UE2!E=F%L=6%T97,@:6YV M96YT;W)Y(&QE=F5L6QE/3-$)W=I9'1H.B`V-24[(&)O6QE/3-$)W1E M>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)W!A M9&1I;F6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`U."4[)SY287<@36%T97)I86QS/"]T M9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,3@E.R<^,BPS M,S0L-C$S/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!W:61T:#H@,3@E.R<^,BPP.38L-C@Q/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#LG/C@X-2PS,C@\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L M969T.R<^)B,Q-C`[/"]T9#X\+W1R/CQT6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0[)SXF M(S$V,#L\+W1D/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q M<'0@'0M86QI9VXZ(')I9VAT.R<^-3(V+#DV,SPO=&0^/'1D M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M M86QI9VXZ(&QE9G0[)SXD/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A M9&1I;F6QE/3-$ M)W!A9&1I;F6QE M/3-$)V)O3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V-V8R M-S,U95\Q,31F7S0T8C9?831B8E]F,V4Y860P,C=D,S0-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO-C=F,C'0O:'1M;#L@8VAA6QE/3-$)VUA M#L@9F]N=#H@,3!P="!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&IU#L@9F]N=#H@,3!P="!T:6UE&-E'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'`@6QE/3-$)VUA#L@9F]N=#H@,3!P="!T:6UE M6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E M6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R<^)B,Q-C`[/"]T9#X\ M=&0@6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M=V5I9VAT.B!B M;VQD.R<^)B,Q-C`[/"]T9#X\=&0^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)O6QE/3-$)W!A9&1I;F65A6QE/3-$)V)O6QE M/3-$)W!A9&1I;F'0M86QI9VXZ(&-E M;G1E6QE/3-$)W!A M9&1I;F6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N M+"!T:6UE6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D M('-T>6QE/3-$)W=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B0\+W1D/CQT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#$T)3LG/C6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3LG/B8C,38P M.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3LG/B0\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED M=&@Z(#$T)3LG/C(L,S@W+#8Q,CPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$ M)W=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B0\+W1D/CQT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#$T)3LG/C4L-#6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B8C,38P M.SPO=&0^/"]T6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^-3$R+#`P M,#PO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\ M+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L M969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#LG/C,S.2PX.#4\+W1D/CQT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\+W1R/CQT6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SY46QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@ M;F5W(')O;6%N+"!T:6UE6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#LG/C4U."PT,S4\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L M969T.R<^)B,Q-C`[/"]T9#X\=&0^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R<^-C8L.#6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$ M)V)O6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$ M)V)O'0M86QI9VXZ(&QE9G0[)SXD/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V)O'0M86QI9VXZ M(')I9VAT.R<^-BPU,C6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R<^)B,Q M-C`[/"]T9#X\=&0@6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)V9O;G0M=V5I9VAT M.B!B;VQD.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V)O'0M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`Q)3LG/B8C,38P.SPO M=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,30E M.R<^-RPX-3@L-S6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!W:61T:#H@,30E.R<^,BPR-36QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,30E.R<^-2PV,#$L M,C0R/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\ M+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L M969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#LG/C$T-2PQ-#<\+W1D/CQT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0^)B,Q-C`[/"]T9#X\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^,S8V+#@U,SPO=&0^/'1D('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CPO='(^/'1R M('-T>6QE/3-$)V)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R<^-34X+#0S-3PO=&0^/'1D('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^-#DU+#(Q M,SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\ M+W1D/CPO='(^/'1R('-T>6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A M9&1I;F'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT.R<^,S`P+#`P,#PO M=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W!A M9&1I;F6QE/3-$ M)W!A9&1I;F6QE M/3-$)W1E>'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&QE9G0[)SXD/"]T9#X\ M=&0@6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R<^,BPU,C4L.3`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`Q<'0@'0M86QI9VXZ(&-E;G1EF4Z(#=P=#LG/E1O=&%L/"]F M;VYT/CPO=&0^/'1D('-T>6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`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`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`Q<'0@'0M86QI M9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#=P=#LG/B8C M,38P.SPO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT.R<^/&9O;G0@6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#=P=#LG/B8C,38P.SPO9F]N=#X\ M+W1D/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#=P=#LG/B8C,38P.SPO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT M.R<^/&9O;G0@6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#=P=#LG/B8C M,38P.SPO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`Q<'0@'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#=P=#LG/B8C,38P.SPO9F]N=#X\+W1D/CQT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M M86QI9VXZ(')I9VAT.R<^/&9O;G0@6QE/3-$)V9O M;G0M6QE/3-$ M)W!A9&1I;FF4Z(#=P=#LG/B8C,38P.SPO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(&QE9G0[ M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#=P=#LG/B8C,38P.SPO9F]N M=#X\+W1D/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@ M'0M86QI9VXZ(')I9VAT.R<^/&9O;G0@6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#=P=#LG/B8C,38P.SPO9F]N=#X\+W1D/CQT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#=P=#LG M/B8C,38P.SPO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT.R<^+3QF;VYT M('-T>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#=P=#LG/B8C,38P.SPO9F]N=#X\ M+W1D/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#=P=#LG/B8C,38P.SPO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT M.R<^+3QF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#=P=#LG/B8C,38P M.SPO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C M:R`Q<'0@'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#=P=#LG/B8C,38P.SPO9F]N=#X\+W1D/CQT9"!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`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`R+C5P="!D;W5B;&4[('1E>'0M86QI M9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#=P=#LG/B0\ M+V9O;G0^/"]T9#X\=&0@6QE M/3-$)V9O;G0MF4Z(#=P=#LG/B8C,38P.SPO M9F]N=#X\+W1D/CQT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXU<'0[ M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#=P=#LG/B8C,38P.SPO9F]N M=#X\+W1D/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C5P M="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#=P=#LG/B0\+V9O;G0^/"]T9#X\=&0@6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F6QE/3-$)V9O;G0M M6QE/3-$)W!A M9&1I;F6QE/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT.R<^/&9O;G0@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V M-V8R-S,U95\Q,31F7S0T8C9?831B8E]F,V4Y860P,C=D,S0-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-C=F,C'0O:'1M;#L@8VAA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'`@6QE/3-$ M)W1E>'0M86QI9VXZ(&IU#L@9F]N=#H@ M,3!P="!T:6UE2!F86-T;W)S('=H:6-H(&UA>2!I;F1I8V%T92!T:&4@ M6QE/3-$ M)W1E>'0M86QI9VXZ(&IU#L@9F]N=#H@ M,3!P="!T:6UE6QE/3-$)W=I M9'1H.B`Q.'!T.R<^/&9O;G0^)B,Q.#,[/"]F;VYT/CPO=&0^/'1D('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&IU3H@=&EM97,@;F5W(')O;6%N+"!T:6UE2!O M9B!O=7(@:6YD=7-T6QE/3-$)VUA6QE/3-$)W9E2!B;V1Y M(&EN=F]L=F5D(&EN(&YE=R!P6QE/3-$)W=I9'1H.B`Q.'!T.R<^/&9O;G0^)B,Q M.#,[/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU3H@=&EM97,@;F5W(')O M;6%N+"!T:6UEF%T:6]N(&]F(&$@<')O9'5C="!O6QE/3-$)W=I9'1H.B`R M-'!T.R<^/"]T9#X\=&0@3LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE3L@/"]F;VYT/CPO=&0^/"]T6QE/3-$)W=I9'1H M.B`R-'!T.R<^/"]T9#X\=&0@6QE M/3-$)W=I9'1H.B`Q.'!T.R<^/&9O;G0^)B,Q.#,[/"]F;VYT/CPO=&0^/'1D M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)VUA6QE/3-$)W9E M3H@ M=&EM97,@;F5W(')O;6%N+"!T:6UE'!E8W1A=&EO M;B!T:&%T(&$@3L@;6%R9VEN.B`P<'0@,'!X.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R M;VUA;BP@=&EM97,L('-E6QE/3-$)W1E M>'0M86QI9VXZ(&IU#L@9F]N=#H@,3!P M="!T:6UE7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)W1E>'0M86QI M9VXZ(&IU#L@9F]N=#H@,3!P="!T:6UE M3L@;6%R9VEN.B`P<'0@,'!X M.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L('-E6QE/3-$)W1E>'0M86QI9VXZ(&IU#L@9F]N=#H@,3!P="!T:6UE2!T:&4@=V5I9VAT960@879E3L@;6%R9VEN.B`P<'0@,'!X.R!F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;BP@=&EM97,L('-E6QE/3-$ M)W1E>'0M86QI9VXZ(&IU#L@9F]N=#H@ M,3!P="!T:6UE2!H860@;F]T(&)E96X@:6X@82!L;W-S M('!O6QE/3-$)W1E>'0M86QI M9VXZ(&IU#L@9F]N=#H@,3!P="!T:6UE M6QE/3-$)W=I9'1H.B`X,"4[(&)O'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)V)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W=I9'1H.B`Q M)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!W:61T:#H@,30E.R<^,30L-C6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B8C,38P.SPO M=&0^/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B8C,38P.SPO M=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,30E M.R<^,34L-3@S+#$P,SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/"]T6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CPO='(^/'1R('-T>6QE/3-$)V)A M8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE M/3-$)V)O6QE/3-$)V)O'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+W1D/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C5P M="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R<^,30L-C6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V)O3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\V-V8R-S,U95\Q,31F7S0T8C9?831B8E]F,V4Y860P M,C=D,S0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-C=F,C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M6QE/3-$)VUA#L@9F]N=#H@,3!P="!T M:6UE3L@;6%R9VEN.B`P<'0@,'!X.R!F;VYT M.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L('-E6QE/3-$)W1E>'0M86QI9VXZ(&IU#L@9F]N=#H@,3!P="!T:6UE2!O9B!S=&]C:R!O<'1I;VX@86-T:79I='D@9F]R M('1H92!T:')E92!M;VYT:',@96YD960@1&5C96UB97(@,S$L(#(P,3(@:7,@ M<')E6QE/3-$)W=I9'1H.B`Q,#`E.R!B;W)D97(M8V]L;&%P'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE M/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT M.R!W:61T:#H@,3`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`[/"]T9#X\=&0@ M6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M M86QI9VXZ(')I9VAT.R!C;VQO'0M86QI9VXZ(')I9VAT.R!C;VQO6QE M/3-$)V)A8VMG6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ(')I9VAT.R!C;VQO'0M86QI9VXZ(')I9VAT.R!C;VQO3L@;6%R9VEN.B`P<'0@,'!X.R!F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;BP@=&EM97,L('-E6QE/3-$)W=I9'1H.B`X,"4[ M(&)O6QE/3-$)V)O28C,38P.V9O'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`U,B4[(&-O;&]R.B!B;&%C:SLG/CQF;VYT('-T>6QE M/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!W:61T:#H@,3`E.R!C;VQO6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8V]L;W(Z(&)L86-K.R<^)#PO=&0^/'1D M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,3(E.R!C;VQO M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!L969T.R<^)B,Q-C`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`[06-T:79I='DF(S$V,#MF;W(F(S$V M,#MT:&4F(S$V,#M4:')E93PO<#X\<"!S='EL93TS1"=M87)G:6XM=&]P.B`P M<'@[(&UA#LG/DUO;G1H6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)V)A M8VMG6QE M/3-$)W=I9'1H.B`Q)3L@8V]L;W(Z(&)L86-K.R<^)B,Q-C`[/"]T9#X\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8V]L M;W(Z(&)L86-K.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8V]L;W(Z(&)L86-K.R<^)B,Q-C`[/"]T M9#X\+W1R/CQT6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R<^)B,Q-C`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`Q)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,3`E.R<^-3(L-#8Q/"]T9#X\ M=&0@6QE/3-$ M)V)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^,3(L-C$X/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D M/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/C$P.2PS,#(\+W1D M/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\ M+W1R/CQT6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/C6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\ M+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/C(R+#`U-3PO M=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D M/CPO='(^/'1R('-T>6QE/3-$)V)A8VMG65E(%-T M;V-K(%!U6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT.R<^,BPV.3(\+W1D/CQT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!L969T.R!P861D:6YG+6)O='1O;3H@,7!T.R<^)B,Q-C`[/"]T M9#X\+W1R/CQT6QE/3-$)W!A9&1I M;F6QE/3-$)V)O M6QE/3-$)V)O3L@;6%R9VEN.B`P<'0@,'!X.R!F;VYT.B`Q M,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L('-E6QE/3-$)W1E>'0M86QI9VXZ(&IU#L@9F]N=#H@,3!P="!T:6UE2`D,30T+#`P,"!I;B!U;G)E8V]G;FEZ960@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\V-V8R-S,U95\Q,31F7S0T8C9?831B8E]F,V4Y860P,C=D,S0-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-C=F,C'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'`@ M3L@;6%R9VEN.B`P<'0@,'!X M.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L('-E6QE/3-$)W1E>'0M86QI M9VXZ(&IU#L@9F]N=#H@,3!P="!T:6UE M3L@;6%R9VEN.B`P<'0@,'!X M.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L('-E2!A;F0@;6%T97)I86QI='D@;V8@2!P=7)S=64@<')O M9'5C="!C;VUM97)C:6%L:7IA=&EO;B!O9B!T96-H;F]L;V=I97,@86YD('1E M8VAN;VQO9WD@;&EC96YS:6YG(&]P<&]R='5N:71I97,@=&AO=6=H(&YO(&%S M2!C;VUM97)C:6%L:7IE M9"X\+W`^/'`@3L@;6%R9VEN M.B`P<'0@,'!X.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L M('-E6QE/3-$)W1E>'0M86QI9VXZ(&IU M#L@9F]N=#H@,3!P="!T:6UEF5D(&)E;&]W M.CPO<#X\<"!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XZ M(#!P="`P<'@[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE6QE/3-$)W=I9'1H.B`Q,#`E M.R!B;W)D97(M8V]L;&%P'0M86QI9VXZ M(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M M=V5I9VAT.B!B;VQD.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)V9O;G0M M=V5I9VAT.B!B;VQD.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R<^ M)B,Q-C`[/"]T9#X\=&0@6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R<^)B,Q-C`[/"]T9#X\ M=&0@6QE/3-$ M)V9O;G0M=V5I9VAT.B!B;VQD.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3LG M/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3LG/B8C,38P.SPO M=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3LG M/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W M:61T:#H@,3`E.R<^-"PR-3$L.30P/"]T9#X\=&0@6QE/3-$)V)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SY'6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R<^,2PW,#`L-34U/"]T9#X\=&0@6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H=#LG/C8P-2PX,#$\+W1D/CQT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0^)B,Q-C`[/"]T M9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^,3`V+#0U-SPO=&0^ M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT M9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^ M)B,Q-C`[/"]T9#X\=&0@6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SY/<&5R871I;F<@26YC;VUE("A,;W-S M*3PO=&0^/'1D/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#LG/B@V,#8\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T M.R<^*3PO=&0^/'1D/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H=#LG/C,X-2PV-S8\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0^)B,Q-C`[/"]T9#X\=&0@6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R<^*#0U-2PV.30\+W1D/CQT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!L969T.R<^*3PO=&0^/'1D/B8C,38P.SPO=&0^/'1D M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/B@Q,C`L-C8S/"]T9#X\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXI/"]T9#X\+W1R M/CQT6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^ M)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H=#LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[)SY$97!R96-I871I;VX@86YD($%M;W)T:7IA=&EO;CPO=&0^/'1D M/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF M(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/C8R M+#6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H=#LG/C$V,RPP-#@\+W1D/CQT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0^)B,Q-C`[/"]T9#X\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^,34L,#`P/"]T9#X\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/C0R-BPT M-3@\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[ M/"]T9#X\+W1R/CQT'!E;F1I='5R97,\+W1D/CQT9#XF M(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q M-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#LG/C$R,BPQ-#8\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L M969T.R<^)B,Q-C`[/"]T9#X\=&0^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R<^-RPP.3(\+W1D/CQT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0^)B,Q-C`[/"]T9#X\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^+3PO=&0^/'1D('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D M/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/CDT-BPU M,C4\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[ M/"]T9#X\=&0^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R<^-2PP,38L,C`Q/"]T9#X\=&0@6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H=#LG/C(R-"PY.38\+W1D/CQT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0^)B,Q-C`[/"]T9#X\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^-BPU,C6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/C0L.3,X M+#8R-3PO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R<^-"PP,34L,#6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D M/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/BT\+W1D/CQT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0^)B,Q M-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^,3`L,C8T M+#0Y.3PO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+W1D/CPO='(^/'1R('-T>6QE/3-$)V)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[)SY4;W1A;"!!6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#LG/C$P+#8P-RPX,C@\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L M969T.R<^)B,Q-C`[/"]T9#X\=&0^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R<^,3(L,#DR+#4P-SPO=&0^/'1D('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D M/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF M(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/C,V M+#,W.2PV-S4\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^ M)B,Q-C`[/"]T9#X\+W1R/CPO=&%B;&4^/'`@6QE/3-$)W9E6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R<^)B,Q M-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E M>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD M.R<^)B,Q-C`[/"]T9#X\+W1R/CQT6QE/3-$)W=I9'1H.B`S-24[)SY2979E;G5E/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$ M)W=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,3`E.R<^,3(L,3,R+#(Y-3PO M=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3LG M/B8C,38P.SPO=&0^/"]T6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/C(L-#0P M+#(X.#PO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!L969T.R<^)B,Q-C`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`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/C6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\ M+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T M9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXI/"]T9#X\=&0^ M)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^,3@V M+#,R.#PO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+W1D/CPO='(^/'1R('-T>6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG M/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF M(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/B8C,38P.SPO=&0^/'1D M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF M(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q M-C`[/"]T9#X\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[)SY$97!R96-I871I;VX@86YD($%M;W)T:7IA=&EO M;CPO=&0^/'1D/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#LG/C,W+#$V,#PO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^,34L,#`P M/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#LG/C,X,"PQ,C`\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T M.R<^)B,Q-C`[/"]T9#X\+W1R/CQT'!E;F1I='5R97,\ M+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L M969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#LG/C$T,"PX-S8\+W1D/CQT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0^)B,Q-C`[/"]T9#X\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^,BPT-#4\+W1D/CQT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0^)B,Q-C`[ M/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^+3PO=&0^/'1D M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF M(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q M-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X\=&0@6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H=#LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D M/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^)B,Q M-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#LG/C$L,#6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^,C@U+#`P,#PO=&0^/'1D M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF M(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q M-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R<^-"PY,S@L-C(U/"]T9#X\=&0@6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H=#LG/C$L,C@S+#6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D M/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^ M+3PO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\ M+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L M969T.R<^)B,Q-C`[/"]T9#X\=&0-"B!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#LG/C$R+#4R,2PY-S$\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!L969T.R<^)B,Q-C`[/"]T9#X\+W1R/CQT6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R<^,3$L,C@T+#@R-CPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/C$U+#,U,2PX.#`\+W1D M/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\ M=&0^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^ M,S@T+#8X.#PO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF M(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE M/3-$)W1E>'0M86QI9VXZ(&IU#L@9F]N M=#H@,3!P="!T:6UE3L@;6%R9VEN.B`P<'0@,'!X M.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L('-E6QE/3-$)W1E>'0M86QI9VXZ(&IU#L@9F]N=#H@,3!P="!T:6UE6QE/3-$)V-O;&]R.B!B;&%C:SLG/D9O M2P@;V8@0V]N=')A8W0@4F5S M96%R8V@@3L@;6%R9VEN.B`P<'0@,'!X.R!F M;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L('-E6QE/3-$)V-O;&]R.B!R960[)SX\+V9O;G0^/"]P/CQP('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&IU#L@9F]N=#H@ M,3!P="!T:6UE2P@;V8@26YS=')U;65N=',@3L@;6%R9VEN.B`P<'0@,'!X.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;BP@=&EM97,L('-E3L@;6%R9VEN.B`P<'0@,'!X.R!F;VYT M.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L('-E3L@;6%R9VEN.B`P<'0@,'!X.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;BP@=&EM97,L('-E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R<@;F]W6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E6QE/3-$)V)O'0M86QI9VXZ(&-E;G1E6QE/3-$ M)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B8C,38P.SPO M=&0^/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B8C,38P.SPO M=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,3`E M.R<^.#`N-3PO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3LG/B4\+W1D/CQT9"!S='EL93TS1"=W:61T:#H@,24[)SXF(S$V M,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!W:61T:#H@ M,24[)SXD/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H=#LG/C@N-#PO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[)SXE/"]T9#X\=&0^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R<^,2PQ,C8L,S4R/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/CDN,SPO=&0^/'1D('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[)SXE/"]T9#X\+W1R/CQT6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI M9VXZ(')I9VAT.R<^,2PQ-S`L-#0V/"]T9#X\=&0@6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(')I M9VAT.R<^,3$N,3PO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F6QE/3-$)V)O M6QE/3-$)V)O6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+W1D/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@ M'0M86QI9VXZ(')I9VAT.R<^."XQ/"]T9#X\=&0@6QE/3-$)V)A8VMG6QE/3-$)W!A9&1I M;F6QE/3-$)W!A M9&1I;F6QE/3-$ M)V)O6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I M;F'0M86QI9VXZ(&QE M9G0[)SXD/"]T9#X\=&0@'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`R+C5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R<^,3`P+C`\ M+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!P861D:6YG+6)O M='1O;3H@,BXU<'0[)SXE/"]T9#X\+W1R/CPO=&%B;&4^/'`@7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0@ M0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<"!S='EL M93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XZ(#!P="`P<'@[(&9O M;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE&5S/"]B/CPO<#X\<"!S='EL93TS1"=M87)G M:6XZ(#!P="`P<'@[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE M3L@;6%R9VEN.B`P<'0@,'!X.R!F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;BP@=&EM97,L('-E3L@;6%R9VEN.B`P<'0@,'!X.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;BP@=&EM97,L('-E2!A<'!R;V%C:"!T;R!A8V-O=6YT(&9O M"!P=7)P;W-E"!R871E'!E M8W1E9"!T;R!A<'!L>2!T;R!T:&4@<&5R:6]D('=H96X@=&AE(&%SF5D(&]R('1H92!L:6%B:6QI='D@:7,@"!J=7)I6QE/3-$)W1E>'0M86QI9VXZ(&IU#L@9F]N=#H@,3!P="!T:6UE"!A&%B;&4@=&5M<&]R87)Y(&1I9F9E&%B;&4@:6YC;VUE+"!T;R!D971EF5D+B!"87-E9"!U<&]N('1H92!#;VUP86YY)B,X,C$W M.W,@3L@;6%R9VEN.B`P<'0@,'!X.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;BP@=&EM97,L('-E6QE M/3-$)W1E>'0M86QI9VXZ(&IU#L@9F]N M=#H@,3!P="!T:6UE2!W;W5L9"!M;W)E M+6QI:V5L>2UT:&%N+6YO="!S=7-T86EN('1H92!P;W-I=&EO;B!F;VQL;W=I M;F<@86X@875D:70N($9OF5D(&EN('1H92!F:6YA;F-I86P@2!H87,@;F\@=6YR96-O"!P;W-I=&EO;G,N($EN=&5R97-T(&%N9"!P96YA M;'1Y(&-H87)G97,L(&EF(&%N>2P@"!P;W-I=&EO;G,N(%1H92!#;VUP86YY(&-U2!H87,@ M;F\@9F5D97)A;"!O3L@;6%R9VEN.B`P<'0@,'!X.R!F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;BP@=&EM97,L('-E3L@;6%R9VEN.B`P M<'0@,'!X.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L('-E M"!R971U"!L87=S(&]F('1H92!J=7)I28C.#(Q-SMS('1A M>"!F:6QI;F=S(&9O7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'`@3L@;6%R9VEN.B`P<'0@ M,'!X.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L('-E3L@;6%R9VEN.B`P<'0@,'!X(#!P="`P M+C5I;CL@9F]N=#H@,3!P="!T:6UE6QE/3-$)W1E>'0M M86QI9VXZ(&IU"`P<'0@,"XU:6X[(&9O M;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&IU"`P<'0@,"XU:6X[(&9O;G0Z(#$P<'0@=&EM97,@ M;F5W(')O;6%N+"!T:6UE3L@;6%R9VEN.B`P<'0@,'!X(#!P="`P M+C5I;CL@9F]N=#H@,3!P="!T:6UE3L@;6%R9VEN.B`P<'0@,'!X.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R M;VUA;BP@=&EM97,L('-E6QE/3-$)W1E M>'0M86QI9VXZ(&IU#L@9F]N=#H@,3!P M="!T:6UE6QE/3-$)W1E>'0M86QI M9VXZ(&IU#L@9F]N=#H@,3!P="!T:6UE M&EM871E(&9A:7(@=F%L=64@8F5C875S92!O9B!T:&4@:6UM961I871E M(&]R('-H;W)T+71E2!A="!C=7)R96YT(&UA M3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\V-V8R-S,U95\Q,31F7S0T8C9?831B8E]F,V4Y860P M,C=D,S0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-C=F,C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$6QE/3-$)W1E>'0M86QI9VXZ(&IU#L@9F]N=#H@,3!P="!T:6UE3L@;6%R9VEN.B`P<'0@,'!X.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R M;VUA;BP@=&EM97,L('-E6QE/3-$)W1E M>'0M86QI9VXZ(&IU#L@9F]N=#H@,3!P M="!T:6UE'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2P@0W5R6QE/3-$)VUA M#L@9F]N=#H@,3!P="!T:6UE6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)W=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B0\+W1D/CQT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#$X)3LG/C(L,S,T M+#8Q,SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3LG/B8C M,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3LG/B0\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@ M=VED=&@Z(#$X)3LG/C(L,#DV+#8X,3PO=&0^/'1D('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/"]T6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^-C@Y+#$S M-#PO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\ M+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L M969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O'0M86QI M9VXZ(&QE9G0[)SXD/"]T9#X\=&0@7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^/'`@6QE/3-$)VUA#L@9F]N=#H@,3!P="!T:6UE6QE/3-$)W9E6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R<^)B,Q M-C`[/"]T9#X\=&0@6QE M/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)V)O65A6QE/3-$)V)O6QE/3-$)W!A9&1I;F'0M86QI M9VXZ(&-E;G1E6QE M/3-$)W!A9&1I;F6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[)SY+;F]W($AO=SPO=&0^/'1D/B8C,38P.SPO M=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D M/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([)SXQ-3PO=&0^/'1D M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF M(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q M-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#LG/C$W,BPQ,34\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L M969T.R<^)B,Q-C`[/"]T9#X\=&0^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R<^,S,Y+#@X-3PO=&0^/'1D('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CPO='(^/'1R('-T>6QE/3-$ M)V)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D M/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/C8V+#@W,CPO=&0^ M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT M9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^ M)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('!A9&1I;F6QE/3-$ M)W!A9&1I;F'0M86QI9VXZ M(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT.R<^,S`P+#`P M,#PO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$ M)W!A9&1I;F6QE M/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E M6QE/3-$)V)O'0M86QI9VXZ(&QE9G0[)SXD/"]T9#X\ M=&0@6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R<^-BPU,C6QE/3-$)V9O;G0M=V5I9VAT M.B!B;VQD.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R<^ M)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O M;G0M=V5I9VAT.B!B;VQD.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ M(&-E;G1E6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;FF%T:6]N/"]T9#X\=&0@6QE/3-$ M)V)O6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`R."4[ M)SY!8W%U:7)E9"!#=7-T;VUE6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@,3`E.R<^-RPX-3@L-S6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,3`E.R<^,BPR-36QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T M:#H@,3`E.R<^-2PV,#$L,C0R/"]T9#X\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R<^-3$R+#`P,#PO=&0^/'1D('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/C,V-BPX M-3,\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[ M/"]T9#X\+W1R/CQT6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[)SY46QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D M/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([)R!N;W=R87`],T1N M;W=R87`^/&9O;G0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^ M-34X+#0S-3PO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF M(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!L969T.R<^)B,Q-C`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`@("`@(#QT9"!C;&%S'0^/'`@F%T:6]N(&5X<&5N6QE/3-$)V-O;&]R.B!R960[ M)SX\+V9O;G0^F%T:6]N M(&5X<&5N'0@9FEV92!F:7-C86P@>65A M6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B0\+W1D M/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3LG M/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3LG/B0\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#L@=VED=&@Z(#6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE M/3-$)W=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B0\+W1D/CQT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B8C,38P M.SPO=&0^/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B0\+W1D M/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3LG M/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3LG/B0\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#L@=VED=&@Z(#6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE M/3-$)W=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B0\+W1D/CQT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@-R4[ M)SXU+#0W,2PQ-C,\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T M.R!W:61T:#H@,24[)SXF(S$V,#L\+W1D/CPO='(^/'1R('-T>6QE/3-$)V)A M8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SY+;F]W($AO=SPO M=&0^/'1D/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#LG/C(U+#8P,#PO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^,S0L,3,S/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D M/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/C,T+#$S,SPO=&0^ M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT M9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^ M)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R<^,36QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^,30L-C`P/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D M/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/C$T+#8P,#PO=&0^ M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT M9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^ M)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R<^,30L-C`P/"]T9#X\=&0@6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H=#LG/C@Q+#DY,CPO=&0^/'1D('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`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`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0@0FQO8VM=/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<"!S='EL93TS1"=M87)G:6XZ M(#!P="`P<'@[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE6QE/3-$)W=I9'1H.B`X,"4[(&)O'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E M;G1E6QE/3-$)V)A8VMG M6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W=I9'1H.B`Q)3LG/B8C,38P.SPO M=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3LG M/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W M:61T:#H@,30E.R<^,30L-C6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE M/3-$)W=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,30E.R<^,34L-3@S+#$P M,SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3LG/B8C,38P.SPO=&0^/"]T6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[ M/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M)SXF(S$V,#L\+W1D/CPO='(^/'1R('-T>6QE/3-$)V)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V)O6QE/3-$)V)O'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C5P="!D;W5B;&4[('1E M>'0M86QI9VXZ(')I9VAT.R<^,30L-C6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V)O3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\V-V8R-S,U95\Q,31F7S0T8C9?831B8E]F,V4Y860P,C=D,S0-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-C=F,C'0O:'1M;#L@8VAA'0^/'`@3L@;6%R9VEN.B`P<'0@,'!X.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;BP@=&EM97,L('-E2!F;W(@=&AE('1H6QE/3-$)W1E>'0M86QI9VXZ(&IU#L@ M9F]N=#H@,3!P="!T:6UE6QE/3-$)V)O6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E M;G1E&5R8VES928C,38P.U!R:6-E)B,Q-C`[<&5R/&)R("\^4VAA6QE/3-$)W!A9&1I;F6QE/3-$)V)A8VMG6QE/3-$)W!A9&1I;F'0M86QI9VXZ M(')I9VAT.R!W:61T:#H@,24[(&-O;&]R.B!B;&%C:SLG/B8C,38P.SPO=&0^ M/'1D('-T>6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ(')I9VAT M.R!W:61T:#H@,3`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`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`@3L@;6%R9VEN.B`P<'0@,'!X.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;BP@=&EM97,L('-E6QE/3-$)W=I9'1H.B`X M,"4[(&)O6QE/3-$)V)O28C,38P.V9O'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`U,B4[(&-O;&]R.B!B;&%C:SLG/CQF;VYT('-T M>6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@,3`E.R!C;VQO6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8V]L;W(Z(&)L86-K.R<^)#PO=&0^ M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,3(E.R!C M;VQO6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!L969T.R<^)B,Q-C`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`X,"4[(&)O6QE/3-$)V)O#LG/E)E M6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)W=I9'1H.B`U,B4[(&-O;&]R.B!B;&%C:SLG M/DYO;G9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8V]L;W(Z M(&)L86-K.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8V]L;W(Z(&)L86-K.R<^)B,Q-C`[ M/"]T9#X\+W1R/CQT6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R<^)B,Q-C`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`@("`@(#QT M9"!C;&%S'0^/&1I=B!S='EL93TS1"=M87)G:6XZ(#!P="`P<'@[ M(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE6QE M/3-$)W=I9'1H.B`X,B4[(&)O6QE M/3-$)W9E6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)A M8VMG'!E;G-E/"]U/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<#XF(S$V,#L\ M+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([)R!C;VQS<&%N M/3-$,B!N;W=R87`],T1N;W=R87`^)B,Q-C`[/"]T9#X\=&0@;F]W6QE/3-$)W=I9'1H.B`Q)3LG/B8C,38P.SPO M=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3LG M/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W M:61T:#H@,3`E.R<^-3(L-#8Q/"]T9#X\=&0@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R<^,3(L-C$X/"]T9#X\=&0@6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#LG/C$P.2PS,#(\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\+W1R/CQT6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#LG/C6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#LG/C(R+#`U-3PO=&0^/'1D('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CPO='(^/'1R('-T>6QE/3-$)V)A M8VMG65E(%-T;V-K(%!U6QE M/3-$)W!A9&1I;F'0M86QI M9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT.R<^,BPV M.3(\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!P861D:6YG M+6)O='1O;3H@,7!T.R<^)B,Q-C`[/"]T9#X\+W1R/CQT6QE/3-$)W!A9&1I;F6QE/3-$)V)O'0M M86QI9VXZ(')I9VAT.R<^-S,L-3$V/"]T9#X\=&0@6QE/3-$ M)V)O3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\V-V8R-S,U95\Q,31F7S0T8C9?831B8E]F,V4Y860P M,C=D,S0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-C=F,C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)W1E>'0M86QI9VXZ(&IU#L@9F]N=#H@,3!P="!T:6UEF5D(&)E;&]W.CPO<#X\<"!S='EL93TS M1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XZ(#!P="`P<'@[(&9O;G0Z M(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE6QE/3-$)W=I9'1H.B`Q,#`E.R!B;W)D97(M M8V]L;&%P'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A M9&1I;F6QE/3-$)V9O;G0M=V5I9VAT.B!B M;VQD.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)V9O;G0M=V5I9VAT.B!B M;VQD.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R<^)B,Q-C`[/"]T M9#X\=&0@6QE M/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)V9O;G0M=V5I M9VAT.B!B;VQD.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B8C,38P.SPO M=&0^/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B8C,38P.SPO M=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,3`E M.R<^-"PR-3$L.30P/"]T9#X\=&0@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[)SY'6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^ M,2PW,#`L-34U/"]T9#X\=&0@6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#LG/C8P-2PX,#$\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0^)B,Q-C`[/"]T9#X\=&0@6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^,3`V+#0U-SPO=&0^/'1D('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\ M+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T M9#X\=&0@6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[)SY/<&5R871I;F<@26YC;VUE("A,;W-S*3PO=&0^/'1D M/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF M(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/B@V M,#8\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^*3PO=&0^ M/'1D/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG M/C,X-2PV-S8\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^ M)B,Q-C`[/"]T9#X\=&0^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R<^*#0U-2PV.30\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!L969T.R<^*3PO=&0^/'1D/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H=#LG/B@Q,C`L-C8S/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXI/"]T9#X\+W1R/CQT6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T M9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG M/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF M(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^,3@U M+#8R.#PO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H=#LG/C$U+#`P,#PO=&0^/'1D('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^,3@V+#,S,#PO=&0^/'1D M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF M(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q M-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#LG/C6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#LG/BT\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0^)B,Q-C`[/"]T9#X\=&0@6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R<^,S$U+#4V.#PO=&0^/'1D('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CPO='(^/'1R('-T>6QE M/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[ M/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/CDT-BPU,C4\+W1D/CQT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0^ M)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^-2PP M,38L,C`Q/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H=#LG/C(R-"PY.38\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0^)B,Q-C`[/"]T9#X\=&0@6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R<^-BPU,C6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/C0L.3,X+#8R-3PO=&0^ M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT M9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^ M)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R<^-"PP,34L,#6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/BT\+W1D/CQT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0^)B,Q-C`[/"]T9#X\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^,3`L,C8T+#0Y.3PO=&0^ M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CPO M='(^/'1R('-T>6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[)SY4;W1A;"!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/C$P+#8P M-RPX,C@\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q M-C`[/"]T9#X\=&0^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R<^,3(L,#DR+#4P-SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D M/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/C,V+#,W.2PV-S4\ M+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T M9#X\+W1R/CPO=&%B;&4^/'`@6QE/3-$)W9E6QE/3-$)W9E M6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E M6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E M6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R<^)B,Q-C`[/"]T9#X\ M=&0@6QE/3-$ M)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R<^)B,Q-C`[ M/"]T9#X\+W1R/CQT6QE/3-$)W=I M9'1H.B`S-24[)SY2979E;G5E/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W=I9'1H.B`Q M)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!W:61T:#H@,3`E.R<^,2PY.#,L-3,V/"]T9#X\=&0@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[)SY'6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^,2PT M-C(L-#$X/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H=#LG/C$L,C4Q+#0R,SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[)SY/<&5R871I;F<@26YC;VUE("A,;W-S*3PO=&0^/'1D/B8C,38P M.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\ M+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/C$T-2PR,3<\ M+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T M9#X\=&0^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R<^,38T+#$R,SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0-"B!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#LG/C6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXI/"]T9#X\=&0^)B,Q-C`[/"]T M9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^,3@V+#,R.#PO=&0^ M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CPO M='(^/'1R('-T>6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\ M+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/B8C,38P.SPO M=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D M/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T M.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X\=&0@6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H=#LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D M/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[)SY$97!R96-I871I;VX@86YD($%M;W)T:7IA=&EO;CPO=&0^/'1D M/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF M(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/C,W M+#$V,#PO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H=#LG/C$S-"PT-3<\+W1D/CQT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0^)B,Q-C`[/"]T9#X\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^,34L,#`P/"]T9#X\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/C,X,"PQ M,C`\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[ M/"]T9#X\+W1R/CQT'!E;F1I='5R97,\+W1D/CQT9#XF M(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q M-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#LG/C$T,"PX-S8\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L M969T.R<^)B,Q-C`[/"]T9#X\=&0^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R<^,BPT-#4\+W1D/CQT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0^)B,Q-C`[/"]T9#X\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^+3PO=&0^/'1D('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D M/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/C$L,#6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R<^,C@U+#`P,#PO=&0^/'1D('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D M/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^-"PY M,S@L-C(U/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H=#LG/C$L,C@S+#6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^+3PO=&0^/'1D M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF M(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q M-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\ M+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/C$Q+#(X-"PX M,C8\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[ M/"]T9#X\=&0^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R<^,3,L-CDR+#DS-CPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/CQT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D M/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/C,X-"PV.#@\+W1D M/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X\ M=&0^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^ M-#`L-S$T+#,S,#PO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M)SX\+W1D/CPO='(^/"]T86)L93X\<"!S='EL93TS1"=T97AT+6%L:6=N.B!J M=7-T:69Y.R!M87)G:6XZ(#!P="`P<'@[(&9O;G0Z(#$P<'0@=&EM97,@;F5W M(')O;6%N+"!T:6UE'0^/'`@3L@;6%R9VEN.B`P M<'0@,'!X.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L('-E M2!G96]G6QE/3-$)W1E>'0M86QI9VXZ M(&IU#L@9F]N=#H@,3!P="!T:6UE6QE/3-$)W9E M6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R<@;F]W6QE/3-$)V9O;G0M=V5I9VAT M.B!B;VQD.R<@;F]W6QE M/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O M;G0M=V5I9VAT.B!B;VQD.R<@;F]W'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W!A M9&1I;F6QE/3-$)V)O'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`T M."4[)SY5;FET960@4W1A=&5S/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T M:#H@,3`E.R<^,3`L,#(X+#0W.3PO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$ M)W=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,3`E.R<^.#(N-SPO=&0^/'1D M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3LG/B4\+W1D M/CPO='(^/'1R('-T>6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/C@X."PS M-#$\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[ M/"]T9#X\=&0^)B,Q-C`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`@("`\ M=&%B;&4@8VQA&EM=6T@6TUE;6)E'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^-2!Y96%R65A'0^,34@>65A'0^,34@>65A'0^-2!Y96%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%SF%T:6]N/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M<#XR+#'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V-V8R-S,U95\Q,31F7S0T M8C9?831B8E]F,V4Y860P,C=D,S0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO-C=F,C'0O:'1M M;#L@8VAA'1U M86PI("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L M87-S/3-$=&@@8V]L7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V-V8R-S,U95\Q,31F7S0T8C9? M831B8E]F,V4Y860P,C=D,S0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO-C=F,C'0O:'1M;#L@ M8VAA&-L=61E M9"!F'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&-L=61E9"!F'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B M;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V M-V8R-S,U95\Q,31F7S0T8C9?831B8E]F,V4Y860P,C=D,S0-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-C=F,C'0O:'1M;#L@8VAA&5R8VES86)L92Q/<'1I;VYS(&%T(%-E M<'1E;6)E'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES960L3W!T:6]N M&5R8VES92!0&5R8VES86)L92Q796EG:'1E9"!!=F5R86=E($5X M97)C:7-E(%!R:6-E('!E'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES92!0&5R8VES92!0'0^,2!Y96%R(#8@;6]N=&AS(#$T(&1A>7,\'0^,2!Y96%R(#8@;6]N=&AS(#$T(&1A>7,\ M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$65E(%-T;V-K($]P=&EO;B!;365M M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'1U86PI("A54T0@)"D\8G(^/"]S=')O;F<^/"]T M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\V-V8R-S,U95\Q,31F7S0T8C9?831B8E]F,V4Y860P,C=D,S0- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-C=F,C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%RF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT M,C8L-#4X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'!E;F1I='5R97,\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ MF%T M:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV,BPW.#(\'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F%T:6]N/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.#4L-C(X/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'!E;F1I='5R97,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$F%T:6]N/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M<#XQ-2PP,#`\'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'1U86PI M/&)R/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\V-V8R-S,U95\Q,31F7S0T8C9?831B8E]F M,V4Y860P,C=D,S0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-C=F M,C'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$"!2871E+"!#;VYT:6YU M:6YG($]P97)A=&EO;G,\+W1D/@T*("`@("`@("`\=&0@8VQA"!2871E/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-"XP,"4\"!#'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\>&UL M('AM;&YS.F\],T0B=7)N.G-C:&5M87,M;6EC'1087)T7S8W9C(W,S5E7S$Q-&9?-#1B-E]A-&)B7V8S ..93EA9#`R-V0S-"TM#0H` ` end XML 19 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
Earnings (Loss) Per Common Share (Details)
3 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Weighted average shares outstanding    
Basic 14,673,356 15,583,103
Effect of dilutive securities    
Stock Options 0 100,731
Dilutive Average Shares Outstanding 14,673,356 15,683,834
XML 20 R28.htm IDEA: XBRL DOCUMENT v2.4.0.6
Intangible Assets (Details Textual) (USD $)
3 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Amortization of Intangible Assets $ 181,268 $ 162,803
XML 21 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6
Earnings (Loss) Per Common Share (Details Textual)
3 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Effect Of Dilutive Securities Outstanding Assumed   100,731
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 774,483 815,624
Restricted Stock [Member]
   
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 116,834  
XML 22 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Based Compensation (Details) (USD $)
3 Months Ended
Dec. 31, 2012
Sep. 30, 2012
Balance at September 30, 2012 794,483  
Outstanding and exercisable,Options at September 30, 2012 794,483  
Granted,Options Outstanding 0  
Exercised,Options Outstanding 0  
Cancelled,Options Outstanding (20,000)  
Balance at December 31, 2012 774,483 794,483
Outstanding and exercisable,Options at December 31, 2012 774,483 794,483
Balance,Weighted Average Exercise Price per Share at September 30 2012 $ 3.34  
Vested and exercisable,Weighted Average Exercise Price per Share at September 30 2012 $ 3.34  
Granted,Weighted Average Exercise Price per Share $ 0  
Exercised,Weighted Average Exercise Price per Share $ 0  
Cancelled,Weighted Average Exercise Price per Share $ 4.06  
Balance,Weighted Average Exercise Price per Share at December 31 2012 $ 3.32 $ 3.34
Vested and exercisable,Weighted Average Exercise Price per Share at December 31 2012 $ 3.32 $ 3.34
Balance,Weighted Average Remain Contractual Term (In Years) 1 year 6 months 14 days 1 year 9 months
Vested and exercisable, Weighted Average Remain Contractual Term (in Years) 1 year 6 months 14 days 1 year 9 months
XML 23 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Debt Classification
3 Months Ended
Dec. 31, 2012
Debt Disclosure [Abstract]  
Debt Disclosure [Text Block]

Note 2 –Debt Classification

 

The Company was in default of certain financial covenants set forth in the terms of its outstanding indebtedness as of December 31, 2012 and September 30, 2012. Based on the covenant violations and the resulting possibility of an acceleration of the indebtedness by the lenders, all of the outstanding indebtedness of the Company has been classified as current liabilities in the accompanying balance sheets.

XML 24 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Based Compensation (Details 1) (USD $)
3 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Shares Nonvested at September 30, 2012 127,834 403,000
Shares, Granted 4,000 0
Shares, Vested (15,000) (37,500)
Shares, Cancelled 0 0
Shares, Nonvested at December 31, 2012 116,834 365,500
Weighted-Average Grant-Date Fair Value, Nonvested at September 30, 2012 $ 1.92 $ 4.02
Weighted-Average Grant-Date Fair Value, Granted $ 1.45 $ 0
Weighted-Average Grant-Date Fair Value, Vested $ 1.53 $ 4.00
Weighted-Average Grant-Date Fair Value, Cancelled $ 0 $ 0
Weighted-Average Grant-Date Fair Value, Nonvested at December 31, 2012 $ 1.95 $ 4.02
ZIP 25 0001144204-13-008209-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-13-008209-xbrl.zip M4$L#!!0````(`':!34+'WHX[VV8``(3*!0`1`!P`9'ES;"TR,#$R,3(S,2YX M;6Q55`D``Y`!'%&0`1Q1=7@+``$$)0X```0Y`0``[%WI;^,XEO\^P/P/FBPP MG]J)>.A*5V605(X*IJH2)*D^L+LH*!*=:%J6/)*@$/Y0"*>Y=N.]_3QX/O#94\_ M^,?)7__RX6^]GG1%/!*8$;&E44B?2Q=_]GX[N_LR^UQ2#^5#VH+TWS(\`N@( MR@!),CH&^C'2I=NO_RL]CJ5S,S(?`M/Z(Y1ZO5G#9V9(&Z4MQ,W!0[!X%O]R M[ENC`?$BZ2L%UG?HNZ].],SH7]A.Y`?2+U,$E/HA/#26"-$'OQ+;(Z%MCG^2 M+LEC,#*#L0303](,(X3'LD(Q%B;\BT->29*P`]A^['@^A8Z5_0!^DO1X-@S7OTRC#K!L=A;.!WI"_%W>)X:E/9G>=H M&/A#$D0."?EN&C<0C8?TZ]`9#-WY;\\!Z7\\8`ZB-W,"AV^A?7`TW.8IQ]X_H#Q/% M&STD+[Y>/)W]LOC^*,%RM@S0UXL?"/3.B=4^"5`.@X@.960F`R!38UY\SS^? M@[83'T!J^CS!V5.A0OMQ']%6V5!YQF(#$H;WY(G]-3Q]<\(?9XX_(+9CF>Y7 M,G@D03,RGHIH`F3V@TU)4A?O6$XTP2+9#GT^B7^F3N,XDYN#$]8#CY=Y^G"4 MVCPG6`[)^U+_S3"BH\/^J)[GIU/[6K6SKV@$'MV1D-#Q\'E_#""=L\X4UIK" M-1VK@W@JM4=N8(6IS@#6&L!MX-LCB_[%LQ^(]>SYKO\TGKXQD=*/.]-[(O'+ M7\TW9S`:[(^EY'.?83J%D'`R^RDAR7=MGO1WBS"OS29&=T[XQ]GX@4ZQ M)@/5*(QH,!>LO+,;%IC!VL(2!8X5$?L^\JT=L8$$ M"PNMI_+2Z7K1\_W!P/=V7\\K?'0ZGNLXE@J;LOG>3NMXA8].QW,=7PR&KC\F M9%]TO9:?=ZWS>:A]1?RGP!P^L]6W6/_?/2<>X^CSZ6PB*]Z[-UT2WI$7XHU( M(@ION[6L%EL`OV9*U4V`674^9$ MA5V7OR>$]N/280L/7V@8;%][5"U/SJ-+3L.01.'9^*OY+S_XY)KAI$,\!*9- MOIF#^32"V_>ES>S,OF\)GA=1^S+S=6W[\H)LXX2@E9:Y""+GF_0.V1&O7M[P;BUS^2!ZI;3LL3\QT;TV'.KM/YM")=BZU)UO'F3R^(U5;UF@P%\T?VPS"Z?H\%L^/TPF2X;_AUDP^^'J7:Y2IU1=-GPK?!? MW9Q2\+QA;PUTS[/AVVN97=I8DX55=]4.NCRSSAJZQ+1:$]/VQ3:Z3+;F,MGV MQ&:ZU+?W8`/=50SO1]=9>Z@[6S^VT.[I-HNWMM<>NJLYWIN.]^6ZAFUI3O2-E=/I?DD:D4M7+(RQI2B*]?!_SR?J MA\\7'_#5%;C\_.$8Z)>J`BXO/_\,CC]^5CY>?5"O#/5ZVOX$R(A19H+_?G]^ M<#+]<1"'>>3$"7T,@79,G\V`SQ[-_LZ^3V_M!V7ZQ_VS&9!YN[;S0L5]PKW\ M;40G"6;D!QN27OF>_7A./'_@>&G-3HV>H0JSVDTT<91$G\WYI.T5418EG-+B M<,2),-D>>Y37&K.C"S?V'@D3^S#W&F;X?.K9['_,O;R8;NQ9HD]F$(QI,/B+ MZ8Z(-+78.])?7P<8'$B,:OP.LR?))I8S,-WPXX%\<(*Q9NA8_G!4BC!C01C2 MQ?W7F4BAAC0,\3:1!/O`T).^_QX)^13[[KQG_YU8F> M'>_&([\3,Q`@;*`AA7H#SAKJ`KMUB114,S`PH";8L$2NO1=J-7XPIB8DPAU! M#6A\)^?;WX1N0>$A19$U4(#N.>D3VE'L!_-MLHXIU(4`J`*=4V$&-0&@BAK6 M9J!N`S(T'9N9DQ<2ZJCCR>/D"X$20PBKV%B@*T!6(,JB(L0R,*"R,4KA4E.0 MHB-%Y<:$RJ0+BX*&'#H$!4C?LG3<(!K?NG0R1&7$1ODA"T/%^!I,@TF@R+Q2 MUM,3@:N@A!390+*AE<>UO,5"'U/G[XYLZO:O?-]^I2.`@.!6@SHR^'BB"-UZ M<);-*\R,+W5%3HX\+>4JD5^7V=5D35&!L0,LK4DVR^R]T,`[H:[5=*OL282! M#(2VQU=!YZEJ,D*RT@:*>\(O\EDH,P06%5UI16&5RT3)GO( M5R#8/1XS$D`R?8E*">$V#-0YOD2!FBKK;<`I-*"`V##4'>"J<$!A8*JJ+?K\ MJLGKF>X/&;J^"]HJ&4_(0*6-MH*O9L9IUNNV.$X+2=K--=1V=,(:QVF@J%L< MI\4G:N9L'`!0A5V!DWL`:81D:)S#J$Y0Y*`J-PBL^$0;ZDC3E`:A;3)A-I"N MPB9!EANI5&@8B@C#*[H&*D,%`U6D0>425#$=G$02;&O7$A9R`@1D788-0FM% MUQ(;!&(9*+*6(\39M@X=\$S/(O'NX3??LR;K\F*6W(&J8"5E*VDM36$`B_91 M!:K\ED`A@).#"Y.1>OYL/F"O7;T7L@L.(#0@U>R&&&J"7U3:JH&QQ@RB`OSD M-I*`$`C+&L`(<58P:7I38B)]--*QJNL-(2OAI%4#&FAE.[$F7!MX:$!#-*S# MIA"6<\]L-Q8DDK`V`5GRIHN3CTU="4$#5E5C880ENQ*4#8@C76RP'WQO:<'$@S.R:/(U!U@Z#2Z MYX*L%#H58!0=4H%"D?`;50^%D\G5`U*0;'0`3$Q[*R',CV;:P4C,DM:"F=9 M2]/7OCCFH^,ZD4-$#%-48X;"L)6C+!9KX-O_@AVQ"[Z=,N*B(55,B)`;%#R*`MV;UET6T&]IJ)/*1^X M%>#9U6K*12';8:!P#9828_]6.%DM)5(\(!8)N*@WUQ4-J7P.=3T@=LE?5*T` M5BH>V0KP*OYB>4*P'0:$^(NE>'LKG)3U%R`S1ERSD'#JV;5$&ZN;CWE$10'< M>,.R#,!3U_5?69[(I1^<^Z/'J#]R5XLM"%S@Q2KD]5N*?BW`"Q\"-J!>!?AD MI9W[:GKY2#0*/('+E@K0U?FZ?C8U$:B*%O3`LHR+HTI9P;HU@YL@]C-V/,VX M)4%<:&D3D7%EFCB8^.!$/I3E-CB%6'8WEQ@@2%=5E&2I:@.)HBL)40&:8!#%"R1+8&6V*&,'E3C+@8(#YK M/(50!1S%15,2!W\[U[I0M;'D'10""T.##X22%BL1%IGH!.5%\I5&@A3._ MD`&@HH`MP=P@$4R%4($ZVA+@DGEAAHX4/D&U+JRUW0.;;=\RU+%F;($]`;>& MYN3MJHBO-=,88S7<,YFYM*#1J3&NB<^\'$L$M[[;OJ$LTQXKLFR@I:K@:;3 M$H8H9RW-@"J6C;*(K@(_#&\#O[\FO:.,4!0:31A\PB37>`6:(@>X'M2`#AI& M6/QT"E8A!DT+<(,!#6),0^*F@98=R%BY:"088\[2L0I5755%TZPSQ&L$8?$> MP!PKG\S4"+Q->@`$6%:$6Y?8D@^RHLOYSBX>P>])7+Z:CA1?S>`/$M$_3X]8 M5!X6$-N,XF#DT!,++:>_:H:NZ1M!F]D*?>V<1A^N'Y^8%B4S.L%!_.)?)C61 ML'*R>=E!`V,#6%?$(P&-&#W[U!XXGA/&,>$+$24O-APE;H3((2@66]ZN/$7/ MAZPEL-T,V?4I"PM,7]PN)2DZ@K*IU&ZBPF!CIBJK5W?EK")%[JKQMU.4Z4P]3 M)VL4[T[7%%)`0F%!'Z"3?R596Y-OOQKIO+QC52M,>B:+R\`?,&*.-Z(RF@K+ M]\+)<9/)>P_F&PF_.IX?.-%XUBJ-?)*M3'+]OI+HV;?9U3!A%.NLLD15ZL\3 MQ5D;@]Y>B>6XVB!Z2=:!JR_RM$!*#):?304,O M!>0;B03&P8C=,<`!2+1>A6RNA1F)LP+BZ`H^U2!O`>,&9QBV)]#-SRUL0[1B M#BEL`WFY0PE%$&8=8+ZDWMQY\B8ISM;X(3"]T(SO):6.//Z;&SO^4_M?HXGG MSCQS72Z27$M+'*2\00@; MU-9*8YJYY5F*^ID9.E9Y`:5GR<,X2YYSY*G41,`IE+1/X?0H'E0!S[GCCJ(U M^=UU"&A*3PPD04)*P?0K[;#/]+?3%QI#/Y%O(^;3;_HK"=>;6->:U'A%1X!' M60I"G=@+Y*BK&DIU9&.<"[Z=2#JQ2].^D7P;WC"HE)8 M7RBY?PNHLV*Z@@=NQ*$6-(5J6-9"XN>"1XFR4;.6)V>+SD?'&:[ M&`Q=?TS(Y*3;*+">S9"PHG'5-V/!RN'CLA@:8:*^6?G.\KS!+'\?V-Y\O8"Z M/FT?!"!Z"6)G)5%N26.Y'DH-'$\<_-H6ZE]_3!V(\E6=A[L=K)<>@17-R._P MI7F_"DPO2C&*56W/, M?CI]-0.;I<_X7AA3#J^]"='M#])"V6FUH$H/Z3A1PZ0^2:WKQ44W2JZH_V<; M*Z>!$U)SYHVZZ?T=@9!;**'Z(H].GL(CFTZD=25`=)*M+2KKW&R-R24-2S,] M8*B>=&L8$,"\N$0(D/S%`K4,CO5RGDGVNT>'4'=M);I2QX9TJ'$+,F5HUX@Y M)\D#JHC/L-P4].SIC<>*#=ST$_>E9E_86D;$7-RR=:!TBAY[:5Q/2II2P5/R-F M($5&K>>'?57RV`O2$MO=+66L9"T%A)OUXLK[Z`K M*FR_BC;H]2K4=-AZQDKV>A7)N(*VX@D"N\S.#)]%G9%+9A*G4*@.(._0CLZG M(JQ!$!:6L:V.KEP"VZ[^3NS=J. MU@$(-9B($C()BL66TVL5E'(G=+&S?TLR7KTXH?H:A(HU>>DL8"[5&E#FV)XJ M:XGZ"-51SNQUW471IY*:PS)ZY,=.U=O%ET M:+_I3VK\S1;T!51&P8"_HZ$T@KKAYZWWR(J&C8KXU[C6VX`,36?=O>.G84@$ MG%<'$,?W.%?`4#\+.;$+[EEUZ1I0YXL]5074,',Y_D97(%8;XVX6M4R+W5;6 M#52AP1\;SZ4H&E[>)58R4C('HPQXWTCTB<[(XNF%3>RS\?>0A7MSH9]:D?,B MR,0UMMK,[=P4IUT;XKQQ$D)5A541T]@6Q_< MG&T2&?*W*FR*>)+U%#[XIQ9]'I#ZY,MJF?+EPXN3K@^PR'54>:=8*U$P6M;Y MTF`[P-L&:ZMTH)+A;FFPW$(KQ/R]IRU@+V_]3E%4O5V`]]=9B-M\836KV^4L M:MB(8=5=T6YIL&3)3]F`5=E;$_!-:K$)#H^70XOBM&M#G!<>(P6!_(`^!S$? M]+&C:^P66;;>-,^VJ[Y:I`"$TJ/,5(*BT94YGEX*W!T93LWZIO_%]YX>2#`X M)X\"PEQ-`4JB?GDZ(4%@\HK/0X4OG%L$S!I3O'0\*E#1'5>5Y0+SVA3:M2'. MZ;A853&?I;@9XHM^GUAL4?C->F:'4>ZH[[[Q6$/4G;+_,9?Z0J=Q(BJ4]@S5 MX&MEER%>(^B\74A=X6_\W!1T^AN3%.#EY1X!VY,:AICWZV7(UP@[1]8&A@9_ MF?NFJ+^9T2B@/G=1N+40MI._N]'/0RF,QB[Y>#`P@R?'.Y;D843_??M9ZM// MCB7`_AXY`]J)/?(J41]O>C]-?OA)"BFT_L\'?W^*?F9M/;(_?/,C(@&I)[$: M3:'D]Z7;@,9X7C3)=#$]6SJ-5T7'4N1+#)O#UA3-4#*E*Y_5A?G$KA8+/-;B MT>.L[:/A[$_"$)N#X<__!51Y7?M,:#W3=?Z_O6_M<=M(%OT>(/^!US?&=8`> MF6]1<3;`V![G&!L_CNULD$\!);5&C"E2R\>,E5]_J[KYDD1I2(J42`X7V60D MD=WUZNKJJNJJ6Y@#"^Q9B\T+X<1)ORP!U=G,7:U-9Q,5P?%=VYKC=0AA:MJX M>PK^DM(`20+4`W8QRU%0)"(@WV#8)=U^SX^-4/:&FXH!4GN6S>,7+!88%Y[9 MKN__",![;+1@Z5$JP(8=+'V!.J!1]^=E@^%:)`+7!3X,!E/##K]T[3GU?$Y1 M0Y;&+P3*+B24GP"S;82%[=[[U8!C)-LX('LV")*W=CDI\.OK%?!A9K)'_7#J M6W/+9''@9SA+#+PLOGC%V9-\([WXD;"W\#F/LJLK@#O`MTK3M]@%+*0(/`3* MP8%EX`M+$T@^I=01UA@>\Y#'&Y`AQ^0W(=FH\#6H"3.<8Y/$D?"6#0%CAI0LV@>,ZZ16X5KOD*%A6EY]H9-O^`[*8RU=GUV$XK`J'YHY\M8RC6+D0-I@_R_MX*E M<,N[HL#((/ITC=0S>60+`5H#6#-K;=.4XVNF\OP8+G@^)>3*G%,D4@#/K&(X M8)@8.*0F$#]!T()I+0<=!-B()0-[YAV693 M1(L)%BB3AQ4+="(D)H]6XZMV)J07K[^YY<]`><&&AP_/V/YQRY;2@??X3(@* MOH!_E\$S7?;[D'H\.L4?HG$;G3F[[91YB0DYE^B1\`I.\*`JMM0'7Z-!%C<_ M6LE,>-G2CG6+$&FG_X?3.B%`FPMWHF_@+5QLWISM+.768[KJ@%!S1&\NP%)Q M86DS5?6%J;J'B>@OW=`&U8<4,>>1BO@[=-@-'0[3ML[980!7IAA;I2!CAPGR M&9'A^X(8[0O7G$:?&"<$F.T-T!46RM6_D41WEAOZ0(>%97/5G!DOA>LS*L]4 M"F-;&!]<63[F.#X*C7'8;LEE7,[>E[,WY`M>CH1&S/[=80N7N=W\S*Y.!+X1 M,L-WM;;9SUP[A(F2RW*7&9RW;H0+&IPCX7_<>UC2'MEZ<`E/PL:(`@+"AR2P M-WDR.W-!&YA,W,%X`R2#90PT[%4K!JR%BB-3`M%V35B>MV#?I,+N`\NX,6$R M,P6>#7!\M-B$!7`HN_G&.R9N6Y%MM+\(V$+=PB[A&G!IRP6#V9;QX-M;CV&)1?S+*:#CT29 MHA4/1\F%"<9++-;EY7!7]I#/^/T"-B&VJWA^(/PW-&'7\Q[B=SIG9!=LK2!F M%UC,1!;\-1R!%Q8,QN2+04/C-,$IZS<"T/+N(D`5;#I"`-?T>@*W*;*7)Y[= MO'S[Y?7UCSC/POJ&V_H22!_;#"[\$YCV<[`D+4!Q3J?!2+A.Z'>+3:T9N#8B MZ?&_/:R$B^^B_K%Q+7"45GC41N&,R)Y=S&!EPMATCE&`D?`F]'##`D`I$3ZC MP.,-53@5.U^)\'YT30[*?P0H!X?`E!N"5@S3'6MNB5LKL,IA5218Q"03&*1, M.\''-;.S7#93!OTLU+'>A*.Z]E18`MIL99I<8-AH+N)QCPL9^$>9\09\=YE) M1;8HQU0^&M\!F('(J0VL_1DJ>:9*#BC8&=@Q\,X:.XT#O/=P5$4K`_Z+$P.2 M@(EKAZD2!UCA2!*I]7L+K/8I[DY+"\:>/RJ]`)28\03+:#<%6D3;*"QA%/]$ M,&(/--BG%.T@?'1W.\I*,.I[-[Q="F_HU`OQH"@I;-$K9,>@ME!GV$R6<,;, M@<#"C>(6/K'M&ZW;D)E+/H?6"G:$G2VX^=SCT^A.A2A;6$+959MN^.QX-[14#=95P?\/USEPFQ.V6;'?(N=;0LXN`$-[%8 M):W(<\9.54S;^7`0G_%]?H5.P%VI<:=`T0P<:%IO^'Z>/?3RPAM\HL@G-(T" MU%E,F*Z%>3>@09E?$)1#[X7HK0.K'QZ(%C5LZ0&R8$[]F6=-TZ,&VAR4$1T= M);>>N5[ZZ`1#'>*9&64!0_P-#&1G_519X(,>6DW,,9'X#>`L?.^47-@Y@AOY M@",K/L/2[6,.-_T?/JS-7;9OQVY$=D#*>!F9TY-Y-=P$MPP1F`LP4GBS1&,> M(`#ZVJ(_\]_+"C)S&*V8,3;-KJ7(HY#5N5/FV,&EFM4":+)\L_R``C%[+]F[ MQSP48"=`CVYDC\VYN910!]F)'KO(0,//8%IZ+@8*F$H!8WX.'":19,2.+7C( M9I*3,,T4'-8N@NUT<$:WF+N5K2I`,3X[.^SN(M.9A!FS*^N?5,NFPL3,[RL? M?^2"#@8,9M+,@LCOA]#=@99S0S]1;-3?/^AZ464TX=J[A4??I;9)-CB`4[ZS M/'@@*O.%FT>Z3LSYG>7C<1;-$Q!6']4RDZP[TP[YPF"=ONFM-8NT<@PM\\'; MH&`<3I!=2JY=$$UV,O9-FZ$&U)C#JT!\AR9[BIE@-;?XM=J1\,?2LK)A;#8UPML(8AJ&'NB=VU\96?)!6U>%BY,[` M8@$^PO\ME(#L`Y;__7?<64)!Z1`D6&RIH_9B!]&%>0<?_Y!DV4CH&^?[U89L8Z6!*,ODW[T:IJ+(/)F'0@L;._E\<$I)[`[ M#?$8;'$;DA^`;&;TE8];I,[KFU=LQ>$Q#7W?*6$E\>I_"0__L2P:/'I%-0\! M>_@"8>8[_QW?5*/811K?X9#BHTC_Q)1B1(H]09E1T_@&8>;Y>FW#O@_+9R1\ M#J<^O(#2&E$^]1]':A8WDZU`4VS[_;=QWZ)11K8S649[ MB17;-]NGP>L$HR\@CR_MHNEUOS2_@+82,N0DOBU)+UB.VZLMN^O!9(O>K/'L MUG)O^CNNU%C$3W/K[Q[M\U8[4_=YOGI6&5!(3/Q\?P4WPC%ZS',SX.OP]+X;%$T7VCCL'71?9:@ZY*VS[MF)4%Z,K*U$1KH1, M68#'L_"RE1?E?(,+"LS=OWWSX$/"WA2]DGD!F31"WY@BH#DB0:$G\NCPW.TO\ZYZ0E'ANBL M9'H>6U\(&1O%H;@98_%+9JFR[P^9C#B\(`Z)V9HHJH5K@U@! M+7XJ(.9X4J9>8TN+.Q&C>>^M>;#\2="UIR^$*?I(O*L9P&JN?0J`1'^5F1F@ MMVU_;:)W$7-+V>S1Z;,[?M=Q;C&9MTRH-B'] M//"J++N96SE]-X9: M)HJB$EU2JL]?`(?V82U.=*(;4@-8%Y3!^Z45T"(2R)QSD6G^D9OF>U!7)6H5 M;G"2LC=U8T(D1:UOO@OA81@:462CKOG.J87RU"9[\4U\7CW*CEDAHD*T321C"7Q!#8^8N+)8XF,Q::)EUD%SYE?!#]ER\$= M=NDF-3#1'9C6^HR*?_JGN'YK]?*JV7@+\UTR)SB'%_U3,<3,__>[,X6/L$^E MU75;ZA@^K4MZ4T!%CC$#XIFRZ4P@U!\:3`H'*#+2E"!)CLT M22X$#I3)4N8];5A4+A!O4&('=%09<2Z\BDQSECUU$-_37/`QT>L=17N:HHZD MSVYOQ:U$[4K2V/3X6LJ9GH9[0VV#-?/'-.A??FBM82<:YIG9YF+$@:RT&>4\QL#6A% MNZ&E\J:!):`JW5\WNDZ,<8FMO:5HJ!.):&4VZY;LT(>#NVG#`>$+G2T=F/'6 MRM$.=<3(\PX.9QNOC#4])!%$NYTHEK,^!LI%(X\U(-R0MU(A;T56R60R;I1R MS5E=ETR^**(-VS3BD*ZR)?@3(LOP_R'7IPKQ9#(6):*+99Q'`_%BVYQH\AB( M5R);MKY$*?S4FN0"5N1C2"\8T@LZA4@SZ0470Z-Z%:RMQP([.D2-/EETDK6. M\:-B%GY3I2SLAZJG'DU`D43QZ8OOOVMO@8M#%6-WG1RLL=%/POC`TGG0BY%K M^IQK\@H1OD+%?!^"$SM/"L\FPCNVU'[L`*4>*YO4#I#GL?*F8'QUX,T%>*-W M@#R/E3?C#I#G4?+F"W8O9!W8.D"DQ\DA-S#MUM+G`HE?DGXD6VH7BR/)80^2 MCA-I<"D/Y2?:SNO9E)B,E7$`MG2&=$K2].!;3F3::I,]/K2`P>V M#6P;V#:P;6#;P+:+LTTFQD0AXR@;>&!<9QBW78NN38P[;Q)X$;BW$L4/DNIL MLG46*%\$5"R+73:R?W+U*XY@_`V/%WEBAM%@"F8:UB]1$>A M,ZIA$$VJ?)]E8'^WV:\S+YLQL']@_\#^SK/_^^^J"4#E*Q^#`+1+`,J[*H;U M_XC9KQ!)4XAJU'9T&02@6P*@$\D8$^6X`.16X/OY>>A?W9KF^J>W3F`ZMQ9\ M?^W[-/!?6_[,=OW0HU\`L)>V._OZR_??_1P__JOKSN\MV\YY3)@!`/#A$UW\ MZ\DK_O=?RKN;OQ3IZC6=76$QO">_(!RUEY1[[P94T`4N(88L22^$&%"!(3Y- M2'#)NG;KO*7X=^@'UF+S0C@1C@1ARQ?\NM!%S56'30M`D\'P!$J]VY_)'P94E]"K_/['!.#Y48;((NAPI$;A49 MY'-Z:S9/>S<.J@\4GC&!-UCL.54.Q00`KSWD3P2BK62UZ]/ZF<53?+LR5 M96]^$OS-:NK:6]0SE()*-X^##\]8I`ZGX,.@U@+H`H.8!;UBWK8MLN4#E+2+2EQ$M%8H.X"Z0!Y\"AJ M0ZR+NH`W!1.^N,4&H*ZW$:;N'-7^X\!/V9>F98-M@UJ$;:!`(&O-RNS.W-6*>C,+9HUJ[>(SB<2`M,5_VI9#!V%Y M!,+RN[,C(&L:6%PT>)EHL(JX3"3B,K=\+UQC$6?8O:)4/S!U!FFYN+34(1!? ML#0XF+VX_2S8_C-S@13FU+*M8".$#EK<*!AO4S,9'H,SU=KUP5('$?D-#)NK MWRS\Z#K5?8)'Y@<7]8#&OZ3\+N,T1 M+,U@;SD+,]/S-OCI-O(%$%0KVVJ!O1!O0]OO$X'Y#Z84DRKF^*H+2LJ[M\": MGC/=!-K(78RJ;5,7.>0W.BFK/BO<6GS#1H\)/&J#\*4P)K.._ M"A[Z4A8VF`(A8Z2/+A.V%22\@S-&R`S/F(G"//3PAZ(-)T8I"5(WWQ&_7=:] M=V-Z#LSE?Z3>YZ5YFG.O$3YO>?S&6QZ_&';AV6^@#7\4``?A%5CK(.P,EX<] M@;V1S)<@@S.!)@2Q&4%@8V#'%R"(SPAB^+`=^ MIGCTM4%YX)8`.H%M-680>-8TY/M$X&X-Z^-8.`3OP(ZM2=#X`>EW0B:H(-M; MSX_`\K$9$`G$>Z":[4P50C:,P!C#0Y_0"P`&>WW;=3=,/`#DWL> M,NL6X+3%.BJP]A*K\:O)$3?)ZJ?GN& M;J9H6TXD*Q(I'YYG#GC<;$Q8>WP)L@T&M;+EA,S/!03E>PJ35W[NA(G\:-B# MP-Z[(>SV0#D\Q5[%LX^$:]MW87OBC8-`D:[1K;HTL=%-`(]31V!'"@8,,)R? M>$W&]AQR29).#$5-ULD"B(2.V5F0+#,.R!*T!1\^#DZDE)I3QUU9#GKDA-#G M!(ZI1_-%+(OV2'CK).$*<@C6I&$3R=4@3*C&8Y6HAL(>-22-Z'*,&1&R#9H( M.WK!_H\N(Q\UBS4#[,VIBYHC!!T#)ME_0],+J&=O$D4)J_`KZ%_V=$;'I:0! M@X*+$)."8T*4HRH3@;*\2%VR!E#`[AT1:).V.MU6BY110J*M+2I'?1=3'L5Z M9UTLL!6=;@P\JG6K=5;Y=GR8>)LQ:GL^8$>`A7[]1UOF9`[^P-=%/;T MSZ7P[2S>2L-3-D;5)HJ1!"+ M,H(`^\E(UBPG\=/I<<<1=BI\T`_VM#KR>Q6-JY`^&42-1L$"*V.%*)K>*"3M MQ5\CFJ$0J51K\:*0G+,#3JZ4LC=ON!6Z=?BA8!Z#H1[5O^BE.N@1*ILR2(YW!7Y4R@EN_:QL^RO8F!TLI-\LV34B`YVBJ&HAT4_ M+P/]8,PI&YA*XU8?%NB+I([/'#F?N*?UE>L'/GL;&^3-/YH;3*KP6Y.;;@A7 M`M^+&'Q"%@5&ER83U"\4&Q46IN6EX4QTI6T[4F\Q](+.75^@:1O[@'MZT:&+ M05!\1@C].)#R$N7QZO-LZ=IX_F4C,3\I/K!RY]1NE=>RB4FO!3]\A(_C6H?\IX,:6V>W\F+Z80[7D>G9?W:/+LDT?ATHS(Q%3Q MI3UR#\/R@'\N8XM//>$Y^ZJ"W=$H8?K/A=BAF,(7V8)9OMQ$4:OTH8\8D$H_ MKGG?Y?AYMO^FOS[[X<=V4'A@)V//)[HR+2=]!,T@S\1,)#O[V!?JK3),S+[Q M)S4]_Z),/?LI*O:A2D]W4(D\JK:)L50P6C[3=1!MK&+).,[V5/DS-66Y7WA6 M,7?:\81%UT\^C9V,W,"I!SBEC/9.>P.;VL,6E3Y&1E_T:EJ4]1U+OO'0OQZ=.]`^?)3U:-.Z]>A%?2!^Y5ZY M@_A5HOP^44X>YB!WRD3`*D'Q>"E0%=='$Z[>IV;L1!D6U+"@A@55@V-FWZO$ M7GJ%CAC;/K+."@[41/Y"\],<%-UGDC]0G4BG M9.+4FQ.40Z=+`]=TQNV#-GW&15P]TW]K].^_N_P)ZXPNAO'@8KBDB^&PD`Z4 M;]3%H)W7N7.)1/!3';4U*=3+2].@3EO!AD&=]I7REU2G?2^#LY6/N'>IOUI. M8GP%_W+)B:43$EM^Q?J$]*2"23N?$M:G9&,YSYFLI$@8TF]`*M(/(![IAR\H M)PA\G)CTCHE,^@"3G?1C+$3I-R!-Z8=+WJP^T]5G?HWC4DCV@X9Q)MU53@(= MBXQ=O3:#C)2^,:V,Q/T'D]W/2Z%SVNV1IM/D_`P0>[_$7:D\\,Q8[[$:DQ_= M!SB0CU&AX<6IN3G-CE@LE4<>YURQ:1+$,Q/MARJTRI=(:30I8V^W-[^IX5O( MW0DS#1&S2HJ[664=98P<+0O::-RVZ?"O6C*"UJX@>"F%FJ=$U3+)3BW3G.>0 M__]P2Z6WXO],TDY>`(>CQ>V5>ZV,F[0CKO9#8>8:ET.2B5%Y13S.!(*KJ`-] M&_('ZE)*S8Q])+?@XG1MX76'Q@[F^?&W\@O^^^]JC75T,3[!J^.>(*=M"0Z= M`&FI#;OPJ-)H+ MAQVQH?C;<&]Q\(8W1.W!&]Z<8B\(UU%O=+[R0G]($Q M2Q[H:EQT;;I[<.+XO'QVMG"VRQR/ MY(/N1^9<%[AW7+AA3O%3H>DN\+D;[FG[ZL&P2F$5?D;_=9*N5L MHXM[WP\(:'A\WV#`A/G2?#X-4*,>*O?X]]^U`>SSY, M^J:[%!KBA"AE3F`MT5CL&=XOHV6",2:*-NF\7,@R$;42N6&MT1V'ZV#=K-:V MNX$3!57A80=C]=9[8X5H4N^[%S9!.6FB$D4YQ=M=!/F6>F2; MF/0ZYUH`0>^L1X5[TQ?,]=ISO[%F?_9&^$%2V>5*P7*$T/'HS+UUK'^2XC&S M[*E]YOH!0?TP6[*6@7"(9Y9SX`I3*F3>=4%Y"*9P'Z4E"F;4YG0-4+ISK%+# M?HD-"^>Z4CXS\ZXUC^I:=2,GXA2],L5,G]7U8U@OBII@I`K/XG'DM#,9B!3_-?E->O$C8=TN9_[6&Q_85]N/ M60X9T9OFLMRJ,!Z0%HN//-B@9-B3!B-<] MM6W\KWEG6K8YM6RLSL6'"("[)ON,K47IVO1PJD4BW3!D:`?(6L>W_`!%_QY( M`*";00KL2,#NKWM,C`F$A'&=I">L#5)(?7A]!7"F`@1S`TNM-1Y[<7?X??1Y M)-RB:G=PD*M%R.)[L?SP.;D8)!,!=<*%R6#BO6*1KS&6P">44(`$9T#\9ZZ) MZLOG8V7$)']`'_8?I!9N.5E98ZP"B.],V&Y"MN/9%J<_PP21CJ0)A70>H@\( M_T88EB!H-O[ATUGH`2>>S^F"!3GAB\#U(N!2@"X(,FPE[)E,#,=M`1NK3OJ<)$T MG4TD9D#`K6D8F%.P&58`?SB;@<@M0AL`SD)(Y[UO)LQ7Z@J6V69+D2=2E>YG MUJVI"<0+'M/+0G-4/A^Z5H:# MQ`8#HV72LS8R`.N'\NSX139J#S#)6M`]0"=CW?<`F^-.SUIT3)U7)17M:1P+ M!;/MR$W0UD:C53*11&*HU2XW=CX8KQ)9D\CDL:(O$=E0B:B4"3KU"7U1)ZHV M?JS($TU3B%RJ&VC-N2@UI1G\ZKF^+WSTW(45["%3E>JGQN>)+,'2*E.&K:69 M!A(9BR@KM24;7`P37=2((9;(O6HI'J7U5DOQ4(DNZ\302P1_6Y/&$IV*F`?" MN17>.LP;]^PWT$3[5U0O1-]G>IFN?NR5UL"N&!K1Q[5)QN5XH&J`R*1$=;1V M\>&9)(M$U\MN8RV"?X)6;EEEN0O_4'&D8^MN0*7[J'S_78^0::/]\IJN/8P# MLP@9!KVN5Y@%\T^:`M(",NLR&1NU)=I+MT1KQ`RH#*A='Y;QFS5LG,)U;:VIC M3MU[VIJ8E*),B&%TWQ28J#K1Y.['H^`$(NE$[D%$2I95,IET7[)0KL9$%UMN MWOSJNG-,`F\+V8#YBD'T'BQ)B2B8#U5?P84+\D1$%\>X^YAT_\P$(B7K*E$G MM=6=.*]!P](RA6O?I^TIXR$I1)Y@:++[M3Q`/'1Q3(P^>(=E=-,03>Q^=HIB MP)8V[KYMINA$&4\`E2:JQ5R^2=AP[PF_&^X]G7;O22J`XW#O:;CWU%U,AGM/ M+<9FN/=TT!1IJ`HGD66-R$:9+ND]NORAD`E8ZIJV;]WF%];M'0$D,C$4HBEE MZH[U"7V13,IXZWJ%NTPD129RJ<[*P\6GHL=-F:@JECCN@2^#J#I@TX$$TM>_>I?6@\DT6TECM[F8[ELM8771@N0W5,?@=4!E0ZALIP%2HOE`?& MK]Z#*PD3A6AB]ZT;25%[48>A)U>A%$,$H[DV/(:K4(E+1Y>)6!]A+W@Z%(G1 M@YH2Z&+K?JIE]]/Z5%$CBEI;AM!P%:IS$C"@,J#2,52&JU!,=XG06M$A6/A1.G^L5`V^G&>&F-^#)EHYVX^.ER&:@DF$A.`<7V)XQ?# M1"?R9$*T'F3S=^#4E)]"MGU)1),E,JF/'<-U*(G7\C;D[KLW)`7[N8(6[0$J M&E$TB1A&]ZT!!:1+[T%6ERJ2L52R;VIAY=/W!JE)`\U'V302)\`WXCFB787= M/N)/O*G298SP5]QU]-HL(K*?-"T[W([P'ILU)LWZ;BGP!-L%\NZ$K.W@KTG; MP9%0'3P_"Q8C.1("45Z9O56JHQWF9(Q0>G:=K[,R\%O9@Z!;?CZJ._$Z@?,FJ(E^R MBEYMR6;'ON1B[1X#.=]R&J$NS;D0W+L91AY>K'CS^>@:9>U64ZU08>4."_8P MO]/^X9>WANSH)O,.(:9GWC"CZX#"="/!-U'^V[=[[;>W6:LAM+EI0\(1UQFNR^A/08/<@4/]Z MPO_+'3%,,GA)`X%7,B@!:]Z(U;"N.%+WJ%"U;$-/*+VG=AZCN.W9"*V3MMC_ M^T"1D(+@9?;YWZ*=["#&14N$5.1@A;(G#U4?R(/DH5O]#6/9#R(RT_QX78>! MCH,P=DX8RVOL9FYMQ%?R52.ZD_^[8^&I^'-@!CFITSOV=_O*$AA$G:A$+1-A MZ5-5!D,DY$?[A%#PED8@R\'I<(F.K5WR61RZB MWH2>N][?<:H2\L2`I6$8=6:97PZ/4=F+X/NK^D*@2ZQL@U)?)MS%,)F,RN97 M5EMR5;;X/`N$/?8!@UNE#)R20VY76=&K)[]L MH=EH:L)[-Z#PEG`55XX#L",_W;$TA2ZF\+W>.*9OV<(KUP,^\MP'=R%:(*M9X'8"YO.`C:A`],A`^AB M`5_Q1%ZZ0B$"_LPM^-:CS@Q>FM+@GE+.GIGI>1LLR6BN$!KV%H/K1L#'AN!JA:`0%ZT3)QOE8`S7G-*#>RL(E$_HX)P41!A:B*!$.P8!)+@;YOW\"E:0RR]DB5/LM_^#CW+GULSIAL" MA`6>XUSO_5)[ZS"B^PG[8CH';LR$9#%DY2,2:@+S.^8M99F.J!VM.>9)QLIO M8$6`BX>X%I.<"V%+$UJT3MD^Q`PM+<6K4,>/P].X1' M;T$[Q/+`84OV3:X1(AQP+8:+A36S$"*@'*@5SW1B]1EI*Q,@`ESO3#N,*KIA M-B"H/1CG%J;T`[8#LTWW`+5&PC5F*'JL$\\V1D`.M&/G\'/>#*A^4>=_LU8@ M"\"X'Z316%@!\>&YWJ_N[$;*-&6\EX;!TO4L,$U0!P)Y[BR?K0N/VF:LJ/E^ MBG*`7,Q*B.7L[+#7^.9_0PNY-MU$0I(.N\^Q6P?DG<.2;H',5&*:9$H="L++ MN,?7M.M;7`0=X*&Y``E.Y)A+:B3(@`"]8R*(PA.AN1'NW=#F-RJN^`*^P@5\ MA>O/!UJ;T<:03,,S5MD^#M($JBN^L).!!10"I4&\3G+'QFQ9'RS+.82$C,DP6GZV[V>Z#J*OQ6Q6?5;O."X(4;)< M=RVA1+ZV:3R"$PJ@B`1@.IPZI@W\G"T956!'!PEQ-B0KN`=&BF0`U.W,!JUB M+2S*$I\SQA2K]^;3F"NX`ACX2+\MTS^55*"(F[0`.Y5&F)N)LWHA$XT(;R`. M1]NB?@$\M\X8PBP$5>H$=L*"^-3B>M'1A"-NPD+B2"#VL'1!MGS_42A(;NFA M(D1S`?GW3!PIZM,?RR6]1&6H=@"VVVCHO1?#`9D!Q6I&&5@Y?"=73'LQY$VD'/5GGC5-]LODD!+;C=E#"5N3]TL+J&C%)SQZQ)F` M8\'4H+:B4V8DA*B%^*+?'CWA.[S'C'#0DD`"MK.R;4$6Q0D[R0&)0";][=S7_UY4.[K]L^`KD+T[QCZ2PN$#5;\AILJH"30@$CL/P#4X\/$KHLR<0G.0-W9_,3J=P7=9,CS[#4$7 MI)@>3#Q_3)Q,L+?L`^!.@>MWT?F8(1F-HFR/PE41IU5$(3R(YLE$L2MA;5#\ M_+\CS7*J36_(LOY"2)1&1/Z?A%0E?-@C;R)7VQQ_ELK"C]78?\JV>RHAVL@' MN1(?D-"^M;+@3';(J[O''8*HZW8!A3[ M].&,C"0/MFTE]YYY0,/5FMM"YM0-L2H#O!@-8D;D%]8FYGE8:SP;\\-DR`^+ MR-;$?\I+*:H9:WT9K)@WID@3QQH'D*PO%FX`CL-79J]-Y>O,\X/ M*ZEAL,6B9'_F!$.+='>;S6PP5KQZ$R]JM+6QC0GW)<97+AOHP01TK`6L1.[" M9.Z8=./*;'.]9\67O/@5CTNEELV6'V1JVNQ`ZB]IO`_-3'_)=!G[`YV"0$@T M$DCL4>0N;(LO5';[//Y^;6[XEZG'-LN+*9V9N.(BT\Q:8<$&=H8%K;P$**_0 M(0A4@&.6Q7WAW!.9)V'1\6D/7QZ5^P;(L>.Q[3JW?-@YG09)9)>!F3P@9!XX M#CKWM<-IS&:39L!AAE%ZH`;9C%PWL?;A,;546T2RFAPU,UO3U/4\YKWT<\]D M1\]:V4/9YQ`TZG]#`.+F#F'LU($L!5[@T+?S*-:T"P+=?I3K2712`*(?'PN]90)W[L+P[_(*%./T@\=(D<8(BM2WB.X-G+&VA:VTN M;7&,2+MO!^[ZP,5.^Z%Z*T7OW[=FR@YQ63>"MRT">F*-1DJ M9JY6NH3K.\TDWC M&&J9*(I*=*G$A;]V7#0^$6MQHA.]3(OPPE@WT??V#]?[>F4Y5Q\]=T;]UI03 MUXT)D93N=VXV#.T"G8]KT4(';XZ]L1S+Q[P:['QQ6!_UZ++`Y;U-,3Q)&#`HG#X8>Z,*.Z/.65-5;+/CJ>#2 M:;RF:OVC_>[317BXL%AU&,Y87Y8?8W_UW!P3O(.(7,]FX2ID:;LU`O40S#M` M5!WI_&4_<9!8`Z9@H8T]OI!\*!?[,6-)WQ&4OF_/%RN<'E[%KM2N+U0+8Z9_3=21O3;DP,S2C76+0'6,M$,<9$/V)']!%K MC:AP_)9*.>\NY9`_[A7^M^/>"__CWI>VB^OT;4?JB+TJ=;\QKR;)O>B5+8UE M(O6`'XHR(891&QYGM#38,U\\;&WVWESE5`"_Q"H]E&U1W7"0-%9!:4X7S,-8 MT89HJ?1I8!6H2O=7D:X38]S]8L'J1"):F8V[);OUX1!6IN/>%SI;.C`CUFHI M==RJ;E;5-=HQGQ!?1V<"JD^!4D44RUDB`^6BD<<:$&Z(S5>(S#(9BQ+1Q3).I(%XL5U. M-'D,Q"O38ZD*^DU6%+Y@6L3WWPV)$4-B1*<1:28QXF+H-`#39;(ODDRS3/J% M.*1?#.D70_K%D'XQI%\,Z1=#^L60?G%J^H6LC8FF/([[D&GZA2Y*1%:;2#H9 MTB]JF^N<./0Q_4+5B*26\*2W%`\%(\?:N2.N0_K%D'[!M$%?TB\4(LM]2+_0 MB%RF?$-+=NLA_>),0/4I%CZD7U2EG"X.Z1?5TB^4R9!^T8KDAB']8DB_Z`;Q M9*+)&IF(O6_FW$SZQ5A4B-(X\2Z2?I%7.:1P%9"\(B+NL=??L(:+V2#.#6\D M=NGJ(EF0DN9FI9I:8>$1UNWIWO2%'R1#(K)NL&]_D'29&-S6R6G+DO;8SI[* MT\:K]F8DW/B\"]TQ#-91SF9N)PVB_KJ62":Y/TK_?,2$N%VAOFY%]!.O#E?\ZCMCAO:?C MB.E]1>SP`:W+B'U94H^RIK+]1,\-S,.9CVTZ1Q\,?RIB:W(FJD2`Q]&[JHBE M,YLHA]M:E#55)GJ9Z.R`\H#R@'(K488#WT0AXT;R5UJ+]%`SI:F8JHSY4-W/ M=U%4(I5)9!O0&-!X+&A(XS$9UY=#=3EV#*5XZI8,D4RT[BM_2>W%'C:@,:!1 M.QJ&1":3[J?^29I$E#)GGI;8_.U(_6M;HI&J#:EMU5/;!L(-A#L;X;3F4P+[ M2;@K\6J@VL&!O_]NH%N=TC943NM%0J!J&$233FE.]VA)I[,30M.%K`;2#:3; M)]V0_%R!=-IDD+K*'1PE32&J<F1U^:OC6[=N:O+3L,Z/S2N?A?EA0F7:W# M@&>Y1TGMO%01!?XCS+[@AH$/1$&.%\S4+Y8`GY6KOT,_L!:;%T(G"U\VD0&? M6YN@VBDNMZI5M>$;J*F5!\G>K8]+X=M/4MS MU-4>F@794G>XIHDI>X-*T]WA$0383T:R9CE)&IRN1WEP;$L^B,KEZ]OME.U2 MGZ;AV+%"%.WPM8Z6YCW6A+]&-`/L_E*%#6I.@:SE,D&NE+(W;Q8+.F.-U.=H M+N(E0Y_.0L\*\N*BO5$'/4+ELF'U'=&2Q_$1[7.`IXT/:[3Y'T>`?8ATEJ>9 M)(IDK)SB>V]?".6(MGT=Z]CKR)K\S*W)#T>LR0M[@^H?>R??J[2!T4FG6K-D MU(@.=HJA[%Z8SG6'Y=6(*.5#RG=#Q>_1^2MWA2SS-Q>BY,J>W>G\E#)>P5 MHBCAK6IYP88Z_2L1F=@RN[2WY6%8'O"]9.RLJ2<\9U]5V%,:)4S_N1`[BU+X MHGT^RY>;;]2;67ZF7<9'SYIE/J[Y;?SX>:97TU^?_5"RK\;`SD;9^8FN3,M) M'\$=S(,M(^25!^+'OE!OE6%B]HT_*S1+J9?.9[>08_^8]'0'E01%+.FCWYXJ?Z:FK+(+SRKF3CN>J$0U3JG161-)!TX]P"EEM&?)#VQJ M'YND4:GF);72\W)>OPCL?5@S!BYH<-.&;6H\C,R_J)3U::HZUSVCX7X M]>C>@?+EIZI'G=:O0RN8O?M`_.J9SK%VGY4HOT^4DX"E3% M]=&$(O>I&3M1A@4U+*AA0=7@F-GW*K&77J$CQK:/K+."`S41FVY^FH.B^TRN MXVYSSL"G^`'[2&AU))X2&ZY.I'9V?8KH=&G@FLZF?-"FS[B(JV=QM^Q\=48' MPWAP,)QUJN^_VW$QE"DD.M"^1A>#=E[GSB62?$]UU`X*=5"H75K4@SI]C.KT MP/7>2R33Y2545LV&S,^M?.\Z=]0/Z/P3_-NS9O`7&^IWQPHZE%;I)=!'&9;5 M4BN3WEP7R[$LG5?9\EO`)V19%D'$(_TPQ>4 M$P0^SJ_BG;#2!YCLI!]C(4J_`6E*/USR\N^9;N?RFP:70K(?-(P3`J]R\@!9 M@._JM1EDI/2-:64D[C^F'1YNV-.1.]&'=_=(TVER?B*+O=TML?0.G!DKV0V/ MI)7$C1=+F">GIA@U.V*QC"1YG',+I$D0STRT*OU,I'R)E$9E2C2W.$VKX8NR MW8F6#8&_2HJ[664=);X(5;5RZZ/8:LE`8+MB^:44:IX2+56'KV6:\QSR_Q]N MJ?16_)])9>O*EPEZMU?NR_3VZ4K$X%"TO,;ED"245%X1CS,/XO0*W?6E0=2E ME)H9^TB*Q,7IVL);&XT=S//#B#4L^,<69)'TDF?ZMD:X3H"TU'9=>%1I-+G8 MC8.&RM,.,8GB,8DV&+ M!ZA:E>BM<]OW")7AGV`O"==1;7;)YR6-Q1BNZ5G*'Z=7B.\D-?6#,D@>Z M&A?=\9+0%>X!YVX,LPD*$ MTFO,TQSGZH">4^?D%[J@7;IA__E1HN@M\[LY_ MV@9_,,)3>"\YHRN]X=9T=<8W$0:*X<1P7"^8?/1R7;%W_-#$:19.)JI=I[M.#WG$Q[KI(9*,)W,^8 M(+J3[R`X.OD8>K.E">?CC[;IE#/H&C!%S]+T MCHCC$AIK:!88KP6BE[JRV?:Z=OQH[0:\4TR)]-N&O+XI#P_[.:LWJ1LK1)-Z MW^>O"Z!9(;U=PBOM$URXL(N?V MK;-PO14;Y>4F^K&">[C1@B]?EI2=T$TGRNPU9&G\PH='&+B"E>)0W=G+R^58 M_URXHDT)CW#;>P861_OUA33V3-]PKG.&=?-S-U;XI MDJN-3)CF^X`B]'(27\MO=8VFY1^A=N+A/(YCT8S?)A`ON'&4A>:H?#Z4<8V# MQ/WF&"V3GG0^-<&J;@#*L^.'9\O98=]7AS!YZ_B!%^).T0MT7EKNBLYQT?0! MF^-F>"TZILY;!(KV-/;.W5'GR"6)UOI'53*11&*HU?+^.^\>5HFL263R6-&7 MB&RH1%3*N$'ZA+ZH$U4;/U;DB:8I1"[5[:OFZ$A-CN]?/=?WA8^>N[""/62J M4OU4CS&1)5A:9>J3M-3W+9&QB+)2F_O[8ICHHD8,L40TL*5XE-9;+<5#);JL M$T,OX8YL36`E.A4Q#X1S*[QU9F"'"\]^`TVT?W?C0O1]II?IVL->:0WLBJ$1 M?5R;9%R.!ZH&B$Q*%`YI%Q^>2;)(=+WL-M8B^"=HY995EKOP#U=Q.[;N!E0& M5#J&RKFME]=T[=&9Q2-E&/RZ7F$4\!_V15O(K,MD;-26D'4YDQW-&;D'"7*Z M0D2U!WB4+)?:4C14&4^"M;'CO&Z;5^;:"DQ;H)BO,+>",*_JT\76JUXNV:.E M`B+),I'4[A^CQD0LDW364BQ*7.MN*08**$Y-/[?"*6'RU$ZV[[]KJ;G8(\MW M0&5`I0U'JYH,F[=.8#JWUM3&G+KWM#4Q*469$,/HOC$P476BR=V/1\$91-*) MW(.(E"RK9#+IOF2A7(V)+K;

?WEKV?*74AL@'S%8/H/5B2$E$P'ZJ^ M*X`7Y(F(3HYQ]S'I_JD)1$K65:).:KL)>5Z#AJ5E"M>^3]MSL512B#S!T&3W M;Y>">.CBF!A]\`_+Z*@AFMC][!3%@"UMW'W;3-&),IX`*DW<7[Y\_XSAWA-^ M-]Q[.NW>DU0`Q^'>TW#OJ;N8#/>>6HS-<._IH"G24%TH(LL:D8TR[4-[=/E# M(1.PU#7MD58%D\C$4(BFE*F#T2?T13(IXZOK%>XRD129R*5:#@[7GHH>-F6B MJEARKP>>#*+J@$T?BMJQ2ZZJW/VK:,_D,9'*E'-D;[7F+H)&)%DGD_K2)X?[ M3MN"KH)))W7?\RCI*DA*!Y;K]]\]@,EX0C2U[-VG]C'DF2RBM=S9RW0LF[6^ MZ,)P&:IC\CN@,J#2,52&RU!YH3PP?_4>7$J8*$03.V#?/)B"H/:B#D-/+D,I MA@AFA$J>.+A.Q/L)>\'PH$J,'-270R=;]5,ONI_6IHD84M;8,H0Y< MAFJIL3B@,J`RH-)&LZ:M5Z%4>4+4'MB\V,1$([K4_21HC:AP+)PHW3\6RD8_ MSE-CS(\A$^W<[;"&RU`MP41B`C"N+W'\8ICH1)Y,B-:#;/[NGYHP\4R6R*0^ M9@R7H21>R=N0N^_H:$31)&(8W;<%%)`NO0=97:I(QE+)/EZ) M9LA7.0>N0&6'::`S%$[,[D7]_/S$ME[8&6RWI5C\/LON?KGYE;JWGKE>HMK\ MS9VQ@;;;B[6D-U@$L3#="+<)S((=@2Q8CA`P[8T!/M,73&%-/4S3-V^IX"ZB M'ST^"*G8/BYKWTC=HT+5>X,]H?2>VGF,XK9+A,/GB$M)6WP$>>"6:D'P MTMU7B#??@Q@7O:-:D8,5[MT^=/TM#Y*'KI4UC&4_B/@4+9IR?8T'.@["V'IA MK,,55$?:8'PK3#6B:V&_.U8`1X//@1GDY.[LV-_MNQEG$'6B$K7,(;]/%P,- M<73"E<"GYT3X<'?S`GA*(A%EX/6X1,BP5WR61R=T_-OETOZ8O!+K$[@TJ]05B+X;)9%0VO%]QP578X//L#_;8 MAV!)O5)F2Q/&5RGREQEX6]#&(E'+]`L03L&_5[231F6J:1Q$_;`ET2=J3<9C MHNHE-/(@9\D^UHB8-15#WP5`'FDG,*[I5__86V041V6ZM1^A07%-VV6QJU+O9A"[,XK=1:JI_OS\Y)`_Y@W$ MJ0>OZ31("PR^13OX-G/`M&?4^##PLL5NG=`0GSX+OV__JP M^$L1KS[3]2Z$OW]^G050?/*++$YTW9!2&!^>M3X8KI0+ZQ',N'58AIS/6+I#'1 M)WD2>7C6&H$L2$E-UB=ZGD@6`Q*?"NAOUAV=I[=-6'KF[SY=A/9OUB)?^[SY M\R9+R+\.#^2_W+PS_W:]5[;I^]??+/^O+YXYI^]-4+7O6"SZKT_P/&4_O8-A M5N&*?__DEX^2]F>*6Q%@+XY<6EOU"YTM';#\;ZT844"H<_A5U3'=L(2=8\W\]>>.Z@>,& M]$KZ2P)TQ4M@NV.G]4M3GH)<&S7E*?AT1U.>@F4[-&7S?&J%IFQ*=QS5E')C MFM+G57=/-\TGLCR1);$(C'S.^N&K3]4=0U01\7^=P7-;.1P]MTAREQ#;74S' M<=,,5=$Z@]MA?7@4R[&A&>/Q!=`L>#*^F(YHPAQJHXZHQ8!HHXZH:<-MI8ZH MW6:ZB(ZXGLW"56B;`9UG2TW6X?339&TB%H/X`!3GP.$\FD6'Y:?TBA3%E8^D M:I(Z[A7RI124KLBRW"OT*^HP6=;&FM+295`T>4&"_3Z]#V@_>6>VG[==: M,EQ,]]5`$7BVCKL3DU/-/P3D7*B<1_6=)NMM)<M%0+T:=9\B::#[*ALY6^"<%:N6J\&.$*9,Q'@\UBIKQ(Z0HY1N-*3)I&#@ MM+,$J1I5-B;*6#TK<=[3H(Y3L&2,E8+J$&:L&[;S*#595HN>:R^-8PF#39D8 M1K&-^=)(E;/`T"]3;"5=&J_*)M58DO1B6\L.BEG=\6&Q^W"!JU32<=KKLI%- M$3L^7:V`'5=3DB')NE$&,%:IA%7UP%(?IOW*7:U-0U9W90O M[N?`G7W]L,:ARE+09\/MI1"(8T6*:J64AJ!1V.6'8!=/`3MFSA^L\C*=7]]1 MS[RE[T-<$:\M.X3O^#@?PL`'EF&QF^LY-C+!J>JD_8F@;$FV$UAS?`.6YVFP"D-2P'MP,2=/E3.V0 M6@"[!*8/2N%XK*J&T@=,_[J^-[WYE\V:WS_]1'U80#,4/EP[>WM%ODQ+NJ$T MR7?V->Y=T=K/+"&^P$I?1\F7@LFV M%-0.YL5H4'TEM)H&-]^H-[-\W!S:+`=[8%Z,!I>3@T9I\"L\&/AO'=`XECL_ M?#.OO&W2((1;!$#E_-;W0SI_#>K5N>7/<8,A:_5$9*3SNO$K#4"=_'OC>@MJ M!2',%9.H#ORNY.W\F@;`;$BC[UB1,=$_PE9^U`=UZ.KE7VOJ_<4FWZE6J(RR M&_V9,&@9T0Z="(\13>XTT3+*N*.25A"#EA'MPI+6!-'\4AM?:<(===GDDZWD MQET?`K72+1ZYRZ0KA4.MU,O9J<]!/UBQZDC4:R1A243VB#A]6%M,2^]+G^C* MM/"(CZ3RS%D08H#$6\F'Z9C9+G[Y*/TY>;=#H_/"V5HR9;M0`YGT=Y+ZNC>4 M.KS]')I>NHA`58"SM61J5J#JH%05>^;FOZ$5;-*ZZC[K??1E:3H18.]=YX[Z M`$X)M]"#[G!55.HY3I8%OW4T*QY"4'1-&VA6SOTHR6.CEK-2YVE6W-6S&[+H M&M*&9])XV_#WE)Z/>RD MEK0SR=ZLV8$7$C<-@][_XO)+L.\&?U*`>.;>.M8_T9H[=B^W7)4&2=V. M>IX%[BRA`.P9Q=0A_.63Y7\%,N,78/@527?*6FKK,.=PED7NV%QUPO37W@`O M-ZEJB:[T[SVS)Z$Y^(@C1;\`/I\#,+_1;/^5NK>>N5YBJ0R&S>]87V#.?H]Z MHA[#_;-I4_\3O:,.K"%ZBR,^B+6"6!ORN%5HWX2>NVX48S"_6X4Q.Z^]\NC< M"EZ#(KPS\9*PWR@%LN;YF2@@MU"=R$VJ$[5M^%01E\MQYO**,=M8L05HGT$Q M&FJK,#Z_8I2D"HKQQ@FL8/.'-:?1E+SB4*0]TI=.M[G$4=:,+CIO4["FG'L9 M^I9#?3^B-2^T]-%SY^$,/CCSI/379HL;AYN\'R="MD_RA8GPP*XFCO3V,$SN M+,/P9,C=X;;MWINP+(]41J042&4QA"_YA@+;@T]-;[8\42MS!DWT;%6_:H`` M*EA&C%K1$OE$;RT_P`@-5N$K=C_I]9_OKS^__4UX]>'31^'#&^'ZWN-98,E`3_<@@`5F^$C[1-9:M^+Q935V[V'18P8V/O/7R+]O<27VGS'V4O8YX1!>* MXZLW=(H3*0]>`E$GNBB+XA8CC\R:XOS:G;'P(QIAQ5"6Q*O_Y?-DWTU'O(:O MYOCU&]O,1V]OR`7@0?F86V_O@\E=CJ4D#_]]!?_$8IX[U/Y,7#CY0V_@NV); MPB__NS/+WC"'9N)="PK/@U*1-U,R#)_G_UQ="6]<-W!<(-=G5&^N(UQ=H7S: MEO/UIT7TVV_P0?C&O@J`F_]Z`I,"(^C\2?2MY]KP[3((UC\]?WY_?S_Z-O7L MD>O=/@>Q4Y[CS\_QP2?)T+8[VQH1/INP$<0#+CW$[__&P%U)?TGQ3[8YI3:\ M8$[_VOKY^1[8U][V'*"0XT'@SP=@CIYXOC!GP54\XA/!]6#C^M<3.#_'0P7N MOYZD@,3?+CQW=13(T@20CQ-`[@(!\H#<@A`4D1N"M5A&L%+8OJULH(YS"P+J M7/W^>8=@&1A_P0ULP8J]_OQ\"QH$[_F>\+-O<6KK)_PW?/S_4$L#!!0````( M`':!34*5V-+0N`L``+N3```5`!P`9'ES;"TR,#$R,3(S,5]C86PN>&UL550) M``.0`1Q1D`$<475X"P`!!"4.```$.0$``.5=X7/BMA+_WIG^#W[T:PF!W%TO M3.\Z))![S"0Q`^2N[U-'V`NH9R0JV4FXO_Y)QDX`V[),@I'3Z4PO(5II=W_2 M[DI:+;__\;CPK'M@'%/RJ=8\.:U90!SJ8C+[5+L;7]4_UO[X_/-/O_^G7O_S M8GAM=:D3+(#XUHUH,\7@6@_8GUN]'_6>BWW*K*_KOBS1U4GKY-R:K*PN\M&8 M(><[M\0?OH%+@+MH]:MU!1,6(+:RFF>_6JW3YIEU>M9NM=JG[ZW!C56OZPW\ M%<,#;`_\_N2CSE!G']JM\Y*&.F^?MLH9ZMUY^UVSC*$^M)N_M=^=E3.4F!;- MC6GA8?)]@CA88OX2_JDV]_UEN]%X>'@X>9PP[X2R6:-U>GK6B!O6UBW;CQQO MM7XXB]LV&W_>7(^<.2Q0'1/N(^(\4\ENTNB:Y^?GC?"OHBG';1[27U,'^>&* MRN7+RFPA?ZO'S>KRHWJS53]KGCQRMR9UP*@'0YA:X?!M?[6$3S6.%TM/LAU^ M-F@'(L>;[T$..'31D&T:FATV)-L.\IS`"_5S+9C<8A\>?2"N''K]J>S\ MU48/YPUUM@;T)%*4;2LL&B^$8XKX),0DX/490LN&5&0#/)_'GX2JK9\V(VA^ MB3[^J\,Y^/PR8$QP%@_@H0EXX;!_I;=KE,SE)>+S#G'E/[U_`GR//,$%[_B7 MB+&5\`)?D1>`@GL]^EW@.VQ;0,2<>`SQ8P+U[841M6CP8+$(>ZMC`7],/V5T MH5)P/"[=1PZ+,A>8<)3"3P9<,$F7D@'DU:P'P+.Y+_Y4.H0=QZ&!8'8(#@C& M)Q[<@J\Q[U1DY@.FECK"J6423I>4^[Q/>H\.<&Y/+[`GAIAQF]R)B$N:;1_< M2TI\$2KYW&8#1F<,+7CO<0F.^-.87L`E];SPEV_"H6)B$_@?(*9:G@<;T_P9 MLA/(G9O*7'6PPH3[07RS$'8X"4P?S7P$/$%AS(46R[2P=FWI\;G&?/XZU]Q,*&")G;:.T.C(:BJ#+TCA./Y`2?_;F> M']QH7_HJQP3<"R#B!W\@M"Z4*$..HL(4[,B,J9B4+,4P%-*/>>YUX[BW4)2F MIJL0?BKIS7.[(Y\ZW^?4$WQQ&?+[JPN84@9C!H@';!7^70&;'GVY,EW2Q8*2 M<.3<:(6@2%Y@[LILGFGHN"Y>\S!`V.V32[3$/O(V6%=%X?G$5<5. M1R_F60X1.P4+J6N(@B:Z6#*82Y=U#WUY;0[7E,OC>7LJS*%Z@U6HI\KB7%1C MYAV\#,%',D#I(49D@L2&2#)T<;#*Q6L05Q5:';V8MX-(BES(TYN%5A8TFKB: MYRZW&,P+9%(:5P*=-"'S?5W]B'OM#G$+K9M<4C/V-DJQ$D>]V7N;O`5485%3 M-MZFW@#M*VU:2\THI+&3K/_YYY^V_WO!(X1+^W9D7_>[G7&O.QJ+_]_T;L](:=<5_\M7/;O;1O!L/>?WNWH_[77O]6_-J[MD>C`D\37C3,@1XLO(BG MDC/GOC`1O@X8G2K#P,U69>?VC9`'/#IU5U];[[8\:LY>BF(3*W=7,A.?'\A4 M$GLJ*,]H,HE,!T4EKV:44RY`]A*8D)W,XBL1!2[)MN7& M9.$>>@1AIK[0[@UBWV&#'17G.91'=-R9`.Q.K5SIS=O0#(&#T(=\.]45ALJC M87Y)/EQJNBJ`E2.Y>8=[7X`(T3S!;\==8(*Y+P6]AWRP\BBK`%>N].8=S#W) M]GR.J&.Z-UJ;`$R2^00TFT[7\"UG`;%2IJ:!IR#/5[.$P"P73$/25\ M?;2V;C=&C\!O,*%,;"/[Q`<&7&86;O>RWF7>@#^GKGS`Q7UI&E63MTPNCCA[ MCJ#LS%FY.8'-BRMB\";T9:'+$5E;+HVVW.R*NJ0PG-5\B^"8N MV$BL:.9%Z4ZY-C])40V@4R0U<*FE7$=K7-ZKJ(Z(CH8PNUCM`&K>LE$E#5P) M:X%G9'T;XZS&#!&.G%#MQ`U_BT!P_P[6ED$#VP,-6*UI<2BM:V[ZE=Q([W'0I"+U1T'X7Z? M(N>.F`WW6?GT>W12]H'POO'7$<_EBT/R*IZ@Y(NL.6)P@;@L2[.0H46H&=5] M5CI!Q9'*4H.)-9VRG<47A(F<:G>$`?+P#U!=AQ7JIN+P%E-9_JGL$6[48D9M M(F]H[>G6.UM5S9*"'50<:5TUY2=1'@'C+HC@T,&AIL3/'D018&=!F8]_Y)EF M+?**XZNG(A/+087QOTS]DN4>]:Z6=UI7'+I4!912^RED6KZ`$WZ@2X.)/PV\ M^$6SS*=8I[SX`2.9KU6+=%%1G(JK*@+OMX.")R)HF=L+75C_VR=/]?GD=3B[ MSWYBK$-:9;"T5!.!]-$P3[=^WUC\!#>/LJ)X:BLF@O/<)->6G(?)2KGJ0_E\ M\HKCJJ>BIQ,"HQ9KMIE1'T>IZ=XND*-O51-6; M]G+%,6U%<2Z@G!A5HRI^I_(M:PYMO]`*9^F3.M15F%ZMZ[99I*#9_Z^5F M3S>K$2M@S"2I-'K9BC#0QJ1_G=X`&):)[-OQGBH1N4@WQTQ!W4/\G:FT[!D:>QC\X+PAP4ZJ;B M@!=3F68=NLS$\Q8W3JI48&+Z^!/CWRC[+J]-J+P(*XR=@KHZV*E4 M8&(>^7.N$'JX$9:>8>05ARZ;N#K(*12@_:V[*6[N!0XNOD*6J]K%7B`^#3GC=N!S'Q'Y M55:*Z5^TI[+7=@9_"<8N!&I.<3DS^CGJBM\3W%VC4%!SK^N450D>\ACFJ9A[ MR$W']QF>!+Z\MA[3\#3-#H=7YW84ZJC*D.ZK.VUG_;HV/V0B\08M,I6M0F]I ME1T=[#6M`L``00E#@``!#D!``#M M75MSX[BQ?C]5YS_X3%[C\4C>W>Q,94]*MN2)*[:ELC6[R1.+)B$+&8K4@J1M M[:\/P(LDBB0N%$DT%;[LCFT`[*^[`32Z&XV__NU]Y9R](N)CS_WEP^#CIP]G MR+4\&[LOOWSX-K\Y__G#W_[_?__GK_]W?O[/J\>[L[%GA2OD!F?WM,T"(_OL M#0?+L\D?YQ,;!QXY^S4>ZXP.]7'X\?/9\^9L;`;FG)C6=_^,_N$W9+O(M\W- MG\]NT#,)3;(Y&US^^6SX:7!Y]NGRRW#XY=./9[/[L_-SN0__BM$;RG[XQX\_ MRWSJ\JKSET_#=C[UP^WC^S-Q/GKDY6+XZ=/E1=KP0]SRR[N/,ZW? M+M.V@XM_WM\]64NT,L^QZP>F:^UZL6&*^@T^?_Y\$?V5-O7Q%S_J?^=99A#- M*"%=9Z4MV$_G:;-S]JOSP?#\W=-$V=K#]S/X`/U[$?_S`V&42BW@. M>D2+L^2?WQYO\]VP&US8>'61M+DP'8=^B='P)=BLT2\??+Q:.RC]W9*@12G$ M]/N,\A\9S7]BHUT<00W]-W*9WIS;:&&&3E`C;?FQ:Z+46YG8;8;0>.BCZ(R& M.%^AU3,B=1*9&?<8"I>4&&*%S^A\"[Q&.HM&/X9:UPM&M4Z99,"(II0@T>#V MQG?H"(/A8!@O%G]*UV/3M>E_<;#![L(CJVB)^G!VB(Y196].Y9'U1\M; M743HN,,<2>)38`:(#3Y=W&"7+KW8=&:>C]G8UX[I^]$^HD"LY(!'DGUE.FR; M>%HB%,Q,0C^W1`&V3$>!TO(QCB3N>OKP-+V['8_FD_'3G/[W?O(P?YK>3&>3 MQ]'\EOYU]#"^GM[/'B=_GSP\W?XZN7V@/T[NID]/"O0?]9GZU.9I27FW]!R; MVA:3WT.JGB/7GE)>DFMOM:9_8O/[%=U2ZW:%JBF2VB?J@W9M^LL;QWOS;UT; M$V0%UOZMB";+>)T!8]6%G4>\\=IDD@5I14,U"29P[K('#9* MIKJF2@UW+,GHA6WBUZ$?4-N"T(WO*_)>B+E>,DOQ$:T]0G>_EPIJJS9PJS"4 M%%MQY%:!5-"I2N,?O3:2#XKGYO-,/ M'K510V-P*,T1R=)L$BL=+7&.*'D;%\1;2;`K_:0G(/;,(_3,]LL'VB/T*27> MFM',]#IVN'RQZ.&!ZM_$B;K1^1)/O]W?'8\N[[]\"$B(*@K)1];'%^_UPD8X ME@_]QZ%8Z*^,2:3%C^@%^P$QW>#!7!4)IJRI,6Q"-(6.PFI"XA">BFF0DU,; M++^F=!/3H8=C]/X/M.'R_*"M<=D9INEOL$//5I22%X_P53[3TOBQ`TPOICOE]P\M M\WM.3!95?]JLGCVGA-.9-L9/'>#Q(<4I=W_4LX3'3@)V'HL\!?XT#%@@EY'( M7\\Y'8V_=$`.4C!2X?S4LG!2&WU.ART1PWX3X^<.,/R`X)2U?VF9M2-*@\WH MN'',,A7/M#$^=X"YAQ2GW/U9D^+.$,&>S;=/"ML:@T\=8'VPO MQ63=T-\5G:>Y[8U!(R?5AOA?2/[N4*15",QHE1?!MK4QZ,)YE$/\EOTEA]*+ MK$>K$1^79"Y#[^WJO5U0O%W5A10'4T?/S#-D!1PA91N"]WN5DEVWUZLZZUF" MR,BUV?]8>LNKZ5!(_BBX-@G9T"/$KZ83\J:-5'^MOK(\\XN%)(ND=*JU/FLL MRPLIB8_(0I1;5L>:K*`$``#-+<\/_%MW\FXAWY\NKK#C ML.R&J?N-!XXJ[#?3ZEB4E=X!P75[R:LS M?(P6B"XO]MQ\C[%(+;2<7EK]B[+BX--?MT^]NG1F!*U-;+-)[/HH3<^-219+ M2:*W5N>DK+3D<-3MJS_6YIV3`XKK=L$?,U.\-2+!9N:8;D!5 MA-FY:W:&X6\DO&YZO9WRDX./H&Y7_K'3XL%SK5A_I`_%^2YZ':%JLZ68^KIC M`,>87-G$;ZHWU,AT0A9E^^IY]AMVB@*\*MWUNDVY8B@SU^1`@3DP2PAJ1[=^ MEX62,/8)AW,"3DW(V(6-HN/9#A9_UQ'V-0;ZO15*,I)"5,>^S!%9C=&SA%.GH+4QT.D?4&)Z MB=R*,8&QVU*'_\S<,&^_?(@CV\$8Z/0>U""GZG1Y5)52*10XQ^A*/A#.AC+4Z?6H8=OC0X,3$]Z[/R;,]3QH:@SU MWMKB,KA8*D40P&Q+(]O&\:=G)K9OW6MSC0/3V:.9Y_,0=C:&>N^!51"7'"@X M6Q0]6(:KT#$#5%HCD-6V>D#!=$%W7+X+2V4DXU+OI;,JLE5'"&>W>V1U;JCU MFU8LVP/#[&(+\W8]<6?C4N\=M@KBE`,%QYF2!WF%%AY!4BX5A%0,`HXC)0]*:289EWH+O-0R;1@( M.&:^Z$1S1*#:N`3B^*C!0UD*4)`AVL:5X/*BX?TM8%F*^UO`@&\!.X[WQC3\ MQB-C+WP.%J&3O^LG$?U7&:<[=X@54=5Q*"X+,^^1\F0ZB'X_"(G+<:#+=(-? M4$\.!)Q#ZHPDSOUH2Z-;QI1$..W(8IPA$A6,XLPDN0'`5^-3A@/GE)HE.2[P M-0J#I4?P'SO[02BZPX[@:_E)PX!S"BTB]=;W0V4QQ9W`EP*4@@#G2%I$)K]4 MH&1/\+4"Y7'4<5PML1FR'[^.78/X%8WQ*[;I8\,L>2@"H MO?!AC8*1,Q:XY7C!%T:412&JD*@K^!,3*QO]B5OKO>JK(I42XK?"*/$XM.&; M/NI!R-Y]W;NON^^^3KR!T74?_LWV@Y:=<4'GZ8:3><4NTT\7K`I"%,-#Y!5; MR'_R'+XI5=8)O#-:"@(<5_17PIYT)-Z"FQBUUZHS3N4LS7`\Q],U(B9[+VY[ MRTVFLO3?)=[1'-$]"_)Y:G<9(2P@' M3'+V(_(190@K$3RF6Z#C164_Q!+C]M/J.ZX@+Q$8./;`5^12=`Y[+=Q>4=XR M9,S/*A:8H*=6-W,%D8GAP+$2B.A[IEIL`)ZFT! M)3,FN7\OU)]HJ=QS#P'B."M!):!*GE]Z*H(VJ@P`U M'/]2>LTY3?RZ,GUL<<19V%YOY5"5G:&4?%'R@4:1C+$3!MQ4JI(>>@N%'B.6 M/0!;P>@/114J3[2,C+'/8O8AD0I/*8VCMX+HT7.+!VLK6OV1K-_H!KVD&C=Z MI*CDBVI.)+>"J8- M"YX'6F#WM/P@=41B]I*]6UK#I\_NZ[/[3B&[+X43*SQ3=,]EWN'1.Y;2L*)^ MS63^+6E/8H7/Z)S^-B[+*B'2K9@$XBS!`69S.J!O'*WM/*.RJ'U3,?VT MYL8K3T@!$C@Y\ME""4(1%377>H=$53(E`.`DAN[="19*(]=6ZWTJ55$440\G M*?38VJJ=20TMIAV.V:?BZ.YP+0!N`0#]QEJD)7$%B7%(V!.]4>Y!5)5ELEH[ MW@:AN&1+2*PE-5#8$T6B&:,Z7G=R*2O#@V/%E4"(];04`]])6VG$[F1O'@$0 MCD48T?>5F&Y0H+L1E&=V_M@_E8ADKC9:=Q(Y*X*#8VSNCI/[-(X(A?02,>%J MDSMQCMY,8D\CBOT(NW_KQK!%&W-M']*;J*F\J]>*&XZ%7.9JDLTG_4J9S;(9 M1P3[=.KL3Z`C4H!K_'IWGH1OB1EPKHQ5O`;2E3S0'-F"BU$M9Z9 MZ,)D8X*LH,\^Z;-/3B#[A.DU71C9_Y@GY-5TF(>]\IVF*L-UIDI517!P_$IT MC67$SXC'2@+;5YMO5/%NW>UM]1'=)U_CUVK$HE8?3*NKMJKP2G;/O4=$]PT+.RA#[MRK;P(W\3FM(^\!%HA-=0B]F3KMR+(*3^J(4I8(^-#% M<.NR.F`N[;YAI4_):V%)2MFN>G-^6A2H)"_@1`S3C&;UXFJ"GGH3@]K>;86L M@!.GRZOH#K/OHT#&-2,]AMY$H7:U0(DIH,HJ'I"=?UQ9217RW?6F#ZG)15:V MQ2C!N%K*-R+,+2[-[:3;-2%H"T;0VL3VMJ!]6DDD?D\]!BIO<\N,IC?;YABI M'@D:CI^C?".9F9O*6VW25V_Y-MW65@$SX!1)+B27A,B^P^8S=F+0B?IN^;'W M-U6U4!A:;[TX`%JCR"M`]9_S<-*C:/)8G9+:'/356VQ.MUX4,`-0>6?Y5(): M,J3TEI^K.;E&`3.<\%@)W?%C#36EQG$&,X8GGQLG0`_G8$@)MQ"RHX<["L*[ ME%$R,7.%48PAP-0ZD;B*9:^(&HP[)RTM,O=&%B60H$HBEQ[$&`+,DZLH<270 M<&:Y/!-J6>B-H4[77JT25P,-?HN_P:Y);=]ZMGC.8,90I\NOE2U>@!Z.*NQO M4^SR.J4:,7_EMCJ+Y,9>V-<8ZO0"5A2->#LOQ0IF$W]$ZV0SFB[N//=ECLAJ MC)YYT[BLBS'4Z>FK588\B."WXP+(M2S*QJ5.GURM\E4##6<-GBP6R&+QH7=K MR4H#/)H!FKK%^Q1'YBK#&)4CNGP1LJ$K551#1EGB!_V-R]/QI$D#%B2NME$K@;U9XC-W#_(ID6:: M#Q\%=C9S+WE'%XW\KQZEG/YH(>*.60EFQY_33X:4V+ZD@BS%?4D%N"45F'%] MZ]*Y'3*:TC>AV?ZB?B$Z@85H=S7" M?+NGR`@VG?@A56VL=EDJ" MXV*!X]+8TGM#^>HOD?W5\VQUR97WUEJ#I9+DN%C@^"2V]%(2941$FVDM=5)) M%C'1`G]`.Q978+HOF.ZQ<0IQ;W;U9M?IF%ULR0O0'7YE;OBLHE]M[LU_>^3: M,7W1\XX*HW3HL4"- M2R#O4.K1@#J?JRRY,):DJ]G7H1]X*T189:_2YX<$/;3:Y16F5U9*8G#-2>$? MKO?V=^^-S_A,(ZUV=SV\/L0#Q_C MG\6<*23LH[647CUKG``>G*R$1Y8](SB,;=LT4^*ND:/6/LUP-IB(*O'KTKM6 M3=6=DSX"9?C(8?6.7#"GERK,!G+L4.8ZO`?N[RGG5N%*R/],.[VE^0X5N9CQ M.8+AL-Q\EV/Y?CN]Q?,D67Y(,)P5O=Q<^.:C1>C"">IC[`W0>X^P!W'^#N`]P-5&6N/3#:Z5"U##PXW@>>]V3/99(4AWZ@QY7Y M&W)>T3T]NRPK6OX2`VN-C=?E?9*""6?55(/R+V22^9M7FP8DXVE]7JXYP>_0 M=@JPJTL^`W'CA3P;JMJ`>H/@S4H]Q03YA&W^0_0ZLRD-;<@1ID4A`OK<(#V(O#=%'&%/6=HFPD MK8O29:4EA6 MHTV7&!9[B(OP$\)NF$8/`%UM=FV2=_LB-#M(KLV>[9/*]VWB<[JSP7.R+9FQ MS4#O-:E.=@))+]>J4O"*(CPB:N-ABUEKS&07%Z-/A'"T\D*N#M0ROM8SL%+PKR:T@@32-@Z[T2J56QW[^&!_PCV=$ZY:Q;CN MG&SW:09C7ZC7,--\ALQPDQF0GH'9FZ;!9F?P"K94R1&:L?H; MV7#E$75*CD*'G_08#5WWE=[+%0146<);I'#6QG9%#,2&:%/6+53_B),AIJZ@ MY,=!,ZV7JY4F2U8&)5B:9N_\S9-A[[:9UBO,];!W'TN#*53)Q]@562D.[QKJ MO3)<$Y.S*[KU<#F+IL'G(9+/X5Y#?NC-$L&>+RK8W\+7NE`1O"#R<$BY1`/;6 M]T-DC^DN[;[$E,:)!?MI\LF&2! MG$!BAKQE;J'#N!;!1%>PJFKBO2V)EG62%QK$,9+\<::RQH"%/150CLS!NT8-@E M2*#1'J48]E&*/DIQ`E&*ONPVU)VS"\62^[+;O2;U9;=/M^QV\NB(5,GM7-O_ MHG+;1=C!"+&>VNE:PP>M"K,,/Z!P_NZ:J5":N;9ZG>BM2K((.YQ8^&2U=KP- M0BK2+.VCUV? M7O#GWLBV<4S'S,3VK7MMKG%@.L43YF#C^49EY3^BWT/LXP`](?**+10SY!%9 MWDLL2MZ9O5U*.N/D;)\O<#:=O463K;>3=X:-[YPKZJ"W6I[RFE)(/YR](KNC MO;F(^$N\CLA]FL[V%5`L+^6Q]);D4Q%E)6B`$GR**\?L-K?<=38BA_CWO[]VO.# M!R_X%PH2<^F/Q+!*8L8RVUR3W^_,K9:VN`'@6>RG>!9<4PO>6R$R/N'VZU`47X0#3*PE MH4L<1-UOISN.+N1NB5`.,'1="$!"T/5(HX6G0M+J`H_(1Q3GDE^DOKBUWACQ MH0)G.86MI,Q"M+,YQHU)2>%4QV7+]UZ0$?W?'CWP6MNQ.'*B$> MSMHS1FN"+)RXK-<.BICIVJ,5\ZC\(0I(R'3O3JA)%@VJ^CP*>[Y>3= M.T([TJIF'V*X5Q"C56"EP@5 M->C.:T,[>B%<@U0*N/35&_N(RTE%7/:573;:5Q4++YGMQ<0PBQF6(5+W#K%E'? M'%,G(3M#\OFYWP9"B$::E0>$P_'/1B5%K@FR<3!&!+^:`7Y%Y8$>F6X0PCXR M@I'$`L>S>^VY%F*AT^C:!/:_7VTDJDQP>C436&K$AN*C@#.?$]R9(O+*O![:@U!"J9.B>2$ M@,!(;3]8G6S6XOOV97WTABHKB8J+!![^_I];[\4_'CU__.;0[OGP^"C!65OTG&\T>?0'? MU0\T@+SZ#0BK`\?0:E+[;SJ&ZHP5"*9.M6,HH`)^]1Y#=88B*DF*!P7.(:B9 M*YJ-A"2TUW-'\2Q)ZW&."L:=6$`,16J$<:+43_9\2S M0XO2Y=IS9"U=S_%>-J(]1+*GWCM'AXJ=Y;@\A.9XO[NQ)\7PDN9Z[QA)<+F< M[@8O>NYN\6TEBSFI`,(^FN\12;!91#V; M_;\(S"+Y01IRXC=B)*FA@BE2X9:=;]R4-U_:>E+DNUAX.UQ@+*KC903$N&I. M6&T4Q4C<"E-7D!Z8:ZCW,E:)R3=@W:Y%AQIR`YA#+KR[K(* M(CA^UT;2A+I2]T:$`D":4%R8)##?D6_'J4!!GPK4IP(!2`4J=;`RA9V;[R7V M?KY1!Y)W"HENTDF=?*G495#43%>&33%S>`RL,X.F9A9J-LRK\[(%-TI:;I.5 MYWFGLXO!":*]D^]5$?73DJ=2II$%O):@'XQI3K'$-Q&O34(V"X]$#[JMO)!; M8HK32^\M686-D8\!CL6]K3G'JLWMTRI592_72>]EV2JU]HH@P(FJE)-)YSZ. MCPICBKJ:M`[&T%N8M1;AY1'!\8.RQXGB5R\=QWLSZ6%/N!*6=>E,+5<.`#AU M$2>+!;+8+?GM!OQ($;*RWM@-J98EZB9X;49ZD,Z4A%6"!*,`O9\+_WA/U!+`P04````"`!V@4U"Z>?J@OI"``"!_@,` M%0`<`&1Y`L``00E M#@``!#D!``#E?>MSW#B2Y_>+N/\!US<1XXXHV9;=W3/NV)D-O>Q5C&WI)'7/ M3G1L3+"**(G3++*&#TG5?_WA0;+X`$"`#R1*_6%WW"HDF`G\,A-()!+_\9_/ MFQ`]XB0-XN@OWQR_?OL-PM$J]H/H_B_?_'3W\>C/W_SG7__W__J/_W-T]-^G M-Y_1>;S*-SC*T!?29AU@'ST%V0.Z^.WHP@^R.$$_\[X0Z>KUN]BA'!;Y3^Y9N'+-O^^.;-T]/3Z^=E$KZ.D_LW M[]Z^??^F;/@-;_GCO_GO+Y]O5P]XXQT%49IYT6I/1;L1T1U_ M^/#A#?N5-$V#'U-&_SE>>1G3J%Z^D+0%_:^CLMD1_=/1\;NC]\>OGU/_&SH& M21SB&[Q&[/,_9KLM_LLW:;#9AI1M]K>'!*_%/(1)\H;2OXGPO9=AG_;_YR/R M"=[__RW^_`VBC7ZZN:QZ83WDZ9L\/;KWO"WO)/26."R[^N;-7]$,W'V@TA__ M4.?N,_ULE\7V4'YH],6)"(\V.+S&21#[%]$P5EO45GF^S;PD&\%UC=X2WW=Q MYH6#.*Y16N+U*QXVMA6=K3$EAAH/&],]Y82\9ET^C0=R/X+4C]!_?R;?;W"& MGS,<^=3\\;]22H4MYS:0^@#FFN)5H[.0.H,X:LZ3B*A]%F2[RV@=)QOF3$Z6:49645G9$6.==?]/?=HW?RV%;O"8X#3.DQ4V M$IB/>Y,9;VG`#'6NA)(N-7%T]-/M-W^M5@Y>Y"-.B&J4Z)>2]G_^@W]_.G'( M(G@95V!_*5+YQ:?9A^82ZT0HUNNV,"=)4S&\9%5R1/[9(TW1XLTJ)LNR;7;4 M0-\ZB3>FFE"R$IL.Q!MM):\OF=9>NF32E`LGJOQO<)A52REF#H[>'I=+L.+/ M_R2>-,.4JSMON3>7->V7-+2@ZE(6VU"I&J!?6!/KZCL=IS90K)[Z$K+*>0?` M)W&C^)+\,]7!Z+XQ!$[KK"H00)LAU@X>L.-9!D%N!Q12]+8188K@%*]>W\>/ M;WP<+14^;;W689=\:[8+[9QA(FVXRUI[?X'?$&$#`S.O)B.-YLXNLWBU:^W#QZ9G:L\HP>]E`WUREI%:'>9K19!MGYE5(B1+1`G M1#5*P"6X%7DL+\\U8"98J_=C;"[M*./>=Z1;B1XTFEA"?(LMZ?D#_1T"P6/X MLX5(T=36L2>8U[E0=D*^X]-O?0P]F;EMMK&$LS9C[8FL?D>T`032QG%H"VO" M":Z#332[<]NT*HE&$8D0M[5LY=J,2LT);P@:?YB:9]O64`@*D5D4(6)NQ/)( M`?_R1_(WT7F:NKUEY(H8EB*AB$,5@&#-(1$\->^VD2P%BPC-,J38032-?>GC M>=\:!,UU9OOPP&*JCB!Y&KYA4-P!B!S#;70`I#MM`J)1<1KTI.@9 MD4.D1*C%D6<<7*U118A*2L!$OFPV-F$L08.0+^?T]O;B[M;2`"+Y[L-5>%DVP/EF9<^G$0^_9^+?^?! MHQ<2K4E/LC,O279!=/^S%^:JA$P]>HL0UA6HK."=\W.`5)CPM0_P59T4:@\HUJ\AL.FHU^QUG6#1'^_8+1"@6J*`! M<^,#Y4AJ_?DM4S3R M'S\LWAWS_T@)*FFO69Y$::TK2O3==XNW;[_C--\?+_[\PUOVA7/"PF:)$_3^ MF%WA?<=:W!)U*O[\EO]Y0;I-MWB5!8\XW'5NC(P>Z:QV)]`:7A:(72@$75YI M:'!GL=6OOA:77G&:I9?1Q?,*I^G5^C0(R2?NTZOHIV@5TVN#&?;/XHBM"].K MY#J)[Q-ODUX\4S#1&YVG^"P.0_8??P^RAR"ZBC`-&JB6:[-]T^82;\:!Z_AE M^BUT&2'^-1H**+^'KB)4^R*J/HFN$E1^%)5?)0J#3C&J/HSXETDGF`6IP-:4 MU@>3"(WY8!+KNBP'DQK//*+_2<9F;]Y!PG;6-+2S5II9/>T9M\OHD=C4.-D1 M`ZNP1XUF%DU(B[TV4*N?F=>;WF77KIR/93'`:;4$(KS@Y+&K,[9LB4LL:RV+ MC&#@P)I'I%5M&R)0*7MJ?X[7F*RF_#OOF0>VM'95*BJ+1D'-?.>DJ6B-2'/$ MVS.8T"4"W=/R>^\GY58"?*LU4+J,2.?1]I"XUX!56PWZ,65/*ZX3O/4"G[KI M*,4GD7^5/>"$L]6O'3K4%K5$3Y@VG@HJ5)"QY1XCK%0'6#W&B84Y&5_&QDRN M57$IB2D/D'^S+)1-DV"@4VW3H*]0M@\'-0*04&K?!QI'U+B/3;:$A.J)+/J697L=\TT;[Y`C(!7 M7BI)YMFX:OO2*06)YMB!ZWG/B>=#LH.T>>HZ@TRGY:DK.O5"NM6!.WV=0;H+ M=OHJ$\WNBJ??NG67.KVFS?8:YRN1EOL'[50H`8GUE8^0;=DB:-_8F50I+?[K M.S+XM88<*>)EAQ0F-L/>&1G/8!GB*NAP\;P*WNV M3,->0=@D!6#*GV","@1CFM8#@C6#38D&>\C+NKE5QW`[C:$LOX,T47UF",S4 ME(=/(V/`/< M2\N?ECP$BM('3'9AOI?A(NV^&``Y>D_JZ"5]D861EV!VOLQ28;,8+3%*L!<& MOY'_#")V"V:!TCCT49P0HQNE9"A\Y*W)2AS%$48[>J^;_+3$NYCT3OF+Z#,& M9$[(E\F045N]6]&\]6"-PCBZQPG<:PW#;6+C[8;!!M%VC+,L@#+(`IT0%69&[!V+`<))2=7%+3KY>HYN[Z[. M_O9?5Y_/+VYN_X@N_M]/EW?_@+(N,XN%7M%K"$&48[\3PK=I"$QUKFTJ#!7. MHC$A*Y8[G&S.\5(C@5K4VJ:)$#+;P15I=42;(=JNRA1#7[PL3]@4@"F+%O\E MO]LX8:G=,5]7'F54))^0PCAK@\'/5(/OP!&*`O0=Q94BWOX=\FMO1Z^JZ=\> M;Q$`W!OOL"R]`5RTA$_L-.9\RUO"7K@>/M`.Z*,:X+++U4)TVS]+N,&/F*Q/ M]&\?M0@`3@TZ+$L#TD5+<*TTYSSA+5V(GHL1(@N9"^$Q)DZ^6B5D^5S<0DC+ M:PA%_[6%J30\KMV!M:BX@4@".TAIRPM":>V&4+E6J74`$P*?0#S!G9IP1K'T M8L@CY*H*8SW2,CZ]T>)X&0;WC!E:!X"%,7TV%-O2^]$XIA>P=.(LYL=M^XAQ M2@3)Z=U6&B..Z-*54-`?JK[(NGQ57)#/:3!X_[T%#1=[*S(>>O:;/A`MS']/KDW1I'41D[8W3C!:#*8YS\JP8U=?H)$SCDH(T;L7@ M>P>U!B#&$8/54Y"2=EN\"M8!CZG3#@@[<11ONF5H[(7"3,P)N:/-`HG\: M^_5N8YB(GF+#N&\$OLK08KAY7VI.HZJW+9^49Z"86M\F7`9C$+4SNEB@IH-1 M1JT4_89>.G7/P%B2*B2E6-@!`5__ZH$.D*QN?H,(^ZBHL M9%.]*3;IR.YFV4Q$P5:4=H"*'E#1!05QK'P5.P M(S?')D@-'*-%H9H.I@Z.UBJF40G'I77C8$%HT1M7%*8?2XK2-ZZNT$Q79N`K M,OV5F%/++^F>8W]RZ=).:2K&P5>-1JM%@/==!N0FN9&-9)3)(LHW.LFR)%CF M&8TVTIJLUYXCVZ?!DOVQ$`WVL1;3S!N'OW[Y]^SW:>@GG?(&^>[L@?Z+_ MAU+^9K.79P]Q0C/;%^CX^\4/[]XNWA_S>O+T/X_?+KX__E/9.&"311I^M_@S M^>7X>]Z0-29_(CV__[YJ'.]?3Z:7#0^J(OTX-#M026>L``Z5S1DKBCLU:.^3Y[CVWR"$ID@_BS3;!#S0,_8@OZ4,-^'.$*1BWK)#9$#U@E80K+]"8W9 MA+K@-R"E=\G'0(Z#0_YHF`D79+P/L-_V/-4-IJF4V+_P$@J_M,8O/4-=!:IX MKP:Q17^D)4H;JR41*JG0JSI\"\+I:Q!J.IQQ,N&""L:=.,J[@4N8$U%.V?QY M!77'J.M;N[8=US9UD$=TIW@=)_@NP5Z:)[N^$)$>/>C!G5@@G3,\3HE*4MA( MT>$)IF7@IQ#KCT9RP9Y7*M2K_^A2KEOV+$;CZWWGF(+&%FV!D-5.ND<#+,69 M`Y22:W'\F;YIRD[M?J@._^C%G5(0=L2)CNA1';W7!*/7!R&)P3)N.):<6J2- M$4.]!!LNPP`7+]:[38A5W9:J[V MQ*EH[JQC11:(Y6"FC34>%F:?0:U289DV<%Q:K(/[I3%&&1263+#?7CG6T*I)+9?]DNJ^I/2.JNA2F\)86 M:.#^_`%GP3?)A)Y=2:4J?" M;2#RNW-4.LAD=;)?!MBK,?7R:I^[]4),OI'E2:2X6*]%9JTV7B_[:K/):%!! M!&8G1XM"U25EHB2<:%Z3J%?_SEP>=MN+=4H?0)'(AGVTW*%5GF;QAFPQ`&NN MZ:E.L]*:EMZ`7-(DR[ZKA+BY#/LL.'V-DUL:>5>LK72H8:YR*H11W\$BA.B* MV`5&RH^"$"%&C-J!&Y3F@A570*O+E'730.M"\O,5T/<&#%"HN'+6`T$0I6(, MI"?5754]9>I0P2B1@'FU\G`"M*=P0&'TA2@4I7._V!'-D$%)H1$2'`%J`K_; M:J(%!06D!E1,ZZ!_MLH`0Z'?QWT3]L%,90T,+Z^/&'@'*OSWP+Y78QN8!]36 MJWTE!!.5K9-!ZFV3?3T,U6B4I6,* M>LU8UPX`Y>UR=A0F3-0:*G.W8K8O3Y$W=")WMY_GIGFB6U#^3]!]IP(DRN2] M!D+L89K??60[W(U>/6X9A45LRYEN8Z6XXUHU=:!ZW"S,VT1X#V3:*%?CQ6*> M*@^-LJ>!OF)E_<162YL9JATFN]?]BO>DR,\PE>*T>03+C^UED-YUESQO96=; MVL]B>8JTGVT'-J$2'>HD;@H5R.:F,\VNUI_BV&?)8SAYI,\$W<:A.DHD);*Z MX52PWEW^IZP4"VM>E!#D!(A2P&TV366(U[#J."7'=K=4?4#O;JAZ4&Y/2S\E M<9I>)_%:6=RBWLJB'C:9:T.`_8KXSU!:!LBAED[I\+<5\F=3@P0@;*M,%X'V M=.1JBQ,O"Z+[ZAVU_@V:G,:B_J@8;V.A:KM_4A)^FS9,@/+1R!\A,=T+FC;" M^Q!C$>^T.-,M#DG']\0_??&27W&-,17J>RAM8K]7B`Z`6'FN@H0MY"JB4B?` M],!8&+YSH4)L*B'TKA*OX:HZ:Q6 M"%,+T`TG\/8,4S4*:-48)8=?DZ/4#MB:3!JHZI9CZH>4Q0T%CH@?"PDS)_XF MB`+JPVCE_'[5Z*.TN?'H%:*SE.84#%5-&F@%&2>+UY3%!2711%AG!Z$%+\!= MA@.QSMG0VC1815VSE;5*$_$A'.XHAH>4X4?6^B>)53 MWN[.>\;IER"*DR#;E:R3K4BS%UY5Y0O.'F+RRR-I0G?RJJ6*32ZLYY;9&ER9 MXV&K$T1IT9Z%F@]"19W>HCX=[QK5^EZ4"QW&X8)8+K+GC!,_B+QDARXSO"F> M0B:]DW$)^=*(\P^SD'-CX+G'7_+1Y:_`L#?&7RWY&_;?TC/+QX"^8P^;0`@\ M4)T1@MK".C$:8V!C/W73JN<0IX/:=!NV'3/AN5@9G/+)[W6B70KK#D_$M`3L MI&FY$$:OBM9`FW]]WN=YU\K(8AL,L2V/8V!A#;G')4"6.I_I@X[8C5%#-L"6%-]#Y0=1[8LLRZWV3;3_Z*ROK.OE M5=@:Q'*$5N4(9;41\:H>Z-D@O74W:\1Y`IML;6R`$D!<$'U1@N$/WW]8O/_3 M6Z9(?WAWO/C^AW<-@)#_0,2N'K,&Y!]OH5;)3@Q;39M<=>_C/9J)RQ_MSJS6 M46M+H.'+551VJZ@IF!<4M>KXT[H_7#CV')N9=#R=5K3T!BN0.`GW#NSN-71$ M4%^L1T'LJ7CYIGE98_C42X.50KG%[2VJM8SA-FBJA^FKHM<+Q-I"::PNX^SO M;*U18'S+=\VL-B(E+.M>>Z&R[K4=31X]'0X4F%'J0%MY50H`I[;G09AGRGK$ M,@I`U=TSK8.6HK4KZBMGOOA%1X5[2M?#J/"@:7%0C5LZT:?(384`]L!L`W$> MI"NROLD3K0H<9OU`>VR%@`:N@\?":MTX$#L?*^[?R>[P@=H/CWS0N\<:E9#! MG64?7+6<:`]6[6ED.0,G?`*^YILE3J[6G5K`?6MELWXL:J2I@%*(%AT@W@/= M*A`U!>I4W:M>":#VOT99WA&%WXZ/%RUNBO;' M?MFL5DMMC!OUU6,JG:UZ!?> M;'JL:VT1=-CE?'Y*/(9F";M`;YHUP:!XR*R!!'NX/?%]MCCVPFLO\"^C,V\; MD+U`+X;5=!;QW"=`Y^GWJCVB!$>7$2I(G(".UGRT8:0S&18AM5KEFSRD"9"R M-+M^>&GW81-J!H)U8+>G18H$<2<@:#I_'3@:3I[-(MF9%T38+X^W>G$H(;!: M%EO".-&^(JN-8%\"D'O%NY6C%<`,]Z=F+$5%KJ"<]I>AH/NGI!#04HZQ\ M$Q,(%"8G#*!G"#IA2H<>H=9AMWBG>-88N,%==K=8UKC8/A'#5F,"NK%H%Z+- MQ"I=IFF._?,\(1SPRZ(_>V&.+S;;,-YAS-I M^62K@,M!X'_G2Z>[O9-KKT=_=/)DY?X5UM6 MEI:?.EU&7+*^D,!T'[(=3YARB(3!"(':H]HWT.FN81Z*[R#VH04J/K4H3P$O MH\JV.&0Z9A](I55Q9LTPB\H)PP)3ZQM\@2?=XA2?O""BQ2Q.DB`EAK=N?D=4 M>YKRZPZ4?IIV,.>N`T6YJ,JZ<.KI(,)I]7Q+XRC9<2($;A5O:NF2"QIB!`J;I24"DR=&6( MLIB%2#@@NDO_AV9%/GHA38@<7!AV4'W+950]ZWA" M_/=CD`5:%2D&=&;WL0-S446%QAFNRVYH(.$5[8F@^MO:D\O[WAS0[$E$9V*O MF7NM/[9*9/4JA??8#I$08@;5>7OXNE4>Y;/ M64WKGF6XNMG@U6=HRM543`<,27 M@K-@\#IV:J#K'418UTYYL*\,[_T4D:U-&/RFK%)IU(U%33843Q9`%@;B:X'W M!=IW`Z7[$XF*GUN0;$>3L=AU["U=RBBLB&8'%NV'MDAM]-5/Y:XB1*EID+ZD9UF+ M&:IZ@#(:X^2CF8E4L'A-U^R,<,'R$#,6.,332V=F06"DLVE3S%2N;4V,],V> M'3G'6[)5#-B"B/P[Q,79X\DF3K+@M[[]@Q:Y11NB*4ZG9%2-;($J0H:].BF4 MZ9A`+":+-ZG,GSCVI>WU&IM.\^H MPZPX+ZAHABYFVHV;Y.OTLEPR&T09)LQDLAB"]80:,3*$"3!"6.@`V=^E(8/G M\;L"G/0O_V2AN)3H!%FJG\?Y,EOGX>T!%'D4T>;WN`L3X2W?XR[L`#C M`6*U@5)1T]0V5-*CL@-F,ED7J.C#-NXGE7%-9/1+&;VZC"F3,9E)1C]>Y9NR MRO$\0A*CG_,L':([15Y=AOB%XU+[$=EO)_>T$#X-(1"K4,3P62(V)8O7ZQ1G MZ.DA6!';D:)[')$&8;BCIP"T`?EW_,0N0XF'DOZ5MMOFR99,*F4GP7Z^HL<$ MQ%?AX)$^]D6^%D2K,*>7?U$49VSDRQ\7]%M>1%*8)EO4Y+1^PP5(2HI06SG4(E*YI.YF-JH&D?I=5(1Y\0W3TTIRB3*@A-N?5!KPHRL+<[1H@SZ\/3 MFD$-*W-A-XJAI2/=`(:.@MA3]:[YV:=KI&1AK)/'I=^'1?4W$4RZMJGE$I/5 M32U_BO7@0.[4&"EYC(>?1[+WQCTN%=T;AL$R".'SFXS1V58W4VA"*EZY3[FI M]H5&.B<@!U4WH3B:FE;%8O;$[FB8EF"5!,E\$K!U=?!XD"*8G9U.)\&"1E'< M,FERO>^W9E*EAS1DY08F$,8_].A`35=3`$V;52-RQU;U23(?RUK[@BF&/F@, M_>1O]HTU5(-G`-8H"72XWQIU%1C2#)T&(?G*_65T\;S":7JU/HO3[&I=UFTV M,DU]?8&:JWY!-4U8T1'])^^*7>4FG='_+;MSQ[B9RWW&:LP$+`^3BA>OT9)W MDJ(W*(_H?V"_?FSCCB$QE_8KO]C2"0D3^2NI&V,!7MAKL!+WVR8]#9[T-.@Z MP5LO\(L(#SU_XE4N^$$EWW_J'Q!I]09W9J0IK*8E*GHK0WX\*%$4JRG.>7F7 MCIPO#92^%!/7Q8QY7*80TYM'S($G40/EI(=3[$8=3WY7G#Y1@U0[T29&J?9D M/=K$$=XA-F0T7N4_5N?7]W'L$QN6('ID$JS8&;>7H27[$+VL%F^"%5KR*"L_ MM%_GM-):\=WZT->N^?&(6!1G_*>G@""5O=:)*TXS[YGVOG/EW&QZ*(HA"'BR M9F)8>P[;#*RJ"['!:V\W.#!8TCH1%=P+8AH2+"C=68;VBU3QOA7S[D;\J84M M_>!3$UC`:I+DQ&(&7GE\42IT%?:O_6:J129=0RN9V3#HZR#M%]6(:PNS_?%8 M[7>GU'3[,Y"G?SXH*W,"<#-F7R\VJ8C)C8JQUX%:%'@ZE4Y7_4W4&;V74HAI:FZHS MMZIV32)ZN_Q?4,GJ2(&MX5C65-A^(-M37,+;"F,__4B&07`'GZSP=>IFF/1B M457-A!/`6-!=L1@I?1F$A2II"2FA,+=XI.#`!M6S7-$6M1 M)_FK'^E=?+(B3"1XD$KJ=V)3(TU$Z\"T(*8E+PMRV^J8X41#&<<(>>9M`[)6 MYA$G'_9AH'&S5;R$EUJLSF.RVY@&BIDN%(&3U`YN*IOBWH$\(1;0V="DTY*=<`RVE?/#JH!94U][<_.,T(5@FK%$/*9=2L02 M[)E$J4@BJ*"9$G"J4)D*;?9TYP9OBUW,U?IS'-W?X61SCIQ3!0ACFO=-N??GX%YK_3YLZ.-BZ+-RZ(&#.&-F MX$@Z`S:-4)_FMFU/C]JZN,R>9'GMYK)ZFN6T^VMHG4VNSN(9-#8QHUQN;@K& M;P:L6Y6+]1JOZ(W$XHF0&^(%KB+Q@Y\*NV+4C47+8BA>&YNPW+V6N,Q0S28Z8,ZG M9]UN46T56+JUM!5(@4)XY4FT(;ZG`,-XG>E>I#A@P^?A'@[I'="HH=Y&C,V+ M]<7;%$8F745E]3*]BGGYVR).6?A9A;![C[X72MT;]'TX`M4$'=.O)(/5!949 M%>/(`4\PMQS`&M'KP-**F):V1N:^869305"6/ZE#9JE'9R[RH.FRS]FU) M!&CW+8IBK:*?'JP:E?NT,#4YTE4678L,%NLJ2ZA""*!='RC->4#/\^E;U[Z/ M3KW5K^@\Q_1NZ'52E@YBZ8GH+"8&,V$OH\XJIE9]57,Y;^C[URF_;?B`D;]W M8D7Y9EKP.2]>_:I5=B[*J?+ZUG#/>VIJF8;FPVV!/L6Q_T2X.(G\2S*_T7VP M##$O%&JT*3+KQ^+2T%3`-D9+>G:>MN^A?#3+J=W46%GO'G""O76&$\B%XR!( MME>20_!H<[LE8TEOU]5/;77SI2-,=^^B4B4G]F)#Q#(P%\[LT[2QV-VNZ0+1 MOD,S4RD5%8"S,L2:8YHSKQ00KLA`)_J19#$)MW@.Y!HGMP^>UCI.2F(SN5;. M=B?GLFA*,]80:^S`,FPN_JWFAO9`IY,'JL8-'.9UK+^BGVRXHY1FF*@SH&R60< M.`2*-$%^C;OJ$A5]LE?ET@6'\=$I[1=5=;3@_=&<(Q+KC,A2=T1@,BS'J(H\ M"7.$GCAH+T[K[&IE!8WLV46+(1V$J4V&`[Y\UD$99#4<61U,I#*##8=27^Q9 MCEM\3SFX*5^\TUA#2$DLZKJ"[39>BZ:H:NN`*S=@WX''1?HPTM:!'H#`@=LL MF*A##0AYO;!<%_V.11DMBP6I-P;A1WWL67V_*M[@.^_9,,U63F7WS2H%\X+7 MJDAK1)J[=3(\KQ26'ZSJ`Y/@J:H>)('J@MZ1KX(,5AO4A[Q"(#G@/687!%@G M-,YN>Q%E3RL^>D'RLQ?F>,^,3E!22691*WK8;X.)-D>L?0U,+@0*YY;#ID[H M0*JM$QIX@M4)'5>AI@/6"I6-E<')`6]A011HW>AU&#JXLKA#SY]%C$_NH!^SE]RZZZ(7A&[X5$V9VW#/6"LKI=V-0, M?;$Z,"M(Z?EB1;Q`!3G!'.T`N:`[$\@8#Y31JG890K2C;&;XA-"]CT$49/AS M\(@[=RH&J*%^;R`::2*L2CEY/T>L(\&%`!<5=1+1XPE$A]%?8YC+5=D4X_:U M.E;Q^#&G!;=.-O0HZ3>6C7!!W^Y,L;&Z3_(9`#LPT?`,-Q`+Q+^"ZI]!Q7<< MM!YS#UBO61D[8!`V9THEE!FC"3408NW13K$^]=)@=1+YYT&8T[<`S=8O8>+_1OR_\GDD7\Q?G\B*ZHQQF=(OR!V M9]@`J$Q.U2/:=UDH#NO4;5,S\7C$TXX'C,48H21R8S%<0T:43ZO9*OJMNIG2 M#8`,Z\=6@;4!`BJ7#T4QLMJ-'GTZK*QYW[IV[][ MV3'O$*X2VU"%;91F&ZBM(#NB5I;_9;2.DPUC]717_&BX#3+J$6;O8RBT4H$[ MUT!JO2WH2Y]E"W@#-N-(Q+TCL309":"=RA!E4&Q/!FC"-&N-\L/LWM[I[A.. M[Q-O^Q"LO/`S[9%P8+SN,.\38`TR1'`][68]4G6N]XG*3AU0[@,:"@AO/E@E M9)Y]J#[8?8#E,B*;';;&NXPR3&"7T7E7G%VM;W"*DT?E M6_8:Q!!/6ZA$D3X,L2``>T(5W0+1IT*)6RAIP1^Z,)&J(8H33UOTPDOZP$4? MM@!TY>]Q\NME=)W$M#:YL;(HJ"&T12F,0ETH'7U(H*!T3V&,!*.-CX+HJ&CN MA,[TPTRJ-+T8`]`:FE63DN4EK?MJKC4*:@BM40JCT)J2#C'"^96&&$X#E3&2 MJBD*N+H/G1'2U`EM[UO(I!>; M]W2-A!/IBR+)^W2'6!>(]8%^H;W`7>.=4]*ECJ16;_F:@[9SY]<8L4[HY)ZS MK]X&G\<;+^B5U+;(CFBK"LX&&JO` M\HCSBY/5O_,@P?Y9GF;Q!BL+WBQQ(M"X/@I;9P]*IMMP*ANCLC7-&":@ MX01P8?+^D6\$P7N'?00(_A;%3_\5/ZGGO=G(UE2W66O/+OT=D0;P\RDG7W=X]1#%87P?*.:WG\:66O M7>^^C44C4&>L>XS`\NY!=Z)#^;-IE3J3VS9'[9FUC+M>+U1O91M[4DM4S"[P M)FL,C]8QJ':*W5FVA\,O9+>UR3>]2&RVLXC%-H/MF2Y^=V(5)!S,]FR+1M+B M?'O/>O/=:&=SOEL,=N:;_^[&?(L&LS/?@I%T(<;X4XK7>?@Y6*NRL;3(G8@F M-L0QBJTGZK9LAP"[:].-^':BYH#[IIR1.!YZ5 M<5(GU*82PS0$S>C01ZKJR+*(.P>!U.3JC&R6J5;W+VZE.] M(LLP99%UYH;ZR$4U5:A:3XW*/P[JF+[0ND(YHH$]P#70235JW=#2;K&DK_@Y MNWO"X2/^$D?9PT#WIM.Q(]JK-03&FBRHVT7SF9XSQ'M&O&L7-7O0@!#LO4>O M/A1B.;H"-<&[B:)K@]U5I?\'V3;WQ<'16(C^!U`^'I;)U[([7V!IP MG598TG9:A:4=NJVP7.0I%9;0P-R=FDSZNP><8&]-/GI`ED$PJTRMU1G,TBQ;W#87<*KFKT$)LC]-J M$;"=4.VO6/GLKYK0#07E(ICJH.#:K@,:)I;E+LZ\T(C;(5_57]=0=DHAM7AU M1-=KBLTA1K7=T@RD.@S`HBAW. M]Y*RC]?4:).O?,H#WXN4WF_^T?&*T4GYF,3[/J'LEDLRV[1PTQJ'MB6)4GA".XTF[`8H+;0'-UUS)^QKH^XAHU*W3*GF0(S^+-)H[X M5T^R+`F6><8*"L?U%XX$AFM@1[8N7`\1L5N?K.H#\4ZJ)[1JW:"[N/GL&$A- M[BGDG5<*K6=`IA#CQ/>9R2:S5BRI@F@5YCYQ)$&$L@>,5EZXHNFZQ<[2+]S, MQ?4M\E+D(4*3A\P@T=;;.",,!5X8[O8&"EOZ0Q7: M8E#GR4O\._*5GGO\S78V0S8M!COPI+\CV@#X4O]H1JT&7$33WHFO".;[O9MKKT=<^J4Y3W?D4_?7]0J`S?+YVR^E#//<*E0#%S% MP!V)K;Y\,Z-:=)[%F4\G+%8+:3X=V%\W1-C>9@41"<.=.AWMER)=N-:O'.U. M\0[%4#L?A9H^^G0`4:>IHTT'%G611UNNUEQ@NIFYK:(M3:G3E.S8_`.,P$P< M>;&_R2'[S7*KN9^^C?U(AHGZMSPK3A(OO"0B#*?7.&%2G+"+[ZK-T23] MV]Q4330@G;52K=^Z&I0](]HUJO5-]:;L'5W3Q]-I_RP;35!KP-I6#FIXUNWA MB4V&Q^H&;:9]A#K[5VQ:<0^]:BC-PNZDY\4:QN8/+R;0SH:[$.,(ST(\]>,;)*DCI4L)A^5%^7*I@YK:E\N\T^'X M\D^D899>1M<,LWU%1N?XV@'Y<_%@S>G1^1?9^[KLFW,50K7BU?6&C[7"_DMR MY`:X*><<]M!C1JLRM0F6FQ2+1I@>Q5ZF:8[]\SPA0.7,\`FMYZH5_@+[*AMK MWIE-$SI$5`M['EPSDD#6<8J1J7YSROQ-(1FE9X$CFK!:W#-:HQ5/:N89K'GD MDP5H/9L5;4D?Z%40%22@M3Z':WG'Y@U5\<-95WZ,DS4.LIP(5-KF&=>5HJ\= MT+I2/%AS6LW:%\'MII7!.Z.V)PP=,ZP6<;-4XV99XF:IC9M`AIM#6JDJ[-34 M*U6YD3HT=QGG,:)0<'9/[U!]7:D7TG0['D!#%6#M-3 M#!_G\JB[9UC0MLPW.E2/\JC5Y]K230A%RXMBR8=W"%+HW1X$M)A+I!F M'?$R;>GP5T6S#E,SRL!&@QWM+PXAZVEZ>SA=^9"AQO"`W$V5Z@/M<=?GG2QS8]M!61]LN"R^ MBBM48PM1O@"=%/CX2S.+>">=L4*OB/.GKT!V[Z-8]5?@`S=E9OE4P+7N%&%L MM=`O@ACJPW&-\G,XF8S',[K&(=PVI7.=QP.Q3@E.V2+_Z=!]GN,DJSA+V5E%YE#SBY M>_"B0OJO7`II#GAP,[@##D7J,8&8GP@RLC>PE2\S%9&;NX4 MSJF&NSX85LN'S9NK.=GP`(W.G.F7 M%@LOPO-VAA7.\;93+5^>W]4;[`,O@S90D^W92*$:OP03R0,6H":RQ<*+,)&= M884SD45(Z@6;2+W!KH;B95I(L2+;LY!"+7X)%K)(@``VDETN7H2=%`TNG*FL MN'G)UE)[R,F`'$8JU?2J;<]LRO3Z)5C.*K#0"ONSQ?2YE^&/7I#\[(7Y+!4@ MIF3O1=A:H^EP(I;>.:MCK"+**Z+,(L;MRS/1HV:JI#EJ#-I1:]"D8?IW/!!] M_,+#]``C^[L(\5L;U]_;Z8"V#P4X.-!UH"]A4:.\,.S(RL:4QQ>QO#&?&'>. M+7Z_2YWQLZ;K/7Y'YR,.^HIA)NDE.(QF8-1-AV'*XXMP&.83X\XASN_788R? M-5V'\?LY+7+07PRS2"_!7]0NW+KI+(P8?!&>PG!*P`^P!5?!\%OV&__BZOCK^;]?L0OG/F`97[8?YAE<&K#M+YYQ>(,=#< MG%(62,L,$2;0GHM%P\^#64K'1GDY>I1W)J,,LHJR82"D*S(+UL'FZH[L3]G^ M-T^#"*?I+;YGV]R3YT!E*]5T5M=L:@$Z%<.*9JALAWZA+3N[`WOKK'GXM[M* MT0!1=T'2CR"+>L`_?A[3,B`JW#?:V<1YB\'.MH/_CG[A+>#P/))/J[@537H' MIX(9U\&EOTM#AK;C=P76Z%_^6=:7N<$I)NP^2*,PJM86<*=FME,ON&B(RI:@ M41>-@2YGN7^41\PU=>JK5#W#C3:VYK7%F.C)V54JG<+1O/GQBL72A=$B31Y/ M4,H5$PQ@HMEMP$HPM2/`5#N"4".JV]`6K$0LMN>M?FX(;B.D8]J81]F`CIC, MTR#>8#]8>:%Z+COM;$VE@,'.2K1J`C^1LO%LS*-D,`$V6Y]P?)]XVP?*B^Y& MJT,#L"]M710&^Y:-J(C9O,B3^)MST0VVMB:PQ9CG5`_^QE^XD3CUY@SP>#9D`YZ5W.JZ@@]:#!O#:&@!?U\TH!J@M=,/7J0@=)%G4A3[-X M0WQ4FZ?>)48?I4V=Z!6B@ZB"`@F@Y<):0W-:.LC2FA.+81,OQ.D-?L11CHL- M;7_*OI3&9MA$P7@GZ$#;HJ+Q`E6'P0[`J'?\.U&'GL$'=-+7.*%_\.ZQZADL M)1FDFVZRW^_A%FA/X8R7GE((4"1?X=7#U$< MQO>[/A.I2VDKPJ,E1!LE)1%[Q6M/UFLW1XNB?.=LN#P]B076XECZB&I$M[3A M9#%G/LJ";/?WP,>%)_KB_2M.RK7-7@T5;D"["YN9Z_IB=6*EC/2(TNX7&HP< ME?0N^`LX":UF;!O"LY-T;89->WI'[\WP*\1A&#_1^]24DLZI6" M[<[[D6535+5=(-X:2F?FX=ZF/O3!IHW_'LQ8]#/K-5[1@/QEM"*J=^<]WW@9 MIHF3090'T?W5%O/5G_*"E7XG-GV-B6@=6UP2(TZ-"#FB]`NT[P'MNP!S-Y!" M6O4XQD#M^!Q3E$)K(;U*%*V",."6(ON(?<)A2$_.<\+(KM'86#W->@?76]/! MT,8Z:O9,O$F&BLY1U7N;R"UUMS.EX(@6VIVLUFAVYH=6-1E;9&Z\=6"D-]Q7R!"BZX2GB?I\W(M M-)+"K]9#J>H$XJ5DB*QG44J[^!92&9%?A#=&ZI!G1)8%YI"Z"I$CPQ@OM5PW!+R), MSKC56)\*)IU0G@(C]I!]7JA;O8!@ITA]__U&HVXLZH&A>&V4E>3-(I:L`]1X MN,*-&Y%#)K,-RP$S";6-Z46EL#G8AD61@=MS$Q\G5TF1 M/DM`>^JM?@WC^_ZKV6I"FY>S^T3HI#I3`GJ6L"=!!["H(?I" MM='%4Y<9*7W\@!*S"P_%.G)/#WPE?1H)XP$2VM0P0W"V5=44O9HGP,;56.@#M#`J:IC\:KU5U%/2:5V,YME;IOLB2ZD MD849:>)`M5L=5D&KW0JFNE/PMCO/H_%U]Q3KX&O?S"Z^ZNQ)\$6:.(&O?E:! M\=69:@&^VO,\'E^DC98%JS>TC+$&BS*4T49NX$R#76BD=2==A+7.C(]&VT=;@+/.9(^'6?"H9=-J[2S#K,Z@#&;T MP-@)F/4S"PVSSGR+8-:>;,O/B+(7D64/$"[;CVE]2N)471I]8)>VGQ0=)K;X M8=&B+^.715FOH(^)3CX*$XKS@8L3X7N:,^Z(.%:K7XU43^%SH\-UTYY=.O'_ ME:<9.SB]BT]\/Z"L>.&U%_B7T9FW#3(O%+_U=X/3+`E667&V1LM5IS?XWWF0 M!EGY2B`7NGCK3^1F:E-@FQ.+5M#^('>>"]IS@.YBM.F,&JQ5/Y@!L>D7@,QCVYW` MV$;+JV.^1K\FD+AXIORK+F%*"&RO;$4LBY M'5ATCN;6^II2"FKABE&&:(!'Z!D[3Q%.TH=@RSBZO;JN6Y9^)37O"^)Q>`-! MY4^0^'J_>HBC;??+IH)FL`Z/X/4UX35!^)VF-!0UL&V7%93MX>JI/0) M=T-]G.353JV"M;+F]E_P["OENF_I1!5OG<&6/.H)6\#U!M,[0_ZUEV2[.^*R M4X\E**:GN_HO/>F`!IU8]#!&HG7W0JP)8FV`$_]F%\2F-34'7-N,&J,-1IMZ MT_D$C8&T0YJZU@(/A"Q#(5Z=.B=%Q(@50%FLN#=+KMO0EM<7L2A]!4:5 M*V?-TTL'M>'C92,Z:CU7U/:2>&1!(WMKMR9KW15;59X-QIU.PZ7%U:1@JEMK MR.X\3X$MJ><2-K..+ZGIK\\=D*N:CE/[.!/[)L63O6X25(DP M:B?52V<+C1H""(Y7&`E/_F\2P;LTW1EIX$)S.NPMP*L"EV=>DNS6<4(/0GN? M1E!165R2JYGO%`.IRIFB>GOH1Q)F%<+FLET#2NWU>S^.+%YZYF7BH_O/<9K6 M^5$%K<"Z#.-><^]+B`?N*G`OY^ MPCG9:P]3AG8?3NA&5S`3I"W0GAZQ#MQ3GKDE=$.[)`#55S8A.KFHGTE/?R7_ M)O]#\Q_)#_\?4$L#!!0````(`':!34(/<6$\OR@``/_W`@`5`!P`9'ES;"TR M,#$R,3(S,5]P&UL550)``.0`1Q1D`$<475X"P`!!"4.```$.0$``.U] M77/CN([V_5;M?\C;>[O]86>^NFMGMYS$Z9/:)'8E[ID]5RI%HAV=EB4/)27Q M_/J7E"Q;MD2*E&B!8OMFII.0%!X`_`)`X+_^YVWIG[T@''EA\/N[P8=/[\Y0 MX(2N%RQ^?_=M=OW^MW?_\]___F__]?_>O_^_BX?;LZO0298HB,_N2)NYA]RS M5R]^/AO__7[L>G&(S_[(QCHC0WT8?OA\]K0^N[)C>X9MYWMT1O[P)W(#%+GV M^C_/KM$33FR\/AN<_^?9\-/@_.S3^9?A\,NGG\^F=V?OWXM]^`\/O:+]#__\ MX3>13YW_\F7XN:-/??[RZ;R;3_WT^??GX\?7U]$,5VX.QZT6&J^@T^?_[\,?TK:1IY7Z*T_VWH MV'$ZHVKI.F.VH#^]SYN]I[]Z/QB^/Q]\>(O<=Y0'./31`YJ?I9__$J]7Z/=W MD;=<^93L]'?/&,U_?^>N(Y_T'PP'PZSW?^0"L@.7_->+UUXP#_$RI?G=&1WW MV\/-'O'N.K`CSW="O/K@A,N/M,U'[C`?VY'X&-LQHH-/YM=>0&3AV?XTC#PZ M]J5O1U&J6!+$"@[8DNP+VZ=Z\_B,4#RU,?G<,XH]Q_8E*&6/T9*XR\G]X^3V MYFHT&U\]SLA_[\;WL\?)]60Z?AC-;LA?1_=7EY.[Z3Q48+^5I]1IS:/SX1WSZ'ODL5F_%="U',4N!/"2WP9+E?D3RB(O!=T0[:[ M)6JF2'*?4`?MTHZ>K_WP-;H)7`\C)VY&?GF8UMH?>=%D/L4HHLL"G5J$(:,G MSR>LF867(5DE@@2-HJ\A.6"0'QV$91:<9N.W!'6%GN)\@7"DE\ARYY;DW`0O M!'N(/11)T%'LU785":.8:,SXS4$1$<:%YY/FBX@(XEM`).$C]P$YR'NQGWPI M$N7&;>32Y92LI;*SCS%`6[+0@JZ?ETD4DV4=$P7] MBL(%ME?/=)-^0*L0DV5H(4.GX(BME9[N0S/[37+IV/5J2<"U[>$_;#]!=\B. M$IQN0S*D5/=O*\[D*4)_)62H\8LD/:6NZM;VF>SR6>ZK>(EL0%'E`$=;LZ0) MK!WJ*.N7-)G<8;I9R^1IEAH7XMAYA6+;\Z,9>HL3R>M9^Z^I6R*)C15CW`3'7CW5L8N6GN_"01]DLY'G, M'^>81,HH;&Z.2\T4%NY@3N%(:78DB-W"J2!3C4: M7\D]-:8W3C<;.)8FG#V&%'%5WAD?X^P;`5K8,7*I;^8S]V-EG3[^]UD7%)+MS`O=<=",U(/>G=+\&-LX;D%UH7]'=,_"V/8; M45SHV1&M]Z@9;[?]NN(IPA%JQM-=3X6TQF4ZI1FYXR!9I5:%.^8M(6./0+*< MH<"E/M#LMW2`EC[;U+,>.GN?\:DO.\1U:S;]C94/3K:)<3KXS6[PT5,48YNZ MJK*!?(HS'=X2[FM]RE9O(1HWG$BY/+>CIY352?1^8=NKCY3VC\B/H_PW*9KW MGP8;!_M_;'YM;=UEJ:FB@OCJAM9F9R]*<(3WJ;:QDX]'_ED2WWXTP*;%QU7J M$'[O/'O^5O)S'"[E.9G3$M;@.`NQB_#O[TB/)"(DABLZ$-V,";@YPGBS:W&( M3RE_0?@IW,TZ(#&2:81NR#\C$5%N&UM#$'&R95(CNR+A&LDO0LZ'1?CRT45> M)CKRCT.)D5]9F=H^H(5'M36([^UEU=1C-;7.]9#6GA3V)<8AG2FO+GA^2W_T5K+M,/VEH_]8CK9=ISM@\ZYOME@BF\:R\B%ZI_(AN3$_45@<)@ M/:NY]7,ON,\A/Q?`$$3QKST?X4M"R2+$?+7?:VG]T@NV5U.><_R\8X[/L$T# MC!_7RZ?09_!ZKXWU:R^X?$ASSM^?8);RS%)-C8*IN3J:)#&-:G73V`3>NL[I M:/W6"TD(`!OB>B_6_LVN@R7U64`*5`'(I?`:5`CW#BLM@V]H:]...RB%_=V&J%L#'0^OE M(5Q%%DW!AQU0!J<*JCBF4)GN)VNHK++SF7DRB)X,HKV17Q;K);"2[#?L@6F4 M2;@1(4Z@]LBBU+KEK"HEB, M$/S(<<*$P-L]8KI'\<8^R1>QNNU2?"-!B*M?!33 ML+P@954TP5-,HZB6T?AMA9PTR.,"78:^G_[PIQ<_>\$D0/2\S5L+CO5-8*NV M\/IQ1/QL;T2?M#*/]5^3&<=1I&(S8%N[J.P/2&:[,OHDKJL-I3/[+>.#T!;! MZ05LKA<5)A\!VXW2)]E.,5K9GDL7GR!">9Z`#&Z]C`5Z`_L)1&4MAH3MF^F3 MS$6ENX\>V"$A?*P[))KM\I&465R,>.UZEH8KA./UU+>S`#IR+UG1"RM_`^5U M@W9WB$],/@:VOZE_4_(^#)Q,<84M*.4NT%X4N8E:33_;E=4GH1X^@20:2RX% M?D(=_;OT&ISC;WUW:(<-5XBL([(8+"/,*P)BWF'6P3PF)E5?L<2_FY;V]<:Z&`9DY*P$"9HHP3CV<8-P*-UGFBKYIQE#?IA@-I1RPY$Z8]P;CT[36#B(9IP+0V9W,]K6'], M%AW"&N@?0]H$D[)].2X^3NQ8#<)@,4-XF:8MK#5;5+2V!K!6*"F!,61>CPAK`F*@529@,SZWS]@%Y0D`A(NKJ#-80U7BF0-!N8 MKL=IQ\$)RBWDT3:E<$9X@2/,4[3H`-80UH+50KKR0,UP$19`"6S0I<;6$-:, MI6)_K@2ES$FHQR%C<\,;R'9J,B-Q+U``?E'/*6YX\.` MF@,J\?.WNLQ]71*E$4?X0JR$U%[`[6<-8:UH+72`#\J,P[SL M`L"8`;"&M:8R9H)1=GP'W/(;6=HXF^@0UK:F8+/G@U,68P(<++Q]F%X;[W_0 MU!I"/P?GBJ=:IE4@C-B,1Z[K961/;<^]"2[ME4?6D@)>GFVMMK-U#OTVO8&P MQ6"9L3&/'"=9)CY-*<@J^T3S1M^C>#(G9Q2^H55F).L<^DEE$\V0QPAMHE.C M)@\T`RVYJ^2YQ`N,H+<8Q^/M]O6=K7/HUY@-E$$,EAE&NS*#+M`\Q&B&TSHV MZ[J=0JB_=0[]MK.!%@@C,\&^MP>J[N!7;FR=0V?8:R#@:ACM#7;5:;.AI[74 M'+;.H7/V*9FP%(8)H?]U=]<6H2_6N3;F-04V>"9$92\$#K6@JU0R[,J[;7VZ MS)'KTF+7=CQE@1')B2W"1N:*=\K_)=.M#IFXQ&&98$:FQ MBFQ/$YSRR$WO2U.$-R69F9-8;(`>I`B7!F2&?7`?;I:K>)3$SR'V_MZ=86L% M?]BQ!\G)A8&880BL@GD318FTD+-./:*\%[0E??BN2APHP=&EFOASGW(XRX#QKA0C`8'+X'>T.E<9&:O M(!PS,H&4JD,(G;@XO:`3O324=!4,,]*"E$#6'K48/:`SO;22[`Z"LH?*>DE5 M[(S%+0;3@VS\HC@X:?G[).4]OW$&5-19GK6&SO(B(U,&^5M1'L&\U95+[7)R M_SBYO;D:S<97CS/RW[OQ_>QQ7D;OHP_L?X_O'FC_'- M/?EQ?#MY?.RZ9D,6@K85G$`D-J/'R2;.QM]1`3!/OOR>P`XPKN08PJX%9,2V^D#D07A)R_MT'[`=K(.TZ.(9LLR@@G/$)R)&[]`*/G M5@7I9H0?[/3QFC"(%BOS@H3HZ49APR#*WD-F[6;V&XKNO"#$7KS.>4+VFOU1 ML@Z5>O3) M?<>!8$8@Q3V*A4X)>^V@BS#(2+!$N`DYW1M*K3^&LQ+AZF(?`'.PBZ1&F2+L MT?W#H8$#Z`IE_Q>QE[8>'+H^@]2Q7PG:8X9A:*)7U^04XRV"[&&5LYYA.X@( M>BK9P$U_\C,YN_]*LA.+0$JCXWP0NGR$(IV25]AV+#/"JES!&0$]Y/2"+E=Q M5&6JP:VN7@G<$2=/'I5'IU_8D>=P5*&R/70U"YD=C0E@*\U^VY4/\5UY?A)S M0[89/:`+5[01:@'"5JS]=@!7JFVZ^%UYD>.'48*%W/U2XT!7MV@]KWG`MHK1 M[S>3?Y(CS3/1]1&APEZ@^V3YA/!D7HILKUO8I<:!+H(A+^QJI9$&K>H0"'@[ M9F#>+)DR#T(D1X*NHW%DI>'!/F*40E?/$+9K\69Z[*<_"YCY:+M^@E"DLUEJ M>('^I^<)LCMX#3<94\WPQPH9&^BD"0/JPQJ]>4+O%JKZ]>T)`P.#$0(NO#"\ M0W1WX-M6]MOJ\J*!)2"FJ:0$0Y4L?0V2D=3*L:JY+F\9Y$3)0*+L#`,C3D91 MA5JY"R/+`Q9_EQ(`CQRKR51DW5FEP"B$( MQT"BE/#X]"'O%T>0_&Q?O1+14M]UTU9V/`U?'=3,["8(S7B"RH"?31,F?OYFW6A$#1\Z2"N-"$8SI41FXT#5]8U*B+/#XS$KKOK(E%?"-,V+%(.7BQ M+AD<1Z\V=B165N;BC\.O0[#BDM[8@?9KQI;_CN4!/CI8@ZE"A79MDJHO^: M>"ZM?M4[\XA^[RFDS".%UQ2MGVUGU^IQ`%6AN)5U1+\G%#+6D<+KB=:ON*O$ M"!"Z>FE'S]=^^$K..ZZ'D1,#AJ=N:9&+2BUU.P6CR@>C5C&QSHQO9@QJ0Q^, M)O;['S9A-E5@GK]41^,.`8V*:29UY;Y.&;HD4-KJ2P9OUF MTA*YL/YLAE!WB2ZB6?B`G#!P/!_M09V%ZA:/8WP../)6I8H=B3V&!)Q46KFE M/0+`<;G'$K&,9\"4!.ELRW%N*_X6D&W=KRE'*3,,<+1OM]HCR9CVR\SG3*D" MM*`!Z#!*E4.;!+1:SV1..$EX%Z^I"S\-XDS3SW/426P`X#CC;A5)F"7MHVIT M4*$K1(AUO%2FY-\^VCBS1LL0Q][?=?N62'?HL.9N]4>4(V9$UZ2.TGO"47IC M%:ONLM\:.CRZ6^5@,``Z?(;6@4\E/!ANY+NI#$\@1X00LKE>A.$ M"7T2$+B;"G%Q@BNC[&2'@(ZR[D83FG`%.L*%H1Z'!JF;@"8X#TCW-:V#@U\J MJX2(=H6.U>Y0'02YT3Y:1(\#1T:I?.;XFI[0L=Q='S-JF6'&\ZORY-CQ*XI0 M+&+*$QX#.K2[6QV28HL9E0W*D/-]EW`;>2\U`0(BW:'CO>6D*JH9U3A;F^9T MV)'8VZ_'K7/&[0<=E'T<+3@`:(85K0SSPDOK==X$XS<'1=%DGM5.SA,02.E$ MS5C08=''T1,!T-"/TH0O-5.,5K;G;FM"YLDC4TMSG#%)_)XC,AIT;'0;G6@) MN[U53,\5)=\^I_:Z\1%CTQ M%OXFJU020T.'AFN@:2C.=S`T/#X@R@+W3"?FBMJF"'(;6G MQ`.-E$1O0B?X5QRZ)X%:V2D:MFYA%>*L6JJBD%_.8-")_CN)^:W!;T;4'0'M M(.2F=7-G84CAX##J)'""`]B M#;6,_VVH+U*PS3`5BC-0R19E#6&-R$KU10ZVP0>;:R^PR4U#S<&&,Y@UA#4M M=W*PJ<$/;656?["AN;QHE@AJ4]\6L1`\SE3VM8:PUN:&@JT_Q##1&G%T>4"K MS08\F=^&P6*&\/(*/?&6$%87ZQS6HJQ4`W@@C3Z$5+!+R79BG0 M8"<_.@@'7:=&VU5AGA&4%^1+WP6L.)Q>`(G1[NV84#*9;YR+(3=;>KDQ<((T M/B]9%X`J%,@-]]*WH\B;>T[V:+?S=SU/\4XB(E.AL@/`+-@G9*M+ MPJ1O>T#/!Q9#&5.!C:+_\Z$8P=]YR-3F[9[4;.#T`I@2%=2(S`M>-^#)P>[*/U-V#X-;OP6D..63V/3\O<^$A.)$5M/OU;Q,?;D$.@E M-3FDZ.(IO$@W((47X]F!P@OBZ;_"WY#A@H5'U'GS<*/KC#UAZ+X2SI(9=DB* MU'8A-0[(!L(B2FP?J>T-O)W(\I^YP8@`[?^TR]EUFF['Q2DWS3B]S)A>?(#] MGU;Y>TKZ4F&:%JRA80XTCV+7$RVGA%"1?E]@3K&Z`$R?0U)$)@^S#_#4X;"5 MY>#D(.G_'$FC?LJI6,&LQ6DTTI:.!^330)+T'K8KKY>'UDH9E)L,#&%M$R6X M6`&.>QE3-#*T]:ZM(%E6OM9<,6`-0`N*ZC*)XG"),#E5?$7A`MNK9\^Q_0>T MHJD9@T7GU74RLK;?%ZFLP^@"457G@!2YLZ=`;^CZ.VQ6,Z::&*;^3Z=MSC$( MX_KFTY+&=68O$-M(B1HQHPB[&[AQG<=?INV#BZ?_T^3:]G`:F'&';(HNW5B[ MGC!;(G9<%CE6\KH!3)DJ4R>(O170D8=OT#, MF,/OBYS*&%T@3F4'I`B=Q5A]H$]@;+:R3F`<)/V?&86@AIFD1_84VK!5$><9 MN0E]WKZE:Y.%+.6IT'P1'`+\5-8@Y$$"FPD3:M^W`#.K?A0GU4ZUKKW`B]&M M]X)*E#:8A,*CF>'4:@;O.?20!_TZH1&^Q7(KFZR3TJJEXC/`I8<5ZYPB MCAPQW1"\ZQ5F$^FW`W:WIAT21=^".$1[KSP_B9';8'N0&K%WSMOF./M_?*MV M[<+,OY.#MZR1U14]4ZE-4F6+-L_MUPVF==/!#77S*F&,48?$R?P^3'-+T2!V MPC[/(?]*V?"-'&':J%Z#<8&/@'#%IEV81)S!GE9['G>P4ZH"HFV`>XF4JQHOUYH^2APJ9$:&](_+Q M*8UQ`A\,ZI?I'$^:2/UB79QLMZ&SNQ?(+-G28P)O\N(*H0*I`3:<1GDFKE!L M>W[J64SLSA^TF)!UXI&P.@V&F=64PMEOJ,W%32+;1`F!&3>L'!69A^B&_).7 M-J3<&'J9+,FD1G9%PHV0'TW\;FS>UNP^4$;R9V+1EVR00F:X*.\#W]A)=A4O;"YJI0]5(P-<>25%+ZPL#LIX>S4TE13>/&Z!A M7'=H^81PA;QK>@!?;!J(I,))R86G2H:^&N'];Q"^_B-\YVULP:PIJ1#052+JT0RU#5!D:3L-S%)%=M9`U@[ MCZ"D#DGN^=6A;7S!0!,'M'R`P>"HCS:TL,)]B]`\\6^].<_R+M+=&FCG<1XP M;P:B@(S8%#G'\*\XC!J:X-.NUD`[=W,3H>_`F'%=U(*SCPS-@6#@'?HWC\YOB)ZP6+;6T37KQ"?7=K`&M,DM(%44#J M0AP.8E*`0QP&IQB'4XS#*<;A%.-PBG$XQ3B<8AQ.,0ZG&(=3C$-_#)6G&`>M M8ARZ'@38,(86#H3??@"#8CDQ[CUZBV>OR']!=V$0/S>\ M_P@,K$L\Q)[`Y`==APKLM-!L0.EKEN#J3(U1V-.V;RI"V:E6& MM-4F5N8X*K-!J"QDMT1R/[G<3XG.?H1$9\6=G19BW-=OCBSY'7N4 MX*P62/^3EY";%>;F,-"GZ==JS3CJ6=_/Y$WN*9AG\3*NP%ND^H M/W93BRJ:)'%$%G`:'+PI1K<[HJ5<$%AIU'R@1SN@,L"J],M%M-.SG!?F+E<;#I:0C]Q_)5%,IVW3=4I\9.!H M.1!ED^*.,G=MJ^6,$;&5%@V@!-M^X3@?C>(8>T])G);0"8N5&%EA7-(#`8?E M*9#KOL(TYH*YR]-DSF*H_$['&@DX1%"Y&C5G@[)U!LJ:7FM>`*I@=;(RG*P, M8';55QN[,_*5FL=F>^UZ8ELXI-D(@577LAYA3//+I-5G+]:[-IN*M"DG=NP( MW*EO!T*ORH[Q.6"30TDM&//].,B-4,*#BM;UV[XK\2+U[O#AF;-K!YV90Y%L]O#TO`[:J.6^>/:A+3(?DO#Y!GL.@5'0:_JM+I"V`M=@@?'_=3#\1O"CA?1B7QT/2Q] M2\/D'E4#J!F\HU4$ZM%R=1WB M.?+BA/`IGT5'7*XJOF8--$D4W<5RQ<"O[!K88T4$ODAHEY2ZTXO$SL#:.CE? M=H`;!VX_U1#V'C'4+LEUE_>(X\Q/,%'L.-R2P&PJL MH78YMCM9.>MXDBORKS_\A;@PSX%469`":ZA)=&7'JV\=3W)5_LU\56:^/*LT M-QQ+G=5180TU\;`H46FU?,G5^K/)EZXZEN5<`==I*4*LH4E^'^6LV1GC?V35 MKK"U0"FW)"G6T"1WTA&8LU7P]AEQ-%9P])TT.2G>IX]2<_^!T1#`\GO+\,@?>>:T*JQ>#FLT^INJ;&& M??/&=<^?K;;WWEW7@G?LU8'%N\$1-;T!-=:P;RZ_[OFSU?367L%#3=[6"S.=R'P0N*R)9P MO(`'61IZ5!NC2YZ`S[(YWXH&J\ M3X(N&4-!U;C$DA_\#6`MPS:^'6!-+E&A2\(94&6NXHJR%Q&&ZK..1V7M7!(: M')5_5?>D0@>/Q'%Y=F`13,]J5T2JU[:'_[#]Y"B.-X7D`:<@TFP&B+!+\6./ M'^`BJ><BC:OQ7I.5,D:81.TJ7'5&G`-&7/7@R= M*X5@1STGB@R!T-G2])@ELAQ3]IS&T"EBSKT$.&&='M-#CE_*'N547=NU"#H9 MGLJIG`)83N543F55Y8-;3F553V553V55CZ&$FXKD0B552VVA(SR.)-=J+:I" MKTH%`,/AU=35!8Z1Z%016!SH>=&;0K+`6B4HM86.*^A4`:K0@]4!4!2?OUSY MX1HA&25@]H%VS'>J##PN@!4@T"-P7A/OM'S@_&^F1&E2G4S-3?O985.C4_7+ MJMJTS0V'U,\#^QMW>6\&T8@KP:Y^>#0+1Z[K91BFMN?>!)?VRHMMOWJ-/3@9 M?0N\.'I`?R5>Y,7H$>$7ST$9+Q^0$RZ"=&2>J:);2C3T?3*5%(`U!JV)V3Y- MM_CQ&V4,WR1:U4%##R!_0:M$T/[4^CD3:8`6U"0+(]+](]AK0"[3S]XJA?HX MF19UOU[:TF-IZ.MB*D(C<.T/L3KH""-/_FY/+ZV3=4N"U&#:%'P272ZDT2D+ M.R[O#EIX+V=DS(2@.?DP3S[,DP]34XN#)EOQ#_M4?WO`R*X1U;O%-BXF-;>1 MZPNYJA3_3N?$?1C_$\6;"\C?FZO*)JY&Y/1VS._WZ(E^5_PXGO)VMO>C!>7I M);E4ATN$1X'[%84+;*^>/8Z@.(BNUTV019@F'(\P`" ML/P8=<+SA'0/A+6$+<_\:N'5K:%#64;7>B^I+M>1OH M8!@!UA^0"Q:YPN!X(:B>S_920^@X%`'>5]$,%CW"$,"%1P[!+CWY\OE_V`XZ M\D.`_14DG\(T=-C)?^`P#=M'T0-Z04&"[A'W4K??LD]!%27*#8B=3<,^ICB< M>SRA%5KU*<+@@&PSIMIDA;!-;_,W@4/V@5M^L%-%ZS[Y_1GDFU`B_@H14AUO MXZ!;^2@50^".EM18\W>=`U>D>Y\<^Z)XS,AREGO)9N'(^2OQ,"*K%%'U>$TC M&6("FS[-7=$F'!40'Z1/OGLY5"947[\A`@D6'CD[CJ((Q1$Y7(S?'#^AM2V^ MAJ'[ZOD^1PU$NEL#[3+9,A5`%(^R1%B@*X&`@'>@M*+^SW(?77RA5<+B^D$KH>CI$Z7/5&C8$8'*=TF4&NKA":UF=85_ MHHI^S1RBXX1>*OEB*+;1PR$J+($#TGO^K#_-2G9):/3B*X2]%\+]%\1VJXIT MT\/)*B)/030]?[Q_&08.HK$4:6"Y%WV_6`OD@>+T@G;C"IY2^`C,<%B4,%*$ MM4<53B]@=V^-S`0%O0?'B`-I?O,N0:W/RL3O">PCKA$=0]ZUD*!.1.H=_IO= MK#[E#JL/M$^YD82Y:'I^XFH;CZ.+AUD^($>E<[FG$3GZ.8T';`F6:3<@**>T M'DT1IK^P%XA7B)W734,/,%NJ=4".>"[6TUL!]'+[Y+,X^2RT60-;6P0TV=9: M6`0,\5RH-PC`[FTU(I,W"(![,'0W",#Z0VI$U\P@`.&G.<@ M],/%NFY=%>P)_5SN4``5#FPA$*"6GMIWOT+"8C2'?A4G("$VY;H]Q=X]E]VJ MDL<)'ZCM`^VM$)%.'?T]#Q?8I)Z;VCA>S[`=1+:3YG&Z6!?_4G,Z$1^D+_X, M.41F^#F*R&J/+^7&T-X.29'5RWT'2\^#37X/G@0UX7>EAM`N#`:7*U;?2M+[ M?;U_H)5'ZA;4O(TVK\WJULLBP68\+$TAU5?`VK6"?E2V+P..G';D&F$B[:&&CO['^%.-^F=]$%',&*#F$--$E&M"_&:IG+@#)BU3U*9(UV*8S8`J\# M8D!D398I)K;?4.1FT3,Q3/1,1LC,?MLET!<(H.'T.L70"$X)/@_K]C]-PFB8 M!N8--L9EK-Q(\\"72H(UYSW3T%35#"@ZI9JO/-[K$GW"X'Z>9)>F`'I;(>PM M#L;>JEC?%Z'N*T M%O$R3+@)S#B]=(D.V1-5M5CY*(RX-FW3,-($C$680JDG2YUT"1P1$"X7A!ES MEPV1;#9>=E6\(AQK)NN#,:!C3Y2(OHS)#%\JK8^82<3WPU<[<%#M$L[J`AW! M(B%G#@0S?$+C^1PY-%W$]K3Y0+A#:U=X04+T>Z/H-77)A`R0__'U!+`P04````"`!V M@4U"'-D550)``.0`1Q1 MD`$<475X"P`!!"4.```$.0$``.U<_W/:.!;_?6?V?]#QRW5G2@C0=!NFZ0X) MT#";0`Y(MSPUCO M?WN<.^B!N()R=E&JGIR6$&$6MRF;7I3N1YWRN])O'W[^Z?T_RN7/EX,;U.*6 M-R=,HEN@F5!BHR65,]3^J]RVJ>0N^N3+0B#JI'9RCL8KU,(2CUQL?1$(!OX@ M-B/"QJO7J$/&KH?=%:K67Z/::;6.3NN-6JUQ>H;N;E&YG$_Q)TJ6)*[X[.1= M'E7UMXW:^0NI.F^-2F6Y7)[8*X8%=2SN+DXL/J^`I%JU5J_"#'>(,J_# MW7F+3+#GR(O25P\[VM82@B7!1,->"2>G/,T0HUW63[@[!9+3:N7S[%T@QBRH3$ MS-H8D3`Z<+%Z?GY>T:,A*2-3+(F=*OR\XG*'5`*RD,L3Y2G&BS77!(NQY@@& M--SETVIY#7C#XAZ3[BJ.C"#6R90_5()!$YOGNI#CTOB"40.C3:B9!P8,Y.31 MFIGIU8B!@;('(J29Q1\S,#%,+6'FT4.*I1IG$=0R,\"`@1P"(%<+(HRAT2,& MLX1>Y9!Y4TFALO^U?UM MNS="S5X+P?_NZ-^HV^OT![?-4;??>U_9EA`*]02Q^^R#OH88"66%(E#I).`* M2$P<&X'YZ"WL6)Z3KJ`2@_@`S(?@A=X&^I,.99#K*';NN-"F7CE8B&`W4.CG MI#7'H0;@KP7`]56_-^S?=%O-4;N%+ILWS=Y5&PVOV^W1L'!!N,2.VF6&,T+D M'8;$*V=$4E#OXYX^;(:ZGA]J])^8P/\6#OHH-L,1_%7)8=CO]._:`YT1AI`H MKOJW=X/V=;LW['YJ=WOPL7W3'P[]Z!PDP1S`-UD!W.A`_0[::-$9+:8'^8K0 M*Z7JE\*%-I*NAC.8Y3/NV%!QM[]ZL'$TF=V'6>]>\3FX/"-,T`?2A9YO3A+) M;C]N0O1@H'_U^W7_IM4>#/^)VO^ZA^VJR'&\PF+6+M'/)K#:]2YZ?]1Q(U)4-&?W$4\@JG?'%,'%L&(7W$H MPIA'FN(CIVP*'RWBLG#3>@JK.5B_JL*-"LOAPG,)?-#"$9^@J'@$52$*%"#) M4:@"88$PTFI0H*=P@6R1L0Q+-"M:4"?OFT/P;CL$BA/%60N':A?:40:=%R7" MAS-ZPXSC^3:.$9;"X7?%A81$W7ZTB(!<<4D=$#05D"?N&:QCA]@#8A'Z@,=. MB/!^+,885$^W8Z"%(LJ0+U8EEE"P3BJA:!217;A@=57;/:7@>U,((M'SFWES"M?!S7G\SXU;;Q"^D+!UL;NTPMS!LNQ)VNP.>< MZ0K=!S)CW`QM?1O:4`+T32#C%P12D"\&:3F%@WPHN?4%2BYBJWX'FIU(`9$R M9H;ZS3;4FAMI=A3E+Q[$9*H:D2M/2.@A7=C./A(^=?%BIKZ6&9`%=Z&6G0:8 MYR0V!^$L$01?W&L4"M1[7E0D6LLL7&#\IGZ$'S"WR;U.L2#-4S@` M.YBZG[#CD5N"%1YJJ@50FH?,H"9:0,6,-#>*LA<.WZ$W%N2K!]ZT'S;0)NZ: M44UT=1L^Y#,6#L](/S:*]!W)VV9$L_H[],IG+=Y7L=M=0AQ9XY@1WEJB=4OT M$<4%.;WRC<*]D\H,?**!VU4E%S<.YI(X&H-,"C/^B08PK70N,.[YRN)8(/9B M,4C[0(A)31XS(H_0V3\3=C;D:R(S\HG&-P/YPN;J]%8AEEUVDYECD&B5=[<4A4T[ M.S&.E42YJ8V!J2>:[-R!*>Y:,;=TL76236(.1:+M3F_["KLV,G&MYL`^99.H M[]%S%WB7SH2VE@/^6@K\R<9Z)_RU'_#'H(WM"KDHS:'(_>#VQTZ0]VNH^-:P M'X\Y2`<]V"WR_K$7^-6G1"QMATFTVD\*62%WG;WPC^?!)[&:`YCHX)\6P,(F M2_^G$5+],L+VL9#14*4/F\-A:.LW/[WXOX-;_5&O2`_(!.EWCQOJ!6=;W9BZ97)34>]SE\%WM/\&ED\>Y$Y(HR1EO0>M(;:,0*`Y%!.^D9K\; M#4+X@L#<)Z(2&E^J/(,_`/B^_L1C=%3>.'B\KS?`0IRC;-Y=A`#R!E(R8\02%M",!_,,7;KC_\D,&B_I4#OG*ZE:Y6BO7JR>/ MPO8-VT/_VJ,]]8=\^^DW'[.04W/(H%2>Y5"6>=A!BDZMS\A8(8X4X9WR1E1> MKS/.',BRQ<`67!]@@^D8ASQ&1/G"#X>883H5(I<=4<;UIP,L29P=D<>*-9.^ M.D![\DB)/.HW7/YE>2-@7P.VCZC(HS[D41>'J-X^N"*7[I!)7^VG?=?!*7F2 MD>.Z,2Z5DJCG[[(^\UD2EM#="]C,N\_"7/+,BY%$7 M^ZW&[)-)QG!&>]I]B1?0C-T_=,+'[VBKRO#/?.1^>:G/9FK`/>B4NY+,5>M30CB@NBA)UU/% MIZ:"Z3Y;,\-WD]AU''4KZM"6N$!,Y6>&OWHA",4:Q&"9\#MHCFNV.PY?*W`YWA]@A8D"DYS(1Q"D:T%V4?X,PPBI\ MH.K\/?"AQ;VQG'@.3%15)*L9&G4KXOE>7`>CL(GNMUK.70:(0EO8(O[_+@M_ M3[<:$$'4Y!8E\`OX.X*C7X0VOV">S MVR["XTEM9DO5]\"7#K>^[/0I0ND[Y9^OUY#A_2?&\'#/U*&:MN>0_D0_DXT^ MC`VFHOZ%N&2=.":A)20?C\ M23VCOR7S,7%C!5DZ4^14D8';]]1/9"XVA[EFX2USE_%=0; M"2_R$!^5;V1"H,VQ_3K2F^LGN`^D11^H39@M!C"'8N[EH@\\!/?`<`O4/>T; MA.?)HYSU67*Z)4:.*"J^;:,E3[$Z,G)\5L]A"V8*;L8QH[(\O5)2,U'NE7W1^^_\)=`MFS8 M=*Y.9.8:F6S36QI!D_'A2$[`7Z0G"5L-]3 M'W[^Z7]02P$"'@,4````"`!V@4U"Q]Z..]MF``"$R@4`$0`8```````!```` MI($`````9'ES;"TR,#$R,3(S,2YX;6Q55`4``Y`!'%%U>`L``00E#@``!#D! M``!02P$"'@,4````"`!V@4U"E=C2T+@+``"[DP``%0`8```````!````I($F M9P``9'ES;"TR,#$R,3(S,5]C86PN>&UL550%``.0`1Q1=7@+``$$)0X```0Y M`0``4$L!`AX#%`````@`=H%-0MFP(F9-(0``\D<"`!4`&````````0```*2! M+7,``&1Y`Q0````(`':!34+IY^J"^D(``('^`P`5`!@```````$```"D M@7-L+3(P,3(Q,C,Q7VQA8BYX;6Q55`4``Y`!'%%U>`L``00E#@`` M!#D!``!02P$"'@,4````"`!V@4U"#W%A/+\H``#_]P(`%0`8```````!```` MI($2V```9'ES;"TR,#$R,3(S,5]P&UL550%``.0`1Q1=7@+``$$)0X` M``0Y`0``4$L!`AX#%`````@`=H%-0G,MV?.,"P``?&D``!$`&````````0`` M`*2!(`$!`&1Y'-D550%``.0`1Q1=7@+``$$)0X```0Y 9`0``4$L%!@`````&``8`&@(``/<,`0`````` ` end XML 26 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED BALANCE SHEETS (USD $)
Dec. 31, 2012
Sep. 30, 2012
ASSETS    
Cash and cash equivalents $ 2,471,900 $ 3,414,880
Accounts receivable, net of allowance for doubtful accounts of $149,280 and $146,210 and sales returns allowance of $44,004 and $51,860 for December 31, 2012 and September 30, 2012, respectively. 4,849,552 5,475,142
Costs in excess of billings and unbilled receivables 1,941,547 1,735,798
Inventories, net of reserves 3,550,710 3,271,700
Deferred tax asset 126,187 126,187
Prepaid expenses and other current assets 1,401,925 1,334,649
Total current assets 14,341,821 15,358,356
Property, Plant and Equipment, net 5,093,097 4,984,150
Other Assets    
Intangibles, net 6,527,608 6,703,305
Goodwill 10,264,499 10,254,160
Deferred financing costs, net 152,650 165,457
Total other assets 16,944,757 17,122,922
Total Assets 36,379,675 37,465,428
LIABILITIES AND STOCKHOLDERS' EQUITY    
Current portion of long-term debt 11,511,905 11,984,492
Accounts payable 2,807,421 2,416,397
Deferred revenue 826,880 694,672
Accrued expenses and other liabilities 1,951,680 2,809,580
Total current liabilities 17,097,886 17,905,141
Long-term Liabilities    
Pension liability 342,848 345,443
Deferred tax liability 365,328 371,256
Total long-term liabilities 708,176 716,699
Stockholders' Equity    
Common Stock, $0.0005 par value, 40,000,000 shares authorized, 15,620,314 and 15,610,517 shares issued, 14,810,154 and and 14,800,357 shares outstanding at December 31, 2012 and September 30, 2012, respectively. 7,810 7,805
Additional paid in capital 17,117,241 17,037,618
Accumulated other comprehensive income 91,645 61,906
Retained earnings 2,343,259 2,722,601
Stockholders' Equity Before Treasury Stock 19,559,955 19,829,930
Less 810,160 shares of treasury stock - at cost (986,342) (986,342)
Total stockholders' equity 18,573,613 18,843,588
Total Liabilities and Stockholders' Equity $ 36,379,675 $ 37,465,428

XML 27 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
3 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Cash flows from operating activities:    
Net income (loss) $ (379,342) $ 370,338
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Stock compensation expense 73,516 199,212
Foreign exchange loss 26,398 (48,277)
Gain on sale of property, plant and equipment (87,803) 0
Depreciation and amortization 426,458 380,120
Noncash interest expense 12,807 9,978
Provision for doubtful accounts and sales returns 3,160 60,970
Inventory reserves 11,208 0
Deferred income taxes 1,532 (122,727)
Other changes in assets and libilities:    
Accounts receivable, net 607,217 (1,647,098)
Inventories (322,298) 272,350
Costs in excess of billings / unbilled receivables (205,749) 184,105
Prepaid expenses and other assets (76,842) (124,256)
Accounts payable 399,184 (484,930)
Accrued expenses and other liabilities (852,463) (92,853)
Deferred Revenue 140,355 262,942
Net cash used in operating activities (222,662) (780,126)
Cash flows from investing activities:    
Proceeds from sale of property, plant, and equipment 80,252 0
Purchases of property, plant and equipment (315,568) (405,341)
Net cash used in investing activities (235,316) (405,341)
Cash flows from financing activities    
Proceeds from issuance of common stock 6,110 15,133
Repayment of long-term debt (472,587) (475,159)
Net cash used in financing activities (466,477) (460,026)
Effect of exchange rates on cash and cash equivalents (18,525) (96,923)
Net decrease in cash and cash equivalents (942,980) (1,742,416)
Cash and cash equivalents, beginning 3,414,880 4,479,840
Cash and cash equivalents, ending $ 2,471,900 $ 2,737,424
XML 28 R35.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment, Customer and Geographical Reporting (Details) (USD $)
3 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Sep. 30, 2012
Revenue $ 10,553,275 $ 12,132,295  
Gross Profit 4,626,866 5,126,948  
Operating Income (Loss) (191,287) 186,328  
Depreciation and amortization 426,458 380,120  
Capital expenditures 315,568 405,341  
Intangibles, net 6,527,608 7,283,952 6,703,305
Goodwill 10,264,499 12,521,971 10,254,160
Total Assets 36,379,675 40,714,330 37,465,428
Contract Research [Member]
     
Revenue 4,910,840 6,225,283  
Gross Profit 2,214,053 2,440,288  
Operating Income (Loss) (606) 145,217  
Depreciation and amortization 62,782 37,160  
Capital expenditures 186,330 262,020  
Intangibles, net 339,886 429,400  
Goodwill 4,938,625 4,938,625  
Total Assets 13,290,669 11,284,826  
Optics [Member]
     
Revenue 4,251,940 3,912,551  
Gross Profit 1,700,555 1,462,418  
Operating Income (Loss) 385,676 164,123  
Depreciation and amortization 185,628 193,503  
Capital expenditures 122,146 140,876  
Intangibles, net 946,525 1,075,619  
Goodwill 1,310,802 1,283,775  
Total Assets 10,607,828 13,692,936  
Instruments [Member]
     
Revenue 1,284,038 1,983,536  
Gross Profit 605,801 1,251,423  
Operating Income (Loss) (455,694) 79,544  
Depreciation and amortization 163,048 134,457  
Capital expenditures 7,092 2,445  
Intangibles, net 5,016,201 5,493,933  
Goodwill 4,015,072 6,299,571  
Total Assets 12,092,507 15,351,880  
Biomedical [Member]
     
Revenue 106,457 10,925  
Gross Profit 106,457 (27,181)  
Operating Income (Loss) (120,663) (202,556)  
Depreciation and amortization 15,000 15,000  
Capital expenditures 0 0  
Intangibles, net 224,996 285,000  
Goodwill 0 0  
Total Assets $ 388,671 $ 384,688  
XML 29 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Based Compensation (Tables)
3 Months Ended
Dec. 31, 2012
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]  
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]

A summary of stock option activity for the three months ended December 31, 2012 is presented below:

 

  Options
Outstanding
  Weighted Average
Exercise Price per
Share ($)
  Weighted Average
Remain Contractual
Term (in Years)
 
Balance at September 30, 2012  794,483   3.34   1.75 
Outstanding and exercisable at September 30, 2012  794,483   3.34   1.75 
Granted  0   0     
Exercised  0   0     
Cancelled  (20,000)  4.06     
Balance at December 31, 2012   774,483   3.32   1.54 
Outstanding and exercisable at December 31, 2012   774,483   3.32   1.54 

 

Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]

A summary of restricted stock activity for the three months ended December 31, 2012 and 2011 is presented below:

 

Restricted Stock Activity for the Three
Months ended December 31, 2012
 Shares  Weighted-Average
Grant-Date Fair Value
 
Nonvested at September 30, 2012  127,834  $1.92 
         
Granted   4,000  $1.45 
Vested   (15,000) $1.53 
Cancelled   -0-   -0- 
Nonvested at December 31, 2012  116,834  $1.95 

 

Restricted Stock Activity for the Three

Months ended December 31, 2011

 Shares  Weighted-Average
Grant-Date Fair Value
 
Nonvested at September 30, 2011  403,000  $4.02 
         
Granted  -0-   -0- 
Vested  (37,500) $4.00 
Cancelled  -0-   -0- 
Nonvested at December 31, 2011  365,500  $4.02 
Schedule Of Stock Compensation Expense [Table Text Block]
 

Stock Compensation Expense for the three months ended December 31, 2012 and 2011 is as follows:

 

  Three Months Ended  Three Months Ended 
 December 31, 2012  December 31, 2011 
Stock Compensation Expense      
Stock Grants  52,461   60,281 
Restricted Stock Grants  12,618   109,302 
Option Grants  7,359   22,055 
Employee Stock Purchase Plan  1,078   2,692 
Total $73,516  $194,330 
XML 30 R36.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment, Customer and Geographical Reporting (Details 1) (USD $)
3 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Revenue $ 10,553,275 $ 12,132,295
Concentration Risk, Percentage 100.00% 100.00%
Customer Concentration Risk [Member]
   
Concentration Risk, Percentage 40.00% 36.00%
Sales Revenue, Segment [Member]
   
Concentration Risk, Percentage 100.00%  
United State [Member] | Sales Revenue, Segment [Member]
   
Revenue 8,494,488 10,028,479
Concentration Risk, Percentage 80.50% 82.70%
Europe [Member] | Sales Revenue, Segment [Member]
   
Revenue 888,341 1,126,352
Concentration Risk, Percentage 8.40% 9.30%
Other Credit Derivatives [Member] | Sales Revenue, Segment [Member]
   
Revenue $ 1,170,446 $ 977,464
Concentration Risk, Percentage 11.10% 8.10%
XML 31 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6
Basis of Presentation and Ability to Continue as a Going Concern (Details Textual)
3 Months Ended
Dec. 31, 2012
Debt Instrument, Interest Rate Increase 5.00
XML 32 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 33 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Basis of Presentation and Ability to Continue as a Going Concern
3 Months Ended
Dec. 31, 2012
Disclosure Text Block [Abstract]  
Nature of Operations [Text Block]

Note 1 - Basis of Presentation and Ability to Continue as a Going Concern

 

The accompanying consolidated balance sheet as of December 31, 2012, the consolidated statements of operations and comprehensive income (loss) for the three months ended December 31, 2012 and 2011, changes in stockholders’ equity for the three months ended December 31, 2012 and cash flows for the three months ended December 31, 2012 and 2011 of Dynasil Corporation of America and subsidiaries (the “Company”), and the related information contained in these notes have been prepared by management and are unaudited. In the opinion of management, all adjustments (which include normal recurring and nonrecurring items) necessary to present fairly the financial position, results of operations and cash flows in conformity with generally accepted accounting principles for the periods presented have been made. Interim operating results are not necessarily indicative of operating results for a full year.

 

The preparation of our unaudited consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Certain information and note disclosures normally included in the Company's annual financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted. These consolidated financial statements should be read in conjunction with the financial statements and notes thereto included in the Company's September 30, 2012 Annual Report on Form 10-K previously filed by the Company with the Securities and Exchange Commission.

 

The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplates continuation of the Company as a going concern. However, the Company has failed to comply with the financial covenants set forth in the terms of its outstanding loan agreements and sustained a substantial loss from operations for the year ended September 30, 2012. The Company has continued to sustain losses from operations for the three months ended December 31, 2012. These factors raise substantial doubt over the Company’s ability to continue as a going concern.

 

The Company continues to be in default of the financial covenants set forth in the terms of its loan agreements for its fiscal first quarter ended December 31, 2012. These covenants require the Company to maintain specified ratios of earnings before interest, taxes, depreciation and amortization (EBITDA) to fixed charges and to total/senior debt. A default gives the lenders the right to accelerate the maturity of the outstanding indebtedness. Furthermore, Sovereign Bank, N.A, the Company’s senior lender, may, at its option, impose a default interest rate with respect to the senior debt outstanding, which is 5% higher than the rate otherwise in effect. To date, the lenders have not taken any such actions. However, the Company cannot predict when or whether a resolution of this situation will be achieved.

 

The Company is current with all principal and interest payments due on all its outstanding indebtedness through February 13, 2013, the date of this filing, and management is engaged in discussions with its senior lender to address the financial covenant situation. Because of the uncertainty of any resolution of the covenant violations and possibility of an acceleration of the indebtedness by the lenders, the Company reclassified all of its outstanding indebtedness as a current liability in the accompanying consolidated balance sheets.

 

The Company’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and positive cash flows and/or to obtain the necessary financing from shareholders or other sources to meet its outstanding obligations and repay its liabilities arising from normal business operations when they become due.

 

In view of the matters described in the preceding paragraphs, recoverability of a major portion of the recorded asset amounts shown in the accompanying consolidated balance sheet is dependent upon the continued operations of the Company. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence.

 

The Company has recently taken and will continue to take actions to improve its liquidity, including the implementation of a number of initiatives designed to conserve cash, optimize profitability and right-size the cost structure of its various businesses. The Company has retained Argus Management Corporation and Mirus Capital as financial advisors to assist it in evaluating strategic and restructuring alternatives, including the potential sale of product lines and/or a Company division. While the Company is actively considering such strategic alternatives, there can be no assurances that any such transaction will occur, or, if a transaction is completed, it will be on terms favorable to the Company. The Company does not currently have cash available to satisfy its obligations under its indebtedness if it were to be accelerated or payment demanded. If the Company is not able to resolve its current defaults under its outstanding indebtedness and improve its liquidity through the actions described above, it may not have sufficient liquidity to meet its anticipated cash needs for the next twelve months.

 

We consider events or transactions that have occurred after the unaudited consolidated balance sheet date of December 31, 2012, but prior to the filing of the unaudited consolidated financial statements with the SEC on this Form 10-Q, to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure, as applicable. Subsequent events have been evaluated through the date of the filing of this Quarterly Report on Form 10-Q with the SEC.

XML 34 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED BALANCE SHEETS [Parenthetical] (USD $)
Dec. 31, 2012
Sep. 30, 2012
Allowance for doubtful accounts (in dollars) $ 149,280 $ 146,210
Allowance for sales returns (in dollars) $ 44,004 $ 51,860
Common stock, par value (in dollars per share) $ 0.0005 $ 0.0005
Common stock, shares authorized 40,000,000 40,000,000
Common stock, shares issued 15,620,314 15,610,517
Common stock, shares outstanding 14,810,154 14,800,357
Treasury stock, shares (in shares) 810,160 810,160
XML 35 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value Measurements
3 Months Ended
Dec. 31, 2012
Fair Value Disclosures [Abstract]  
Fair Value Disclosures [Text Block]

Note 11 – Fair Value Measurements

 

The Company uses a fair value hierarchy that prioritizes the inputs to valuation methods used to measure fair value. Assets and liabilities measured at fair value are to be categorized into one of the three hierarchy levels based on the inputs used in the valuation. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of fair value hierarchy are as follows:

 

Level 1: Observable inputs based on quoted prices (unadjusted) in active markets for identical assets or liabilities.

 

Level 2: Observable inputs based on quoted prices for similar assets and liabilities in active markets, or quoted prices for identical assets and liabilities in inactive markets.

 

Level 3: Unobservable inputs that reflect an entity’s own assumptions about what inputs a market participant would use in pricing the asset or liability based on the best information available in the circumstances.

 

A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

 

The carrying amounts reported in the consolidated balance sheets for cash and cash equivalents, accounts receivable and accounts payable approximate fair value because of the immediate or short-term maturity of these financial instruments. The carrying amounts for fixed rate long-term debt and variable rate long term debt approximate fair value because the underlying instruments are primarily at current market rates available to the Company for similar borrowings.

XML 36 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
DOCUMENT AND ENTITY INFORMATION
3 Months Ended
Dec. 31, 2012
Feb. 07, 2013
Entity Registrant Name DYNASIL CORP OF AMERICA  
Entity Central Index Key 0000030831  
Current Fiscal Year End Date --09-30  
Entity Filer Category Smaller Reporting Company  
Trading Symbol dysl  
Entity Common Stock, Shares Outstanding   14,960,200
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Dec. 31, 2012  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2013  
XML 37 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
Subsequent Events
3 Months Ended
Dec. 31, 2012
Subsequent Events [Abstract]  
Subsequent Events [Text Block]

Note 11 – Subsequent Events

 

The Company has evaluated subsequent events through the date that the financial statements were released.

XML 38 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (USD $)
3 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Net revenue $ 10,553,275 $ 12,132,295
Cost of revenue 5,926,409 7,005,347
Gross profit 4,626,866 5,126,948
Operating expenses:    
Sales and marketing expenses: 479,878 392,801
Research and development expenses 637,129 519,395
General and administrative expenses 3,701,146 4,028,424
Total operating expenses 4,818,153 4,940,620
Income (loss) from operations (191,287) 186,328
Interest expense, net 186,757 124,157
Income (loss) before income tax (benefit) provision (378,044) 62,171
Income tax (benefit) provision 1,298 (308,167)
Net income (loss) (379,342) 370,338
Net income (loss) (379,342) 370,338
Other comprehensive income (loss):    
Foreign currency translation 29,739 (60,360)
Total comprehensive income (loss) $ (349,603) $ 309,978
Basic net income per common share (in dolalrs per share) $ (0.03) $ 0.02
Diluted net income per common share (in dollars per share) $ (0.03) $ 0.02
Weighted average shares outstanding    
Basic (in shares) 14,673,356 15,583,103
Diluted (in shares) 14,673,356 15,683,834
XML 39 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
Goodwill
3 Months Ended
Dec. 31, 2012
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill Disclosure [Text Block]

Note 6 – Goodwill

 

Goodwill is subject to an annual impairment test. We consider many factors which may indicate the requirement to perform additional, interim impairment tests. These include:

 

·A significant adverse long term outlook for any of our industries;
·An adverse finding or rejection from a regulatory body involved in new product regulatory approvals;
·Failure of an anticipated commercialization of a product or product line;
·Unanticipated competition or the introduction of a disruptive technology;
·The testing for recoverability under the Impairment or Disposal of Long-Lived Assets Subsections of Subtopic 360-10 of a significant asset group within a reporting unit;
·A loss of key personnel; and
·An expectation that a reporting unit carrying goodwill, or a significant portion of a reporting unit, will be sold or otherwise disposed of.

 

There were no changes, aside from foreign exchange rate fluctuations, in the carrying value of goodwill during the three months ended December 31, 2012.

XML 40 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
Intangible Assets
3 Months Ended
Dec. 31, 2012
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets Disclosure [Text Block]

Note 5 – Intangible Assets

 

Intangible assets at December 31, 2012 and September 30, 2012 consist of the following:

 

  Useful  Gross  Accumulated    
December 31, 2012 Life (years)  Amount  Amortization  Net 
Acquired Customer Base  5-15  $7,858,775  $2,387,612  $5,471,163 
Know How  15   512,000   172,115   339,885 
Trade Names  15 - Indefinite   558,435   66,872   491,563 
Biomedical Technologies  5   300,000   75,003   224,997 
      $9,229,210  $2,701,602  $6,527,608 

 

  Useful  Gross  Accumulated    
September 30, 2012 Life (years)  Amount  Amortization  Net 
Acquired Customer Base  5-15  $7,858,775  $2,257,533  $5,601,242 
Know How  15   512,000   145,147   366,853 
Trade Names  15 - Indefinite   558,435   63,222   495,213 
Biomedical Technologies  5   300,000   60,003   239,997 
      $9,229,210  $2,525,905  $6,703,305 

 

Amortization expense for the three months ended December 31, 2012 and 2011 was $181,268 and $162,803respectively. Estimated amortization expense for each of the next five fiscal years is as follows:

 

  2013 (9 Months)  2014  2015  2016  2017  Thereafter  Total 
Acquired Customer Base $406,961  $542,615  $542,615  $542,615  $542,615  $2,893,742  $5,471,163 
Know How  25,600   34,133   34,133   34,133   34,133   177,753   339,885 
Trade Names  10,950   14,600   14,600   14,600   14,600   81,992   151,342 
Biomedical Technologies  45,000   60,000   60,000   59,997   -0-   -0-   224,997 
  $488,511  $651,348  $651,348  $651,345  $591,348  $3,153,487  $6,187,387
XML 41 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment, Customer and Geographical Reporting (Tables)
3 Months Ended
Dec. 31, 2012
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]

The Company’s segment information for the three months ended December 31, 2012 and 2011 is summarized below:

  

Results of Operations for the Three Months Ended December 31, 
2012 
  Contract
Research
  Optics  Instruments  Biomedical  Total 
Revenue  4,910,840   4,251,940   1,284,038   106,457   10,553,275 
Gross Profit  2,214,053   1,700,555   605,801   106,457   4,626,866 
Operating Income (Loss)  (606)  385,676   (455,694)  (120,663)  (191,287)
                     
Depreciation and Amortization  62,782   185,628   163,048   15,000   426,458 
Capital expenditures  186,330   122,146   7,092   -   315,568 
                     
Intangibles, Net  339,886   946,525   5,016,201   224,996   6,527,608 
Goodwill  4,938,625   1,310,802   4,015,072   -   10,264,499 
Total Assets  13,290,669   10,607,828   12,092,507   388,671   36,379,675 

 

Results of Operations for the Three Months Ended December 31, 
2011 
  Contract
Research
  Optics  Instruments  Biomedical  Total 
Revenue  6,225,283   3,912,551   1,983,536   10,925   12,132,295 
Gross Profit  2,440,288   1,462,418   1,251,423   (27,181)  5,126,948 
Operating Income (Loss)  145,217   164,123   79,544   (202,556)  186,328 
                     
Depreciation and Amortization  37,160   193,503   134,457   15,000   380,120 
Capital expenditures  262,020   140,876   2,445   -   405,341 
                     
Intangibles, Net  429,400   1,075,619   5,493,933   285,000   7,283,952 
Goodwill  4,938,625   1,283,775   6,299,571   -   12,521,971 
Total Assets  11,284,826   13,692,936   15,351,880   384,688   40,714,330

 

Schedule Of Segment Revenue By Geographical Location [Table Text Block]

Revenue by geographic location in total and as a percentage of total revenue, for the three months ended December 31, 2012 and 2011 are as follows:

 

  Three Months Ended  Three Months Ended 
  December 31, 2012  December 31, 2011 
Geographic Location Revenue  % of Total  Revenue  % of Total 
United States  8,494,488   80.5% $10,028,479   82.7%
Europe  888,341   8.4%  1,126,352   9.3%
Other  1,170,446   11.1%  977,464   8.1%
  $10,553,275   100.0% $12,132,295   100.0%

 

XML 42 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
Inventories (Tables)
3 Months Ended
Dec. 31, 2012
Inventory Disclosure [Abstract]  
Schedule of Inventory, Current [Table Text Block]

Inventories, net of reserves, consists of the following:

 

  December 31,  September 30, 
  2012  2012 
Raw Materials $2,334,613  $2,096,681 
Work-in-Process  689,134   885,328 
Finished Goods  526,963   289,691 
  $3,550,710  $3,271,700
XML 43 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment, Customer and Geographical Reporting
3 Months Ended
Dec. 31, 2012
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block]

Note 9 – Segment, Customer and Geographical Reporting

 

Segment Financial Information

 

Dynasil’s business is comprised of four segments: contract research (“Contract Research”), optics (“Optics”), instruments (“Instruments”) and biomedical (“Biomedical”). Within these segments, there is a segregation of reportable units based upon the organizational structure used to evaluate performance and make decisions on resource allocation, as well as availability and materiality of separate financial results consistent with that structure. The Contract Research segment is one of the largest small business participants in U.S. government-funded research. The Optics segment manufactures optical materials, components and coatings. The Instruments segment manufactures specialized instruments used in various applications in the medical, industrial, and homeland security/defense sectors. The Biomedical segment is developing technologies for a wide spectrum of applications, including hematology, hypothermic core cooling and tissue sealants and will primarily pursue product commercialization of technologies and technology licensing opportunities though no assurance can be given that any of these technologies will become successfully commercialized.

 

The Company’s segment information for the three months ended December 31, 2012 and 2011 is summarized below:

 

Results of Operations for the Three Months Ended December 31, 
2012 
  Contract
Research
  Optics  Instruments  Biomedical  Total 
Revenue  4,910,840   4,251,940   1,284,038   106,457   10,553,275 
Gross Profit  2,214,053   1,700,555   605,801   106,457   4,626,866 
Operating Income (Loss)  (606)  385,676   (455,694)  (120,663)  (191,287)
                     
Depreciation and Amortization  62,782   185,628   163,048   15,000   426,458 
Capital expenditures  186,330   122,146   7,092   -   315,568 
                     
Intangibles, Net  339,886   946,525   5,016,201   224,996   6,527,608 
Goodwill  4,938,625   1,310,802   4,015,072   -   10,264,499 
Total Assets  13,290,669   10,607,828   12,092,507   388,671   36,379,675 

 

Results of Operations for the Three Months Ended December 31, 
2011 
  Contract
Research
  Optics  Instruments  Biomedical  Total 
Revenue  6,225,283   3,912,551   1,983,536   10,925   12,132,295 
Gross Profit  2,440,288   1,462,418   1,251,423   (27,181)  5,126,948 
Operating Income (Loss)  145,217   164,123   79,544   (202,556)  186,328 
                     
Depreciation and Amortization  37,160   193,503   134,457   15,000   380,120 
Capital expenditures  262,020   140,876   2,445   -   405,341 
                     
Intangibles, Net  429,400   1,075,619   5,493,933   285,000   7,283,952 
Goodwill  4,938,625   1,283,775   6,299,571   -   12,521,971 
Total Assets  11,284,826   13,692,936   15,351,880   384,688   40,714,330 

 

Customer Financial Information

 

For the three months ended December 31, 2012 and 2011, the top three customers for the Contract Research segment were various agencies of the U.S. Government. For the three months ended December 31, 2012 and 2011, these customers made up 68% and 78%, respectively, of Contract Research revenue.

 

For the three months ended December 31, 2012 and 2011, there was no customer in the Optics segment whose revenue represented more than 10% of the total segment revenue for the three months ended December 31, 2012 and 2011.

 

For the three months ended December 31, 2012 and 2011, the top three customers for the Instruments segment made up 40% and 36%, respectively, of Instruments revenue.

 

For the three months ended December 31, 2012, the Biomedical segment had two customers whose revenue represented 100% of the total segment revenue. There was no revenue for the three months ended December 31, 2011.

 

Geographic Financial Information

 

Revenue by geographic location in total and as a percentage of total revenue, for the three months ended December 31, 2012 and 2011 are as follows:

 

  Three Months Ended  Three Months Ended 
  December 31, 2012  December 31, 2011 
Geographic Location Revenue  % of Total  Revenue  % of Total 
United States  8,494,488   80.5% $10,028,479   82.7%
Europe  888,341   8.4%  1,126,352   9.3%
Other  1,170,446   11.1%  977,464   8.1%
  $10,553,275   100.0% $12,132,295   100.0%

 

XML 44 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
Earnings (Loss) Per Common Share
3 Months Ended
Dec. 31, 2012
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block]

Note 7 – Earnings (Loss) Per Common Share

 

Basic earnings (loss) per common share is computed by dividing the net income applicable or loss attributable to common shares by the weighted average number of common shares. Diluted earnings per common share adjusts basic earnings per share for the effects of common stock options, common stock warrants, convertible preferred stock and other potential dilutive common shares outstanding during the periods.

 

For purposes of computing diluted earnings per share, 100,731 common share equivalents related to stock options were assumed to be outstanding for the three months ended December 31, 2011. For the three months ended December 31, 2012, no common share equivalents related to stock options were included in the calculation of dilutive shares since there was a loss from continuing operations and the inclusion of common share equivalents would be anti-dilutive. Also, if the Company had not been in a loss position as of December 31, 2012, 116,834 shares of restricted stock would have been considered in the denominator used to calculate diluted earnings per common share. In addition, as of December 31, 2012 and 2011, common stock options for 774,483 and 815,624 shares, respectively, with exercise prices above current quarterly average market price per share have been excluded from the calculation of dilutive earnings per share since their effect is also anti-dilutive.

 

The computation of the weighted shares outstanding for the three months ended December 31 is as follows:

 

  December 31, 2012  December 31, 2011 
Weighted average shares outstanding        
Basic  14,673,356   15,583,103 
Effect of dilutive securities        
Stock Options  0   100,731 
Dilutive Average Shares Outstanding  14,673,356   15,683,834
XML 45 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Based Compensation
3 Months Ended
Dec. 31, 2012
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

Note 8 - Stock Based Compensation

 

The fair value of the stock options granted is estimated at the date of grant using the Black-Scholes option pricing model.

 

A summary of stock option activity for the three months ended December 31, 2012 is presented below:

 

  Options
Outstanding
  Weighted Average
Exercise Price per
Share ($)
  Weighted Average
Remain Contractual
Term (in Years)
 
Balance at September 30, 2012  794,483   3.34   1.75 
Outstanding and exercisable at September 30, 2012  794,483   3.34   1.75 
Granted  0   0     
Exercised  0   0     
Cancelled  (20,000)  4.06     
Balance at December 31, 2012   774,483   3.32   1.54 
Outstanding and exercisable at December 31, 2012   774,483   3.32   1.54 

 

A summary of restricted stock activity for the three months ended December 31, 2012 and 2011 is presented below:

 

Restricted Stock Activity for the Three
Months ended December 31, 2012
 Shares  Weighted-Average
Grant-Date Fair Value
 
Nonvested at September 30, 2012  127,834  $1.92 
         
Granted   4,000  $1.45 
Vested   (15,000) $1.53 
Cancelled   -0-   -0- 
Nonvested at December 31, 2012  116,834  $1.95 

 

Restricted Stock Activity for the Three

Months ended December 31, 2011

 Shares  Weighted-Average
Grant-Date Fair Value
 
Nonvested at September 30, 2011  403,000  $4.02 
         
Granted  -0-   -0- 
Vested  (37,500) $4.00 
Cancelled  -0-   -0- 
Nonvested at December 31, 2011  365,500  $4.02 

 

Stock Compensation Expense for the three months ended December 31, 2012 and 2011 is as follows:

 

  Three Months Ended  Three Months Ended 
 December 31, 2012  December 31, 2011 
Stock Compensation Expense      
Stock Grants  52,461   60,281 
Restricted Stock Grants  12,618   109,302 
Option Grants  7,359   22,055 
Employee Stock Purchase Plan  1,078   2,692 
Total $73,516  $194,330 

 

At December 31, 2012, there was approximately $144,000 in unrecognized stock compensation cost, which is expected to be recognized over a weighted average period of eight months.

XML 46 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes
3 Months Ended
Dec. 31, 2012
Income Tax Disclosure [Abstract]  
Income Tax Disclosure [Text Block]

Note 10 - Income Taxes

 

Dynasil Corporation of America and its wholly-owned U.S. subsidiaries file a consolidated federal income tax return and various state returns. The Company’s U.K. subsidiary files tax returns in the U.K.

 

The Company uses the asset and liability approach to account for income taxes. Under this approach, deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and net operating loss and tax credit carryforwards. The amount of deferred taxes on these temporary differences is determined using the tax rates that are expected to apply to the period when the asset is realized or the liability is settled, as applicable, based on tax rates, and tax laws, in the respective tax jurisdiction then in effect.

 

In assessing the ability to realize the net deferred tax assets, management considers various factors including taxable income in carryback years, future reversals of existing taxable temporary differences, tax planning strategies and projections of future taxable income, to determine whether it is more likely than not that some portion or all of the net deferred tax assets will not be realized. Based upon the Company’s recent losses and uncertainty of future profits, the Company has determined that the uncertainty regarding the realization of these assets is sufficient to warrant the need for a full valuation allowance against its U.S. net deferred tax assets. As a result, the Company recorded a valuation allowance of approximately $1.7 million.

 

The Company applies the authoritative provisions related to accounting for uncertainty in income taxes. As required by these provisions, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more-likely-than-not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being reached upon ultimate settlement with the relevant tax authority. As of December 31, 2012 and September 30, 2012, the Company has no unrecorded liabilities for uncertain tax positions. Interest and penalty charges, if any, related to uncertain tax positions would be classified as income tax expense in the accompanying consolidated statement of operations. As of December 31, 2012 and September 30, 2012, the Company had no accrued interest or penalties related to uncertain tax positions. The Company currently has no federal or state tax examinations in progress.

 

The effective rate of (0.34%) for the three months ended December 31, 2012 differs from the U.S. federal statutory income tax rate of 34% primarily due to a full valuation allowance against the Company’s U.S. deferred tax asset. The effective rate of (96.85%) for the three months ended December 31, 2011 is primarily due to the recognition of research credits.

 

The Company files its tax returns as prescribed by the tax laws of the jurisdictions in which it operates. The Company’s tax filings for federal and state jurisdictions for the tax years beginning with 2009 are still subject to examination.

XML 47 R34.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Based Compensation (Details Textual) (USD $)
Dec. 31, 2012
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Stock Options $ 144,000
XML 48 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
Earnings (Loss) Per Common Share (Tables)
3 Months Ended
Dec. 31, 2012
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

The computation of the weighted shares outstanding for the three months ended December 31 is as follows:

 

  December 31, 2012  December 31, 2011 
Weighted average shares outstanding        
Basic  14,673,356   15,583,103 
Effect of dilutive securities        
Stock Options  0   100,731 
Dilutive Average Shares Outstanding  14,673,356   15,683,834
XML 49 R26.htm IDEA: XBRL DOCUMENT v2.4.0.6
Intangible Assets (Details) (USD $)
3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2012
Sep. 30, 2012
Dec. 31, 2011
Dec. 31, 2012
Acquired Customer Base [Member]
Sep. 30, 2012
Acquired Customer Base [Member]
Dec. 31, 2012
Acquired Customer Base [Member]
Minimum [Member]
Sep. 30, 2012
Acquired Customer Base [Member]
Minimum [Member]
Dec. 31, 2012
Acquired Customer Base [Member]
Maximum [Member]
Sep. 30, 2012
Acquired Customer Base [Member]
Maximum [Member]
Dec. 31, 2012
Know How [Member]
Sep. 30, 2012
Know How [Member]
Dec. 31, 2012
Trade Names [Member]
Sep. 30, 2012
Trade Names [Member]
Dec. 31, 2012
Trade Names [Member]
Minimum [Member]
Sep. 30, 2012
Trade Names [Member]
Minimum [Member]
Dec. 31, 2012
Trade Names [Member]
Maximum [Member]
Sep. 30, 2012
Trade Names [Member]
Maximum [Member]
Dec. 31, 2012
Biomedical Technologies [Member]
Sep. 30, 2012
Biomedical Technologies [Member]
Useful Life (years)           5 years 5 years 15 years 15 years 15 years 15 years     15 years 15 years 0 years [1] 0 years [1] 5 years 5 years
Gross amount $ 9,229,210 $ 9,229,210   $ 7,858,775 $ 7,858,775         $ 512,000 $ 512,000 $ 558,435 $ 558,435         $ 300,000 $ 300,000
Accumulated Amortization 2,701,602 2,525,905   2,387,612 2,257,533         172,115 145,147 66,872 63,222         75,003 60,003
Net $ 6,527,608 $ 6,703,305 $ 7,283,952 $ 5,471,163 $ 5,601,242         $ 339,885 $ 366,853 $ 491,563 $ 495,213         $ 224,997 $ 239,997
[1] Indefinite
XML 50 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (USD $)
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Income [Member]
Retained Earnings [Member]
Treasury Stock [Member]
Total
Balance at Sep. 30, 2012 $ 7,805 $ 17,037,618 $ 61,906 $ 2,722,601 $ (986,342) $ 18,843,588
Balance (in shares) at Sep. 30, 2012 15,610,517       810,160  
Issuance of shares of common stock under employee stock purchase plan 3 6,107 0 0 0 6,110
Issuance of shares of common stock under employee stock purchase plan (in shares) 5,797       0  
Stock-based compensation costs 2 73,516 0 0 0 73,518
Stock-based compensation costs (in shares) 4,000       0  
Foreign currency translation adjustment 0 0 29,739 0 0 29,739
Net loss 0 0 0 (379,342) 0 (379,342)
Balance at Dec. 31, 2012 $ 7,810 $ 17,117,241 $ 91,645 $ 2,343,259 $ (986,342) $ 18,573,613
Balance (in shares) at Dec. 31, 2012 15,620,314       810,160  
XML 51 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
Costs in Excess of Billings and Unbilled Receivables
3 Months Ended
Dec. 31, 2012
Cost In Excess Of Billings [Abstract]  
Dividend Add Back Due To Preferred Stock Conversion [Text Block]

Note 4 – Costs in Excess of Billings and Unbilled Receivables

 

Costs in excess of billings and unbilled receivables relate to research and development contracts and consist of actual revenues earned under the contracts which have not yet been billed to customers.

XML 52 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
Intangible Assets (Details 1) (USD $)
Dec. 31, 2012
2013 (9 Months) $ 488,511
2014 651,348
2015 651,348
2016 651,345
2017 591,348
Thereafter 3,153,487
Total 6,187,387
Acquired Customer Base [Member]
 
2013 (9 Months) 406,961
2014 542,615
2015 542,615
2016 542,615
2017 542,615
Thereafter 2,893,742
Total 5,471,163
Know How [Member]
 
2013 (9 Months) 25,600
2014 34,133
2015 34,133
2016 34,133
2017 34,133
Thereafter 177,753
Total 339,885
Trade Names [Member]
 
2013 (9 Months) 10,950
2014 14,600
2015 14,600
2016 14,600
2017 14,600
Thereafter 81,992
Total 151,342
Biomedical Technologies [Member]
 
2013 (9 Months) 45,000
2014 60,000
2015 60,000
2016 59,997
2017 0
Thereafter 0
Total $ 224,997
XML 53 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 78 162 1 true 25 0 false 4 false false R1.htm 001 - Document - DOCUMENT AND ENTITY INFORMATION Sheet http://www.dynasilcorp.com/role/Documentandentityinformation DOCUMENT AND ENTITY INFORMATION true false R2.htm 002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.dynasilcorp.com/role/StatementOfFinancialPositionClassified CONSOLIDATED BALANCE SHEETS false false R3.htm 003 - Statement - CONSOLIDATED BALANCE SHEETS [Parenthetical] Sheet http://www.dynasilcorp.com/role/BalanceSheetParenthetical CONSOLIDATED BALANCE SHEETS [Parenthetical] false false R4.htm 004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) Sheet http://www.dynasilcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) false false R5.htm 005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Sheet http://www.dynasilcorp.com/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY false false R6.htm 006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.dynasilcorp.com/role/StatementOfCashFlowsIndirect CONSOLIDATED STATEMENTS OF CASH FLOWS false false R7.htm 007 - Disclosure - Basis of Presentation and Ability to Continue as a Going Concern Sheet http://www.dynasilcorp.com/role/BasisOfPresentationAndAbilityToContinueAsGoingConcern Basis of Presentation and Ability to Continue as a Going Concern false false R8.htm 008 - Disclosure - Debt Classification Sheet http://www.dynasilcorp.com/role/DebtClassification Debt Classification false false R9.htm 009 - Disclosure - Inventories Sheet http://www.dynasilcorp.com/role/Inventories Inventories false false R10.htm 010 - Disclosure - Costs in Excess of Billings and Unbilled Receivables Sheet http://www.dynasilcorp.com/role/CostsInExcessOfBillingsAndUnbilledReceivables Costs in Excess of Billings and Unbilled Receivables false false R11.htm 011 - Disclosure - Intangible Assets Sheet http://www.dynasilcorp.com/role/IntangibleAssets Intangible Assets false false R12.htm 012 - Disclosure - Goodwill Sheet http://www.dynasilcorp.com/role/Goodwill Goodwill false false R13.htm 013 - Disclosure - Earnings (Loss) Per Common Share Sheet http://www.dynasilcorp.com/role/EarningsLossPerCommonShare Earnings (Loss) Per Common Share false false R14.htm 014 - Disclosure - Stock Based Compensation Sheet http://www.dynasilcorp.com/role/StockBasedCompensation Stock Based Compensation false false R15.htm 015 - Disclosure - Segment, Customer and Geographical Reporting Sheet http://www.dynasilcorp.com/role/SegmentCustomerAndGeographicalReporting Segment, Customer and Geographical Reporting false false R16.htm 016 - Disclosure - Income Taxes Sheet http://www.dynasilcorp.com/role/IncomeTaxes Income Taxes false false R17.htm 017 - Disclosure - Fair Value Measurements Sheet http://www.dynasilcorp.com/role/FairValueMeasurements Fair Value Measurements false false R18.htm 018 - Disclosure - Subsequent Events Sheet http://www.dynasilcorp.com/role/SubsequentEvents Subsequent Events false false R19.htm 019 - Disclosure - Inventories (Tables) Sheet http://www.dynasilcorp.com/role/InventoriesTables Inventories (Tables) false false R20.htm 020 - Disclosure - Intangible Assets (Tables) Sheet http://www.dynasilcorp.com/role/IntangibleAssetsTables Intangible Assets (Tables) false false R21.htm 021 - Disclosure - Earnings (Loss) Per Common Share (Tables) Sheet http://www.dynasilcorp.com/role/EarningsLossPerCommonShareTables Earnings (Loss) Per Common Share (Tables) false false R22.htm 022 - Disclosure - Stock Based Compensation (Tables) Sheet http://www.dynasilcorp.com/role/StockBasedCompensationTables Stock Based Compensation (Tables) false false R23.htm 023 - Disclosure - Segment, Customer and Geographical Reporting (Tables) Sheet http://www.dynasilcorp.com/role/SegmentCustomerAndGeographicalReportingTables Segment, Customer and Geographical Reporting (Tables) false false R24.htm 024 - Disclosure - Basis of Presentation and Ability to Continue as a Going Concern (Details Textual) Sheet http://www.dynasilcorp.com/role/BasisOfPresentationAndAbilityToContinueAsGoingConcernDetailsTextual Basis of Presentation and Ability to Continue as a Going Concern (Details Textual) false false R25.htm 025 - Disclosure - Inventories (Details) Sheet http://www.dynasilcorp.com/role/InventoriesDetails Inventories (Details) false false R26.htm 026 - Disclosure - Intangible Assets (Details) Sheet http://www.dynasilcorp.com/role/IntangibleAssetsDetails Intangible Assets (Details) false false R27.htm 027 - Disclosure - Intangible Assets (Details 1) Sheet http://www.dynasilcorp.com/role/IntangibleAssetsDetails1 Intangible Assets (Details 1) false false R28.htm 028 - Disclosure - Intangible Assets (Details Textual) Sheet http://www.dynasilcorp.com/role/IntangibleAssetsDetailsTextual1 Intangible Assets (Details Textual) false false R29.htm 029 - Disclosure - Earnings (Loss) Per Common Share (Details) Sheet http://www.dynasilcorp.com/role/EarningsLossPerCommonShareDetails Earnings (Loss) Per Common Share (Details) false false R30.htm 030 - Disclosure - Earnings (Loss) Per Common Share (Details Textual) Sheet http://www.dynasilcorp.com/role/EarningsLossPerCommonShareDetailsTextual Earnings (Loss) Per Common Share (Details Textual) false false R31.htm 031 - Disclosure - Stock Based Compensation (Details) Sheet http://www.dynasilcorp.com/role/StockBasedCompensationDetails Stock Based Compensation (Details) false false R32.htm 032 - Disclosure - Stock Based Compensation (Details 1) Sheet http://www.dynasilcorp.com/role/StockBasedCompensationDetails1 Stock Based Compensation (Details 1) false false R33.htm 033 - Disclosure - Stock Based Compensation (Details 2) Sheet http://www.dynasilcorp.com/role/StockBasedCompensationDetails2 Stock Based Compensation (Details 2) false false R34.htm 034 - Disclosure - Stock Based Compensation (Details Textual) Sheet http://www.dynasilcorp.com/role/StockBasedCompensationDetailsTextual Stock Based Compensation (Details Textual) false false R35.htm 035 - Disclosure - Segment, Customer and Geographical Reporting (Details) Sheet http://www.dynasilcorp.com/role/SegmentCustomerAndGeographicalReportingDetails Segment, Customer and Geographical Reporting (Details) false false R36.htm 036 - Disclosure - Segment, Customer and Geographical Reporting (Details 1) Sheet http://www.dynasilcorp.com/role/SegmentCustomerAndGeographicalReportingDetails1 Segment, Customer and Geographical Reporting (Details 1) false false R37.htm 037 - Disclosure - Segment, Customer and Geographical Reporting (Details Textual) Sheet http://www.dynasilcorp.com/role/SegmentCustomerAndGeographicalReportingDetailsTextual Segment, Customer and Geographical Reporting (Details Textual) false false R38.htm 038 - Disclosure - Income Taxes (Details Textual) Sheet http://www.dynasilcorp.com/role/Incometaxesdetailstextual Income Taxes (Details Textual) false false All Reports Book All Reports Element us-gaap_ConcentrationRiskPercentage1 had a mix of decimals attribute values: 2 3. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue had a mix of decimals attribute values: 0 2. Process Flow-Through: 002 - Statement - CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: Removing column 'Sep. 30, 2011' Process Flow-Through: 003 - Statement - CONSOLIDATED BALANCE SHEETS [Parenthetical] Process Flow-Through: 004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) Process Flow-Through: 006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS dysl-20121231.xml dysl-20121231.xsd dysl-20121231_cal.xml dysl-20121231_def.xml dysl-20121231_lab.xml dysl-20121231_pre.xml true true XML 54 R38.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes (Details Textual) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Valuation Allowance, Amount $ 1.7  
Effective Income Tax Rate, Continuing Operations (0.34%)  
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate 34.00%  
Effective Income Tax Rate Reconciliation, Tax Credits, Research   (96.85%)
XML 55 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
Intangible Assets (Tables)
3 Months Ended
Dec. 31, 2012
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Finite-Lived Intangible Assets [Table Text Block]

Intangible assets at December 31, 2012 and September 30, 2012 consist of the following:

 

   Useful  Gross  Accumulated    
December 31, 2012  Life (years)  Amount  Amortization  Net 
Acquired Customer Base  5-15  $7,858,775  $2,387,612  $5,471,163 
Know How  15   512,000   172,115   339,885 
Trade Names  15 - Indefinite   558,435   66,872   491,563 
Biomedical Technologies  5   300,000   75,003   224,997 
      $9,229,210  $2,701,602  $6,527,608 

 

   Useful  Gross  Accumulated    
September 30, 2012  Life (years)  Amount  Amortization  Net 
Acquired Customer Base  5-15  $7,858,775  $2,257,533  $5,601,242 
Know How  15   512,000   145,147   366,853 
Trade Names  15 - Indefinite   558,435   63,222   495,213 
Biomedical Technologies  5   300,000   60,003   239,997 
      $9,229,210  $2,525,905  $6,703,305 

 

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

Amortization expense for the three months ended December 31, 2012 and 2011 was $181,268 and $162,803respectively. Estimated amortization expense for each of the next five fiscal years is as follows:

 

  2013 (9 Months)  2014  2015  2016  2017  Thereafter  Total 
Acquired Customer Base $406,961  $542,615  $542,615  $542,615  $542,615  $2,893,742  $5,471,163 
Know How  25,600   34,133   34,133   34,133   34,133   177,753   339,885 
Trade Names  10,950   14,600   14,600   14,600   14,600   81,992   151,342 
Biomedical Technologies  45,000   60,000   60,000   59,997   -0-   -0-   224,997 
  $488,511  $651,348  $651,348  $651,345  $591,348  $3,153,487  $6,187,387